data_6wap_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6wap _Structure_validation_residue.Date_analyzed 2020-08-28 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.485 0.984 0 N-CA-C 108.837 -1.255 . . . . 0.0 108.837 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.6 pt -67.62 119.32 13.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 110.071 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.47 138.07 48.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.505 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -69.71 125.01 25.44 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.958 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -78.33 -172.46 2.85 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.201 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -58.77 -38.18 77.92 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.44 -22.87 65.48 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.594 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.33 -7.75 58.46 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.77 127.78 33.82 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 120.171 -0.611 . . . . 0.0 109.524 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.3 mtt -77.14 127.19 32.21 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.763 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 82.3 t -126.27 128.61 71.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.553 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -61.75 142.55 57.19 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.035 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -145.34 146.83 31.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.218 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.82 143.04 49.62 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.265 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.4 pt -61.81 144.25 14.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 120.902 0.382 . . . . 0.0 110.609 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 t -62.05 120.35 56.94 Favored Pre-proline 0 N--CA 1.453 -0.313 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -53.56 -36.9 82.17 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 N-CA-C 109.492 -1.003 . . . . 0.0 109.492 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -57.8 -48.49 79.56 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.164 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 84.1 m -60.84 -47.15 87.67 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.231 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -57.03 9.04 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.905 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -58.3 -39.31 79.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.778 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.03 98.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.197 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 22.1 t-105 -59.06 -49.76 76.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.483 0.658 . . . . 0.0 109.505 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.39 -40.3 88.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.095 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.4 -49.02 79.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.554 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.3 m -61.95 -35.55 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.713 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.7 t -66.83 -36.22 76.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.0 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -53.61 -47.07 70.54 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.579 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -89.42 -37.47 14.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -120.68 38.06 4.12 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.954 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.9 -51.16 5.64 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -96.11 -4.59 42.51 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.8 m -55.05 145.93 41.7 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.741 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.25 -32.59 20.38 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.486 2.124 . . . . 0.0 112.437 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.61 -20.07 30.37 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.886 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.69 -41.88 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.754 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.7 mt -45.72 -61.22 2.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.872 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.78 -41.61 76.47 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 CA-C-N 120.176 1.099 . . . . 0.0 111.729 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 58.8 ttm -59.69 -46.87 87.77 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.338 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -55.07 -47.49 74.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -58.2 -44.48 88.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.719 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.67 -44.77 93.46 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.097 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.6 -22.61 62.53 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.138 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.7 m -87.66 5.81 37.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.593 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.9 126.16 26.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.742 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.01 11.23 69.77 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 121.315 -0.469 . . . . 0.0 112.231 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.13 146.26 50.97 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 112.543 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.0 m -99.72 141.3 22.54 Favored Pre-proline 0 C--O 1.215 -0.727 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -46.36 -36.2 17.18 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 CA-C-N 120.789 1.318 . . . . 0.0 113.222 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -68.59 -63.9 0.97 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.301 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.453 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -59.82 -37.58 79.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.265 1.031 . . . . 0.0 108.737 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.07 -45.31 92.76 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.773 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -57.72 -39.69 77.87 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 86.3 m -59.91 -39.28 84.87 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.48 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 97.9 mtp -57.98 -48.27 80.48 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.153 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.6 mt -65.53 -41.78 92.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.826 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -61.54 -36.46 80.65 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.206 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.5 m -65.56 -34.45 78.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.924 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.7 141.72 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.026 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -130.6 -140.27 4.65 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.4 -127.89 46.06 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.743 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -53.08 -11.33 0.24 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.853 -0.673 . . . . 0.0 111.669 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -41.92 -22.78 0.02 OUTLIER 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.78 -41.52 70.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.78 98.1 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 57.7 ttm -57.28 -26.22 60.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.038 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -56.97 -35.24 68.92 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.3 ttp -58.01 -46.2 85.66 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -57.65 -37.88 74.13 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -56.26 -42.95 78.23 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.37 -40.15 93.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.294 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -58.88 -43.46 90.91 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.8 -43.04 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -59.99 -41.48 92.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.027 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.24 -47.07 84.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.869 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -61.79 -40.1 94.02 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.25 94.15 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.862 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.04 74.69 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.404 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.43 -38.56 90.26 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.903 0.859 . . . . 0.0 108.975 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -58.2 -45.92 86.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.659 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -49.8 -47.44 51.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.856 0.722 . . . . 0.0 109.136 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -64.0 -39.87 95.08 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.301 0.572 . . . . 0.0 110.892 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -176.123 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 . . . . . 0 C--O 1.237 0.435 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -56.53 141.64 71.72 Favored Pre-proline 0 C--O 1.238 0.465 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.8 111.72 0.98 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.25 1.3 . . . . 0.0 113.035 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.39 167.32 21.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.28 -43.28 89.47 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 119.072 -1.537 . . . . 0.0 109.788 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.4 t -61.0 -41.9 97.41 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.539 0.685 . . . . 0.0 109.232 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -61.94 -37.84 86.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.013 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.4 mm -57.7 -45.67 86.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.53 -17.64 64.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.55 0.16 89.28 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.1 p -64.22 -21.77 66.7 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.986 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.2 p -127.41 33.27 4.89 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.4 p -137.88 145.74 42.54 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.651 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.0 m -82.91 145.41 29.42 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -49.74 -44.94 48.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.61 -40.93 96.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.545 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -63.7 -43.26 97.13 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.163 0.506 . . . . 0.0 111.152 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -58.4 -47.86 82.53 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.35 -40.6 88.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.306 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.68 -63.91 4.42 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.662 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.438 ' CD1' ' N ' ' A' ' 118' ' ' MET . 1.2 p90 -59.75 -29.25 68.03 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 117.731 -1.587 . . . . 0.0 109.654 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.438 ' N ' ' CD1' ' A' ' 117' ' ' TRP . 26.2 ttt -65.72 -45.01 84.3 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 82.3 p -119.55 -24.27 6.33 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -58.19 -70.72 0.13 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.776 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -76.54 -177.34 0.74 Allowed Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -48.23 136.3 24.77 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 CA-C-N 120.619 1.257 . . . . 0.0 109.541 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -38.26 119.84 0.4 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.874 2.383 . . . . 0.0 114.509 -176.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.0 mm -112.98 106.84 54.87 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.57 59.95 4.26 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.257 1.971 . . . . 0.0 113.712 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.8 m -48.99 -38.74 11.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.28 99.71 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.627 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.52 -47.18 85.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.308 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 89.6 mt -63.64 -48.76 85.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.511 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -59.05 -48.56 81.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.909 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -62.38 -38.06 88.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.592 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -58.73 -42.09 87.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -62.3 -43.83 97.92 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.64 -45.26 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.62 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.404 HG22 HD13 ' A' ' 135' ' ' ILE . 87.4 mt -59.14 -41.85 84.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.87 -42.53 99.8 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.23 -42.26 98.61 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.98 -36.21 83.23 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -58.45 -44.49 89.22 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.37 -38.9 91.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.557 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.4 mm -60.49 -49.64 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.0 m -57.74 -35.56 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -65.1 -39.83 93.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -59.2 -45.12 91.91 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -70.71 -22.06 62.49 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.442 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.7 t -43.03 106.59 0.49 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.538 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.01 -32.88 8.21 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.107 1.872 . . . . 0.0 113.758 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.9 p -137.95 172.6 12.69 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.3 m -104.98 149.99 25.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.125 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.4 mm -49.92 -42.03 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.9 tp -60.33 -39.26 86.46 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.19 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.85 -11.43 55.59 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.633 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.8 mm -75.71 119.95 24.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.82 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -152.93 134.1 14.18 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 C--O 1.237 0.437 0 CA-C-O 121.007 0.432 . . . . 0.0 111.665 -179.596 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 CA--C 1.548 0.884 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.28 139.34 11.62 Favored 'Trans proline' 0 N--CA 1.507 2.271 0 C-N-CA 123.577 2.851 . . . . 0.0 114.267 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -59.28 -26.72 65.2 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -62.67 -51.44 67.23 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.811 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.27 -37.93 86.62 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.713 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -60.24 -50.56 73.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.674 0.75 . . . . 0.0 109.857 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.7 -45.0 96.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.304 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -60.49 -51.51 69.13 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.948 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -66.24 -39.37 89.48 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -58.78 -49.49 77.48 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -66.36 -36.25 82.42 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.299 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -58.27 -47.89 82.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 96.6 m -68.5 -39.39 81.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.133 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.24 -39.38 72.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.025 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.307 179.279 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 . . . . . 0 C--O 1.241 0.61 0 CA-C-O 121.279 0.561 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 91.1 mmm -62.56 -43.89 97.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.177 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 62.1 m -61.09 -45.75 93.43 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.609 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.81 -48.29 80.17 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.205 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 96.7 m -67.35 -47.27 70.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.236 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.9 -31.55 71.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.838 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.4 mt -52.38 -43.4 64.7 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.309 -0.957 . . . . 0.0 108.892 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.3 t -85.72 -47.82 16.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.817 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -61.06 -49.38 77.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -70.12 -22.7 62.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.704 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.52 150.86 25.74 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -68.97 153.71 95.81 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.184 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.09 -45.68 34.06 Favored 'Trans proline' 0 N--CA 1.509 2.393 0 C-N-CA 122.544 2.162 . . . . 0.0 115.521 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.76 -50.22 74.68 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.554 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 36.4 t -69.4 -39.34 78.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -49.02 -32.12 8.8 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.427 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.9 m -59.71 -48.79 80.29 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.935 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 48.2 mm -67.67 -43.14 86.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.466 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.87 -39.67 86.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -61.35 -38.99 88.94 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -59.73 -40.1 86.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.478 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.76 -41.23 90.57 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.911 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.77 -159.18 52.59 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.779 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.19 166.49 5.71 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 123.5 2.8 . . . . 0.0 112.557 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.76 -126.35 40.68 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 56.73 96.62 0.02 OUTLIER 'General case' 0 C--O 1.238 0.48 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.332 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 76.4 p -61.65 157.58 17.26 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.152 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.35 -34.84 61.95 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -61.64 -50.15 73.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.352 0.596 . . . . 0.0 109.799 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.99 -42.43 94.19 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.6 ttm -60.87 -46.84 89.03 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.415 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 1.7 mmt -64.11 -41.43 97.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.1 0.476 . . . . 0.0 109.753 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.8 m -63.36 -49.83 72.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.409 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.96 -43.75 94.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.51 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.4 m -60.48 -40.76 92.49 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -60.97 -41.82 97.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.11 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.0 -39.93 96.31 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 34.4 m -91.95 6.04 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.903 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.234 0 C-N-CA 120.27 -0.966 . . . . 0.0 111.842 179.273 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo . . . . . 0 N--CA 1.483 0.904 0 N-CA-C 109.349 -1.058 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.6 pt -77.78 125.06 37.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.5 t -127.63 127.4 68.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.457 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -63.66 126.15 26.62 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -81.43 -173.39 4.34 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.291 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.7 mt -59.71 -38.54 81.9 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.39 -21.7 65.59 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.566 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.49 -7.73 58.17 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -72.15 124.86 25.91 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.695 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.0 mtt -79.52 130.98 35.9 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.735 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.96 138.91 50.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 120.174 -0.611 . . . . 0.0 111.396 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -57.5 142.23 44.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.219 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -144.91 140.37 28.25 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.606 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.56 139.84 51.59 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.785 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.0 pt -61.87 137.24 24.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.558 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.7 t -60.28 122.76 69.33 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.637 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.36 -38.55 73.48 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 120.852 1.035 . . . . 0.0 110.973 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -56.91 -43.35 81.32 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.279 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.4 m -63.11 -46.81 85.58 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.74 -60.51 2.82 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.328 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -57.74 -39.42 77.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.891 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.51 -43.1 99.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.491 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -58.93 -50.2 74.94 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.56 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.5 t -62.07 -42.23 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.206 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.99 -41.95 88.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.027 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -58.74 -45.38 91.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.1 t -64.17 -37.12 79.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.844 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -55.56 -45.66 77.25 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.685 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -92.86 -27.75 16.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.85 38.25 3.56 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.697 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.82 -54.48 3.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -96.03 -5.75 40.33 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 t -51.81 139.2 31.86 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.208 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.98 -32.83 34.21 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.476 2.117 . . . . 0.0 112.959 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -57.98 -18.65 25.19 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.995 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.81 -42.74 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.834 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.0 mt -44.79 -61.18 2.36 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.853 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.38 -42.0 71.6 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 120.081 1.065 . . . . 0.0 111.732 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 20.7 ttt -60.63 -44.94 95.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.349 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -55.42 -47.1 76.48 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -58.41 -44.84 89.2 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.997 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.59 94.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.53 0.681 . . . . 0.0 110.2 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -70.44 -24.8 62.96 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.097 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.1 m -89.43 6.45 40.7 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.601 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.33 125.47 23.88 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.565 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.64 10.83 76.73 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.598 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.42 150.26 46.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.344 0.592 . . . . 0.0 112.354 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.8 m -99.72 142.38 24.51 Favored Pre-proline 0 C--O 1.217 -0.649 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.38 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -42.71 -38.82 6.8 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.466 1.444 . . . . 0.0 113.365 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -73.88 -61.32 1.89 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.041 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.93 -38.36 75.8 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 57.3 tp -64.9 -44.29 90.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.648 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -57.72 -39.97 78.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 92.9 m -63.09 -39.58 95.13 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.953 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 28.2 ttt -56.8 -49.37 75.55 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.99 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.9 mt -69.8 -40.38 76.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.518 0.675 . . . . 0.0 110.155 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.53 -37.75 79.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.987 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.33 -20.32 66.06 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.792 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.85 140.0 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.51 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.84 -151.84 7.88 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.1 -127.75 45.92 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.924 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -51.32 -10.0 0.08 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.813 -0.693 . . . . 0.0 112.287 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -42.99 -21.28 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.39 -40.46 71.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.11 97.78 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.413 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 11.3 tmm? -58.32 -20.17 41.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.488 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.3 tp-100 -58.22 -39.32 78.75 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.4 tmm? -59.56 -42.36 92.26 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HB3' ' O ' ' A' ' 66' ' ' MET . 61.3 tp -57.68 -40.7 80.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -59.15 -41.81 89.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.2 -39.64 93.1 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.81 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.1 m -59.83 -44.06 94.26 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.5 mt -60.82 -43.87 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -60.34 -41.91 94.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.483 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.06 -46.84 87.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.19 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -63.83 -38.6 91.69 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.86 -39.19 88.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.53 -51.24 63.89 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.845 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -64.8 -43.29 93.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.048 0.928 . . . . 0.0 109.468 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -61.2 -41.47 96.87 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.779 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -59.6 -43.07 93.84 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -60.53 -33.77 73.14 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.597 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -177.033 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 . . . . . 0 C--O 1.239 0.547 0 CA-C-O 121.357 0.598 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.78 156.42 86.93 Favored Pre-proline 0 C--O 1.24 0.565 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.096 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.24 128.76 14.86 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.921 1.748 . . . . 0.0 113.475 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.4 mtt85 -126.13 151.95 46.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.778 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -42.1 -61.32 2.38 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.479 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.7 m -61.34 -37.88 84.88 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 122.073 -0.663 . . . . 0.0 110.844 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.53 -38.1 86.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.865 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.0 tp -58.44 -31.47 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.578 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.24 -10.42 56.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.613 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.92 0.12 87.95 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 48.8 p -63.48 -23.99 67.63 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.06 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.8 p -123.92 18.75 9.33 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.746 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.5 m -119.21 131.17 55.79 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.34 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -70.94 147.54 48.62 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.3 tp -53.46 -44.69 69.12 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.287 -0.965 . . . . 0.0 108.448 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.43 -40.58 94.96 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.08 -43.51 98.67 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.19 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -62.78 -41.25 99.17 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.246 0.341 . . . . 0.0 110.979 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 34.7 pt -68.15 -41.83 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.924 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.99 -41.86 70.31 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -58.88 -46.16 88.48 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.013 -1.094 . . . . 0.0 109.102 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.9 ttt -71.39 -42.58 68.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.44 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.6 m -125.78 -26.9 3.42 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -58.43 -49.92 75.57 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 118.455 -1.298 . . . . 0.0 109.814 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -81.54 -177.88 1.05 Allowed Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.51 144.51 32.18 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 N-CA-C 107.105 -1.921 . . . . 0.0 107.105 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -45.86 124.0 6.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 121.348 1.365 . . . . 0.0 112.997 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.8 mm -113.47 108.33 52.28 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.72 56.86 4.21 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.958 1.772 . . . . 0.0 113.111 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.6 m -58.74 -45.75 91.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.63 -44.37 96.57 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.205 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.32 -44.63 95.29 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.973 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.09 -47.85 91.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.865 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -59.09 -50.13 75.26 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.912 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -61.91 -38.57 88.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.967 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -56.66 -43.67 80.61 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -63.35 -44.44 94.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.593 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 29.7 mm -58.33 -44.88 89.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.455 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 135' ' ' ILE . 88.8 mt -59.74 -42.44 88.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.16 -43.67 97.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.381 0.61 . . . . 0.0 109.615 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.32 -42.28 99.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.26 -35.9 81.88 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -58.32 -45.0 88.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.79 -38.64 91.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.473 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.4 mm -60.9 -49.8 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 16.7 m -58.28 -36.16 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -65.49 -38.79 90.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.822 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 63.7 tpp -59.74 -46.75 88.17 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -71.62 -15.62 62.25 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.215 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.3 t -49.07 116.94 5.98 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.846 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.46 -40.19 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.949 1.766 . . . . 0.0 113.539 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 58.3 p -138.38 169.04 18.49 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.2 t -92.26 148.53 22.07 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.471 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 17.5 tt -51.28 -36.45 17.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.43 -39.45 92.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.238 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -66.8 -9.84 41.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.492 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 81.6 mt -81.87 120.31 33.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.945 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -142.33 123.55 14.67 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.56 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 . . . . . 0 C--O 1.236 0.353 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.34 179.944 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 CA--C 1.541 0.626 0 CA-C-O 119.822 -0.133 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.36 135.13 18.04 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.704 2.27 . . . . 0.0 114.019 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -61.55 -36.27 80.12 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -61.83 -47.7 83.9 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.087 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -61.33 -41.62 97.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.86 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -61.13 -50.4 73.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.788 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.14 -47.7 91.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.618 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.43 -50.99 70.57 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.28 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -64.85 -39.12 93.05 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.252 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.42 -50.21 74.5 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.08 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -69.49 -41.61 75.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.305 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -60.38 -46.33 90.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 91.9 m -65.21 -37.68 88.04 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.595 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.55 -49.15 78.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.314 0.578 . . . . 0.0 110.049 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.515 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 . . . . . 0 C--O 1.238 0.5 0 CA-C-O 121.281 0.563 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 59.9 ttm -60.67 -46.05 91.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.575 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 65.8 m -59.35 -48.68 80.71 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.976 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.25 -47.68 84.95 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.702 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 97.1 m -63.15 -48.03 80.18 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.98 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.2 mp -68.4 -34.18 75.56 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 17.1 mt -50.01 -45.88 52.26 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.142 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.0 t -81.37 -47.38 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.852 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -61.92 -50.77 70.83 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -73.21 -23.13 60.35 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.365 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.02 155.09 8.67 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.787 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -72.58 155.68 90.83 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.72 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.19 -39.78 82.04 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 122.454 2.102 . . . . 0.0 113.72 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -59.3 -49.33 78.25 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.808 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -73.51 -36.79 65.78 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -47.14 -37.88 10.66 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.741 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.3 m -60.3 -50.22 74.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.293 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.4 mm -68.11 -44.02 84.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.45 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 81.9 mt -59.12 -44.11 91.99 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -63.41 -38.1 89.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.46 85.97 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.976 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.34 -35.84 70.42 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.699 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.02 172.75 49.03 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.55 155.31 54.95 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 123.733 2.955 . . . . 0.0 113.459 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.39 1.78 88.81 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.469 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.42 128.15 34.7 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.279 0.561 . . . . 0.0 111.126 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 34.7 m -66.31 143.97 56.86 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.4 tp -54.32 -44.67 72.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -57.92 -46.96 84.2 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -58.12 -43.72 87.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 98.3 mtp -62.35 -46.14 90.03 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.957 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 98.3 mtp -65.22 -41.04 94.81 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.825 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.0 m -63.28 -50.02 71.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.512 0.672 . . . . 0.0 110.468 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.31 98.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.408 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 76.2 m -60.88 -40.35 92.67 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.29 -39.23 82.31 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.83 -38.83 92.98 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.3 m -94.59 4.52 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 120.713 -0.395 . . . . 0.0 112.022 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.831 179.424 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo . . . . . 0 N--CA 1.49 1.268 0 N-CA-C 109.147 -1.136 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.0 pt -73.07 109.57 5.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.147 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.82 145.68 34.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -61.75 138.22 58.31 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.384 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -97.31 -170.8 2.08 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.482 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.08 -41.54 83.65 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -69.95 -17.86 63.33 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.867 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.5 -7.96 63.95 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -72.1 127.73 33.49 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.698 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.1 mtt -74.81 128.37 35.4 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -127.61 130.16 70.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.097 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -59.48 141.27 55.12 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.733 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -146.07 144.73 30.22 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.912 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.3 142.52 50.47 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.201 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.3 pt -62.24 141.83 17.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.83 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.0 t -60.68 119.76 46.83 Favored Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.0 -36.19 74.81 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 N-CA-C 109.434 -1.025 . . . . 0.0 109.434 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -57.18 -49.02 77.27 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.015 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.6 m -61.27 -47.12 87.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.266 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.54 -60.27 3.01 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.813 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -55.07 -40.7 70.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.687 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.37 97.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.429 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -58.25 -50.44 73.57 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.187 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.8 t -62.67 -43.11 98.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.875 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.37 -44.04 92.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.891 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.86 -45.88 91.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 31' ' ' ALA . 69.8 t -63.51 -36.34 75.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.745 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -54.46 -46.41 73.33 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.384 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -87.88 -33.57 18.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -130.46 40.05 3.56 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.918 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 27' ' ' VAL . . . -42.36 -50.03 5.1 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -95.12 -4.93 45.28 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.5 m -56.42 146.72 52.4 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.98 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.25 -34.97 11.98 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 122.661 2.241 . . . . 0.0 112.949 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -58.02 -18.57 25.05 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.914 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.0 -42.3 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.49 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.0 mt -47.16 -60.59 3.76 Favored Pre-proline 0 C--O 1.24 0.57 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.594 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.36 -42.15 67.48 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 119.971 1.026 . . . . 0.0 111.727 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.6 mtt -60.38 -44.51 95.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.496 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.66 -48.09 75.61 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.9 m -58.87 -42.88 90.51 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.824 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.22 -44.42 95.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.349 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.61 -22.45 60.97 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.388 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.0 m -88.27 5.89 39.57 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -61.88 125.89 25.43 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.857 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.15 10.74 74.3 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.804 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.99 149.34 39.32 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.1 p -99.76 147.78 33.88 Favored Pre-proline 0 C--O 1.213 -0.851 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.379 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.26 -38.1 19.59 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.391 1.394 . . . . 0.0 113.221 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -68.31 -63.46 1.05 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.367 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.462 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.7 m-20 -58.24 -35.85 72.33 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.501 1.144 . . . . 0.0 108.024 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.3 -48.86 78.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.104 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -58.18 -37.23 74.33 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 88.3 m -59.56 -40.83 88.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.455 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.0 -46.9 84.5 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.769 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.85 -39.71 87.68 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.689 0.757 . . . . 0.0 109.514 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -60.68 -39.59 89.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.439 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.4 p -67.34 -23.99 65.67 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.815 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.65 135.66 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.917 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.8 -149.17 7.54 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.13 -125.82 38.88 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.723 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -49.57 -12.62 0.07 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.326 -0.437 . . . . 0.0 111.675 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -42.65 -21.57 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.139 0.576 . . . . 0.0 112.177 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.13 -42.56 77.09 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.52 92.66 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 47.1 ttp -60.62 -28.68 68.71 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -58.14 -39.78 79.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.0 tmm? -60.75 -41.84 96.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.28 -39.43 75.69 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.483 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -60.14 -40.62 90.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.41 -40.28 95.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.235 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.0 m -59.64 -50.53 73.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.615 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.5 pt -67.75 -27.6 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.767 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -62.73 -43.27 99.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -63.38 -44.28 95.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.147 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.02 -37.13 78.87 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.398 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.88 98.92 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.776 -0.77 . . . . 0.0 108.965 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.47 -50.32 65.79 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.549 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.28 -41.69 98.7 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.85 0.833 . . . . 0.0 108.998 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -61.55 -42.27 98.58 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.07 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.49 -39.16 75.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.71 -13.14 61.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.505 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -178.527 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 . . . . . 0 C--O 1.236 0.39 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.44 142.99 90.33 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.05 110.85 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.497 1.465 . . . . 0.0 113.498 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -83.15 169.92 15.31 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.47 -49.53 72.48 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.025 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.7 t -60.29 -40.55 90.87 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.746 0.784 . . . . 0.0 109.142 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.16 -34.43 76.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.428 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.43 HD13 HG23 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -53.78 -28.82 17.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.14 -14.11 26.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.347 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.86 -1.34 88.59 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.3 p -61.77 -20.28 63.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.7 p -127.96 33.06 4.83 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.503 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 t -134.66 131.69 38.04 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.935 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.6 m -65.82 146.14 55.11 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -53.25 -43.41 67.36 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -39.97 93.3 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.705 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -62.79 -44.54 95.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.971 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -53.58 -63.37 1.17 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.7 pt -59.2 -25.28 29.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.971 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.7 -64.56 3.74 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 118' ' ' MET . 1.4 p90 -64.13 -28.23 69.63 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.247 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.405 ' N ' ' CD1' ' A' ' 117' ' ' TRP . 33.1 mtm -68.22 -40.0 82.21 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.6 p -115.63 -23.11 8.88 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -63.83 -75.66 0.08 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.128 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.22 -176.21 0.45 Allowed Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.38 144.44 13.43 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 N-CA-C 108.779 -1.277 . . . . 0.0 108.779 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.4 127.33 13.24 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.678 1.586 . . . . 0.0 114.009 -175.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.6 mm -114.73 108.74 48.61 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 114.637 -1.165 . . . . 0.0 107.894 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -87.34 60.2 3.67 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.811 1.674 . . . . 0.0 113.553 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -50.1 -39.47 16.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.87 -42.94 99.58 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.037 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -60.44 -47.85 84.3 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.312 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.17 -47.91 87.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.466 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -59.2 -49.21 78.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.38 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -62.87 -37.96 88.95 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.659 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -57.83 -43.43 85.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -63.03 -42.72 99.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.645 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 80.8 mt -59.02 -43.9 90.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.112 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.06 -40.28 80.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.91 -45.11 90.78 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.223 0.535 . . . . 0.0 109.709 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.32 -43.31 97.41 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.12 -36.49 83.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -58.46 -46.48 86.5 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -64.79 -38.57 91.44 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.713 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mm -60.42 -49.87 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.8 m -58.23 -34.48 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -66.65 -38.27 86.52 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 67.7 ttp -60.07 -46.28 90.07 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -71.13 -16.72 62.57 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.1 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -47.97 112.31 2.14 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.52 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.72 -35.87 4.18 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.936 1.757 . . . . 0.0 113.818 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.3 p -140.24 172.32 12.9 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 44.5 t -98.7 151.04 21.18 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.852 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.6 mm -51.9 -41.92 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.29 -39.08 81.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.802 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -66.7 -10.05 42.68 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.494 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.8 mm -80.29 125.36 39.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.739 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -152.49 129.7 11.22 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.99 0.424 . . . . 0.0 110.089 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.218 -179.608 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 . . . . . 0 CA--C 1.547 0.841 0 N-CA-C 111.45 0.167 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -67.55 134.36 32.79 Favored 'Trans proline' 0 N--CA 1.508 2.364 0 C-N-CA 122.524 2.149 . . . . 0.0 113.174 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -58.73 -28.19 65.62 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -63.76 -50.36 69.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.867 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -63.07 -40.23 97.06 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -58.65 -50.26 74.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.412 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.21 -49.23 82.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.712 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -59.5 -51.43 69.89 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.641 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -63.07 -41.69 99.49 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.089 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -56.41 -48.58 76.64 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -63.71 -37.38 87.12 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.231 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -58.05 -49.5 76.67 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 93.0 m -67.18 -38.24 85.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.861 0.839 . . . . 0.0 108.831 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 22.6 tp -55.46 -42.03 73.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.606 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 . . . . . 0 N--CA 1.446 -0.636 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.535 179.225 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 . . . . . 0 C--O 1.242 0.705 0 CA-C-O 121.464 0.649 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 98.4 mtp -61.69 -40.68 95.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.441 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 58.1 m -61.3 -48.26 82.19 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.563 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.67 -49.06 78.02 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.278 0.561 . . . . 0.0 110.17 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 98.4 m -62.46 -48.69 78.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.16 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 81.8 mt -67.61 -35.83 79.68 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.79 -1.096 . . . . 0.0 112.898 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.1 mt -44.75 -49.19 10.72 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.17 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 11.3 p -81.27 -37.22 15.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.73 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -61.97 -50.03 73.75 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.12 -23.89 62.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.831 0.348 . . . . 0.0 111.767 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.15 145.75 25.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.638 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -66.1 152.6 93.58 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.31 -45.61 36.51 Favored 'Trans proline' 0 N--CA 1.508 2.367 0 C-N-CA 122.705 2.27 . . . . 0.0 115.727 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -59.68 -49.46 77.67 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 118.799 -1.16 . . . . 0.0 110.417 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 37.9 t -66.66 -38.98 87.96 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -48.79 -34.54 12.5 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.008 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 97.5 m -58.42 -50.36 73.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.185 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 26.2 mm -65.41 -45.21 93.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.596 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -53.9 -49.36 68.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.111 0.958 . . . . 0.0 108.858 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.64 -38.16 86.65 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.729 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -59.04 -39.43 81.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.913 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.15 -36.4 75.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 81.44 174.19 48.88 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.65 154.43 59.57 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 123.484 2.789 . . . . 0.0 112.902 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 86.91 -7.71 79.11 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.69 129.58 41.15 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.442 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.9 p -75.38 161.96 28.8 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.652 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 65.4 tp -59.6 -44.23 93.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.32 -50.3 74.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.162 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.6 -39.05 86.7 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.979 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 25.9 tpp -62.39 -50.58 70.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.938 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 15.2 tpt -63.25 -45.1 93.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.323 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.8 m -62.92 -48.43 78.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.85 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.73 -50.54 70.71 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.768 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 29.5 p -61.95 -30.61 71.03 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -64.85 -42.74 94.65 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.031 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.74 -40.42 98.76 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.006 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.67 -35.31 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.262 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.221 -179.451 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 N--CA 1.488 1.191 0 N-CA-C 108.948 -1.212 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.8 pt -63.74 112.3 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.253 0.549 . . . . 0.0 110.169 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.37 140.8 45.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.65 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -65.81 124.07 21.47 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.968 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -81.72 -172.23 3.76 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.369 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.24 -38.96 85.05 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -66.85 -19.2 65.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.453 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.52 -8.14 68.79 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.41 127.01 31.96 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.497 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 89.1 mtp -72.2 128.1 34.6 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.8 t -126.61 128.84 71.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.747 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -64.8 139.19 58.74 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.351 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -141.62 155.08 45.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.246 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.28 146.33 34.88 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.238 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.3 pt -62.79 144.15 14.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.916 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.8 m -61.89 121.18 63.44 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.44 -38.86 83.31 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 N-CA-C 109.794 -0.887 . . . . 0.0 109.794 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -59.53 -47.91 83.69 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.871 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.0 m -61.11 -46.11 91.92 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.87 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.04 -49.14 77.9 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.245 0.545 . . . . 0.0 109.991 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -58.28 -42.3 86.25 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.22 -41.58 98.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.25 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -57.78 -49.42 76.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.6 t -62.08 -44.88 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.92 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -59.24 -42.78 91.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.529 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.4 t -57.6 -44.58 85.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.63 -38.25 82.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.982 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -55.18 -49.22 72.43 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.086 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -81.07 -44.6 17.76 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -120.46 39.52 3.72 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.73 -52.19 3.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -95.83 -4.79 43.12 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -55.52 146.28 44.96 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 118.951 0.796 . . . . 0.0 111.734 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.19 -32.19 17.23 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 122.47 2.114 . . . . 0.0 112.544 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.26 -21.62 35.61 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.269 0.557 . . . . 0.0 109.667 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.5 t -63.27 -40.77 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.487 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.4 HD12 HG22 ' A' ' 37' ' ' ILE . 15.8 mt -42.75 -61.27 1.77 Allowed Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.317 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.04 -33.12 52.03 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 120.799 1.0 . . . . 0.0 111.499 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.1 tpt -60.23 -48.15 82.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.374 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -55.77 -47.33 77.2 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.2 t -58.68 -43.89 90.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.89 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.05 94.02 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.04 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.7 mt -70.62 -24.53 62.75 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -91.34 25.94 2.4 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.561 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.6 126.17 30.56 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.161 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.29 11.21 75.56 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.055 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.28 150.67 43.37 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 111.915 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.9 p -99.3 149.12 35.53 Favored Pre-proline 0 C--O 1.218 -0.574 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.821 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -47.17 -37.44 23.64 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.192 1.261 . . . . 0.0 112.528 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -74.95 -62.51 1.52 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.61 -0.436 . . . . 0.0 112.139 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.429 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.77 -38.29 75.16 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.4 tp -64.36 -44.21 92.13 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.595 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -58.22 -38.72 77.37 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 87.7 m -61.07 -40.36 93.36 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.963 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.16 -47.96 81.74 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.865 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.6 -41.5 92.69 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.218 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -61.62 -38.31 87.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.117 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.28 -24.15 66.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.522 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.8 t -58.67 154.52 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.78 -149.49 5.21 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.7 -128.5 47.79 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.208 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -53.82 -10.87 0.34 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.99 -0.605 . . . . 0.0 111.756 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -43.57 -22.2 0.04 OUTLIER 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.22 -40.29 67.53 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.08 97.63 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.2 tmm? -57.32 -21.4 34.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.52 -37.15 72.55 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.1 tpt -58.17 -45.63 87.17 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -56.23 -38.14 70.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -43.51 71.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.6 -35.53 73.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.987 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -58.34 -48.74 79.6 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 pt -67.68 -28.51 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -62.28 -43.47 98.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.02 -42.33 97.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.121 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.66 -40.02 90.51 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.24 98.29 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.225 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.3 -50.3 72.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.064 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.9 -39.18 93.58 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.893 0.854 . . . . 0.0 108.768 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -58.39 -45.29 88.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.779 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -57.38 -40.49 78.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -71.88 -14.07 61.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.599 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -177.797 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 . . . . . 0 C--O 1.24 0.56 0 CA-C-O 121.256 0.55 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -65.25 152.44 91.77 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.3 80.44 0.22 Allowed 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.216 1.944 . . . . 0.0 114.43 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -66.23 163.77 17.17 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.11 -44.29 96.45 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.6 m -61.38 -39.97 92.62 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.07 -41.37 92.27 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.49 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 37.3 mm -58.72 -45.95 90.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.08 -20.5 65.82 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.89 -0.75 89.45 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 76.1 p -60.01 -21.41 61.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 p -123.68 20.97 9.34 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.0 p -125.22 132.06 53.04 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.731 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -73.13 145.81 46.15 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.6 tp -50.98 -46.97 61.53 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.356 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.76 -41.29 97.49 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.29 -38.48 89.53 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.354 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -63.07 -42.08 99.57 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.824 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 35.0 pt -67.86 -42.14 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 118.907 -1.117 . . . . 0.0 111.06 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.26 -42.16 58.01 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -58.48 -44.71 89.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.2 ttt -73.29 -42.22 62.68 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.245 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 66.0 p -126.62 -23.66 3.7 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -56.11 -51.03 69.39 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.993 1.269 . . . . 0.0 110.279 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -81.14 -179.07 1.32 Allowed Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.05 143.65 17.67 Favored 'Trans proline' 0 N--CA 1.485 1.002 0 N-CA-C 107.441 -1.792 . . . . 0.0 107.441 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.85 123.85 4.23 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.849 1.699 . . . . 0.0 113.599 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.9 mm -113.64 108.41 51.76 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.79 57.34 4.4 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.273 1.982 . . . . 0.0 113.503 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.0 m -60.5 -44.49 96.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.515 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.3 -43.06 99.0 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.759 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.03 -44.89 94.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.63 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.5 mm -61.28 -47.54 93.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -57.87 -47.44 82.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -58.93 -41.85 88.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.785 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -57.72 -43.86 85.56 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -62.32 -45.54 92.77 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.765 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 32.3 mm -60.25 -46.67 94.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.424 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.61 -41.47 85.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 65.6 tp -60.52 -45.6 93.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.06 -41.14 96.35 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.35 -36.39 83.55 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -58.63 -44.83 90.13 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.49 -40.17 95.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.802 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.74 -49.26 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.353 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.7 m -58.02 -32.68 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.1 ttm-85 -67.98 -38.0 82.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 58.9 ttm -58.57 -44.15 89.65 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -74.84 -17.56 60.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.705 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.8 p -43.1 104.96 0.4 Allowed Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.39 -32.66 6.19 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.943 1.762 . . . . 0.0 113.673 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 70.6 p -139.35 173.04 11.95 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.6 t -106.72 150.12 26.6 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.887 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.6 mm -50.88 -46.51 29.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -59.4 -37.98 79.39 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.461 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -65.96 -5.04 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.216 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.6 mt -97.14 126.01 50.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.86 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -152.22 134.57 15.18 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.496 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 -179.246 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 CA--C 1.544 0.712 0 CA-C-O 119.895 -0.097 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -81.46 135.82 9.53 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.654 2.236 . . . . 0.0 113.418 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -58.93 -36.8 75.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -59.86 -49.77 76.4 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.02 -40.65 94.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.517 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -58.92 -49.59 77.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.463 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.65 -45.77 98.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.473 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.01 -52.19 66.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.019 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.64 -39.75 91.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.666 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -56.71 -47.89 78.95 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -64.7 -36.59 84.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.943 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -57.98 -48.77 79.02 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 96.6 m -66.62 -38.91 87.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.729 0.776 . . . . 0.0 109.061 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 29.2 tp -56.42 -39.82 73.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.926 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 . . . . . 0 C--N 1.321 -0.669 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.954 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 . . . . . 0 C--O 1.241 0.623 0 CA-C-O 121.436 0.636 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 98.3 mtp -60.67 -41.04 94.28 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.079 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 66.4 m -60.44 -48.84 80.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.143 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.03 -47.72 85.11 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.01 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 99.0 m -62.09 -48.42 80.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.684 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.17 -21.69 58.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.42 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 67.2 tp -54.06 -49.97 67.79 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.625 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.7 m -87.33 -38.24 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.646 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.63 -45.96 92.09 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.958 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -80.27 -9.87 59.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.23 155.7 34.24 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -70.4 151.22 95.72 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.119 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.41 -42.91 63.49 Favored 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 122.316 2.011 . . . . 0.0 115.072 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.16 -60.49 3.79 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.538 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 49.4 t -62.16 -38.93 90.94 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -48.58 -34.64 11.87 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.856 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 99.3 m -59.92 -49.48 77.53 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 118.813 -1.155 . . . . 0.0 108.708 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.75 -45.01 96.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.016 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.79 -42.16 92.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.51 -38.9 91.75 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.47 83.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.278 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.0 -40.38 97.58 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.536 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.16 -160.49 53.3 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.999 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.05 165.91 4.65 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 123.822 3.015 . . . . 0.0 113.398 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.08 -123.85 33.7 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 64.86 99.29 0.04 OUTLIER 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.139 0.495 . . . . 0.0 111.231 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 50.9 m -57.76 144.27 38.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.2 tp -50.36 -40.96 50.89 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.223 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -57.98 -45.58 86.52 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.43 -42.23 91.42 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 5.5 mmt -61.58 -50.85 70.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.101 0.476 . . . . 0.0 110.961 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 59.3 ttm -63.69 -46.29 86.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.349 0.595 . . . . 0.0 110.574 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.8 m -61.8 -48.1 82.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.48 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.05 -45.13 96.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.994 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 92.1 m -61.35 -40.98 96.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -56.7 -38.65 72.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.23 -38.98 93.99 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.97 5.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.341 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.267 -179.586 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo . . . . . 0 N--CA 1.487 1.141 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.7 pt -71.21 110.11 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.403 0.621 . . . . 0.0 110.575 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.6 t -129.54 126.37 63.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.573 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -56.6 115.57 2.61 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.359 0.599 . . . . 0.0 109.847 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.56 -176.09 1.83 Allowed 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.281 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.99 -38.49 82.74 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.26 -19.51 66.0 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.731 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.25 -7.72 62.26 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -80.07 124.2 28.53 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.4 mtt -75.64 131.61 40.05 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.8 t -126.66 129.23 71.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.553 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -66.84 136.16 55.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.531 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -137.78 153.72 49.65 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.955 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.28 148.15 37.76 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.392 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.8 pt -62.44 144.48 14.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.173 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 m -63.68 121.98 73.87 Favored Pre-proline 0 N--CA 1.451 -0.399 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.15 -36.52 77.38 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 N-CA-C 109.507 -0.997 . . . . 0.0 109.507 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -57.63 -49.69 75.62 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.124 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 95.0 m -61.46 -46.14 91.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.458 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 65.8 tp -57.68 -49.9 74.96 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.832 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -58.47 -41.87 86.21 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.44 -41.67 98.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.751 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -57.55 -50.97 71.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.374 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.42 -41.84 94.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.365 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.74 -40.68 84.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.172 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -58.55 -44.09 88.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.41 -35.96 72.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.998 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -57.03 -43.7 82.15 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.403 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -93.65 -27.1 16.76 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.545 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.41 38.3 3.46 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.956 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.79 -54.13 3.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -96.63 -5.17 39.64 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.4 m -52.49 144.34 24.24 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 118.906 0.776 . . . . 0.0 111.508 -177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.26 -31.62 17.96 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.453 2.102 . . . . 0.0 112.706 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -59.08 -18.86 39.04 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.771 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.23 -41.27 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.944 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.4 mt -45.7 -60.79 2.99 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.237 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.23 -41.22 77.92 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 CA-C-N 120.001 1.036 . . . . 0.0 111.795 176.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.9 mtt -60.86 -44.21 97.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.798 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -56.92 -49.44 75.62 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.779 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.4 p -60.86 -38.88 87.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.721 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.66 -46.08 91.7 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.067 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.61 -27.13 62.9 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.221 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -85.84 12.32 9.37 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.216 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -64.76 122.54 17.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.522 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.99 10.47 84.05 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 121.428 -0.415 . . . . 0.0 112.896 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.96 149.1 41.56 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.165 0.507 . . . . 0.0 112.117 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.3 p -99.19 148.69 34.97 Favored Pre-proline 0 C--O 1.212 -0.901 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.412 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -45.74 -37.17 15.76 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.477 1.451 . . . . 0.0 113.558 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -70.29 -63.35 1.1 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.254 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -57.88 -35.81 71.51 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.4 -44.15 97.13 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.297 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -58.26 -38.05 76.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 88.3 m -61.21 -40.13 92.82 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.101 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 83.9 mmm -56.08 -46.49 78.99 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.581 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.78 -44.62 48.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.451 0.644 . . . . 0.0 111.145 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.25 -39.09 78.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.064 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.2 p -67.2 -19.69 65.6 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.999 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.79 154.48 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.741 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.65 -151.9 5.68 Favored Glycine 0 CA--C 1.535 1.338 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.96 -128.12 46.74 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.123 -1.037 . . . . 0.0 110.934 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -51.5 -10.59 0.1 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.956 -0.622 . . . . 0.0 112.11 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -43.46 -21.98 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.27 -41.09 68.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.13 96.36 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.3 tpp -56.78 -21.11 26.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.12 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -58.65 -38.4 78.03 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -58.58 -45.36 89.21 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.11 -43.04 66.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.086 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -59.62 -40.65 88.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -64.61 -40.78 96.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.593 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.7 m -60.17 -44.05 95.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.6 mt -60.33 -43.93 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -60.43 -42.13 95.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.444 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.23 -46.24 91.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.055 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.59 -39.21 93.81 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.66 98.51 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.435 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.29 -49.33 74.44 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.179 0.514 . . . . 0.0 111.186 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.22 -41.62 99.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 122.122 0.963 . . . . 0.0 109.1 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -59.62 -44.42 93.44 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.083 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -53.87 -42.53 68.69 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.4 -26.75 68.13 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.477 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.351 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -60.62 158.92 27.97 Favored Pre-proline 0 C--O 1.239 0.541 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.069 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -48.17 130.44 20.52 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.718 1.612 . . . . 0.0 112.207 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.73 154.06 34.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -44.09 -61.28 3.16 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.605 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.9 t -60.85 -39.03 87.59 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.667 0.746 . . . . 0.0 110.136 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -35.94 77.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.005 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.5 tp -59.37 -33.35 50.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.59 -28.06 64.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.21 -8.1 79.82 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.7 p -57.78 -23.71 53.68 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.0 p -114.79 8.51 16.09 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.684 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 62.0 m -111.79 131.34 55.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.078 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.0 m -71.04 156.03 40.11 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.8 tp -58.67 -47.83 83.16 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.244 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -61.61 -43.83 98.14 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.904 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.3 -39.38 86.75 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.192 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.619 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.5 pt -71.09 -39.76 74.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.952 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.33 -43.34 79.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -59.34 -45.15 92.16 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.915 -1.143 . . . . 0.0 109.084 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.2 ttt -72.04 -41.32 67.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.475 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.2 m -127.16 -26.4 3.11 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -57.4 -50.39 73.15 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 118.336 -1.346 . . . . 0.0 110.269 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.88 -178.23 1.13 Allowed Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 134.49 30.08 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 120.665 1.273 . . . . 0.0 109.224 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -36.77 116.72 0.16 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.681 2.254 . . . . 0.0 113.601 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.7 mm -108.83 108.54 60.82 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.5 58.92 6.0 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.146 1.897 . . . . 0.0 112.692 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.3 m -58.86 -45.08 91.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.956 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.18 -42.05 98.12 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.208 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.85 -45.89 92.74 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.415 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.84 -47.99 86.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.318 0.58 . . . . 0.0 110.415 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -58.59 -48.48 80.8 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.825 0.821 . . . . 0.0 108.858 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -62.89 -38.16 89.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.035 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.7 tpp180 -57.79 -43.18 85.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -62.71 -43.74 98.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.885 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.32 -44.57 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.933 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.37 -41.79 85.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.86 -42.42 99.75 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.25 -42.86 98.89 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.13 -36.47 84.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.7 -44.63 90.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.28 -39.5 92.67 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.607 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mm -60.58 -49.65 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.6 m -57.47 -35.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -65.15 -40.39 94.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 94.2 mmm -60.62 -43.09 97.9 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.329 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -71.61 -19.68 62.09 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.889 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.4 t -48.42 117.39 5.85 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.625 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -85.15 -25.03 1.87 Allowed 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 122.174 1.916 . . . . 0.0 113.67 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.1 p -138.97 169.66 17.39 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 40.8 t -107.43 148.9 28.54 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.985 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 tp -48.94 -36.38 8.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.5 tp -66.55 -39.48 88.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.609 0.719 . . . . 0.0 109.581 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -64.63 -26.36 68.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.153 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.21 108.36 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.071 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -144.85 122.62 11.9 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 C--N 1.328 -0.331 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.217 -179.067 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 119.877 -0.106 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.07 155.94 23.03 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.62 2.213 . . . . 0.0 114.598 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -60.16 -39.68 87.26 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.453 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -62.99 -47.54 82.7 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.742 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -61.0 -43.34 99.03 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.907 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -62.15 -50.15 73.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.277 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.07 -44.53 98.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.545 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -62.11 -53.88 49.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.6 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 61.5 mtm-85 -64.62 -41.0 96.46 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.173 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -58.45 -48.8 79.54 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -64.92 -36.9 85.88 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.538 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -59.62 -48.1 82.99 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 97.3 m -64.89 -39.6 93.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.579 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 17.0 tp -58.37 -38.26 76.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.103 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 27.9 ttt-85 . . . . . 0 N--CA 1.444 -0.741 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.656 179.76 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 . . . . . 0 C--O 1.242 0.677 0 CA-C-O 121.603 0.715 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 98.7 mtp -61.62 -40.33 94.46 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.027 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 60.4 m -59.69 -46.92 87.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.283 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.68 -47.71 84.55 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.797 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 98.0 m -64.23 -47.54 79.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.596 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.7 mp -66.82 -33.81 76.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.327 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 13.2 mt -49.43 -44.95 45.85 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.964 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.6 -47.52 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.553 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -61.48 -50.28 73.39 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -72.08 -25.9 61.95 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.311 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.08 156.97 10.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.304 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -70.63 152.88 95.22 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.081 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.28 -45.9 31.83 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 122.778 2.319 . . . . 0.0 114.708 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -54.6 -62.11 1.87 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.032 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 46.5 t -58.5 -45.09 89.44 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.857 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -48.95 -31.06 6.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.578 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.9 m -59.76 -50.59 73.24 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.679 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.5 mm -79.3 -30.14 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.697 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -55.1 39.02 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.58 -39.28 90.61 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.22 -32.5 66.58 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.92 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 56.2 tp -56.34 -38.47 71.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 96.61 160.1 32.0 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.778 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.0 156.05 66.45 Favored 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 123.594 2.863 . . . . 0.0 113.215 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 81.15 -0.34 87.64 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.532 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -68.37 136.82 53.96 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.458 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.6 p -76.22 160.81 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.886 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 63.3 tp -60.41 -44.03 96.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.94 -48.97 79.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.808 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.28 -43.43 92.52 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.0 ttm -60.33 -48.88 79.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.524 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 94.9 mmm -62.86 -39.07 93.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.5 m -61.69 -50.27 73.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.215 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.36 96.5 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.94 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 97.0 m -60.45 -40.44 91.17 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -68.62 -39.31 80.86 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.995 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.28 -40.66 92.21 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 12.4 t -95.09 -25.15 4.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-O 121.189 0.519 . . . . 0.0 110.598 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.125 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.441 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.486 1.049 0 N-CA-C 108.987 -1.197 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.5 pt -62.31 109.85 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.494 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.1 t -128.88 123.58 59.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.486 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -57.13 110.63 0.87 Allowed 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.346 0.593 . . . . 0.0 110.003 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -68.5 177.78 2.28 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.011 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 pp -58.27 -33.45 69.42 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -63.18 -26.8 68.97 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.641 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.49 -7.19 53.55 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -85.73 124.72 32.56 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.894 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.0 mtt -73.75 134.49 43.47 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -128.62 130.07 68.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.813 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -68.19 136.27 53.35 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.518 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -137.9 153.6 49.52 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.254 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.86 142.95 40.0 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.985 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.9 pt -63.67 139.7 20.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.086 0.469 . . . . 0.0 110.488 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.0 t -61.01 126.09 85.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.82 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.09 -32.79 50.58 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 120.929 1.086 . . . . 0.0 109.884 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -58.76 -39.88 82.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 95.9 m -60.93 -46.2 91.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.732 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.1 mt -59.9 -45.02 93.87 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.64 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -60.55 -40.86 93.11 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.068 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.94 -46.65 80.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.284 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 42.3 t-105 -60.47 -50.69 72.57 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.878 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.89 -45.94 97.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.6 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.48 -43.5 98.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.364 0.602 . . . . 0.0 110.852 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.7 t -59.27 -46.56 92.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.165 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -69.52 -25.94 29.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.393 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -58.98 -45.13 91.33 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.738 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -91.62 -36.35 13.71 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -120.92 38.12 4.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.147 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.08 -51.64 4.49 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -96.11 -5.07 41.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.2 m -54.62 140.57 57.6 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 118.874 0.761 . . . . 0.0 112.22 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -59.93 -39.55 70.25 Favored 'Trans proline' 0 N--CA 1.507 2.265 0 C-N-CA 122.489 2.126 . . . . 0.0 112.817 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -54.15 -20.25 6.42 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.554 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.9 t -62.57 -43.56 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.62 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.4 mt -46.97 -61.38 2.83 Favored Pre-proline 0 C--O 1.24 0.578 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.084 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -53.62 -42.08 68.78 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 120.273 1.133 . . . . 0.0 111.781 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.0 mtp -61.41 -42.84 99.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.845 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -56.52 -48.84 76.37 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.8 t -59.23 -43.86 92.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.983 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.08 92.86 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.47 0.653 . . . . 0.0 110.069 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.4 mt -70.77 -25.64 62.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.459 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.9 m -89.53 7.76 34.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.785 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.22 128.41 35.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.573 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.76 10.54 76.79 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.58 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.67 149.86 38.05 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 111.973 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.9 p -99.05 150.29 36.56 Favored Pre-proline 0 C--O 1.218 -0.568 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.626 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.8 -39.55 18.82 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.492 1.461 . . . . 0.0 112.795 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -69.29 -63.35 1.08 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.349 -0.54 . . . . 0.0 112.018 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.461 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.96 -36.15 72.16 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.27 1.034 . . . . 0.0 108.405 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -62.18 -46.45 88.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.879 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -59.08 -37.46 77.16 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 85.5 m -58.6 -41.0 84.83 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.225 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.15 -46.07 89.33 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.298 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.8 mt -66.14 -41.84 89.91 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.814 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.97 -26.94 68.51 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.403 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 m -65.7 -34.64 78.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.238 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 t -59.13 163.54 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.199 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.6 -161.98 11.31 Favored Glycine 0 N--CA 1.473 1.109 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.43 -125.28 38.99 Favored Glycine 0 C--N 1.342 0.868 0 C-N-CA 118.867 -1.635 . . . . 0.0 109.774 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -48.37 -17.05 0.12 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.58 -0.31 . . . . 0.0 110.866 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -45.77 -21.71 0.14 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.324 0.25 . . . . 0.0 111.302 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.91 64.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.31 -40.55 96.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.0 mtt -63.74 -16.51 61.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.514 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -59.55 -39.05 82.73 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -60.62 -42.09 96.18 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -57.65 -39.28 76.67 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.096 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -60.63 -39.31 87.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.54 -40.48 95.68 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -59.39 -43.44 92.93 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 84.9 mt -60.78 -42.33 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -60.13 -41.8 93.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.486 -0.779 . . . . 0.0 108.97 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.32 -43.47 97.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.504 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.77 -40.47 97.39 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.73 98.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.564 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.1 -50.15 71.67 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.309 0.576 . . . . 0.0 110.87 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.81 -39.55 94.5 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -58.12 -46.32 85.8 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.678 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -55.71 -41.79 74.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -72.26 -14.18 61.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.095 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -177.75 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 . . . . . 0 C--O 1.239 0.509 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -62.35 159.2 42.28 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.936 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.24 141.31 39.79 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.437 2.092 . . . . 0.0 114.043 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -138.44 160.14 40.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.292 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.11 -47.64 85.96 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 118.348 -1.882 . . . . 0.0 109.63 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.1 p -64.78 -39.04 92.95 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.992 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.91 -43.21 96.64 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.961 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.98 -37.89 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.69 -22.75 67.05 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.426 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.61 -3.26 69.31 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.4 p -67.53 -23.42 65.44 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.4 p -117.33 -2.32 11.61 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.154 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.0 m -105.45 131.42 52.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.726 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.8 m -70.65 151.47 44.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.82 -49.73 74.52 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.039 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.91 -40.43 88.79 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.69 -41.74 86.96 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -61.8 -37.68 85.29 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.5 mm -57.75 -62.03 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.291 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.71 -40.69 97.64 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -56.33 -44.94 80.47 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.4 ttt -72.67 -42.02 64.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.356 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 75.5 p -125.52 -23.89 4.0 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -51.72 -64.34 0.84 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.852 1.205 . . . . 0.0 110.429 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -76.71 -175.89 0.55 Allowed Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.24 143.82 14.06 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 N-CA-C 108.28 -1.469 . . . . 0.0 108.28 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.23 129.71 16.03 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.813 1.676 . . . . 0.0 113.526 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.7 mm -113.82 108.57 51.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.1 55.87 2.99 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.17 1.914 . . . . 0.0 113.431 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.7 m -61.1 -48.19 90.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.926 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.59 -42.51 98.8 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.603 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -62.18 -46.26 89.73 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.389 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 89.8 mt -63.61 -48.77 85.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.372 0.606 . . . . 0.0 110.517 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -58.25 -47.1 84.64 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.417 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -61.53 -39.99 93.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.486 -1.233 . . . . 0.0 109.596 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.29 -41.74 89.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 47.9 m0 -62.08 -43.8 98.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 85.8 mt -60.47 -44.44 96.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.973 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.56 -41.27 81.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.729 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.8 -45.13 94.08 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.609 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.93 96.96 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -63.41 -36.41 83.65 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -58.05 -44.73 87.59 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.26 -38.62 90.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.778 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.66 -49.49 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.2 -36.06 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -65.81 -38.79 89.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.6 tpt -59.13 -47.39 85.45 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -72.93 -12.75 61.07 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.195 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.4 t -51.09 117.47 8.87 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.578 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -78.4 -35.04 1.29 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.956 1.771 . . . . 0.0 113.555 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.1 p -139.81 172.47 12.73 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.7 m -105.62 151.54 24.24 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.861 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.7 mm -49.35 -43.4 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 tt -58.79 -39.86 82.35 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.78 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -67.71 -14.49 62.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.081 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.2 mm -80.04 113.67 19.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.388 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -144.0 128.31 17.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.763 -179.45 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 119.658 -0.211 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 148.53 54.1 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.247 1.965 . . . . 0.0 114.116 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.74 -43.09 94.39 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.836 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.1 ttp85 -60.58 -46.61 89.59 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.68 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -59.86 -41.42 91.42 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.962 -1.095 . . . . 0.0 108.313 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -61.52 -50.45 72.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.126 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.32 -43.95 97.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.763 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.59 -56.37 20.59 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.63 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -62.24 -39.54 93.18 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -57.32 -47.62 81.06 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -64.39 -37.66 88.3 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.624 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -61.07 -45.35 95.11 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.719 0.771 . . . . 0.0 109.6 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 94.7 m -66.1 -40.2 90.59 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 16.7 tp -58.51 -38.98 78.84 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.323 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 . . . . . 0 N--CA 1.445 -0.678 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.991 179.435 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 . . . . . 0 C--O 1.244 0.785 0 CA-C-O 121.577 0.703 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.4 -41.21 96.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.289 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 66.7 m -60.54 -45.5 93.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.029 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -59.36 -49.86 76.2 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.813 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 97.6 m -64.62 -47.36 78.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.591 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.59 -37.56 87.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.28 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.4 mt -43.23 -54.0 4.79 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.013 0.435 . . . . 0.0 110.722 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 71.8 t -86.92 -40.62 14.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.947 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -59.76 -49.36 78.04 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 49.3 p30 -89.32 -4.96 57.91 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 119.074 -1.051 . . . . 0.0 112.087 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.31 162.98 24.0 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -66.85 150.83 97.48 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.624 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.2 -38.74 34.12 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.407 2.072 . . . . 0.0 113.588 -177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -59.51 -50.54 73.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.21 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 53.2 t -64.19 -43.59 94.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.035 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -48.31 -30.27 4.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.847 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 92.6 m -59.47 -49.05 79.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.925 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.67 -30.23 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.156 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.94 -45.14 95.9 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.2 -39.45 94.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.001 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -59.05 -37.46 77.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.962 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 72.6 mt -59.78 -38.99 83.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.27 167.76 43.97 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.649 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.1 154.36 67.88 Favored 'Trans proline' 0 N--CA 1.507 2.32 0 C-N-CA 123.936 3.091 . . . . 0.0 113.871 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.19 16.3 80.8 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.749 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -79.9 135.54 36.45 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.094 0.473 . . . . 0.0 111.353 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.0 m -73.35 137.37 44.71 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -51.64 -39.32 57.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.25 -45.76 90.31 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.18 -42.18 90.24 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.7 mtt -62.7 -43.06 99.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.206 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 59.8 mtt -63.8 -43.54 95.98 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.682 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.1 m -65.86 -49.65 67.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.561 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.16 -44.53 95.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.031 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 81.0 m -61.32 -39.29 89.94 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.13 -36.68 83.79 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.174 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.37 94.35 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.49 -16.58 7.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.199 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.67 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 N--CA 1.486 1.077 0 N-CA-C 109.408 -1.035 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.2 pt -75.85 125.61 35.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.481 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -127.18 130.0 71.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.877 -178.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.42 121.58 13.03 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -84.04 -174.12 5.1 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.349 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.86 -38.32 81.83 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -66.82 -23.37 66.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.353 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.42 -7.14 56.02 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -71.85 132.54 44.56 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.371 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.1 mtt -85.04 109.49 18.25 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.8 t -109.73 130.22 63.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.805 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -61.29 137.38 58.24 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.841 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -138.55 152.34 48.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.006 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.86 143.59 49.36 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.029 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mm -64.42 138.46 23.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.2 t -58.69 121.58 54.78 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.44 -35.21 64.85 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 120.87 1.047 . . . . 0.0 110.029 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -59.42 -43.65 93.03 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.0 m -62.01 -46.19 90.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.97 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.7 mt -57.96 -50.17 74.3 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.311 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.11 -40.59 90.2 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.571 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.4 98.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.693 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -59.75 -50.39 74.0 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.531 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.5 t -62.4 -42.66 96.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.175 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.82 -43.19 90.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.2 t -58.79 -44.41 90.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.1 t -64.79 -35.92 76.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.636 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -54.07 -46.94 72.14 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.515 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -91.09 -39.47 12.15 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.675 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -116.83 38.17 3.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.001 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.6 -54.37 3.24 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -175.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -97.06 -5.69 36.95 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -50.83 140.4 20.13 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.399 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.3 -32.46 41.53 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 122.432 2.088 . . . . 0.0 112.7 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -57.84 -18.9 25.16 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.002 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.47 -42.76 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.766 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.2 mt -45.96 -61.5 2.47 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.731 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.39 -41.53 75.86 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 CA-C-N 120.115 1.077 . . . . 0.0 111.569 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.5 tpt -59.66 -46.88 87.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.36 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -54.64 -48.65 72.02 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.2 m -59.48 -41.52 89.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.677 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.84 -44.67 93.97 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.094 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.58 -18.52 59.72 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.427 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -95.66 26.35 4.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.224 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -78.49 125.89 30.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.061 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.42 11.4 71.84 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.926 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.21 149.08 49.96 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.301 0.572 . . . . 0.0 112.036 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.2 m -99.55 142.74 25.16 Favored Pre-proline 0 C--O 1.218 -0.569 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.482 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -43.64 -38.69 9.39 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.328 1.352 . . . . 0.0 112.852 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -71.54 -63.72 1.06 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.407 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.9 m-20 -58.91 -38.58 79.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.988 0.899 . . . . 0.0 108.917 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.95 -49.31 73.07 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.597 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -57.74 -39.83 78.24 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 96.9 m -61.17 -41.93 97.65 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.799 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 41.9 ttp -59.32 -48.16 82.66 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.888 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.3 -41.93 98.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.095 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -59.07 -33.8 71.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.374 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.4 m -65.37 -32.94 74.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.238 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.5 t -58.96 142.85 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.525 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.07 -151.88 6.95 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.79 -128.27 40.19 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -53.47 -12.85 0.5 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.817 -0.192 . . . . 0.0 111.414 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -44.38 -21.54 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.54 -39.26 70.35 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.67 93.79 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.5 ttm -57.54 -21.59 39.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.777 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -56.38 -37.35 69.98 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.2 ttp -58.55 -45.92 87.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 tt -58.19 -39.9 80.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -56.84 -41.56 78.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.007 -1.077 . . . . 0.0 108.377 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.9 -40.18 94.68 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -59.74 -43.95 94.01 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.79 -43.03 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -60.76 -40.02 90.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.949 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.55 -43.57 98.48 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -61.67 -39.48 91.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.83 -42.87 99.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.693 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.2 84.4 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.393 0.616 . . . . 0.0 110.393 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.48 -39.78 95.36 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -58.53 -47.98 82.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.259 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -55.07 -41.0 70.97 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.82 -22.89 64.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.745 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 CA--C 1.544 0.721 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -177.49 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 C--O 1.238 0.458 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -63.31 158.08 59.37 Favored Pre-proline 0 C--O 1.24 0.563 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.01 136.8 36.94 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.584 1.522 . . . . 0.0 112.872 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -134.67 139.11 45.01 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -43.22 -49.71 6.57 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.223 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -61.72 -41.21 97.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.325 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.87 -43.68 98.35 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.037 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.17 -41.5 83.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.4 -27.4 68.98 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.79 -7.89 80.59 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.3 p -60.13 -29.85 68.9 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.6 p -116.94 -7.69 11.36 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.981 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.1 t -99.28 129.15 45.48 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.205 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.7 m -72.85 146.29 46.33 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.5 tp -54.36 -47.44 72.6 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.375 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.4 -39.37 87.12 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.49 -40.62 97.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.199 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.2 -41.35 96.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.192 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 24.9 pt -63.77 -47.66 89.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 118.342 -1.343 . . . . 0.0 111.388 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.41 -41.67 66.66 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -57.78 -45.03 86.59 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.8 ttt -71.86 -43.77 64.92 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.451 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.8 p -125.92 -23.62 3.93 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -57.44 -50.77 71.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 118.535 -1.266 . . . . 0.0 110.206 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -83.57 -178.12 1.12 Allowed Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.79 144.04 21.48 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 N-CA-C 107.785 -1.659 . . . . 0.0 107.785 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.54 126.8 10.84 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.43 1.42 . . . . 0.0 113.421 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.1 mm -114.24 108.07 50.79 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.24 55.68 4.15 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.834 1.689 . . . . 0.0 113.341 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.6 m -59.44 -42.47 87.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.67 -45.05 96.6 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.768 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.63 -43.9 97.64 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.153 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.58 -48.07 89.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.443 0.64 . . . . 0.0 110.071 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -59.48 -46.85 87.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.522 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -60.69 -39.37 88.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.392 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -59.13 -43.09 91.96 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 50.6 m0 -62.4 -43.66 98.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.186 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 84.7 mt -61.76 -45.52 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.035 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.19 -42.6 87.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.25 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.38 -43.05 99.74 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.6 98.46 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.43 -36.75 84.78 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -58.29 -44.03 88.33 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.69 -38.31 88.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.748 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.6 mm -60.84 -49.37 84.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.611 -0.436 . . . . 0.0 112.031 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.6 m -58.34 -35.9 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -65.16 -38.99 92.32 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.3 tmm? -60.41 -47.51 85.79 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.443 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -71.44 -15.2 62.33 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.202 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.9 t -48.11 115.16 3.85 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.717 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.66 -41.85 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.979 1.786 . . . . 0.0 113.801 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 43.1 p -140.83 170.17 16.26 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 39.9 t -90.84 148.19 22.68 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.98 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 tp -50.17 -34.35 10.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.8 tp -65.06 -39.42 93.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.724 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.7 -11.3 44.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.837 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 88.2 mt -79.16 125.99 38.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.862 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -144.46 133.16 22.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.095 0.474 . . . . 0.0 111.016 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.634 178.512 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 . . . . . 0 C--O 1.24 0.588 0 CA-C-O 119.593 -0.242 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.86 136.55 16.84 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.203 1.936 . . . . 0.0 112.873 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -59.56 -34.74 73.06 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -60.19 -52.45 65.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.111 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.52 -41.47 98.5 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.874 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -59.49 -50.09 75.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.634 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.76 -46.66 96.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.13 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -58.47 -49.63 76.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.121 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.23 -41.58 99.12 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.581 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -56.53 -49.35 75.03 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.924 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -67.29 -37.43 83.37 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.825 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -58.6 -49.96 75.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.696 0.76 . . . . 0.0 108.974 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 94.6 m -66.83 -37.35 84.32 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.88 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 64.6 tp -59.28 -48.65 80.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.318 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.592 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 . . . . . 0 C--O 1.239 0.52 0 CA-C-O 121.25 0.548 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 57.4 mtt -63.54 -45.33 91.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.7 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 73.0 m -60.65 -50.15 74.66 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.818 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.58 -49.4 76.8 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.187 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.5 m -64.41 -48.31 75.85 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.906 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.37 -37.85 88.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.992 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.2 mt -48.92 -47.88 43.08 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.467 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.1 m -86.18 -38.17 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.077 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.55 -50.12 72.59 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -74.79 -21.83 59.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.979 0.419 . . . . 0.0 111.347 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.56 150.84 25.99 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.222 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.94 138.8 97.6 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.36 -50.06 15.29 Favored 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 122.354 2.036 . . . . 0.0 116.145 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -63.32 -44.02 96.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.982 -176.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 37.0 t -67.96 -42.14 81.36 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -52.11 -28.57 18.21 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.105 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 87.7 m -59.09 -48.59 81.05 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -68.52 -43.93 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.865 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.6 -52.73 36.59 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.57 -39.82 95.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.923 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.17 -35.0 64.33 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.346 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 58.6 tp -58.73 -39.84 82.02 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 104.9 163.66 24.05 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.63 155.08 54.77 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.301 2.667 . . . . 0.0 113.321 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 71.81 15.19 75.84 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.31 138.1 47.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.035 0.445 . . . . 0.0 111.201 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 88.7 m -62.61 139.29 58.63 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 67.6 tp -54.86 -44.22 73.8 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.04 -46.52 85.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.03 -40.86 86.35 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 56.0 ttm -61.65 -50.02 74.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.124 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 63.8 tpp -62.1 -47.42 84.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.584 0.707 . . . . 0.0 110.171 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.5 m -61.56 -47.17 86.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.126 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.8 -46.35 90.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.987 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.68 -40.57 97.5 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -58.2 -38.33 76.55 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.862 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.67 -37.5 89.64 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 35.9 m -97.22 -4.71 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.824 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.985 179.444 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.486 1.043 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.6 pt -57.42 108.26 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.342 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.01 133.54 19.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.18 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -60.97 136.42 58.08 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.38 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -98.38 -168.07 1.6 Allowed 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.657 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.67 -38.97 79.34 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -66.71 -23.32 66.1 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.237 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.4 -8.04 62.13 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.57 132.1 40.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.1 mtt -83.78 134.23 34.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.146 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.0 t -128.26 130.1 69.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.507 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -74.95 110.46 9.27 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.293 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -113.26 143.32 44.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.613 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.2 143.09 56.73 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.376 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.0 pt -60.57 144.57 13.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.721 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 m -62.76 122.76 76.38 Favored Pre-proline 0 N--CA 1.454 -0.26 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.877 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.58 -36.74 81.76 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 120.722 0.948 . . . . 0.0 109.738 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -56.75 -48.82 76.96 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.933 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.3 m -61.02 -46.94 88.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.042 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.9 -60.52 2.69 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.289 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -57.65 -38.79 75.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.821 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.35 98.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.457 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -59.05 -51.06 71.66 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.829 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.7 t -63.18 -41.84 94.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.379 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.07 -43.68 91.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.372 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.7 t -59.02 -44.98 92.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 31' ' ' ALA . 60.7 t -62.45 -37.0 77.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.94 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -54.31 -46.72 72.89 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.528 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -89.42 -30.7 18.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.91 38.44 3.69 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.871 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 27' ' ' VAL . . . -42.51 -51.26 5.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -96.02 -4.65 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.2 m -54.97 147.22 34.36 Favored Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 118.866 0.757 . . . . 0.0 111.772 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.72 -34.71 10.98 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 122.663 2.242 . . . . 0.0 112.831 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.64 -19.36 25.85 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.904 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.2 -41.77 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.608 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.1 mt -46.54 -61.31 2.76 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.279 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.74 -40.61 83.86 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 CA-C-N 120.111 1.075 . . . . 0.0 111.557 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.0 tpt -59.0 -48.13 82.71 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.25 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -56.0 -46.77 78.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m -57.72 -44.2 85.79 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.858 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.27 99.17 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.462 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.91 -26.5 64.19 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.926 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.4 p -87.44 1.18 54.16 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -54.56 126.16 22.59 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.734 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.12 10.95 78.93 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.597 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.33 149.23 46.29 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.327 0.585 . . . . 0.0 112.564 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.7 m -99.96 141.7 23.25 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.135 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -41.74 -38.68 4.62 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.436 1.424 . . . . 0.0 113.056 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -71.05 -64.12 0.97 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.196 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.463 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.5 m-20 -59.18 -37.61 77.79 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.327 1.06 . . . . 0.0 108.503 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.08 -47.89 82.65 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.826 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -58.12 -39.27 78.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 91.6 m -60.65 -39.93 90.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.404 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 97.8 mtp -57.39 -48.08 80.01 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.654 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.09 -40.62 94.86 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.799 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -60.54 -39.33 87.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.515 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.6 p -67.45 -19.04 65.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.896 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.2 t -61.18 152.97 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.587 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.54 -153.09 5.92 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.99 -128.16 46.85 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 120.363 -0.923 . . . . 0.0 111.018 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -51.93 -10.29 0.11 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.846 -0.677 . . . . 0.0 112.113 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -42.95 -21.7 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.14 66.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.6 96.29 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.6 tpp -57.09 -22.12 37.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.03 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -58.42 -38.11 76.75 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -58.85 -42.91 90.44 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.61 -40.86 76.07 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.498 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -58.18 -41.33 83.65 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.736 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.92 -40.4 95.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.499 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.5 m -59.61 -46.43 88.99 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.38 -41.06 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.305 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -60.33 -42.17 95.07 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.902 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.69 -46.03 90.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.996 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -61.43 -38.54 87.51 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.68 90.93 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.54 66.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.891 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.46 -43.75 96.47 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.015 0.912 . . . . 0.0 108.854 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -60.5 -39.82 89.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.613 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -54.32 -41.0 68.5 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -69.55 -20.56 63.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.832 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -177.831 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 . . . . . 0 C--O 1.238 0.454 0 CA-C-O 121.337 0.589 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.83 154.36 67.68 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.777 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.15 126.29 6.23 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.661 1.574 . . . . 0.0 113.118 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.441 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 1.1 mpt_? -115.55 151.32 35.1 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 113.773 -1.558 . . . . 0.0 107.774 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -49.35 -54.29 16.57 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.3 p -63.65 -33.94 76.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.875 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.441 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 82.9 m-20 -63.08 -39.86 95.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.857 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.5 tp -56.8 -31.92 36.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.72 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.1 -27.8 61.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.204 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.88 -8.2 80.22 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 108.441 -1.863 . . . . 0.0 108.441 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 71.4 p -62.31 -19.24 63.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.0 p -122.96 10.57 9.5 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.003 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.1 m -114.81 130.77 56.92 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.271 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 m -73.0 151.14 41.9 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.3 tp -54.54 -46.03 73.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -61.01 -40.63 94.29 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -61.87 -45.85 91.98 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.277 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -62.29 -41.94 98.93 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.142 0.276 . . . . 0.0 111.38 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.1 pt -65.84 -43.26 93.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.931 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.52 -41.05 58.63 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -58.56 -45.9 88.01 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.247 -0.976 . . . . 0.0 108.717 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.7 ttt -72.98 -41.1 64.71 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.377 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 72.2 p -125.96 -24.26 3.8 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -53.54 -64.78 0.71 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.93 1.241 . . . . 0.0 110.54 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -77.14 -177.4 0.78 Allowed Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.54 137.41 25.87 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 N-CA-C 108.276 -1.471 . . . . 0.0 108.276 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.59 127.31 3.32 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.627 2.218 . . . . 0.0 114.415 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.7 mm -113.34 108.26 52.65 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.99 57.31 4.52 Favored 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.309 2.006 . . . . 0.0 113.725 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.3 m -59.48 -46.09 93.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-O 121.145 0.497 . . . . 0.0 109.975 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.92 -42.86 99.59 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.089 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.42 -45.24 95.13 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.339 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 mm -63.77 -48.63 85.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-O 121.318 0.58 . . . . 0.0 110.415 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -58.49 -49.45 77.32 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.142 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.41 -39.24 92.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.402 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -56.58 -43.34 79.93 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -62.73 -43.45 98.78 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.293 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 82.2 mt -58.25 -44.05 87.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.809 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.7 mt -59.23 -41.97 85.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.308 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.82 -42.63 99.8 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.57 98.42 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.55 -35.68 81.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -58.01 -45.35 87.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.55 -39.19 93.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.684 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.5 mm -60.55 -49.74 83.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.168 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.2 m -58.74 -36.0 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -64.73 -39.52 93.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 60.8 ttm -60.08 -47.27 86.59 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -68.82 -22.08 64.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.062 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 p -43.09 114.84 1.65 Allowed Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.357 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.25 -41.79 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.93 1.753 . . . . 0.0 113.943 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.9 p -138.53 167.56 21.67 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 40.1 t -87.4 146.92 25.67 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.308 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.8 tp -52.66 -35.55 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.35 -38.61 90.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.029 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -64.57 -27.44 68.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.263 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.82 121.31 13.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.364 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 85.9 mtp180 -142.56 132.38 24.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.754 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--O 1.235 0.34 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.647 -179.603 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.59 136.89 52.15 Favored 'Trans proline' 0 N--CA 1.508 2.33 0 C-N-CA 122.626 2.217 . . . . 0.0 114.223 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -60.38 -38.52 84.17 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -60.19 -50.12 74.92 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.674 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -61.48 -39.5 91.16 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.146 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -60.29 -50.61 72.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.753 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.62 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.501 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -58.32 -51.23 70.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.345 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.27 -38.91 91.73 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.498 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -57.8 -48.69 78.98 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -67.87 -38.8 83.54 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.235 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -58.71 -47.49 84.39 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 98.2 m -64.94 -38.38 90.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.85 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.48 -47.8 84.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.716 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 . . . . . 0 CA--C 1.514 -0.421 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.182 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 99.2 m95 . . . . . 0 C--O 1.235 0.336 0 CA-C-O 121.159 0.504 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 54.8 mtt -63.1 -47.22 83.75 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.547 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 86.5 m -60.45 -48.81 80.16 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.478 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.04 -49.22 78.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.996 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 74.8 p -70.66 -44.81 66.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.148 0.499 . . . . 0.0 111.493 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.34 -36.41 84.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.975 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 65.0 tp -46.86 -51.52 16.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.651 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.06 -40.39 13.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.166 0.508 . . . . 0.0 111.859 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.8 -48.2 82.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -86.8 -1.57 57.88 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.541 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.74 158.87 33.83 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.814 0.34 . . . . 0.0 111.677 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -69.85 152.77 95.92 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.147 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.81 -43.37 31.85 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 122.751 2.301 . . . . 0.0 115.993 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.2 -45.27 93.74 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.871 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 41.1 t -71.88 -40.07 69.18 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -49.83 -34.32 19.4 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.888 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.2 m -58.87 -49.97 75.78 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.606 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.4 -46.3 87.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.654 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.08 -50.72 68.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.203 1.001 . . . . 0.0 108.609 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.38 -37.03 79.46 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.385 -1.279 . . . . 0.0 107.777 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -58.2 -40.01 80.49 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.176 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 88.9 mt -61.97 -36.72 82.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.74 -164.9 41.6 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.82 171.93 11.45 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.188 2.592 . . . . 0.0 112.463 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.63 -130.35 48.14 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 59.88 109.8 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.274 0.559 . . . . 0.0 110.435 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.1 p -62.49 158.4 17.96 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.289 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 65.9 tp -56.77 -38.44 72.47 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -57.19 -49.25 76.55 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -59.96 -42.4 93.99 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 119.626 -0.83 . . . . 0.0 108.966 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.9 mtt -62.43 -45.73 91.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.199 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 25.9 ttt -65.84 -44.93 84.03 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.24 0.543 . . . . 0.0 110.355 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.2 m -62.78 -47.63 82.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.53 0.681 . . . . 0.0 110.201 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.89 -44.19 97.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.326 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 92.6 m -61.54 -39.43 91.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -58.11 -38.55 76.68 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.088 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.79 -39.11 93.34 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.1 m -92.65 3.42 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.609 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.257 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.661 179.211 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.486 1.047 0 N-CA-C 108.949 -1.212 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.9 pt -54.9 109.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.504 0.668 . . . . 0.0 110.837 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -132.44 126.84 55.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.345 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -65.33 121.5 14.96 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -74.0 -170.07 0.86 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.182 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.85 -39.41 85.08 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.35 -23.41 66.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.365 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.61 -7.78 57.99 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -71.79 125.65 27.7 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.7 mtt -75.71 133.69 40.7 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.312 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.4 t -127.98 129.91 69.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.804 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -78.14 109.87 12.61 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.04 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -107.71 157.09 18.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.11 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.63 150.08 38.07 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.051 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.7 pt -65.51 143.02 16.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 120.966 0.412 . . . . 0.0 110.435 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.0 t -62.14 120.3 56.78 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.53 -36.07 69.16 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 120.763 0.976 . . . . 0.0 110.104 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -58.85 -48.28 81.91 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.723 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.7 p -66.64 -39.03 88.07 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.035 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.9 tp -59.0 -50.09 75.44 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.072 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -59.16 -41.81 89.28 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.405 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.13 -42.1 98.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.588 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.1 t-105 -58.16 -48.73 79.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.44 -44.3 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.336 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.84 -40.02 83.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.255 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.08 -45.19 88.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.48 -37.72 80.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.126 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -53.94 -46.94 71.7 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.641 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -89.53 -39.24 13.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -120.65 38.23 4.08 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.78 -54.19 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -95.76 -5.74 41.29 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -53.94 140.23 51.45 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 118.561 0.618 . . . . 0.0 111.571 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.82 -29.68 34.83 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 122.563 2.175 . . . . 0.0 113.275 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -59.32 -21.69 60.13 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.542 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.73 -43.35 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.131 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.7 mt -45.09 -61.19 2.44 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.844 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.43 -42.25 66.97 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 120.072 1.062 . . . . 0.0 111.803 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.2 ttt -61.53 -44.14 97.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.726 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -54.82 -47.74 73.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -58.79 -43.54 90.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.809 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.85 -46.23 89.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.379 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.67 -26.11 64.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.254 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.0 m -88.14 6.7 35.25 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.483 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -62.65 125.1 22.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.617 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.66 10.67 83.08 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.961 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.1 150.74 35.62 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.12 0.486 . . . . 0.0 112.221 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.1 p -98.91 148.75 34.99 Favored Pre-proline 0 C--O 1.216 -0.677 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.694 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -45.08 -36.63 11.94 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 121.577 1.518 . . . . 0.0 112.923 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -69.74 -64.55 0.86 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.792 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.472 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -59.69 -37.37 78.63 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 122.378 1.085 . . . . 0.0 108.565 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -61.78 -46.81 87.97 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.243 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -59.19 -38.59 80.2 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 84.9 m -60.38 -40.12 89.74 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.045 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.72 -48.4 81.27 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.046 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.84 -41.46 95.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.229 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.49 -37.74 84.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.14 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.3 m -65.22 -34.81 79.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.327 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.5 t -55.34 151.3 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.44 -144.51 4.49 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.69 -127.65 45.74 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 119.926 -1.131 . . . . 0.0 110.545 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -54.26 -11.12 0.45 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.636 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -43.57 -24.36 0.11 Allowed 'General case' 0 C--O 1.234 0.286 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.33 -44.09 68.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.58 97.86 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.781 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 58.0 ttm -56.14 -22.39 28.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.397 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -57.04 -35.06 68.86 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 63.3 ttp -56.71 -46.9 80.99 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 tt -58.38 -38.31 77.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -55.68 -42.58 75.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.73 -40.19 88.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.699 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.9 m -57.75 -45.59 85.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.403 HD12 HG23 ' A' ' 73' ' ' ILE . 88.2 mt -59.99 -41.57 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.093 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -59.96 -41.82 92.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.399 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.34 -47.3 86.52 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.235 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.74 -37.24 85.82 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.428 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.44 -42.38 91.81 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.223 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.91 -51.58 57.44 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.88 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.53 -43.23 94.67 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.592 0.71 . . . . 0.0 110.203 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -60.77 -50.52 73.14 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.955 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -58.42 -37.68 75.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -63.14 -43.68 97.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.096 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -176.487 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 . . . . . 0 C--O 1.238 0.495 0 CA-C-O 121.201 0.524 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -88.9 155.35 50.06 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.468 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -39.99 103.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.136 0 C-N-CA 122.477 2.118 . . . . 0.0 114.386 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -99.05 158.45 15.65 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.99 -52.7 44.99 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.772 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.8 m -63.46 -36.63 84.38 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 117.553 0.676 . . . . 0.0 109.701 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.31 -38.75 81.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.022 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.23 -30.82 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 119.487 -0.885 . . . . 0.0 108.938 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.28 -20.53 37.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.158 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.97 -0.97 89.44 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.2 p -63.95 -25.89 68.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.5 p -117.13 4.46 12.7 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.146 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 t -110.75 130.26 55.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.532 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.6 p -74.82 164.37 26.64 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.5 tp -59.38 -46.66 88.03 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.48 -41.78 94.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 117' ' ' TRP . 54.2 tp10 -61.51 -46.34 90.39 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.882 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -61.66 -43.21 99.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.398 0.436 . . . . 0.0 111.289 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.8 tt -66.03 -44.07 92.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.048 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.76 -42.37 79.66 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.416 ' CB ' ' O ' ' A' ' 113' ' ' GLU . 12.4 t90 -58.49 -45.77 88.04 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.165 -1.018 . . . . 0.0 109.275 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.9 ttt -72.5 -41.91 65.44 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.582 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 66.6 p -125.32 -24.85 3.88 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -58.81 -49.06 79.09 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 118.317 -1.353 . . . . 0.0 109.324 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.18 179.52 1.86 Allowed Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.91 135.5 36.11 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -35.84 114.74 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.866 2.378 . . . . 0.0 113.5 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mm -106.88 109.04 62.89 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.47 57.75 4.96 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.951 1.767 . . . . 0.0 112.872 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.4 m -58.78 -43.28 87.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.09 -42.49 98.09 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.442 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.21 -45.15 93.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.322 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 89.0 mt -63.47 -49.47 82.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.05 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -59.3 -48.2 82.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.219 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.17 -40.43 93.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.687 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -57.41 -43.08 83.44 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -60.8 -44.63 96.59 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.04 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 84.7 mt -58.52 -43.86 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.286 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.99 -41.69 87.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.759 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.63 -45.49 86.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.308 0.575 . . . . 0.0 110.044 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.74 -43.1 98.15 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.16 -36.79 84.81 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -58.67 -45.28 89.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.81 -39.69 94.85 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.494 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.1 mm -61.1 -49.97 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.9 m -58.09 -36.81 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.2 ttm105 -65.51 -38.67 90.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.803 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -60.58 -46.36 90.53 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -67.78 -25.49 65.63 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.73 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.3 t -43.78 111.93 1.22 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.972 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.74 -21.43 7.12 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.96 1.773 . . . . 0.0 113.761 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 70.8 p -138.18 167.57 21.56 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.1 m -107.18 149.47 27.67 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.949 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.1 tp -48.98 -36.54 8.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.589 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.1 tp -66.76 -39.62 87.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.43 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.61 -12.37 57.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.609 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 90.1 mt -79.45 123.33 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.411 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -152.5 154.95 36.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.077 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 . . . . . 0 C--N 1.327 -0.372 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.321 -179.631 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -62.36 143.09 93.15 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.15 1.9 . . . . 0.0 111.218 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -57.44 -33.47 67.96 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -61.32 -45.91 92.49 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -60.29 -45.35 93.67 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.74 -50.57 71.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.341 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.7 -46.75 95.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.421 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -61.57 -51.97 66.36 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.203 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -63.05 -43.69 97.94 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.048 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -58.55 -48.11 81.97 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.559 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -63.36 -37.33 86.87 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.625 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -59.42 -48.67 80.77 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 95.4 m -66.28 -39.5 89.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 7.7 tt -55.89 -37.81 69.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.137 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.9 ttt-85 . . . . . 0 N--CA 1.443 -0.789 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.049 179.593 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 44.9 m0 . . . . . 0 C--O 1.242 0.699 0 CA-C-O 121.408 0.623 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 61.9 mtt -61.98 -41.6 98.21 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.204 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 61.1 m -60.0 -43.5 95.14 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.855 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -57.92 -48.33 80.2 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.694 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 77.5 p -72.08 -43.55 64.65 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.833 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.2 mp -66.93 -31.29 71.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.344 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.3 tp -51.82 -49.28 63.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.08 -45.18 18.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.89 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -59.11 -48.84 80.14 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -70.12 -24.93 63.27 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.66 145.27 54.97 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.556 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -59.48 143.53 85.78 Favored Pre-proline 0 C--N 1.346 0.447 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.487 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.46 -44.33 47.83 Favored 'Trans proline' 0 N--CA 1.504 2.131 0 C-N-CA 122.786 2.324 . . . . 0.0 115.477 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.38 -46.41 90.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 118.766 -1.173 . . . . 0.0 110.437 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 42.5 t -66.16 -43.13 87.84 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -49.62 -27.27 4.38 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.74 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 91.1 m -59.65 -49.35 78.09 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.602 -0.839 . . . . 0.0 108.778 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 4.5 tp -77.3 -38.37 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.746 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -44.11 72.12 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.03 -38.08 89.7 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.732 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.69 68.12 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.966 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.31 -35.32 67.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.75 171.33 44.08 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.668 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.06 146.95 97.03 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 123.49 2.794 . . . . 0.0 113.357 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.16 1.28 87.78 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.43 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -64.62 136.02 56.55 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.259 0.552 . . . . 0.0 111.695 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.4 m -68.83 139.29 55.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.0 tp -57.03 -44.12 82.59 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.246 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.2 -45.38 87.69 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -58.69 -42.3 88.23 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.5 mtt -63.51 -43.84 96.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.944 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 60.3 ttm -62.16 -50.11 73.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.52 0.676 . . . . 0.0 110.162 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.2 m -64.75 -45.43 86.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.064 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.05 79.12 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.109 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 97.8 m -64.69 -36.68 85.07 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.6 -36.76 76.91 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.986 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.73 -42.15 91.03 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.21 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.56 -18.27 6.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 117.179 0.489 . . . . 0.0 111.325 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -178.329 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo . . . . . 0 N--CA 1.482 0.794 0 N-CA-C 109.13 -1.142 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.1 pt -65.42 113.78 2.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 109.891 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.0 t -126.27 126.71 69.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.187 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -63.58 127.57 31.95 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -83.96 -172.69 4.3 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.52 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.85 -38.04 80.99 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -66.71 -22.9 66.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.131 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.69 -7.96 57.95 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -73.21 126.35 29.86 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.985 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.2 mtt -81.56 135.22 35.58 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.005 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.5 m -133.1 134.1 58.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.518 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -57.27 142.23 43.94 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.008 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -144.63 144.21 31.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.746 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.17 143.07 50.65 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.6 pt -61.87 142.42 16.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -61.07 118.68 38.23 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.23 -36.7 78.73 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 N-CA-C 109.734 -0.91 . . . . 0.0 109.734 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -58.44 -48.27 81.25 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.149 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.6 m -61.05 -46.18 91.73 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.96 -58.36 5.01 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.843 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -58.35 -39.19 78.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.843 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.4 98.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.511 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -58.74 -50.68 73.02 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.546 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.3 t -62.74 -42.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.492 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.99 -42.89 91.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.371 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.8 t -58.74 -44.32 89.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.29 -35.95 75.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.772 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -53.7 -46.71 70.83 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.679 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -92.28 -35.14 13.93 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.698 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.22 37.84 4.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.778 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.14 -53.62 3.94 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -96.96 -5.93 36.72 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -51.7 138.87 31.31 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.224 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.91 -31.89 46.4 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.392 2.061 . . . . 0.0 112.709 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.04 -18.75 26.44 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.935 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.82 -42.48 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.925 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 mt -44.86 -60.67 2.84 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.814 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.95 -42.4 67.06 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 CA-C-N 119.985 1.03 . . . . 0.0 111.857 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.1 mtp -61.17 -43.41 98.93 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.672 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -56.03 -47.77 77.22 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.9 t -58.6 -44.69 89.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.042 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.77 -44.77 93.71 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.518 0.675 . . . . 0.0 110.114 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.72 -25.12 63.7 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.022 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.4 m -87.04 6.4 32.67 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.612 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.84 125.33 23.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.562 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.41 11.22 76.12 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 116.35 -0.387 . . . . 0.0 112.605 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.52 149.57 40.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.7 p -99.99 148.93 35.5 Favored Pre-proline 0 C--O 1.215 -0.722 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.622 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -45.81 -38.2 17.43 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.543 1.495 . . . . 0.0 113.323 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -70.37 -62.78 1.26 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.649 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.471 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -58.15 -36.73 73.43 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.12 -45.36 93.8 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.429 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -57.91 -37.86 74.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 84.8 m -59.47 -41.86 90.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.652 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.9 mtt -49.69 -50.08 45.04 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.274 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.09 -42.75 68.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.798 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -60.68 -40.72 93.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.799 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.3 p -68.73 -26.53 65.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.89 158.54 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.87 -149.72 5.08 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.43 -127.54 45.43 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -51.21 -10.55 0.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.044 -0.578 . . . . 0.0 112.171 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -41.8 -24.34 0.04 OUTLIER 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.68 -42.97 75.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.91 94.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -56.92 -28.04 61.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.471 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -56.38 -35.41 67.69 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.8 ttp -58.07 -44.99 87.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.22 -40.71 86.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -54.26 -41.57 68.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.75 -41.53 95.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.7 m -59.28 -42.62 91.67 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.9 mm -60.01 -44.16 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -60.63 -41.87 95.77 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.194 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.71 -45.94 91.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.448 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.26 -39.25 94.07 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.23 -41.59 97.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.072 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.4 -50.46 69.76 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.447 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -64.23 -41.52 96.97 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.048 0.928 . . . . 0.0 108.94 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 78.5 t90 -60.37 -38.84 85.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 113.91 -1.496 . . . . 0.0 109.36 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -53.67 -45.33 70.25 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -66.64 -40.62 88.81 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.424 0.63 . . . . 0.0 110.946 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -176.427 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 . . . . . 0 C--O 1.237 0.443 0 CA-C-O 120.951 0.405 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -70.42 151.18 95.7 Favored Pre-proline 0 C--O 1.237 0.446 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.96 112.95 3.53 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.446 1.431 . . . . 0.0 113.675 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -73.4 171.52 12.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.23 -48.97 61.64 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 119.111 -1.518 . . . . 0.0 109.884 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.3 m -60.65 -38.04 83.51 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.579 0.704 . . . . 0.0 109.517 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -59.61 -38.74 82.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.592 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -31.39 28.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.78 -21.35 26.56 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.276 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.17 -6.93 82.37 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.7 p -57.6 -22.82 47.44 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.1 p -119.55 29.87 7.38 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.632 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.9 m -129.53 135.05 48.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.279 -0.569 . . . . 0.0 112.393 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.2 m -76.86 145.31 38.43 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tt -50.03 -45.96 52.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.154 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.07 -39.33 92.02 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.065 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.04 -40.36 96.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.289 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.37 -50.18 74.63 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.4 pt -70.67 -24.31 25.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.809 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.07 -65.91 2.65 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.451 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.437 ' C ' ' CD1' ' A' ' 117' ' ' TRP . 2.0 p90 -61.62 -31.44 71.53 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 118.125 -1.43 . . . . 0.0 109.137 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.6 ttt -63.59 -45.14 91.75 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.8 m -115.26 -26.7 7.52 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -58.87 -72.61 0.1 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.085 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -73.74 -177.01 0.54 Allowed Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.61 141.6 15.0 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 120.641 1.265 . . . . 0.0 109.459 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -46.16 123.94 6.99 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.671 1.58 . . . . 0.0 113.766 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.415 ' HB ' ' HD1' ' A' ' 117' ' ' TRP . 47.3 mm -114.91 107.97 49.38 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.84 60.13 4.06 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.909 1.739 . . . . 0.0 113.943 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.6 m -51.57 -37.34 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.73 99.67 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.423 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.46 -45.71 89.56 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.472 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 90.2 mt -64.71 -48.67 83.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.569 0.699 . . . . 0.0 110.17 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -59.01 -48.98 79.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.021 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -63.02 -39.03 93.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.886 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -57.43 -43.19 83.64 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -62.69 -43.2 99.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.837 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 78.9 mt -58.43 -42.84 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.525 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.03 -41.6 83.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.78 -44.24 93.98 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.26 -42.57 97.36 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.52 -35.7 81.33 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -58.09 -44.51 87.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.67 -37.89 87.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.415 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.2 mm -60.77 -48.32 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.75 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.8 m -59.27 -34.76 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 118.42 -1.312 . . . . 0.0 107.471 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -65.83 -39.18 90.56 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.4 ttt -58.88 -45.44 90.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -74.89 -15.32 60.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.321 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.1 t -49.3 115.67 5.01 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.72 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -84.12 -30.35 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.107 1.871 . . . . 0.0 113.812 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.3 p -138.01 170.94 15.17 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 39.1 t -105.68 148.22 27.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.638 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.4 tp -49.46 -38.41 12.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.549 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.7 tp -65.6 -39.33 91.43 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.556 0.693 . . . . 0.0 109.798 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -67.64 0.32 3.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.553 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.8 mt -100.65 119.0 48.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.025 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -145.93 132.04 19.35 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.8 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 . . . . . 0 C--O 1.237 0.428 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.407 -179.491 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.28 136.19 23.85 Favored 'Trans proline' 0 N--CA 1.512 2.579 0 C-N-CA 123.171 2.58 . . . . 0.0 113.613 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -61.51 -28.17 69.12 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -61.96 -50.94 70.09 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.775 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -64.92 -40.26 94.78 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -59.2 -50.86 72.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.395 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.76 -43.82 97.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.8 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.68 -59.16 5.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.058 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.44 -40.75 97.59 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.073 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -57.69 -47.1 83.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -62.5 -41.77 99.05 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.542 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -59.75 -40.29 87.65 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.092 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 93.6 m -62.63 -41.89 99.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 82.6 mt -60.69 -39.45 88.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 . . . . . 0 N--CA 1.448 -0.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.002 -179.648 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 . . . . . 0 C--O 1.242 0.693 0 CA-C-O 121.243 0.544 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 74.0 mtm -62.84 -41.29 99.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.947 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 54.4 m -59.46 -46.05 89.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.148 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.46 -47.05 86.99 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.513 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.3 m -67.49 -49.54 63.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.315 0.579 . . . . 0.0 112.007 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.35 -32.29 73.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.876 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 62.9 tp -51.03 -46.36 61.57 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 85.2 t -85.79 -46.16 16.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.028 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -60.31 -49.44 77.61 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -70.37 -22.55 62.76 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.705 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.74 153.75 10.16 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.621 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -68.99 148.5 97.89 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.74 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.23 -41.98 67.7 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.377 2.051 . . . . 0.0 114.376 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.62 -50.0 75.56 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.447 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 10.5 t -70.0 -37.77 75.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -47.11 -26.89 1.21 Allowed 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.092 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 69.0 p -62.49 -55.06 31.11 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.421 -1.312 . . . . 0.0 108.455 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.0 mm -65.07 -45.66 93.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.154 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -51.5 65.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.057 0.932 . . . . 0.0 108.834 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.31 -36.55 78.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.71 82.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.747 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -57.46 -44.38 84.74 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 119.421 -0.911 . . . . 0.0 108.713 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 79.43 175.57 47.66 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.085 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.73 150.95 79.98 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 124.011 3.141 . . . . 0.0 113.38 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 81.06 0.27 88.54 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.6 119.2 13.48 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.178 0.513 . . . . 0.0 110.382 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.2 m -61.07 139.36 58.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.1 tp -54.82 -46.08 74.5 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.604 -0.838 . . . . 0.0 108.873 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -55.41 -48.11 74.88 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.482 0.658 . . . . 0.0 109.332 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -57.76 -42.47 84.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 58.9 ttm -63.01 -45.72 91.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.75 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 61.8 tpp -61.99 -45.64 92.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.9 m -62.54 -49.75 74.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.74 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.72 95.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.708 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 78.3 m -61.02 -40.81 94.99 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.67 -40.85 97.86 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.087 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.12 97.92 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 23.9 m -82.59 -23.61 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.675 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.567 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.844 178.788 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.485 0.984 0 N-CA-C 108.837 -1.255 . . . . 0.0 108.837 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.6 pt -67.62 119.32 13.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 110.071 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.47 138.07 48.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.505 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -69.71 125.01 25.44 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.958 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -78.33 -172.46 2.85 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.201 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -58.77 -38.18 77.92 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.44 -22.87 65.48 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.594 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.33 -7.75 58.46 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.77 127.78 33.82 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 120.171 -0.611 . . . . 0.0 109.524 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.3 mtt -77.14 127.19 32.21 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.763 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 82.3 t -126.27 128.61 71.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.553 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -61.75 142.55 57.19 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.035 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -145.34 146.83 31.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.218 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.82 143.04 49.62 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.265 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.4 pt -61.81 144.25 14.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 120.902 0.382 . . . . 0.0 110.609 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 t -62.05 120.35 56.94 Favored Pre-proline 0 N--CA 1.453 -0.313 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -53.56 -36.9 82.17 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 N-CA-C 109.492 -1.003 . . . . 0.0 109.492 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -57.8 -48.49 79.56 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.164 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 84.1 m -60.84 -47.15 87.67 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.231 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -57.03 9.04 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.905 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -58.3 -39.31 79.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.778 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.03 98.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.197 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 22.1 t-105 -59.06 -49.76 76.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.483 0.658 . . . . 0.0 109.505 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.39 -40.3 88.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.095 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.4 -49.02 79.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.554 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.3 m -61.95 -35.55 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.713 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.7 t -66.83 -36.22 76.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.0 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -53.61 -47.07 70.54 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.579 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -89.42 -37.47 14.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -120.68 38.06 4.12 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.954 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.9 -51.16 5.64 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -96.11 -4.59 42.51 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.8 m -55.05 145.93 41.7 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.741 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.25 -32.59 20.38 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.486 2.124 . . . . 0.0 112.437 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.61 -20.07 30.37 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.886 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.69 -41.88 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.754 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.7 mt -45.72 -61.22 2.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.872 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.78 -41.61 76.47 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 CA-C-N 120.176 1.099 . . . . 0.0 111.729 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 58.8 ttm -59.69 -46.87 87.77 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.338 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -55.07 -47.49 74.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -58.2 -44.48 88.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.719 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.67 -44.77 93.46 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.097 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.6 -22.61 62.53 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.138 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.7 m -87.66 5.81 37.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.593 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.9 126.16 26.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.742 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.01 11.23 69.77 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 121.315 -0.469 . . . . 0.0 112.231 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.13 146.26 50.97 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 112.543 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.0 m -99.72 141.3 22.54 Favored Pre-proline 0 C--O 1.215 -0.727 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -46.36 -36.2 17.18 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 CA-C-N 120.789 1.318 . . . . 0.0 113.222 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -68.59 -63.9 0.97 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.301 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.453 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -59.82 -37.58 79.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.265 1.031 . . . . 0.0 108.737 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.07 -45.31 92.76 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.773 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -57.72 -39.69 77.87 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 86.3 m -59.91 -39.28 84.87 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.48 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 97.9 mtp -57.98 -48.27 80.48 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.153 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.6 mt -65.53 -41.78 92.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.826 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -61.54 -36.46 80.65 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.206 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.5 m -65.56 -34.45 78.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.924 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.7 141.72 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.026 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -130.6 -140.27 4.65 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.4 -127.89 46.06 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.743 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -53.08 -11.33 0.24 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.853 -0.673 . . . . 0.0 111.669 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -41.92 -22.78 0.02 OUTLIER 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.78 -41.52 70.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.78 98.1 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 57.7 ttm -57.28 -26.22 60.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.038 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -56.97 -35.24 68.92 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.3 ttp -58.01 -46.2 85.66 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -57.65 -37.88 74.13 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -56.26 -42.95 78.23 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.37 -40.15 93.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.294 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -58.88 -43.46 90.91 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.8 -43.04 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -59.99 -41.48 92.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.027 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.24 -47.07 84.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.869 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -61.79 -40.1 94.02 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.25 94.15 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.862 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.04 74.69 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.404 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.43 -38.56 90.26 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.903 0.859 . . . . 0.0 108.975 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.449 ' O ' ' HD2' ' A' ' 85' ' ' PRO . 76.2 t-105 -58.2 -45.92 86.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.659 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -49.8 -47.44 51.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.856 0.722 . . . . 0.0 109.136 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -64.0 -39.87 95.08 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.301 0.572 . . . . 0.0 110.892 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.14 -44.56 68.63 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -121.04 -60.6 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.229 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 85.1 Cg_exo -52.08 -33.08 51.77 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 CA-C-N 120.85 1.339 . . . . 0.0 111.343 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -77.88 -16.89 14.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.103 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -45.83 -30.01 1.54 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.52 -16.84 0.43 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.731 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.8 -114.03 4.1 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 106.437 -2.665 . . . . 0.0 106.437 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.82 141.12 97.65 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 119.347 1.573 . . . . 0.0 109.606 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -137.09 158.53 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.49 148.72 89.84 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-O 120.488 0.185 . . . . 0.0 111.363 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.39 168.27 25.19 Favored 'Trans proline' 0 N--CA 1.504 2.129 0 C-N-CA 122.976 2.451 . . . . 0.0 113.019 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.44 -7.41 68.7 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.974 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -123.95 152.74 42.14 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 122.618 -0.342 . . . . 0.0 110.589 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -60.28 136.47 58.05 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.525 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -56.14 121.09 8.63 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -56.53 141.64 71.72 Favored Pre-proline 0 C--O 1.238 0.465 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.8 111.72 0.98 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.25 1.3 . . . . 0.0 113.035 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.39 167.32 21.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.28 -43.28 89.47 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 119.072 -1.537 . . . . 0.0 109.788 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.4 t -61.0 -41.9 97.41 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.539 0.685 . . . . 0.0 109.232 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -61.94 -37.84 86.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.013 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.4 mm -57.7 -45.67 86.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.53 -17.64 64.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.55 0.16 89.28 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.1 p -64.22 -21.77 66.7 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.986 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.2 p -127.41 33.27 4.89 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.4 p -137.88 145.74 42.54 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.651 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.0 m -82.91 145.41 29.42 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -49.74 -44.94 48.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.61 -40.93 96.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.545 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -63.7 -43.26 97.13 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.163 0.506 . . . . 0.0 111.152 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -58.4 -47.86 82.53 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.35 -40.6 88.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.306 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.68 -63.91 4.42 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.662 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.438 ' CD1' ' N ' ' A' ' 118' ' ' MET . 1.2 p90 -59.75 -29.25 68.03 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 117.731 -1.587 . . . . 0.0 109.654 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.438 ' N ' ' CD1' ' A' ' 117' ' ' TRP . 26.2 ttt -65.72 -45.01 84.3 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 82.3 p -119.55 -24.27 6.33 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -58.19 -70.72 0.13 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.776 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -76.54 -177.34 0.74 Allowed Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -48.23 136.3 24.77 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 CA-C-N 120.619 1.257 . . . . 0.0 109.541 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -38.26 119.84 0.4 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.874 2.383 . . . . 0.0 114.509 -176.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.0 mm -112.98 106.84 54.87 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.57 59.95 4.26 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.257 1.971 . . . . 0.0 113.712 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.8 m -48.99 -38.74 11.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.28 99.71 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.627 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.52 -47.18 85.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.308 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 89.6 mt -63.64 -48.76 85.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.511 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -59.05 -48.56 81.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.909 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -62.38 -38.06 88.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.592 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -58.73 -42.09 87.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -62.3 -43.83 97.92 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.64 -45.26 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.62 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.404 HG22 HD13 ' A' ' 135' ' ' ILE . 87.4 mt -59.14 -41.85 84.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.87 -42.53 99.8 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.23 -42.26 98.61 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.98 -36.21 83.23 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -58.45 -44.49 89.22 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.37 -38.9 91.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.557 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.4 mm -60.49 -49.64 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.0 m -57.74 -35.56 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -65.1 -39.83 93.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -59.2 -45.12 91.91 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -70.71 -22.06 62.49 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.442 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.7 t -43.03 106.59 0.49 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.538 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.01 -32.88 8.21 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.107 1.872 . . . . 0.0 113.758 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.9 p -137.95 172.6 12.69 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.3 m -104.98 149.99 25.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.125 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.4 mm -49.92 -42.03 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.9 tp -60.33 -39.26 86.46 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.19 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.85 -11.43 55.59 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.633 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.8 mm -75.71 119.95 24.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.82 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -152.93 134.1 14.18 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -94.79 134.25 37.61 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.007 0.432 . . . . 0.0 111.665 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -90.7 158.17 25.96 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.7 -33.44 96.48 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.64 1.56 . . . . 0.0 111.275 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -81.13 -17.76 48.76 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.164 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -79.39 146.63 66.64 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.28 139.34 11.62 Favored 'Trans proline' 0 N--CA 1.507 2.271 0 C-N-CA 123.577 2.851 . . . . 0.0 114.267 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.439 ' HB3' ' HA ' ' A' ' 224' ' ' PRO . 26.3 t80 -59.28 -26.72 65.2 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -62.67 -51.44 67.23 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.811 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.27 -37.93 86.62 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.713 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -60.24 -50.56 73.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.674 0.75 . . . . 0.0 109.857 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.7 -45.0 96.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.304 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -60.49 -51.51 69.13 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.948 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -66.24 -39.37 89.48 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -58.78 -49.49 77.48 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -66.36 -36.25 82.42 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.299 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -58.27 -47.89 82.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 96.6 m -68.5 -39.39 81.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.133 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.24 -39.38 72.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.025 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -59.3 -41.72 89.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.307 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -80.87 -11.2 59.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.03 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -57.88 140.45 51.91 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.179 0.514 . . . . 0.0 111.705 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -71.93 -93.72 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.432 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -43.29 139.47 1.93 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.805 0.812 . . . . 0.0 112.082 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 70.8 m -64.8 178.11 0.84 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.955 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -48.8 -21.73 0.68 Allowed 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.025 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -56.15 -46.88 79.12 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 86.8 t -89.45 -56.51 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.921 176.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -42.33 -51.22 4.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.167 -1.378 . . . . 0.0 112.448 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -59.58 -44.55 93.31 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.741 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -60.9 -50.11 74.76 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.724 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 91.1 mmm -62.56 -43.89 97.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.177 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 62.1 m -61.09 -45.75 93.43 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.609 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.81 -48.29 80.17 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.205 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 96.7 m -67.35 -47.27 70.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.236 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.9 -31.55 71.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.838 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.4 mt -52.38 -43.4 64.7 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.309 -0.957 . . . . 0.0 108.892 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.3 t -85.72 -47.82 16.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.817 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -61.06 -49.38 77.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -70.12 -22.7 62.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.704 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.52 150.86 25.74 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -68.97 153.71 95.81 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.184 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.09 -45.68 34.06 Favored 'Trans proline' 0 N--CA 1.509 2.393 0 C-N-CA 122.544 2.162 . . . . 0.0 115.521 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.76 -50.22 74.68 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.554 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 36.4 t -69.4 -39.34 78.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -49.02 -32.12 8.8 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.427 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.9 m -59.71 -48.79 80.29 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.935 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 48.2 mm -67.67 -43.14 86.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.466 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.87 -39.67 86.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -61.35 -38.99 88.94 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -59.73 -40.1 86.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.478 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.76 -41.23 90.57 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.911 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.77 -159.18 52.59 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.779 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.19 166.49 5.71 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 123.5 2.8 . . . . 0.0 112.557 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.76 -126.35 40.68 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 56.73 96.62 0.02 OUTLIER 'General case' 0 C--O 1.238 0.48 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.332 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 76.4 p -61.65 157.58 17.26 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.152 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.35 -34.84 61.95 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -61.64 -50.15 73.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.352 0.596 . . . . 0.0 109.799 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.99 -42.43 94.19 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.6 ttm -60.87 -46.84 89.03 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.415 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 1.7 mmt -64.11 -41.43 97.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.1 0.476 . . . . 0.0 109.753 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.8 m -63.36 -49.83 72.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.409 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.96 -43.75 94.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.51 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.4 m -60.48 -40.76 92.49 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -60.97 -41.82 97.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.11 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.0 -39.93 96.31 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 229' ' ' ARG . 34.4 m -91.95 6.04 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.903 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 70.34 18.85 75.51 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 120.27 -0.966 . . . . 0.0 111.842 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.419 ' N ' ' HD2' ' A' ' 224' ' ' PRO . . . -58.85 -42.16 96.48 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-O 119.038 -0.868 . . . . 0.0 112.128 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 161' ' ' PHE . 44.2 Cg_endo -69.04 -1.9 8.7 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.615 2.207 . . . . 0.0 112.809 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -98.85 -48.27 1.79 Allowed Glycine 0 CA--C 1.535 1.335 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -156.3 -49.0 0.08 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.263 0.554 . . . . 0.0 110.123 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -173.28 -158.85 0.1 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.453 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.23 -13.71 3.47 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.629 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 221' ' ' VAL . 66.7 mtp180 -50.67 128.39 20.41 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.732 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.8 m -37.43 -33.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 123.897 0.748 . . . . 0.0 112.568 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.431 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo . . . . . 0 N--CA 1.483 0.904 0 N-CA-C 109.349 -1.058 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.6 pt -77.78 125.06 37.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.5 t -127.63 127.4 68.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.457 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -63.66 126.15 26.62 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -81.43 -173.39 4.34 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.291 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.7 mt -59.71 -38.54 81.9 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.39 -21.7 65.59 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.566 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.49 -7.73 58.17 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -72.15 124.86 25.91 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.695 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.0 mtt -79.52 130.98 35.9 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.735 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.96 138.91 50.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 120.174 -0.611 . . . . 0.0 111.396 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -57.5 142.23 44.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.219 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -144.91 140.37 28.25 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.606 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.56 139.84 51.59 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.785 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.0 pt -61.87 137.24 24.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.558 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.7 t -60.28 122.76 69.33 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.637 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.36 -38.55 73.48 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 120.852 1.035 . . . . 0.0 110.973 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -56.91 -43.35 81.32 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.279 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.4 m -63.11 -46.81 85.58 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.74 -60.51 2.82 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.328 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -57.74 -39.42 77.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.891 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.51 -43.1 99.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.491 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -58.93 -50.2 74.94 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.56 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.5 t -62.07 -42.23 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.206 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.99 -41.95 88.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.027 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -58.74 -45.38 91.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 67.1 t -64.17 -37.12 79.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.844 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -55.56 -45.66 77.25 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.685 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -92.86 -27.75 16.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.85 38.25 3.56 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.697 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.82 -54.48 3.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -96.03 -5.75 40.33 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 t -51.81 139.2 31.86 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.208 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.98 -32.83 34.21 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.476 2.117 . . . . 0.0 112.959 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -57.98 -18.65 25.19 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.995 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.81 -42.74 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.834 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.0 mt -44.79 -61.18 2.36 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.853 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.38 -42.0 71.6 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 120.081 1.065 . . . . 0.0 111.732 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 20.7 ttt -60.63 -44.94 95.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.349 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -55.42 -47.1 76.48 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -58.41 -44.84 89.2 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.997 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.59 94.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.53 0.681 . . . . 0.0 110.2 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -70.44 -24.8 62.96 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.097 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.1 m -89.43 6.45 40.7 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.601 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.33 125.47 23.88 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.565 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.64 10.83 76.73 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.598 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.42 150.26 46.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.344 0.592 . . . . 0.0 112.354 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.8 m -99.72 142.38 24.51 Favored Pre-proline 0 C--O 1.217 -0.649 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.38 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -42.71 -38.82 6.8 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.466 1.444 . . . . 0.0 113.365 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -73.88 -61.32 1.89 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.041 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.93 -38.36 75.8 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 57.3 tp -64.9 -44.29 90.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.648 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -57.72 -39.97 78.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 92.9 m -63.09 -39.58 95.13 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.953 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 28.2 ttt -56.8 -49.37 75.55 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.99 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.9 mt -69.8 -40.38 76.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.518 0.675 . . . . 0.0 110.155 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.53 -37.75 79.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.987 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.33 -20.32 66.06 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.792 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.85 140.0 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.51 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.84 -151.84 7.88 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.1 -127.75 45.92 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.924 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -51.32 -10.0 0.08 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.813 -0.693 . . . . 0.0 112.287 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -42.99 -21.28 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.39 -40.46 71.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.11 97.78 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.413 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 11.3 tmm? -58.32 -20.17 41.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.488 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.3 tp-100 -58.22 -39.32 78.75 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.4 tmm? -59.56 -42.36 92.26 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HB3' ' O ' ' A' ' 66' ' ' MET . 61.3 tp -57.68 -40.7 80.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -59.15 -41.81 89.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.2 -39.64 93.1 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.81 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.1 m -59.83 -44.06 94.26 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.5 mt -60.82 -43.87 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -60.34 -41.91 94.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.483 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.06 -46.84 87.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.19 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -63.83 -38.6 91.69 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.86 -39.19 88.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.53 -51.24 63.89 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.845 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -64.8 -43.29 93.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.048 0.928 . . . . 0.0 109.468 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -61.2 -41.47 96.87 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.779 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -59.6 -43.07 93.84 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -60.53 -33.77 73.14 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.597 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt -108.53 -48.41 3.33 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.407 ' CB ' ' HD3' ' A' ' 85' ' ' PRO . 8.5 m-70 -72.28 -69.08 0.37 Allowed Pre-proline 0 N--CA 1.473 0.709 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -177.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.407 ' HD3' ' CB ' ' A' ' 84' ' ' HIS . 51.5 Cg_exo -58.24 -37.6 94.62 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 CA-C-N 121.578 1.599 . . . . 0.0 110.254 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.93 -14.66 3.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.724 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -45.98 -31.66 2.35 Favored 'General case' 0 C--N 1.348 0.503 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.71 -2.64 0.16 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.542 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 53.1 -116.22 5.38 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 107.776 -2.13 . . . . 0.0 107.776 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.36 145.75 92.52 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 CA-C-N 119.269 1.534 . . . . 0.0 110.405 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.2 tp -132.2 148.77 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.72 148.7 94.03 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -63.73 165.83 17.42 Favored 'Trans proline' 0 N--CA 1.508 2.357 0 C-N-CA 122.823 2.349 . . . . 0.0 113.048 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.37 -7.35 63.87 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.143 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -123.82 153.09 41.52 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.902 0.382 . . . . 0.0 111.085 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.1 mmt -63.17 146.34 53.54 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.498 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 -52.06 115.61 1.78 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.357 0.598 . . . . 0.0 109.555 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.78 156.42 86.93 Favored Pre-proline 0 C--O 1.24 0.565 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.096 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.24 128.76 14.86 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.921 1.748 . . . . 0.0 113.475 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.4 mtt85 -126.13 151.95 46.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.778 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -42.1 -61.32 2.38 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.479 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.7 m -61.34 -37.88 84.88 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 122.073 -0.663 . . . . 0.0 110.844 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.53 -38.1 86.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.865 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.0 tp -58.44 -31.47 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.578 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.24 -10.42 56.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.613 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.92 0.12 87.95 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 48.8 p -63.48 -23.99 67.63 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.06 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.8 p -123.92 18.75 9.33 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.746 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.5 m -119.21 131.17 55.79 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.34 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -70.94 147.54 48.62 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.3 tp -53.46 -44.69 69.12 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.287 -0.965 . . . . 0.0 108.448 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.43 -40.58 94.96 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.08 -43.51 98.67 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.19 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -62.78 -41.25 99.17 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.246 0.341 . . . . 0.0 110.979 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 34.7 pt -68.15 -41.83 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.924 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.99 -41.86 70.31 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -58.88 -46.16 88.48 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.013 -1.094 . . . . 0.0 109.102 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.9 ttt -71.39 -42.58 68.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.44 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.6 m -125.78 -26.9 3.42 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -58.43 -49.92 75.57 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 118.455 -1.298 . . . . 0.0 109.814 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -81.54 -177.88 1.05 Allowed Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.51 144.51 32.18 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 N-CA-C 107.105 -1.921 . . . . 0.0 107.105 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -45.86 124.0 6.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 121.348 1.365 . . . . 0.0 112.997 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.8 mm -113.47 108.33 52.28 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.72 56.86 4.21 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.958 1.772 . . . . 0.0 113.111 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.6 m -58.74 -45.75 91.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.63 -44.37 96.57 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.205 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.32 -44.63 95.29 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.973 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.09 -47.85 91.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.865 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -59.09 -50.13 75.26 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.912 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -61.91 -38.57 88.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.967 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -56.66 -43.67 80.61 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -63.35 -44.44 94.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.593 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 29.7 mm -58.33 -44.88 89.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.455 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 135' ' ' ILE . 88.8 mt -59.74 -42.44 88.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.16 -43.67 97.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.381 0.61 . . . . 0.0 109.615 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.32 -42.28 99.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.26 -35.9 81.88 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -58.32 -45.0 88.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.79 -38.64 91.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.473 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.4 mm -60.9 -49.8 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 16.7 m -58.28 -36.16 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -65.49 -38.79 90.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.822 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 63.7 tpp -59.74 -46.75 88.17 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -71.62 -15.62 62.25 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.215 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.3 t -49.07 116.94 5.98 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.846 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.46 -40.19 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.949 1.766 . . . . 0.0 113.539 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 58.3 p -138.38 169.04 18.49 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.2 t -92.26 148.53 22.07 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.471 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 17.5 tt -51.28 -36.45 17.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.43 -39.45 92.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.238 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -66.8 -9.84 41.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.492 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 81.6 mt -81.87 120.31 33.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.945 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -142.33 123.55 14.67 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.56 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -83.12 128.53 34.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.34 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -90.25 164.17 30.69 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -62.17 -28.19 79.36 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.041 1.827 . . . . 0.0 110.572 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.64 1.35 55.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.491 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -99.02 146.88 32.43 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.842 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.36 135.13 18.04 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.704 2.27 . . . . 0.0 114.019 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -61.55 -36.27 80.12 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -61.83 -47.7 83.9 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.087 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -61.33 -41.62 97.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.86 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -61.13 -50.4 73.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.788 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.14 -47.7 91.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.618 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.43 -50.99 70.57 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.28 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -64.85 -39.12 93.05 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.252 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.42 -50.21 74.5 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.08 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -69.49 -41.61 75.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.305 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -60.38 -46.33 90.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 91.9 m -65.21 -37.68 88.04 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.595 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.55 -49.15 78.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.314 0.578 . . . . 0.0 110.049 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -60.72 -43.77 97.45 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.69 -37.5 78.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.379 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -61.18 168.59 2.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.865 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -59.85 -163.52 0.01 OUTLIER 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -109.73 112.67 24.88 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 119.4 -0.92 . . . . 0.0 113.246 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 67.4 m -98.47 134.79 40.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -86.7 -65.49 1.01 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 117.033 -1.867 . . . . 0.0 110.366 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -88.48 -40.75 13.21 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 25.0 t -55.74 -29.08 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 113.239 -1.801 . . . . 0.0 109.82 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 178' ' ' SER . 87.1 tttt -59.73 -50.11 75.13 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 118.236 -1.386 . . . . 0.0 108.953 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -70.0 -43.32 71.65 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.987 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -64.07 -50.89 66.59 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.281 0.563 . . . . 0.0 112.257 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 59.9 ttm -60.67 -46.05 91.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.575 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 65.8 m -59.35 -48.68 80.71 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.976 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.25 -47.68 84.95 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.702 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 97.1 m -63.15 -48.03 80.18 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.98 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.2 mp -68.4 -34.18 75.56 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 17.1 mt -50.01 -45.88 52.26 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.142 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.0 t -81.37 -47.38 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.852 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -61.92 -50.77 70.83 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -73.21 -23.13 60.35 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.365 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.02 155.09 8.67 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.787 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -72.58 155.68 90.83 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.72 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.19 -39.78 82.04 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 122.454 2.102 . . . . 0.0 113.72 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -59.3 -49.33 78.25 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.808 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -73.51 -36.79 65.78 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -47.14 -37.88 10.66 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.741 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.3 m -60.3 -50.22 74.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.293 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.4 mm -68.11 -44.02 84.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.45 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 81.9 mt -59.12 -44.11 91.99 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -63.41 -38.1 89.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.46 85.97 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.976 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.34 -35.84 70.42 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.699 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.02 172.75 49.03 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.55 155.31 54.95 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 123.733 2.955 . . . . 0.0 113.459 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.39 1.78 88.81 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.469 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.42 128.15 34.7 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.279 0.561 . . . . 0.0 111.126 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 34.7 m -66.31 143.97 56.86 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.4 tp -54.32 -44.67 72.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -57.92 -46.96 84.2 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -58.12 -43.72 87.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 98.3 mtp -62.35 -46.14 90.03 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.957 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 98.3 mtp -65.22 -41.04 94.81 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.825 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.0 m -63.28 -50.02 71.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.512 0.672 . . . . 0.0 110.468 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.31 98.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.408 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 76.2 m -60.88 -40.35 92.67 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.29 -39.23 82.31 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.83 -38.83 92.98 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.3 m -94.59 4.52 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 120.713 -0.395 . . . . 0.0 112.022 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.29 19.54 79.8 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.831 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.41 ' N ' ' CD ' ' A' ' 224' ' ' PRO . . . -58.43 -43.81 95.62 Favored Glycine 0 CA--C 1.542 1.723 0 CA-C-O 119.376 -0.68 . . . . 0.0 111.929 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 223' ' ' GLY . 86.3 Cg_exo -47.26 -37.58 24.51 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.951 1.767 . . . . 0.0 111.047 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -79.32 164.97 49.92 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.346 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -46.84 -23.42 0.43 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -96.44 165.16 12.31 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -147.7 148.2 30.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.314 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 69.64 -71.07 0.13 Allowed 'General case' 0 C--O 1.238 0.487 0 O-C-N 123.758 0.661 . . . . 0.0 110.076 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.14 -46.01 95.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.4 tp . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.064 179.333 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo . . . . . 0 N--CA 1.49 1.268 0 N-CA-C 109.147 -1.136 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.0 pt -73.07 109.57 5.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.147 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.82 145.68 34.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -61.75 138.22 58.31 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.384 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -97.31 -170.8 2.08 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.482 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.08 -41.54 83.65 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -69.95 -17.86 63.33 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.867 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.5 -7.96 63.95 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -72.1 127.73 33.49 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.698 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.1 mtt -74.81 128.37 35.4 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -127.61 130.16 70.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.097 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -59.48 141.27 55.12 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.733 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -146.07 144.73 30.22 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.912 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.3 142.52 50.47 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.201 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.3 pt -62.24 141.83 17.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.83 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.0 t -60.68 119.76 46.83 Favored Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.0 -36.19 74.81 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 N-CA-C 109.434 -1.025 . . . . 0.0 109.434 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -57.18 -49.02 77.27 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.015 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.6 m -61.27 -47.12 87.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.266 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.54 -60.27 3.01 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.813 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -55.07 -40.7 70.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.687 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.37 97.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.429 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -58.25 -50.44 73.57 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.187 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.8 t -62.67 -43.11 98.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.875 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.37 -44.04 92.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.891 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.86 -45.88 91.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 31' ' ' ALA . 69.8 t -63.51 -36.34 75.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.745 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -54.46 -46.41 73.33 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.384 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -87.88 -33.57 18.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -130.46 40.05 3.56 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.918 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 27' ' ' VAL . . . -42.36 -50.03 5.1 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -95.12 -4.93 45.28 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.5 m -56.42 146.72 52.4 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.98 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.25 -34.97 11.98 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 122.661 2.241 . . . . 0.0 112.949 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -58.02 -18.57 25.05 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.914 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.0 -42.3 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.49 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.0 mt -47.16 -60.59 3.76 Favored Pre-proline 0 C--O 1.24 0.57 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.594 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.36 -42.15 67.48 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 119.971 1.026 . . . . 0.0 111.727 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.6 mtt -60.38 -44.51 95.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.496 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.66 -48.09 75.61 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.9 m -58.87 -42.88 90.51 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.824 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.22 -44.42 95.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.349 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.61 -22.45 60.97 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.388 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.0 m -88.27 5.89 39.57 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -61.88 125.89 25.43 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.857 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.15 10.74 74.3 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.804 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.99 149.34 39.32 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.1 p -99.76 147.78 33.88 Favored Pre-proline 0 C--O 1.213 -0.851 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.379 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.26 -38.1 19.59 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.391 1.394 . . . . 0.0 113.221 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -68.31 -63.46 1.05 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.367 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.462 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.7 m-20 -58.24 -35.85 72.33 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.501 1.144 . . . . 0.0 108.024 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.3 -48.86 78.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.104 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -58.18 -37.23 74.33 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 88.3 m -59.56 -40.83 88.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.455 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.0 -46.9 84.5 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.769 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.85 -39.71 87.68 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.689 0.757 . . . . 0.0 109.514 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -60.68 -39.59 89.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.439 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.4 p -67.34 -23.99 65.67 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.815 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.65 135.66 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.917 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.8 -149.17 7.54 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.13 -125.82 38.88 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.723 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -49.57 -12.62 0.07 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.326 -0.437 . . . . 0.0 111.675 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -42.65 -21.57 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.139 0.576 . . . . 0.0 112.177 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.13 -42.56 77.09 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.52 92.66 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 47.1 ttp -60.62 -28.68 68.71 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -58.14 -39.78 79.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.0 tmm? -60.75 -41.84 96.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.28 -39.43 75.69 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.483 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -60.14 -40.62 90.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.41 -40.28 95.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.235 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.0 m -59.64 -50.53 73.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.615 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.5 pt -67.75 -27.6 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.767 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -62.73 -43.27 99.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -63.38 -44.28 95.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.147 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.02 -37.13 78.87 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.398 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.88 98.92 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.776 -0.77 . . . . 0.0 108.965 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.47 -50.32 65.79 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.549 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.28 -41.69 98.7 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.85 0.833 . . . . 0.0 108.998 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.402 ' O ' ' HD2' ' A' ' 85' ' ' PRO . 77.8 t90 -61.55 -42.27 98.58 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.07 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.49 -39.16 75.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.71 -13.14 61.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.505 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.8 mt -106.85 -49.0 3.38 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -99.14 -68.96 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.563 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 98.7 Cg_exo -49.09 -26.88 11.26 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 CA-C-N 121.209 1.467 . . . . 0.0 111.029 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -54.02 -17.34 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.147 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -48.22 -38.5 18.55 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.148 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 167.72 123.21 0.01 OUTLIER 'General case' 0 C--O 1.238 0.455 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.27 -61.53 6.81 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.27 148.72 92.74 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.159 2.572 . . . . 0.0 111.704 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.9 tt -156.65 149.09 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.942 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.25 133.89 94.49 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.416 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.06 160.3 22.86 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 122.053 1.835 . . . . 0.0 111.687 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.93 -4.9 59.33 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.812 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -120.36 147.59 44.84 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 117.127 0.464 . . . . 0.0 109.884 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 63.2 mtt -65.01 142.47 58.42 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 120.893 0.378 . . . . 0.0 110.686 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -51.96 115.5 1.72 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.44 142.99 90.33 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.05 110.85 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.497 1.465 . . . . 0.0 113.498 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -83.15 169.92 15.31 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.47 -49.53 72.48 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.025 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.7 t -60.29 -40.55 90.87 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.746 0.784 . . . . 0.0 109.142 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.16 -34.43 76.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.428 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.43 HD13 HG23 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -53.78 -28.82 17.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.14 -14.11 26.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.347 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.86 -1.34 88.59 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.3 p -61.77 -20.28 63.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.7 p -127.96 33.06 4.83 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.503 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 t -134.66 131.69 38.04 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.935 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.6 m -65.82 146.14 55.11 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -53.25 -43.41 67.36 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -39.97 93.3 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.705 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -62.79 -44.54 95.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.971 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -53.58 -63.37 1.17 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.7 pt -59.2 -25.28 29.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.971 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.7 -64.56 3.74 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 118' ' ' MET . 1.4 p90 -64.13 -28.23 69.63 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.247 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.405 ' N ' ' CD1' ' A' ' 117' ' ' TRP . 33.1 mtm -68.22 -40.0 82.21 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.6 p -115.63 -23.11 8.88 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -63.83 -75.66 0.08 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.128 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.22 -176.21 0.45 Allowed Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.38 144.44 13.43 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 N-CA-C 108.779 -1.277 . . . . 0.0 108.779 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.4 127.33 13.24 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.678 1.586 . . . . 0.0 114.009 -175.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.6 mm -114.73 108.74 48.61 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 114.637 -1.165 . . . . 0.0 107.894 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -87.34 60.2 3.67 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.811 1.674 . . . . 0.0 113.553 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -50.1 -39.47 16.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.87 -42.94 99.58 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.037 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -60.44 -47.85 84.3 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.312 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.17 -47.91 87.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.466 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -59.2 -49.21 78.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.38 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -62.87 -37.96 88.95 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.659 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -57.83 -43.43 85.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -63.03 -42.72 99.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.645 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 80.8 mt -59.02 -43.9 90.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.112 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.06 -40.28 80.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.91 -45.11 90.78 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.223 0.535 . . . . 0.0 109.709 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.32 -43.31 97.41 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.12 -36.49 83.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -58.46 -46.48 86.5 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -64.79 -38.57 91.44 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.713 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mm -60.42 -49.87 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.8 m -58.23 -34.48 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -66.65 -38.27 86.52 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 67.7 ttp -60.07 -46.28 90.07 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -71.13 -16.72 62.57 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.1 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -47.97 112.31 2.14 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.52 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.72 -35.87 4.18 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.936 1.757 . . . . 0.0 113.818 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.3 p -140.24 172.32 12.9 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 44.5 t -98.7 151.04 21.18 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.852 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.6 mm -51.9 -41.92 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.29 -39.08 81.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.802 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -66.7 -10.05 42.68 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.494 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.8 mm -80.29 125.36 39.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.739 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -152.49 129.7 11.22 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.99 0.424 . . . . 0.0 110.089 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -86.29 131.92 34.11 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.218 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -90.91 155.7 23.95 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -53.41 -37.26 81.62 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.33 2.02 . . . . 0.0 111.889 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -87.22 -10.16 53.26 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.371 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -81.64 131.75 56.96 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.45 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -67.55 134.36 32.79 Favored 'Trans proline' 0 N--CA 1.508 2.364 0 C-N-CA 122.524 2.149 . . . . 0.0 113.174 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.418 ' HB3' ' HA ' ' A' ' 224' ' ' PRO . 37.4 t80 -58.73 -28.19 65.62 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.426 ' H ' ' HA ' ' A' ' 224' ' ' PRO . 41.9 ttm180 -63.76 -50.36 69.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.867 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -63.07 -40.23 97.06 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -58.65 -50.26 74.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.412 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.21 -49.23 82.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.712 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -59.5 -51.43 69.89 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.641 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -63.07 -41.69 99.49 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.089 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -56.41 -48.58 76.64 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -63.71 -37.38 87.12 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.231 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -58.05 -49.5 76.67 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 93.0 m -67.18 -38.24 85.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.861 0.839 . . . . 0.0 108.831 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 22.6 tp -55.46 -42.03 73.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.606 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -61.69 -42.49 99.0 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.535 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -64.65 -27.01 68.64 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.528 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -46.91 150.07 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.295 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -81.19 -92.63 0.05 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.706 -1.133 . . . . 0.0 112.424 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -42.21 146.28 0.32 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.06 0.934 . . . . 0.0 112.808 -176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 69.0 m -64.42 179.11 0.63 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.094 -1.412 . . . . 0.0 112.126 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -57.49 -22.79 46.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.329 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -55.31 -48.55 73.96 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 118.782 -1.167 . . . . 0.0 108.392 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.3 t -89.94 -51.22 12.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.328 1.061 . . . . 0.0 110.092 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -57.77 -46.51 84.46 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.19 -1.823 . . . . 0.0 112.991 -177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -60.3 -41.99 94.56 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.889 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -59.85 -48.52 81.37 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.464 0.649 . . . . 0.0 109.746 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 98.4 mtp -61.69 -40.68 95.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.441 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 58.1 m -61.3 -48.26 82.19 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.563 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.67 -49.06 78.02 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.278 0.561 . . . . 0.0 110.17 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 98.4 m -62.46 -48.69 78.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.16 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 81.8 mt -67.61 -35.83 79.68 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.79 -1.096 . . . . 0.0 112.898 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.1 mt -44.75 -49.19 10.72 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.17 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 11.3 p -81.27 -37.22 15.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.73 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -61.97 -50.03 73.75 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.12 -23.89 62.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.831 0.348 . . . . 0.0 111.767 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.15 145.75 25.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.638 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -66.1 152.6 93.58 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.31 -45.61 36.51 Favored 'Trans proline' 0 N--CA 1.508 2.367 0 C-N-CA 122.705 2.27 . . . . 0.0 115.727 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -59.68 -49.46 77.67 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 118.799 -1.16 . . . . 0.0 110.417 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 37.9 t -66.66 -38.98 87.96 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -48.79 -34.54 12.5 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.008 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 97.5 m -58.42 -50.36 73.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.185 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 26.2 mm -65.41 -45.21 93.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.596 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -53.9 -49.36 68.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.111 0.958 . . . . 0.0 108.858 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.64 -38.16 86.65 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.729 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -59.04 -39.43 81.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.913 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.15 -36.4 75.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 81.44 174.19 48.88 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.65 154.43 59.57 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 123.484 2.789 . . . . 0.0 112.902 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 86.91 -7.71 79.11 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.69 129.58 41.15 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.442 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.9 p -75.38 161.96 28.8 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.652 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 65.4 tp -59.6 -44.23 93.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.32 -50.3 74.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.162 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.6 -39.05 86.7 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.979 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 25.9 tpp -62.39 -50.58 70.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.938 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 15.2 tpt -63.25 -45.1 93.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.323 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.8 m -62.92 -48.43 78.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.85 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.73 -50.54 70.71 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.768 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 29.5 p -61.95 -30.61 71.03 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -64.85 -42.74 94.65 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.031 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.74 -40.42 98.76 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.006 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.67 -35.31 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 126.03 10.17 4.39 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.221 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -56.64 -47.64 83.23 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-O 119.114 -0.826 . . . . 0.0 113.498 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.426 ' HA ' ' H ' ' A' ' 162' ' ' ARG . 52.0 Cg_endo -70.29 -0.88 8.02 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 CA-C-N 120.274 2.037 . . . . 0.0 113.974 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -96.17 -51.25 1.77 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -156.11 -58.17 0.09 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.599 0.714 . . . . 0.0 109.71 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -140.25 -174.33 3.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.23 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -45.38 -51.05 11.79 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 123.153 0.283 . . . . 0.0 110.938 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -84.93 154.54 22.14 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.176 0.513 . . . . 0.0 111.599 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 9.6 p -55.53 -29.94 25.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.391 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.435 179.431 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 N--CA 1.488 1.191 0 N-CA-C 108.948 -1.212 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.8 pt -63.74 112.3 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.253 0.549 . . . . 0.0 110.169 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.37 140.8 45.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.65 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -65.81 124.07 21.47 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.968 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -81.72 -172.23 3.76 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.369 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.24 -38.96 85.05 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -66.85 -19.2 65.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.453 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.52 -8.14 68.79 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.41 127.01 31.96 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.497 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 89.1 mtp -72.2 128.1 34.6 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.8 t -126.61 128.84 71.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.747 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -64.8 139.19 58.74 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.351 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -141.62 155.08 45.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.246 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.28 146.33 34.88 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.238 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.3 pt -62.79 144.15 14.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.916 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.8 m -61.89 121.18 63.44 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.44 -38.86 83.31 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 N-CA-C 109.794 -0.887 . . . . 0.0 109.794 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -59.53 -47.91 83.69 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.871 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.0 m -61.11 -46.11 91.92 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.87 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.04 -49.14 77.9 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.245 0.545 . . . . 0.0 109.991 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -58.28 -42.3 86.25 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.22 -41.58 98.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.25 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -57.78 -49.42 76.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.6 t -62.08 -44.88 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.92 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -59.24 -42.78 91.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.529 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.4 t -57.6 -44.58 85.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.63 -38.25 82.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.982 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -55.18 -49.22 72.43 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.086 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -81.07 -44.6 17.76 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -120.46 39.52 3.72 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.73 -52.19 3.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -95.83 -4.79 43.12 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -55.52 146.28 44.96 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 118.951 0.796 . . . . 0.0 111.734 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.19 -32.19 17.23 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 122.47 2.114 . . . . 0.0 112.544 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.26 -21.62 35.61 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.269 0.557 . . . . 0.0 109.667 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.5 t -63.27 -40.77 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.487 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.4 HD12 HG22 ' A' ' 37' ' ' ILE . 15.8 mt -42.75 -61.27 1.77 Allowed Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.317 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.04 -33.12 52.03 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 120.799 1.0 . . . . 0.0 111.499 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.1 tpt -60.23 -48.15 82.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.374 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -55.77 -47.33 77.2 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.2 t -58.68 -43.89 90.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.89 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.05 94.02 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.04 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.7 mt -70.62 -24.53 62.75 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -91.34 25.94 2.4 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.561 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.6 126.17 30.56 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.161 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.29 11.21 75.56 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.055 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.28 150.67 43.37 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 111.915 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.9 p -99.3 149.12 35.53 Favored Pre-proline 0 C--O 1.218 -0.574 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.821 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -47.17 -37.44 23.64 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.192 1.261 . . . . 0.0 112.528 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -74.95 -62.51 1.52 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.61 -0.436 . . . . 0.0 112.139 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.429 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.77 -38.29 75.16 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.4 tp -64.36 -44.21 92.13 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.595 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -58.22 -38.72 77.37 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 87.7 m -61.07 -40.36 93.36 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.963 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.16 -47.96 81.74 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.865 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.6 -41.5 92.69 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.218 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -61.62 -38.31 87.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.117 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.28 -24.15 66.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.522 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.8 t -58.67 154.52 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.78 -149.49 5.21 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.7 -128.5 47.79 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.208 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -53.82 -10.87 0.34 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.99 -0.605 . . . . 0.0 111.756 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -43.57 -22.2 0.04 OUTLIER 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.22 -40.29 67.53 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.08 97.63 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.2 tmm? -57.32 -21.4 34.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.52 -37.15 72.55 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.1 tpt -58.17 -45.63 87.17 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -56.23 -38.14 70.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -43.51 71.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.6 -35.53 73.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.987 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -58.34 -48.74 79.6 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 pt -67.68 -28.51 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -62.28 -43.47 98.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.02 -42.33 97.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.121 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.66 -40.02 90.51 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.24 98.29 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.225 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.3 -50.3 72.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.064 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.9 -39.18 93.58 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.893 0.854 . . . . 0.0 108.768 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.479 ' O ' ' HD2' ' A' ' 85' ' ' PRO . 76.4 t-105 -58.39 -45.29 88.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.779 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -57.38 -40.49 78.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -71.88 -14.07 61.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.599 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.46 -48.95 3.25 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -97.22 -65.42 0.09 OUTLIER Pre-proline 0 N--CA 1.467 0.389 0 C-N-CA 119.987 -0.685 . . . . 0.0 112.523 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 82.9 Cg_exo -52.26 -29.41 38.01 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 CA-C-N 120.816 1.327 . . . . 0.0 110.212 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 p -54.79 -20.17 5.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.999 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -48.9 -32.66 9.33 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.449 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 168.76 107.15 0.01 OUTLIER 'General case' 0 C--O 1.238 0.448 0 O-C-N 123.415 0.447 . . . . 0.0 110.322 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.19 -62.9 5.78 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.17 143.51 90.14 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.88 2.386 . . . . 0.0 111.171 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.9 tp -150.22 144.53 17.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.84 149.4 93.2 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.915 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.12 161.24 46.73 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.66 2.24 . . . . 0.0 112.331 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.21 3.25 63.55 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.833 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -125.37 150.05 47.57 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 117.077 0.438 . . . . 0.0 110.682 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 53.6 mtt -67.33 152.66 45.32 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.353 0.597 . . . . 0.0 111.768 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -54.24 129.93 36.85 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.604 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -65.25 152.44 91.77 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.3 80.44 0.22 Allowed 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.216 1.944 . . . . 0.0 114.43 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -66.23 163.77 17.17 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.11 -44.29 96.45 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.6 m -61.38 -39.97 92.62 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.07 -41.37 92.27 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.49 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 37.3 mm -58.72 -45.95 90.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.08 -20.5 65.82 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.89 -0.75 89.45 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 76.1 p -60.01 -21.41 61.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 p -123.68 20.97 9.34 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.0 p -125.22 132.06 53.04 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.731 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -73.13 145.81 46.15 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.6 tp -50.98 -46.97 61.53 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.356 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.76 -41.29 97.49 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.29 -38.48 89.53 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.354 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -63.07 -42.08 99.57 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.824 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 35.0 pt -67.86 -42.14 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 118.907 -1.117 . . . . 0.0 111.06 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.26 -42.16 58.01 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -58.48 -44.71 89.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.2 ttt -73.29 -42.22 62.68 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.245 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 66.0 p -126.62 -23.66 3.7 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -56.11 -51.03 69.39 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.993 1.269 . . . . 0.0 110.279 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -81.14 -179.07 1.32 Allowed Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.05 143.65 17.67 Favored 'Trans proline' 0 N--CA 1.485 1.002 0 N-CA-C 107.441 -1.792 . . . . 0.0 107.441 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.85 123.85 4.23 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.849 1.699 . . . . 0.0 113.599 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.9 mm -113.64 108.41 51.76 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.79 57.34 4.4 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.273 1.982 . . . . 0.0 113.503 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.0 m -60.5 -44.49 96.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.515 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.3 -43.06 99.0 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.759 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.03 -44.89 94.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.63 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.5 mm -61.28 -47.54 93.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -57.87 -47.44 82.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -58.93 -41.85 88.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.785 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -57.72 -43.86 85.56 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -62.32 -45.54 92.77 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.765 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 32.3 mm -60.25 -46.67 94.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.424 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.61 -41.47 85.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 65.6 tp -60.52 -45.6 93.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.06 -41.14 96.35 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.35 -36.39 83.55 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -58.63 -44.83 90.13 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.49 -40.17 95.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.802 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.74 -49.26 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.353 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.7 m -58.02 -32.68 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.1 ttm-85 -67.98 -38.0 82.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 58.9 ttm -58.57 -44.15 89.65 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -74.84 -17.56 60.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.705 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.8 p -43.1 104.96 0.4 Allowed Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.39 -32.66 6.19 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.943 1.762 . . . . 0.0 113.673 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 70.6 p -139.35 173.04 11.95 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.6 t -106.72 150.12 26.6 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.887 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.6 mm -50.88 -46.51 29.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -59.4 -37.98 79.39 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.461 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -65.96 -5.04 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.216 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.6 mt -97.14 126.01 50.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.86 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -152.22 134.57 15.18 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.496 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -85.08 128.7 34.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -89.09 164.39 32.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.52 -36.18 78.07 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 121.831 1.687 . . . . 0.0 111.105 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -83.94 -17.15 41.6 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.497 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -77.88 146.78 72.82 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.927 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -81.46 135.82 9.53 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.654 2.236 . . . . 0.0 113.418 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -58.93 -36.8 75.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -59.86 -49.77 76.4 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.02 -40.65 94.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.517 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -58.92 -49.59 77.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.463 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.65 -45.77 98.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.473 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.01 -52.19 66.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.019 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.64 -39.75 91.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.666 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -56.71 -47.89 78.95 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -64.7 -36.59 84.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.943 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -57.98 -48.77 79.02 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 96.6 m -66.62 -38.91 87.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.729 0.776 . . . . 0.0 109.061 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 29.2 tp -56.42 -39.82 73.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.926 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -60.58 -38.87 86.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -76.53 -9.31 58.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.532 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -44.89 163.42 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.727 0.775 . . . . 0.0 112.573 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -104.73 -94.31 0.34 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.884 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -45.16 143.06 1.74 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.683 0.754 . . . . 0.0 111.643 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 67.9 m -51.77 166.74 0.13 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.002 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.71 -16.29 38.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.267 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.82 -45.23 82.43 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 43.9 t -89.33 -50.76 12.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.846 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -55.43 -46.74 76.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.897 -177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -57.35 -43.31 83.37 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.897 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -60.81 -47.25 87.18 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.436 0.636 . . . . 0.0 109.917 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 98.3 mtp -60.67 -41.04 94.28 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.079 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 66.4 m -60.44 -48.84 80.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.143 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.03 -47.72 85.11 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.01 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 99.0 m -62.09 -48.42 80.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.684 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.17 -21.69 58.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.42 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 67.2 tp -54.06 -49.97 67.79 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.625 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.7 m -87.33 -38.24 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.646 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.63 -45.96 92.09 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.958 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -80.27 -9.87 59.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.23 155.7 34.24 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -70.4 151.22 95.72 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.119 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.41 -42.91 63.49 Favored 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 122.316 2.011 . . . . 0.0 115.072 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.16 -60.49 3.79 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.538 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 49.4 t -62.16 -38.93 90.94 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -48.58 -34.64 11.87 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.856 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 99.3 m -59.92 -49.48 77.53 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 118.813 -1.155 . . . . 0.0 108.708 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.75 -45.01 96.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.016 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.79 -42.16 92.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.51 -38.9 91.75 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.47 83.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.278 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.0 -40.38 97.58 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.536 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.16 -160.49 53.3 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.999 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.05 165.91 4.65 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 123.822 3.015 . . . . 0.0 113.398 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.08 -123.85 33.7 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 64.86 99.29 0.04 OUTLIER 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.139 0.495 . . . . 0.0 111.231 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 50.9 m -57.76 144.27 38.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.2 tp -50.36 -40.96 50.89 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.223 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -57.98 -45.58 86.52 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.43 -42.23 91.42 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 5.5 mmt -61.58 -50.85 70.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.101 0.476 . . . . 0.0 110.961 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 59.3 ttm -63.69 -46.29 86.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.349 0.595 . . . . 0.0 110.574 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.8 m -61.8 -48.1 82.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.48 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -61.05 -45.13 96.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.994 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 92.1 m -61.35 -40.98 96.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -56.7 -38.65 72.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.23 -38.98 93.99 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.97 5.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 72.75 20.04 79.55 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.267 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.429 ' N ' ' CD ' ' A' ' 224' ' ' PRO . . . -59.52 -40.87 96.82 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 119.212 -0.771 . . . . 0.0 112.394 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 223' ' ' GLY . 82.6 Cg_exo -48.97 -29.26 15.05 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 CA-C-N 120.016 1.908 . . . . 0.0 109.863 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -90.28 -178.98 44.17 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -57.66 141.7 47.47 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.017 -0.696 . . . . 0.0 109.811 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt 55.93 -172.18 0.07 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.92 0.391 . . . . 0.0 110.714 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -106.36 19.32 20.69 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.602 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -64.47 140.42 58.87 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.329 -0.549 . . . . 0.0 109.787 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 31.6 m -39.24 -31.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 O-C-N 123.848 0.717 . . . . 0.0 112.104 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.589 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo . . . . . 0 N--CA 1.487 1.141 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.7 pt -71.21 110.11 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.403 0.621 . . . . 0.0 110.575 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.6 t -129.54 126.37 63.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.573 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -56.6 115.57 2.61 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.359 0.599 . . . . 0.0 109.847 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.56 -176.09 1.83 Allowed 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.281 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.99 -38.49 82.74 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.26 -19.51 66.0 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.731 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.25 -7.72 62.26 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -80.07 124.2 28.53 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.4 mtt -75.64 131.61 40.05 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.8 t -126.66 129.23 71.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.553 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -66.84 136.16 55.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.531 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -137.78 153.72 49.65 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.955 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.28 148.15 37.76 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.392 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.8 pt -62.44 144.48 14.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.173 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 m -63.68 121.98 73.87 Favored Pre-proline 0 N--CA 1.451 -0.399 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.15 -36.52 77.38 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 N-CA-C 109.507 -0.997 . . . . 0.0 109.507 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -57.63 -49.69 75.62 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.124 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 95.0 m -61.46 -46.14 91.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.458 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 65.8 tp -57.68 -49.9 74.96 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.832 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -58.47 -41.87 86.21 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.44 -41.67 98.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.751 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -57.55 -50.97 71.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.374 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.42 -41.84 94.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.365 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.74 -40.68 84.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.172 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -58.55 -44.09 88.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.41 -35.96 72.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.998 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -57.03 -43.7 82.15 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.403 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -93.65 -27.1 16.76 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.545 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.41 38.3 3.46 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.956 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.79 -54.13 3.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -96.63 -5.17 39.64 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.4 m -52.49 144.34 24.24 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 118.906 0.776 . . . . 0.0 111.508 -177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.26 -31.62 17.96 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.453 2.102 . . . . 0.0 112.706 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -59.08 -18.86 39.04 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.771 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.23 -41.27 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.944 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.4 mt -45.7 -60.79 2.99 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.237 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.23 -41.22 77.92 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 CA-C-N 120.001 1.036 . . . . 0.0 111.795 176.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.9 mtt -60.86 -44.21 97.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.798 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -56.92 -49.44 75.62 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.779 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.4 p -60.86 -38.88 87.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.721 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.66 -46.08 91.7 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.067 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.61 -27.13 62.9 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.221 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -85.84 12.32 9.37 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.216 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -64.76 122.54 17.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.522 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.99 10.47 84.05 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 121.428 -0.415 . . . . 0.0 112.896 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.96 149.1 41.56 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.165 0.507 . . . . 0.0 112.117 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.3 p -99.19 148.69 34.97 Favored Pre-proline 0 C--O 1.212 -0.901 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.412 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -45.74 -37.17 15.76 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.477 1.451 . . . . 0.0 113.558 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -70.29 -63.35 1.1 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.254 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -57.88 -35.81 71.51 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.4 -44.15 97.13 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.297 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -58.26 -38.05 76.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 88.3 m -61.21 -40.13 92.82 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.101 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 83.9 mmm -56.08 -46.49 78.99 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.581 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.78 -44.62 48.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.451 0.644 . . . . 0.0 111.145 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.25 -39.09 78.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.064 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 45.2 p -67.2 -19.69 65.6 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.999 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.79 154.48 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.741 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.65 -151.9 5.68 Favored Glycine 0 CA--C 1.535 1.338 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.96 -128.12 46.74 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.123 -1.037 . . . . 0.0 110.934 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -51.5 -10.59 0.1 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.956 -0.622 . . . . 0.0 112.11 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -43.46 -21.98 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.27 -41.09 68.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.13 96.36 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.3 tpp -56.78 -21.11 26.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.12 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -58.65 -38.4 78.03 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -58.58 -45.36 89.21 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.11 -43.04 66.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.086 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -59.62 -40.65 88.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -64.61 -40.78 96.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.593 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.7 m -60.17 -44.05 95.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.6 mt -60.33 -43.93 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -60.43 -42.13 95.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.444 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.23 -46.24 91.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.055 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.59 -39.21 93.81 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.66 98.51 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.435 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.29 -49.33 74.44 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.179 0.514 . . . . 0.0 111.186 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.22 -41.62 99.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 122.122 0.963 . . . . 0.0 109.1 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -59.62 -44.42 93.44 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.083 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -53.87 -42.53 68.69 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.4 -26.75 68.13 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.477 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.9 mt -98.3 -47.43 5.44 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -97.21 -69.52 0.05 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 119.003 0.82 . . . . 0.0 112.069 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.26 -23.5 6.98 Favored 'Trans proline' 0 N--CA 1.501 1.944 0 CA-C-N 121.316 1.506 . . . . 0.0 111.012 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 p -54.57 -14.68 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.095 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.9 t60 -47.07 -50.82 19.11 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 169.86 123.01 0.01 OUTLIER 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.528 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.58 -53.93 42.01 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -63.35 147.34 93.66 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.882 2.388 . . . . 0.0 112.606 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 tt -162.07 150.63 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.56 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.52 152.54 96.57 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.369 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.47 170.49 18.34 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.709 2.273 . . . . 0.0 112.066 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.42 -5.91 77.74 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -124.58 146.54 48.99 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.3 mtt -66.2 146.84 54.17 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.759 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -52.18 119.01 3.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -60.62 158.92 27.97 Favored Pre-proline 0 C--O 1.239 0.541 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.069 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -48.17 130.44 20.52 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.718 1.612 . . . . 0.0 112.207 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.73 154.06 34.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -44.09 -61.28 3.16 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.605 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.9 t -60.85 -39.03 87.59 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.667 0.746 . . . . 0.0 110.136 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -35.94 77.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.005 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.5 tp -59.37 -33.35 50.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.59 -28.06 64.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.21 -8.1 79.82 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.7 p -57.78 -23.71 53.68 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.0 p -114.79 8.51 16.09 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.684 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 62.0 m -111.79 131.34 55.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.078 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.0 m -71.04 156.03 40.11 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.8 tp -58.67 -47.83 83.16 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.244 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -61.61 -43.83 98.14 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.904 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.3 -39.38 86.75 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.192 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.619 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.5 pt -71.09 -39.76 74.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.952 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.33 -43.34 79.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -59.34 -45.15 92.16 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.915 -1.143 . . . . 0.0 109.084 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.2 ttt -72.04 -41.32 67.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.475 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.2 m -127.16 -26.4 3.11 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -57.4 -50.39 73.15 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 118.336 -1.346 . . . . 0.0 110.269 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.88 -178.23 1.13 Allowed Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 134.49 30.08 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 120.665 1.273 . . . . 0.0 109.224 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -36.77 116.72 0.16 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.681 2.254 . . . . 0.0 113.601 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.7 mm -108.83 108.54 60.82 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.5 58.92 6.0 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.146 1.897 . . . . 0.0 112.692 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.3 m -58.86 -45.08 91.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.956 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.18 -42.05 98.12 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.208 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.85 -45.89 92.74 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.415 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.84 -47.99 86.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.318 0.58 . . . . 0.0 110.415 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -58.59 -48.48 80.8 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.825 0.821 . . . . 0.0 108.858 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -62.89 -38.16 89.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.035 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.7 tpp180 -57.79 -43.18 85.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -62.71 -43.74 98.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.885 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.32 -44.57 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.933 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.37 -41.79 85.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.86 -42.42 99.75 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.25 -42.86 98.89 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.13 -36.47 84.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.7 -44.63 90.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.28 -39.5 92.67 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.607 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mm -60.58 -49.65 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.6 m -57.47 -35.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -65.15 -40.39 94.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 94.2 mmm -60.62 -43.09 97.9 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.329 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -71.61 -19.68 62.09 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.889 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.4 t -48.42 117.39 5.85 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.625 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -85.15 -25.03 1.87 Allowed 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 122.174 1.916 . . . . 0.0 113.67 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.1 p -138.97 169.66 17.39 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 40.8 t -107.43 148.9 28.54 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.985 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 tp -48.94 -36.38 8.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.5 tp -66.55 -39.48 88.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.609 0.719 . . . . 0.0 109.581 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -64.63 -26.36 68.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.153 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.21 108.36 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.071 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -144.85 122.62 11.9 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -85.87 125.58 33.42 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.217 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -87.77 166.37 35.74 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.64 -25.82 75.4 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.19 1.927 . . . . 0.0 110.711 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -82.68 -18.57 40.51 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.875 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -90.22 137.01 28.01 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.07 155.94 23.03 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.62 2.213 . . . . 0.0 114.598 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -60.16 -39.68 87.26 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.453 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.417 ' N ' ' HA ' ' A' ' 224' ' ' PRO . 56.0 ttp180 -62.99 -47.54 82.7 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.742 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -61.0 -43.34 99.03 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.907 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -62.15 -50.15 73.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.277 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.07 -44.53 98.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.545 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -62.11 -53.88 49.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.6 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 61.5 mtm-85 -64.62 -41.0 96.46 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.173 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -58.45 -48.8 79.54 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -64.92 -36.9 85.88 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.538 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -59.62 -48.1 82.99 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 97.3 m -64.89 -39.6 93.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.579 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 17.0 tp -58.37 -38.26 76.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.103 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 27.9 ttt-85 -64.69 -38.23 90.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.656 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.55 -10.68 58.13 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.977 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -51.05 167.58 0.07 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.737 0.78 . . . . 0.0 112.405 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -93.7 -93.07 0.17 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.842 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -44.95 148.75 0.51 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.453 0.644 . . . . 0.0 111.36 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 70.1 m -74.79 179.0 5.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.661 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -47.23 -25.55 0.96 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.842 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.28 -62.03 1.76 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.014 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 49.4 t -87.57 -43.47 15.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.813 0.816 . . . . 0.0 109.931 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -57.48 -48.59 78.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.13 -1.396 . . . . 0.0 112.806 -177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -60.81 -41.64 96.09 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.332 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -59.79 -48.86 79.98 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.603 0.715 . . . . 0.0 109.671 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 98.7 mtp -61.62 -40.33 94.46 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.027 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 60.4 m -59.69 -46.92 87.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.283 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.68 -47.71 84.55 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.797 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 98.0 m -64.23 -47.54 79.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.596 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.7 mp -66.82 -33.81 76.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.327 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 13.2 mt -49.43 -44.95 45.85 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.964 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.6 -47.52 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.553 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -61.48 -50.28 73.39 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -72.08 -25.9 61.95 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.311 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.08 156.97 10.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.304 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -70.63 152.88 95.22 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.081 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.28 -45.9 31.83 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 122.778 2.319 . . . . 0.0 114.708 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -54.6 -62.11 1.87 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.032 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 46.5 t -58.5 -45.09 89.44 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.857 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -48.95 -31.06 6.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.578 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.9 m -59.76 -50.59 73.24 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.679 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.5 mm -79.3 -30.14 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.697 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -55.1 39.02 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.58 -39.28 90.61 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.22 -32.5 66.58 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.92 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 56.2 tp -56.34 -38.47 71.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 96.61 160.1 32.0 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.778 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.0 156.05 66.45 Favored 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 123.594 2.863 . . . . 0.0 113.215 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 81.15 -0.34 87.64 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.532 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -68.37 136.82 53.96 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.458 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.6 p -76.22 160.81 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.886 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 63.3 tp -60.41 -44.03 96.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.94 -48.97 79.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.808 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.28 -43.43 92.52 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.0 ttm -60.33 -48.88 79.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.524 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 94.9 mmm -62.86 -39.07 93.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.5 m -61.69 -50.27 73.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.215 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.36 96.5 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.94 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 97.0 m -60.45 -40.44 91.17 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -68.62 -39.31 80.86 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.995 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.28 -40.66 92.21 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 12.4 t -95.09 -25.15 4.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-O 121.189 0.519 . . . . 0.0 110.598 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 115.03 97.66 2.16 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -139.78 -60.19 0.04 OUTLIER Glycine 0 N--CA 1.469 0.862 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.417 ' HA ' ' N ' ' A' ' 162' ' ' ARG . 34.6 Cg_exo -59.18 104.4 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.238 1.292 . . . . 0.0 109.674 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 87.98 -7.39 81.46 Favored Glycine 0 CA--C 1.54 1.599 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -106.15 116.3 31.7 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.02 0.41 . . . . 0.0 110.195 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -36.37 -42.47 0.33 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -178.31 31.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 118.991 -1.084 . . . . 0.0 112.939 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -65.68 -14.35 61.06 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.024 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 72.9 t -59.99 -44.72 95.31 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.215 -0.751 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.929 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.486 1.049 0 N-CA-C 108.987 -1.197 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.5 pt -62.31 109.85 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.494 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.1 t -128.88 123.58 59.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.486 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -57.13 110.63 0.87 Allowed 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.346 0.593 . . . . 0.0 110.003 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -68.5 177.78 2.28 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.011 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 pp -58.27 -33.45 69.42 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -63.18 -26.8 68.97 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.641 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.49 -7.19 53.55 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -85.73 124.72 32.56 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.894 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.0 mtt -73.75 134.49 43.47 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -128.62 130.07 68.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.813 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -68.19 136.27 53.35 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.518 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -137.9 153.6 49.52 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.254 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.86 142.95 40.0 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.985 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.9 pt -63.67 139.7 20.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.086 0.469 . . . . 0.0 110.488 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.0 t -61.01 126.09 85.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.82 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.09 -32.79 50.58 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 120.929 1.086 . . . . 0.0 109.884 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -58.76 -39.88 82.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 95.9 m -60.93 -46.2 91.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.732 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.1 mt -59.9 -45.02 93.87 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.64 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -60.55 -40.86 93.11 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.068 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.94 -46.65 80.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.284 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 42.3 t-105 -60.47 -50.69 72.57 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.878 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.89 -45.94 97.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.6 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.48 -43.5 98.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.364 0.602 . . . . 0.0 110.852 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.7 t -59.27 -46.56 92.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.165 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -69.52 -25.94 29.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.393 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -58.98 -45.13 91.33 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.738 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -91.62 -36.35 13.71 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -120.92 38.12 4.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.147 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.08 -51.64 4.49 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -96.11 -5.07 41.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.2 m -54.62 140.57 57.6 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 118.874 0.761 . . . . 0.0 112.22 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -59.93 -39.55 70.25 Favored 'Trans proline' 0 N--CA 1.507 2.265 0 C-N-CA 122.489 2.126 . . . . 0.0 112.817 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -54.15 -20.25 6.42 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.554 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.9 t -62.57 -43.56 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.62 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.4 mt -46.97 -61.38 2.83 Favored Pre-proline 0 C--O 1.24 0.578 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.084 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -53.62 -42.08 68.78 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 120.273 1.133 . . . . 0.0 111.781 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.0 mtp -61.41 -42.84 99.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.845 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -56.52 -48.84 76.37 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.8 t -59.23 -43.86 92.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.983 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.08 92.86 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.47 0.653 . . . . 0.0 110.069 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.4 mt -70.77 -25.64 62.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.459 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.9 m -89.53 7.76 34.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.785 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.22 128.41 35.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.573 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.76 10.54 76.79 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.58 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.67 149.86 38.05 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 111.973 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.9 p -99.05 150.29 36.56 Favored Pre-proline 0 C--O 1.218 -0.568 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.626 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.8 -39.55 18.82 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.492 1.461 . . . . 0.0 112.795 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -69.29 -63.35 1.08 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.349 -0.54 . . . . 0.0 112.018 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.461 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.96 -36.15 72.16 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.27 1.034 . . . . 0.0 108.405 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -62.18 -46.45 88.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.879 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -59.08 -37.46 77.16 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 85.5 m -58.6 -41.0 84.83 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.225 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.15 -46.07 89.33 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.298 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.8 mt -66.14 -41.84 89.91 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.814 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.97 -26.94 68.51 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.403 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 m -65.7 -34.64 78.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.238 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 t -59.13 163.54 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.199 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.6 -161.98 11.31 Favored Glycine 0 N--CA 1.473 1.109 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.43 -125.28 38.99 Favored Glycine 0 C--N 1.342 0.868 0 C-N-CA 118.867 -1.635 . . . . 0.0 109.774 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -48.37 -17.05 0.12 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.58 -0.31 . . . . 0.0 110.866 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -45.77 -21.71 0.14 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.324 0.25 . . . . 0.0 111.302 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.91 64.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.31 -40.55 96.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.0 mtt -63.74 -16.51 61.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.514 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -59.55 -39.05 82.73 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -60.62 -42.09 96.18 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -57.65 -39.28 76.67 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.096 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -60.63 -39.31 87.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.54 -40.48 95.68 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -59.39 -43.44 92.93 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 84.9 mt -60.78 -42.33 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -60.13 -41.8 93.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.486 -0.779 . . . . 0.0 108.97 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.32 -43.47 97.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.504 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.77 -40.47 97.39 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.73 98.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.564 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.1 -50.15 71.67 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.309 0.576 . . . . 0.0 110.87 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.81 -39.55 94.5 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.454 ' O ' ' HD2' ' A' ' 85' ' ' PRO . 62.8 t-105 -58.12 -46.32 85.8 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.678 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -55.71 -41.79 74.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -72.26 -14.18 61.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.095 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt -105.1 -48.72 3.65 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.431 ' HB3' ' HD3' ' A' ' 85' ' ' PRO . 4.3 t-80 -102.5 -58.52 0.09 OUTLIER Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 119.696 -0.801 . . . . 0.0 112.913 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 51.7 Cg_exo -58.22 -25.58 72.62 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.125 1.216 . . . . 0.0 109.29 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.3 p -55.32 -17.44 2.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.356 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -48.09 -36.52 13.33 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.476 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 163.12 117.06 0.0 OUTLIER 'General case' 0 C--O 1.239 0.505 0 O-C-N 123.621 0.575 . . . . 0.0 109.893 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.58 -54.62 36.35 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.04 148.57 91.46 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.934 2.423 . . . . 0.0 112.263 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -155.6 152.75 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.929 0.395 . . . . 0.0 110.746 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.18 135.36 93.46 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.06 157.07 35.94 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 122.236 1.957 . . . . 0.0 112.36 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.1 5.98 60.49 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.307 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -125.06 146.58 49.38 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.068 0.461 . . . . 0.0 111.052 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -62.48 147.02 50.08 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.624 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 -56.97 114.56 2.16 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -62.35 159.2 42.28 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.936 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.24 141.31 39.79 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.437 2.092 . . . . 0.0 114.043 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -138.44 160.14 40.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.292 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.11 -47.64 85.96 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 118.348 -1.882 . . . . 0.0 109.63 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.1 p -64.78 -39.04 92.95 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.992 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.91 -43.21 96.64 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.961 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.98 -37.89 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.69 -22.75 67.05 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.426 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.61 -3.26 69.31 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.4 p -67.53 -23.42 65.44 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.4 p -117.33 -2.32 11.61 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.154 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.0 m -105.45 131.42 52.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.726 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.8 m -70.65 151.47 44.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.82 -49.73 74.52 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.039 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.91 -40.43 88.79 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.69 -41.74 86.96 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -61.8 -37.68 85.29 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.5 mm -57.75 -62.03 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.291 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.71 -40.69 97.64 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -56.33 -44.94 80.47 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.4 ttt -72.67 -42.02 64.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.356 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 75.5 p -125.52 -23.89 4.0 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -51.72 -64.34 0.84 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.852 1.205 . . . . 0.0 110.429 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -76.71 -175.89 0.55 Allowed Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.24 143.82 14.06 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 N-CA-C 108.28 -1.469 . . . . 0.0 108.28 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.23 129.71 16.03 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.813 1.676 . . . . 0.0 113.526 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.7 mm -113.82 108.57 51.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.1 55.87 2.99 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.17 1.914 . . . . 0.0 113.431 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.7 m -61.1 -48.19 90.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.926 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.59 -42.51 98.8 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.603 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -62.18 -46.26 89.73 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.389 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 89.8 mt -63.61 -48.77 85.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.372 0.606 . . . . 0.0 110.517 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -58.25 -47.1 84.64 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.417 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -61.53 -39.99 93.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.486 -1.233 . . . . 0.0 109.596 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.29 -41.74 89.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 47.9 m0 -62.08 -43.8 98.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 85.8 mt -60.47 -44.44 96.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.973 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.56 -41.27 81.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.729 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.8 -45.13 94.08 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.609 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.93 96.96 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -63.41 -36.41 83.65 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -58.05 -44.73 87.59 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.26 -38.62 90.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.778 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.66 -49.49 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.2 -36.06 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -65.81 -38.79 89.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.6 tpt -59.13 -47.39 85.45 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -72.93 -12.75 61.07 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.195 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.4 t -51.09 117.47 8.87 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.578 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -78.4 -35.04 1.29 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.956 1.771 . . . . 0.0 113.555 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.1 p -139.81 172.47 12.73 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.7 m -105.62 151.54 24.24 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.861 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.7 mm -49.35 -43.4 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 tt -58.79 -39.86 82.35 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.78 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -67.71 -14.49 62.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.081 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.2 mm -80.04 113.67 19.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.388 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -144.0 128.31 17.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -90.1 125.35 35.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.763 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -89.39 166.38 33.2 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -62.19 -35.46 74.58 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.666 1.578 . . . . 0.0 110.312 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -77.12 -17.41 58.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.484 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -84.62 127.3 66.03 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.662 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 148.53 54.1 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.247 1.965 . . . . 0.0 114.116 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.74 -43.09 94.39 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.836 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.438 ' H ' ' H ' ' A' ' 225' ' ' GLY . 36.1 ttp85 -60.58 -46.61 89.59 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.68 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -59.86 -41.42 91.42 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.962 -1.095 . . . . 0.0 108.313 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -61.52 -50.45 72.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.126 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.32 -43.95 97.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.763 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.59 -56.37 20.59 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.63 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -62.24 -39.54 93.18 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -57.32 -47.62 81.06 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -64.39 -37.66 88.3 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.624 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -61.07 -45.35 95.11 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.719 0.771 . . . . 0.0 109.6 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 94.7 m -66.1 -40.2 90.59 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 16.7 tp -58.51 -38.98 78.84 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.323 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -61.51 -42.57 99.01 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.991 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -82.67 -10.65 58.83 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.205 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -49.78 167.73 0.04 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.592 0.71 . . . . 0.0 111.868 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -98.6 -93.57 0.25 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.494 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -44.57 143.8 1.25 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.675 0.75 . . . . 0.0 111.977 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 66.5 m -63.32 177.26 0.67 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.855 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -50.84 -27.28 7.05 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.051 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -51.65 -48.18 63.49 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 55.3 t -89.87 -61.23 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.175 0.988 . . . . 0.0 108.926 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -42.05 -53.08 4.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.552 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -59.46 -41.9 90.75 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.753 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -60.44 -48.87 79.87 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.577 0.703 . . . . 0.0 109.907 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.4 -41.21 96.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.289 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 66.7 m -60.54 -45.5 93.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.029 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -59.36 -49.86 76.2 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.813 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 97.6 m -64.62 -47.36 78.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.591 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.59 -37.56 87.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.28 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.4 mt -43.23 -54.0 4.79 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.013 0.435 . . . . 0.0 110.722 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 71.8 t -86.92 -40.62 14.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.947 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -59.76 -49.36 78.04 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 49.3 p30 -89.32 -4.96 57.91 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 119.074 -1.051 . . . . 0.0 112.087 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.31 162.98 24.0 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -66.85 150.83 97.48 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.624 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.2 -38.74 34.12 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.407 2.072 . . . . 0.0 113.588 -177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -59.51 -50.54 73.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.21 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . 0.412 ' HA ' ' HB ' ' A' ' 230' ' ' VAL . 53.2 t -64.19 -43.59 94.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.035 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -48.31 -30.27 4.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.847 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 92.6 m -59.47 -49.05 79.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.925 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.67 -30.23 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.156 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.94 -45.14 95.9 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.2 -39.45 94.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.001 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -59.05 -37.46 77.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.962 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 72.6 mt -59.78 -38.99 83.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.27 167.76 43.97 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.649 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.1 154.36 67.88 Favored 'Trans proline' 0 N--CA 1.507 2.32 0 C-N-CA 123.936 3.091 . . . . 0.0 113.871 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.19 16.3 80.8 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.749 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -79.9 135.54 36.45 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.094 0.473 . . . . 0.0 111.353 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.0 m -73.35 137.37 44.71 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -51.64 -39.32 57.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.25 -45.76 90.31 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.18 -42.18 90.24 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.7 mtt -62.7 -43.06 99.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.206 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 59.8 mtt -63.8 -43.54 95.98 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.682 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.1 m -65.86 -49.65 67.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.561 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.16 -44.53 95.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.031 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 81.0 m -61.32 -39.29 89.94 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.13 -36.68 83.79 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.174 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.37 94.35 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.49 -16.58 7.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.199 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 109.98 105.32 2.92 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -147.84 -62.05 0.01 OUTLIER Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.629 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -59.71 90.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 121.945 1.763 . . . . 0.0 110.211 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.438 ' H ' ' H ' ' A' ' 162' ' ' ARG . . . 100.16 -7.17 58.44 Favored Glycine 0 CA--C 1.537 1.434 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -178.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -105.37 124.79 50.13 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 122.558 -0.378 . . . . 0.0 110.711 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -30.31 -66.4 0.1 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.436 1.085 . . . . 0.0 113.409 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -163.11 28.13 0.09 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.056 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -66.21 -6.57 14.06 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.76 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 198' ' ' CYS . 53.2 t -59.04 -44.26 90.93 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.908 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.88 -179.666 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 N--CA 1.486 1.077 0 N-CA-C 109.408 -1.035 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.2 pt -75.85 125.61 35.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.481 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -127.18 130.0 71.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.877 -178.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.42 121.58 13.03 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -84.04 -174.12 5.1 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.349 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.86 -38.32 81.83 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -66.82 -23.37 66.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.353 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.42 -7.14 56.02 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -71.85 132.54 44.56 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.371 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.1 mtt -85.04 109.49 18.25 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.8 t -109.73 130.22 63.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.805 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -61.29 137.38 58.24 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.841 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -138.55 152.34 48.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.006 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.86 143.59 49.36 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.029 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mm -64.42 138.46 23.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.2 t -58.69 121.58 54.78 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.44 -35.21 64.85 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 120.87 1.047 . . . . 0.0 110.029 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -59.42 -43.65 93.03 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.0 m -62.01 -46.19 90.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.97 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.7 mt -57.96 -50.17 74.3 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.311 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.11 -40.59 90.2 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.571 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.4 98.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.693 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -59.75 -50.39 74.0 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.531 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.5 t -62.4 -42.66 96.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.175 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.82 -43.19 90.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.2 t -58.79 -44.41 90.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.1 t -64.79 -35.92 76.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.636 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -54.07 -46.94 72.14 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.515 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -91.09 -39.47 12.15 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.675 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -116.83 38.17 3.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.001 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.6 -54.37 3.24 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -175.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -97.06 -5.69 36.95 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -50.83 140.4 20.13 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.399 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.3 -32.46 41.53 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 122.432 2.088 . . . . 0.0 112.7 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -57.84 -18.9 25.16 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.002 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.47 -42.76 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.766 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.2 mt -45.96 -61.5 2.47 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.731 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.39 -41.53 75.86 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 CA-C-N 120.115 1.077 . . . . 0.0 111.569 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.5 tpt -59.66 -46.88 87.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.36 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -54.64 -48.65 72.02 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.2 m -59.48 -41.52 89.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.677 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.84 -44.67 93.97 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.094 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.58 -18.52 59.72 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.427 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -95.66 26.35 4.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.224 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -78.49 125.89 30.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.061 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.42 11.4 71.84 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.926 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.21 149.08 49.96 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.301 0.572 . . . . 0.0 112.036 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.2 m -99.55 142.74 25.16 Favored Pre-proline 0 C--O 1.218 -0.569 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.482 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -43.64 -38.69 9.39 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.328 1.352 . . . . 0.0 112.852 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -71.54 -63.72 1.06 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.407 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.9 m-20 -58.91 -38.58 79.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.988 0.899 . . . . 0.0 108.917 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.95 -49.31 73.07 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.597 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -57.74 -39.83 78.24 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 96.9 m -61.17 -41.93 97.65 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.799 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 41.9 ttp -59.32 -48.16 82.66 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.888 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.3 -41.93 98.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.095 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -59.07 -33.8 71.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.374 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.4 m -65.37 -32.94 74.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.238 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.5 t -58.96 142.85 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.525 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.07 -151.88 6.95 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.79 -128.27 40.19 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -53.47 -12.85 0.5 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.817 -0.192 . . . . 0.0 111.414 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -44.38 -21.54 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.54 -39.26 70.35 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.67 93.79 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.5 ttm -57.54 -21.59 39.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.777 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -56.38 -37.35 69.98 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.2 ttp -58.55 -45.92 87.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 tt -58.19 -39.9 80.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -56.84 -41.56 78.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.007 -1.077 . . . . 0.0 108.377 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.9 -40.18 94.68 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -59.74 -43.95 94.01 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.79 -43.03 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -60.76 -40.02 90.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.949 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.55 -43.57 98.48 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -61.67 -39.48 91.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.83 -42.87 99.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.693 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.2 84.4 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.393 0.616 . . . . 0.0 110.393 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.48 -39.78 95.36 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.547 ' O ' ' HD2' ' A' ' 85' ' ' PRO . 76.4 t-105 -58.53 -47.98 82.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.259 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -55.07 -41.0 70.97 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.82 -22.89 64.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.745 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.4 mt -101.01 -49.13 4.21 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -102.6 -62.56 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 119.668 -0.813 . . . . 0.0 112.777 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.547 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 68.4 Cg_exo -54.46 -20.86 21.89 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 CA-C-N 120.935 1.37 . . . . 0.0 109.841 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -50.94 -20.0 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.643 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -40.43 -68.51 0.17 Allowed 'General case' 0 C--N 1.347 0.457 0 O-C-N 123.37 0.419 . . . . 0.0 111.112 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -175.62 125.3 0.23 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.061 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.16 -52.11 55.21 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.64 146.06 38.15 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.569 1.513 . . . . 0.0 111.832 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.9 tt -156.28 153.24 7.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.789 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.7 152.56 96.19 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.811 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.04 162.49 42.48 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.483 2.122 . . . . 0.0 112.081 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.57 -4.39 69.36 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 121.108 -0.567 . . . . 0.0 111.783 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -118.16 141.52 48.4 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 116.883 0.341 . . . . 0.0 110.36 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.04 147.11 53.86 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.128 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -52.21 121.24 6.5 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -63.31 158.08 59.37 Favored Pre-proline 0 C--O 1.24 0.563 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.01 136.8 36.94 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.584 1.522 . . . . 0.0 112.872 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -134.67 139.11 45.01 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -43.22 -49.71 6.57 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.223 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -61.72 -41.21 97.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.325 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.87 -43.68 98.35 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.037 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.17 -41.5 83.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.4 -27.4 68.98 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.79 -7.89 80.59 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.3 p -60.13 -29.85 68.9 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.6 p -116.94 -7.69 11.36 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.981 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.1 t -99.28 129.15 45.48 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.205 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.7 m -72.85 146.29 46.33 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.5 tp -54.36 -47.44 72.6 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.375 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.4 -39.37 87.12 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.49 -40.62 97.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.199 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.2 -41.35 96.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.192 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 24.9 pt -63.77 -47.66 89.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 118.342 -1.343 . . . . 0.0 111.388 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.41 -41.67 66.66 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -57.78 -45.03 86.59 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.8 ttt -71.86 -43.77 64.92 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.451 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.8 p -125.92 -23.62 3.93 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -57.44 -50.77 71.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 118.535 -1.266 . . . . 0.0 110.206 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -83.57 -178.12 1.12 Allowed Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.79 144.04 21.48 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 N-CA-C 107.785 -1.659 . . . . 0.0 107.785 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.54 126.8 10.84 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.43 1.42 . . . . 0.0 113.421 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.1 mm -114.24 108.07 50.79 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.24 55.68 4.15 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.834 1.689 . . . . 0.0 113.341 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.6 m -59.44 -42.47 87.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.67 -45.05 96.6 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.768 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.63 -43.9 97.64 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.153 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.58 -48.07 89.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.443 0.64 . . . . 0.0 110.071 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -59.48 -46.85 87.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.522 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -60.69 -39.37 88.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.392 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -59.13 -43.09 91.96 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 50.6 m0 -62.4 -43.66 98.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.186 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 84.7 mt -61.76 -45.52 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.035 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.19 -42.6 87.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.25 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.38 -43.05 99.74 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.6 98.46 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.43 -36.75 84.78 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -58.29 -44.03 88.33 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.69 -38.31 88.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.748 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.6 mm -60.84 -49.37 84.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.611 -0.436 . . . . 0.0 112.031 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.6 m -58.34 -35.9 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -65.16 -38.99 92.32 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.3 tmm? -60.41 -47.51 85.79 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.443 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -71.44 -15.2 62.33 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.202 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.9 t -48.11 115.16 3.85 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.717 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.66 -41.85 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.979 1.786 . . . . 0.0 113.801 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 43.1 p -140.83 170.17 16.26 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 39.9 t -90.84 148.19 22.68 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.98 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 tp -50.17 -34.35 10.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.8 tp -65.06 -39.42 93.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.724 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.7 -11.3 44.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.837 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 88.2 mt -79.16 125.99 38.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.862 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -144.46 133.16 22.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.095 0.474 . . . . 0.0 111.016 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -66.86 105.5 1.62 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.634 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -69.64 159.91 53.09 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.977 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 228' ' ' ALA . 68.9 Cg_exo -53.82 -37.69 85.03 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 123.026 2.484 . . . . 0.0 112.785 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -109.31 22.91 15.21 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -96.75 136.84 21.5 Favored Pre-proline 0 C--O 1.24 0.588 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.198 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.86 136.55 16.84 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.203 1.936 . . . . 0.0 112.873 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -59.56 -34.74 73.06 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -60.19 -52.45 65.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.111 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.52 -41.47 98.5 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.874 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -59.49 -50.09 75.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.634 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.76 -46.66 96.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.13 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -58.47 -49.63 76.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.121 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.23 -41.58 99.12 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.581 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -56.53 -49.35 75.03 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.924 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -67.29 -37.43 83.37 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.825 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -58.6 -49.96 75.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.696 0.76 . . . . 0.0 108.974 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 94.6 m -66.83 -37.35 84.32 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.88 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 64.6 tp -59.28 -48.65 80.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.318 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -60.28 -45.56 92.91 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.81 77.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.236 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -54.11 164.46 0.63 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.725 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -60.66 -163.45 0.01 OUTLIER 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -109.4 110.29 21.39 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 118.866 -1.134 . . . . 0.0 113.271 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.407 ' HB3' ' HB ' ' A' ' 181' ' ' VAL . 66.3 m -101.22 133.48 45.73 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -87.33 -65.68 0.99 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 117.035 -1.866 . . . . 0.0 110.174 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -88.6 -40.76 13.11 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 178' ' ' SER . 24.9 t -52.3 -31.66 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.482 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -59.38 -46.8 87.65 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 119.444 -0.902 . . . . 0.0 108.683 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -64.54 -46.08 84.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.35 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -62.49 -51.12 68.69 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.25 0.548 . . . . 0.0 111.531 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 57.4 mtt -63.54 -45.33 91.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.7 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 73.0 m -60.65 -50.15 74.66 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.818 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.58 -49.4 76.8 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.187 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.5 m -64.41 -48.31 75.85 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.906 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.37 -37.85 88.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.992 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.2 mt -48.92 -47.88 43.08 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.467 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.1 m -86.18 -38.17 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.077 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.55 -50.12 72.59 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -74.79 -21.83 59.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.979 0.419 . . . . 0.0 111.347 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.56 150.84 25.99 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.222 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.94 138.8 97.6 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.36 -50.06 15.29 Favored 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 122.354 2.036 . . . . 0.0 116.145 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.402 ' CB ' ' HA ' ' A' ' 229' ' ' ARG . 97.3 m-20 -63.32 -44.02 96.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.982 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 37.0 t -67.96 -42.14 81.36 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -52.11 -28.57 18.21 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.105 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 87.7 m -59.09 -48.59 81.05 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -68.52 -43.93 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.865 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.6 -52.73 36.59 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.57 -39.82 95.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.923 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.17 -35.0 64.33 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.346 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 58.6 tp -58.73 -39.84 82.02 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 104.9 163.66 24.05 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.63 155.08 54.77 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.301 2.667 . . . . 0.0 113.321 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 71.81 15.19 75.84 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.31 138.1 47.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.035 0.445 . . . . 0.0 111.201 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 88.7 m -62.61 139.29 58.63 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 67.6 tp -54.86 -44.22 73.8 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.04 -46.52 85.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.03 -40.86 86.35 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 56.0 ttm -61.65 -50.02 74.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.124 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 63.8 tpp -62.1 -47.42 84.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.584 0.707 . . . . 0.0 110.171 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.5 m -61.56 -47.17 86.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.126 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.8 -46.35 90.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.987 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.68 -40.57 97.5 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -58.2 -38.33 76.55 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.862 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.67 -37.5 89.64 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 35.9 m -97.22 -4.71 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.5 14.23 57.29 Favored Glycine 0 CA--C 1.543 1.824 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.985 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.426 ' N ' ' CD ' ' A' ' 224' ' ' PRO . . . -59.35 -41.91 97.16 Favored Glycine 0 CA--C 1.553 2.437 0 CA-C-N 117.187 0.493 . . . . 0.0 112.742 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 223' ' ' GLY . 87.5 Cg_exo -50.59 -31.68 32.6 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.246 1.964 . . . . 0.0 111.647 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -78.01 158.91 46.87 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.917 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -56.5 108.94 0.54 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.2 tttt 172.8 143.31 0.04 OUTLIER 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.537 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 157' ' ' PRO . . . -72.41 -16.41 61.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.37 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.402 ' HA ' ' CB ' ' A' ' 197' ' ' ASP . 16.2 ptp180 -109.75 -178.27 3.49 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -177.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 4.0 m -52.21 -30.97 14.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 113.347 -1.752 . . . . 0.0 109.723 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.595 179.883 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.486 1.043 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.6 pt -57.42 108.26 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.342 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.01 133.54 19.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.18 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -60.97 136.42 58.08 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.38 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -98.38 -168.07 1.6 Allowed 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.657 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.67 -38.97 79.34 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -66.71 -23.32 66.1 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.237 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.4 -8.04 62.13 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.57 132.1 40.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.1 mtt -83.78 134.23 34.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.146 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.0 t -128.26 130.1 69.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.507 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -74.95 110.46 9.27 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.293 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -113.26 143.32 44.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.613 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.2 143.09 56.73 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.376 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.0 pt -60.57 144.57 13.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.721 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 m -62.76 122.76 76.38 Favored Pre-proline 0 N--CA 1.454 -0.26 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.877 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.58 -36.74 81.76 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 120.722 0.948 . . . . 0.0 109.738 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -56.75 -48.82 76.96 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.933 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.3 m -61.02 -46.94 88.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.042 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.9 -60.52 2.69 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.289 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -57.65 -38.79 75.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.821 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.35 98.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.457 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -59.05 -51.06 71.66 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.829 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.7 t -63.18 -41.84 94.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.379 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.07 -43.68 91.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.372 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.7 t -59.02 -44.98 92.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 31' ' ' ALA . 60.7 t -62.45 -37.0 77.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.94 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -54.31 -46.72 72.89 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.528 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -89.42 -30.7 18.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -130.91 38.44 3.69 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.871 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 27' ' ' VAL . . . -42.51 -51.26 5.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -96.02 -4.65 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.2 m -54.97 147.22 34.36 Favored Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 118.866 0.757 . . . . 0.0 111.772 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.72 -34.71 10.98 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 122.663 2.242 . . . . 0.0 112.831 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.64 -19.36 25.85 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.904 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.2 -41.77 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.608 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.1 mt -46.54 -61.31 2.76 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.279 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.74 -40.61 83.86 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 CA-C-N 120.111 1.075 . . . . 0.0 111.557 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.0 tpt -59.0 -48.13 82.71 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.25 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -56.0 -46.77 78.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m -57.72 -44.2 85.79 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.858 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.27 99.17 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.462 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.91 -26.5 64.19 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.926 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.4 p -87.44 1.18 54.16 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -54.56 126.16 22.59 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.734 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.12 10.95 78.93 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.597 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.33 149.23 46.29 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.327 0.585 . . . . 0.0 112.564 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.7 m -99.96 141.7 23.25 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.135 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -41.74 -38.68 4.62 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.436 1.424 . . . . 0.0 113.056 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -71.05 -64.12 0.97 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.196 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.5 m-20 -59.18 -37.61 77.79 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.327 1.06 . . . . 0.0 108.503 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.08 -47.89 82.65 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.826 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -58.12 -39.27 78.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 91.6 m -60.65 -39.93 90.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.404 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 97.8 mtp -57.39 -48.08 80.01 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.654 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.09 -40.62 94.86 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.799 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -60.54 -39.33 87.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.515 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.6 p -67.45 -19.04 65.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.896 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.2 t -61.18 152.97 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.587 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.54 -153.09 5.92 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.99 -128.16 46.85 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 120.363 -0.923 . . . . 0.0 111.018 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -51.93 -10.29 0.11 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.846 -0.677 . . . . 0.0 112.113 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -42.95 -21.7 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.14 66.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.6 96.29 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.6 tpp -57.09 -22.12 37.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.03 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -58.42 -38.11 76.75 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -58.85 -42.91 90.44 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.61 -40.86 76.07 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.498 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -58.18 -41.33 83.65 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.736 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.92 -40.4 95.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.499 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.5 m -59.61 -46.43 88.99 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.38 -41.06 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.305 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -60.33 -42.17 95.07 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.902 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.69 -46.03 90.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.996 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -61.43 -38.54 87.51 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.68 90.93 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.54 66.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.891 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.46 -43.75 96.47 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.015 0.912 . . . . 0.0 108.854 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -60.5 -39.82 89.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.613 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -54.32 -41.0 68.5 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -69.55 -20.56 63.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.832 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.95 -48.09 4.36 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -95.14 -67.14 0.08 OUTLIER Pre-proline 0 C--O 1.223 -0.34 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.676 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -51.17 -37.46 58.75 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 CA-C-N 121.626 1.617 . . . . 0.0 111.687 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 t -79.9 -12.17 13.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -42.63 -31.72 0.49 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.557 0.218 . . . . 0.0 110.45 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.1 4.82 0.55 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.082 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.7 -127.1 39.61 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.37 145.13 98.82 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 CA-C-N 119.352 1.576 . . . . 0.0 110.627 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.2 tp -126.94 149.65 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.99 155.0 85.2 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.79 167.35 27.46 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 123.028 2.485 . . . . 0.0 112.837 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.9 -10.17 60.34 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -125.25 154.43 41.67 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 122.602 -0.352 . . . . 0.0 110.774 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 62.0 mtt -61.77 146.38 49.61 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.18 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -51.37 116.41 2.05 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.337 0.589 . . . . 0.0 109.47 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.83 154.36 67.68 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.777 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.15 126.29 6.23 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.661 1.574 . . . . 0.0 113.118 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.441 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 1.1 mpt_? -115.55 151.32 35.1 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 113.773 -1.558 . . . . 0.0 107.774 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -49.35 -54.29 16.57 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.3 p -63.65 -33.94 76.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.875 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.441 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 82.9 m-20 -63.08 -39.86 95.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.857 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.5 tp -56.8 -31.92 36.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.72 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.1 -27.8 61.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.204 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.88 -8.2 80.22 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 108.441 -1.863 . . . . 0.0 108.441 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 71.4 p -62.31 -19.24 63.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.0 p -122.96 10.57 9.5 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.003 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.1 m -114.81 130.77 56.92 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.271 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 m -73.0 151.14 41.9 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.3 tp -54.54 -46.03 73.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -61.01 -40.63 94.29 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -61.87 -45.85 91.98 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.277 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -62.29 -41.94 98.93 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.142 0.276 . . . . 0.0 111.38 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.1 pt -65.84 -43.26 93.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.931 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.52 -41.05 58.63 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -58.56 -45.9 88.01 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.247 -0.976 . . . . 0.0 108.717 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.7 ttt -72.98 -41.1 64.71 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.377 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 72.2 p -125.96 -24.26 3.8 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -53.54 -64.78 0.71 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.93 1.241 . . . . 0.0 110.54 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -77.14 -177.4 0.78 Allowed Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.54 137.41 25.87 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 N-CA-C 108.276 -1.471 . . . . 0.0 108.276 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.59 127.31 3.32 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.627 2.218 . . . . 0.0 114.415 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.7 mm -113.34 108.26 52.65 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.99 57.31 4.52 Favored 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.309 2.006 . . . . 0.0 113.725 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.3 m -59.48 -46.09 93.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-O 121.145 0.497 . . . . 0.0 109.975 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.92 -42.86 99.59 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.089 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.42 -45.24 95.13 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.339 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 mm -63.77 -48.63 85.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-O 121.318 0.58 . . . . 0.0 110.415 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -58.49 -49.45 77.32 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.142 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.41 -39.24 92.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.402 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -56.58 -43.34 79.93 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -62.73 -43.45 98.78 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.293 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 82.2 mt -58.25 -44.05 87.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.809 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.7 mt -59.23 -41.97 85.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.308 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.82 -42.63 99.8 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.57 98.42 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.55 -35.68 81.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -58.01 -45.35 87.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.55 -39.19 93.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.684 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.5 mm -60.55 -49.74 83.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.168 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.2 m -58.74 -36.0 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -64.73 -39.52 93.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 60.8 ttm -60.08 -47.27 86.59 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -68.82 -22.08 64.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.062 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 p -43.09 114.84 1.65 Allowed Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.357 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.25 -41.79 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.93 1.753 . . . . 0.0 113.943 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.9 p -138.53 167.56 21.67 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 40.1 t -87.4 146.92 25.67 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.308 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.8 tp -52.66 -35.55 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.35 -38.61 90.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.029 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -64.57 -27.44 68.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.263 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.82 121.31 13.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.364 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 85.9 mtp180 -142.56 132.38 24.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.754 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -94.28 131.37 39.96 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.647 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -95.6 157.43 21.82 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.97 -42.83 56.23 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.749 1.632 . . . . 0.0 111.508 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -73.74 -18.96 60.92 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.611 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.65 131.95 59.49 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.282 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 225' ' ' GLY . 23.9 Cg_exo -64.59 136.89 52.15 Favored 'Trans proline' 0 N--CA 1.508 2.33 0 C-N-CA 122.626 2.217 . . . . 0.0 114.223 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -60.38 -38.52 84.17 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -60.19 -50.12 74.92 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.674 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -61.48 -39.5 91.16 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.146 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -60.29 -50.61 72.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.753 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.62 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.501 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -58.32 -51.23 70.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.345 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.27 -38.91 91.73 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.498 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -57.8 -48.69 78.98 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -67.87 -38.8 83.54 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.235 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -58.71 -47.49 84.39 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 98.2 m -64.94 -38.38 90.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.85 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.48 -47.8 84.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.716 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -59.95 -44.29 94.49 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.71 79.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.051 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -53.02 158.74 1.36 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.171 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -62.87 -162.4 0.01 OUTLIER 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -104.38 110.35 22.57 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 118.804 -1.159 . . . . 0.0 112.802 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 70.7 m -100.01 132.84 45.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -87.88 -66.66 0.89 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 116.984 -1.886 . . . . 0.0 110.186 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -88.77 -40.04 13.49 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 37.1 t -52.47 -29.35 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.052 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 178' ' ' SER . 63.1 tttm -58.9 -47.02 86.46 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.229 -0.989 . . . . 0.0 108.523 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -68.92 -41.48 78.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.215 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -65.42 -50.68 64.52 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.159 0.504 . . . . 0.0 111.227 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 54.8 mtt -63.1 -47.22 83.75 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.547 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 86.5 m -60.45 -48.81 80.16 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.478 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.04 -49.22 78.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.996 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 74.8 p -70.66 -44.81 66.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.148 0.499 . . . . 0.0 111.493 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.34 -36.41 84.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.975 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 65.0 tp -46.86 -51.52 16.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.651 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.06 -40.39 13.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.166 0.508 . . . . 0.0 111.859 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.8 -48.2 82.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -86.8 -1.57 57.88 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.541 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.74 158.87 33.83 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.814 0.34 . . . . 0.0 111.677 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -69.85 152.77 95.92 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.147 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.81 -43.37 31.85 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 122.751 2.301 . . . . 0.0 115.993 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.2 -45.27 93.74 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.871 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 41.1 t -71.88 -40.07 69.18 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -49.83 -34.32 19.4 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.888 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.2 m -58.87 -49.97 75.78 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.606 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 46.6 mm -66.4 -46.3 87.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.654 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.08 -50.72 68.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.203 1.001 . . . . 0.0 108.609 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.38 -37.03 79.46 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.385 -1.279 . . . . 0.0 107.777 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -58.2 -40.01 80.49 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.176 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 88.9 mt -61.97 -36.72 82.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.74 -164.9 41.6 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.82 171.93 11.45 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.188 2.592 . . . . 0.0 112.463 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.63 -130.35 48.14 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 59.88 109.8 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.274 0.559 . . . . 0.0 110.435 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.1 p -62.49 158.4 17.96 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.289 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 65.9 tp -56.77 -38.44 72.47 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -57.19 -49.25 76.55 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -59.96 -42.4 93.99 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 119.626 -0.83 . . . . 0.0 108.966 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.9 mtt -62.43 -45.73 91.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.199 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 25.9 ttt -65.84 -44.93 84.03 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.24 0.543 . . . . 0.0 110.355 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.2 m -62.78 -47.63 82.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.53 0.681 . . . . 0.0 110.201 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.89 -44.19 97.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.326 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 92.6 m -61.54 -39.43 91.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -58.11 -38.55 76.68 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.088 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.79 -39.11 93.34 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.1 m -92.65 3.42 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.609 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 75.19 17.11 80.27 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.661 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 224' ' ' PRO . . . -57.97 -44.48 94.5 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-O 119.515 -0.603 . . . . 0.0 111.808 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 223' ' ' GLY . 99.2 Cg_exo -47.76 -38.35 29.62 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.179 1.919 . . . . 0.0 110.64 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 160' ' ' PRO . . . -80.22 169.52 52.86 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.989 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -46.4 -26.82 0.91 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.765 -0.218 . . . . 0.0 111.551 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.27 121.19 21.81 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -88.49 30.09 0.93 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.422 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 176.31 174.33 0.35 Allowed 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 8.0 p -50.35 -27.86 4.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 11.6 tp . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.039 179.285 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.486 1.047 0 N-CA-C 108.949 -1.212 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.9 pt -54.9 109.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.504 0.668 . . . . 0.0 110.837 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -132.44 126.84 55.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.345 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -65.33 121.5 14.96 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -74.0 -170.07 0.86 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.182 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.85 -39.41 85.08 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.35 -23.41 66.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.365 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.61 -7.78 57.99 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -71.79 125.65 27.7 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.7 mtt -75.71 133.69 40.7 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.312 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.4 t -127.98 129.91 69.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.804 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -78.14 109.87 12.61 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.04 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -107.71 157.09 18.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.11 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.63 150.08 38.07 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.051 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.7 pt -65.51 143.02 16.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 120.966 0.412 . . . . 0.0 110.435 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.0 t -62.14 120.3 56.78 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.53 -36.07 69.16 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 120.763 0.976 . . . . 0.0 110.104 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -58.85 -48.28 81.91 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.723 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.7 p -66.64 -39.03 88.07 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.035 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.9 tp -59.0 -50.09 75.44 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.072 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -59.16 -41.81 89.28 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.405 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.13 -42.1 98.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.588 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.1 t-105 -58.16 -48.73 79.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.44 -44.3 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.336 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.84 -40.02 83.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.255 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.08 -45.19 88.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.48 -37.72 80.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.126 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -53.94 -46.94 71.7 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.641 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -89.53 -39.24 13.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -120.65 38.23 4.08 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.78 -54.19 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -95.76 -5.74 41.29 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -53.94 140.23 51.45 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 118.561 0.618 . . . . 0.0 111.571 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.82 -29.68 34.83 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 122.563 2.175 . . . . 0.0 113.275 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -59.32 -21.69 60.13 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.542 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.73 -43.35 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.131 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.7 mt -45.09 -61.19 2.44 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.844 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.43 -42.25 66.97 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 120.072 1.062 . . . . 0.0 111.803 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.2 ttt -61.53 -44.14 97.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.726 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -54.82 -47.74 73.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -58.79 -43.54 90.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.809 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.85 -46.23 89.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.379 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.67 -26.11 64.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.254 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.0 m -88.14 6.7 35.25 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.483 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -62.65 125.1 22.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.617 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.66 10.67 83.08 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.961 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.1 150.74 35.62 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.12 0.486 . . . . 0.0 112.221 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.1 p -98.91 148.75 34.99 Favored Pre-proline 0 C--O 1.216 -0.677 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.694 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -45.08 -36.63 11.94 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 121.577 1.518 . . . . 0.0 112.923 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -69.74 -64.55 0.86 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.792 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.472 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -59.69 -37.37 78.63 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 122.378 1.085 . . . . 0.0 108.565 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -61.78 -46.81 87.97 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.243 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -59.19 -38.59 80.2 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 84.9 m -60.38 -40.12 89.74 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.045 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.72 -48.4 81.27 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.046 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.84 -41.46 95.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.229 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.49 -37.74 84.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.14 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.3 m -65.22 -34.81 79.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.327 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.5 t -55.34 151.3 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.44 -144.51 4.49 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.69 -127.65 45.74 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 119.926 -1.131 . . . . 0.0 110.545 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -54.26 -11.12 0.45 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.636 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -43.57 -24.36 0.11 Allowed 'General case' 0 C--O 1.234 0.286 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.33 -44.09 68.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.58 97.86 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.781 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 58.0 ttm -56.14 -22.39 28.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.397 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -57.04 -35.06 68.86 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 63.3 ttp -56.71 -46.9 80.99 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 tt -58.38 -38.31 77.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -55.68 -42.58 75.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.73 -40.19 88.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.699 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.9 m -57.75 -45.59 85.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.403 HD12 HG23 ' A' ' 73' ' ' ILE . 88.2 mt -59.99 -41.57 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.093 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -59.96 -41.82 92.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.399 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.34 -47.3 86.52 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.235 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -62.74 -37.24 85.82 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.428 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.44 -42.38 91.81 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.223 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.91 -51.58 57.44 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.88 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.53 -43.23 94.67 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.592 0.71 . . . . 0.0 110.203 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -60.77 -50.52 73.14 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.955 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -58.42 -37.68 75.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -63.14 -43.68 97.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.096 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 84.2 mt -111.5 -36.42 5.52 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -176.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.17 -58.06 15.67 Favored Pre-proline 0 N--CA 1.47 0.556 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -176.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -52.78 157.42 7.7 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 120.994 1.129 . . . . 0.0 110.983 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.6 t -44.98 145.77 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.251 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 53.85 36.47 24.19 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . 77.31 -55.34 0.54 Allowed 'General case' 0 C--O 1.241 0.608 0 O-C-N 124.026 0.829 . . . . 0.0 108.976 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.67 -66.9 0.06 OUTLIER Glycine 0 CA--C 1.54 1.615 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.86 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.23 140.17 26.36 Favored 'Trans proline' 0 N--CA 1.512 2.592 0 C-N-CA 123.813 3.009 . . . . 0.0 114.617 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 78.6 mt -117.74 129.66 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 114.431 -1.258 . . . . 0.0 110.148 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.52 140.28 84.44 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.348 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.95 163.83 29.59 Favored 'Trans proline' 0 N--CA 1.514 2.698 0 C-N-CA 122.953 2.436 . . . . 0.0 114.268 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 93.09 5.47 63.96 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.768 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -126.75 167.79 15.28 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.948 0.374 . . . . 0.0 111.267 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 66.2 mtt -69.3 154.35 42.18 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.205 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -51.76 112.15 0.72 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.591 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -88.9 155.35 50.06 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.468 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -39.99 103.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.136 0 C-N-CA 122.477 2.118 . . . . 0.0 114.386 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -99.05 158.45 15.65 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.99 -52.7 44.99 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.772 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.8 m -63.46 -36.63 84.38 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 117.553 0.676 . . . . 0.0 109.701 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.31 -38.75 81.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.022 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.23 -30.82 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 119.487 -0.885 . . . . 0.0 108.938 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.28 -20.53 37.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.158 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.97 -0.97 89.44 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.2 p -63.95 -25.89 68.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.5 p -117.13 4.46 12.7 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.146 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 t -110.75 130.26 55.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.532 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.6 p -74.82 164.37 26.64 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.5 tp -59.38 -46.66 88.03 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.48 -41.78 94.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 117' ' ' TRP . 54.2 tp10 -61.51 -46.34 90.39 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.882 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -61.66 -43.21 99.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.398 0.436 . . . . 0.0 111.289 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.8 tt -66.03 -44.07 92.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.048 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.76 -42.37 79.66 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.416 ' CB ' ' O ' ' A' ' 113' ' ' GLU . 12.4 t90 -58.49 -45.77 88.04 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.165 -1.018 . . . . 0.0 109.275 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.9 ttt -72.5 -41.91 65.44 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.582 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 66.6 p -125.32 -24.85 3.88 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -58.81 -49.06 79.09 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 118.317 -1.353 . . . . 0.0 109.324 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.18 179.52 1.86 Allowed Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.91 135.5 36.11 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -35.84 114.74 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.866 2.378 . . . . 0.0 113.5 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mm -106.88 109.04 62.89 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.47 57.75 4.96 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.951 1.767 . . . . 0.0 112.872 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.4 m -58.78 -43.28 87.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.09 -42.49 98.09 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.442 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.21 -45.15 93.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.322 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 89.0 mt -63.47 -49.47 82.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.05 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -59.3 -48.2 82.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.219 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.17 -40.43 93.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.687 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -57.41 -43.08 83.44 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -60.8 -44.63 96.59 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.04 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 84.7 mt -58.52 -43.86 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.286 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.99 -41.69 87.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.759 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.63 -45.49 86.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.308 0.575 . . . . 0.0 110.044 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.74 -43.1 98.15 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.16 -36.79 84.81 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -58.67 -45.28 89.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.81 -39.69 94.85 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.494 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.1 mm -61.1 -49.97 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.9 m -58.09 -36.81 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.2 ttm105 -65.51 -38.67 90.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.803 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -60.58 -46.36 90.53 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -67.78 -25.49 65.63 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.73 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.3 t -43.78 111.93 1.22 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.972 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.74 -21.43 7.12 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.96 1.773 . . . . 0.0 113.761 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 70.8 p -138.18 167.57 21.56 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.1 m -107.18 149.47 27.67 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.949 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.1 tp -48.98 -36.54 8.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.589 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.1 tp -66.76 -39.62 87.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.43 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.61 -12.37 57.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.609 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 90.1 mt -79.45 123.33 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.411 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -152.5 154.95 36.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.077 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -81.95 119.79 24.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.321 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -74.13 160.92 53.59 Favored Glycine 0 CA--C 1.54 1.605 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.92 -38.0 67.84 Favored 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 123.181 2.588 . . . . 0.0 112.844 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -112.68 20.67 16.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.043 0.449 . . . . 0.0 109.801 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -82.65 115.41 58.17 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.398 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -62.36 143.09 93.15 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.15 1.9 . . . . 0.0 111.218 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -57.44 -33.47 67.96 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -61.32 -45.91 92.49 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -60.29 -45.35 93.67 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.74 -50.57 71.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.341 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.7 -46.75 95.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.421 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -61.57 -51.97 66.36 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.203 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -63.05 -43.69 97.94 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.048 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -58.55 -48.11 81.97 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.559 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -63.36 -37.33 86.87 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.625 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -59.42 -48.67 80.77 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 95.4 m -66.28 -39.5 89.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 7.7 tt -55.89 -37.81 69.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.137 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.9 ttt-85 -64.64 -38.36 90.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.049 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.74 -10.71 57.93 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.115 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -49.37 168.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.816 0.817 . . . . 0.0 112.433 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -98.75 -92.84 0.26 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.407 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -44.3 146.53 0.66 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.75 0.786 . . . . 0.0 112.042 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 70.3 m -65.76 169.23 6.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.525 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -47.33 -23.56 0.6 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.801 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.82 -46.93 81.35 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 118.578 -1.249 . . . . 0.0 107.906 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.82 -51.61 11.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 122.017 0.913 . . . . 0.0 110.19 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -57.42 -46.37 83.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.427 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -60.88 -41.7 96.49 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.279 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -60.98 -45.9 92.92 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.828 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 61.9 mtt -61.98 -41.6 98.21 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.204 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 61.1 m -60.0 -43.5 95.14 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.855 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -57.92 -48.33 80.2 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.694 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 77.5 p -72.08 -43.55 64.65 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.833 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.2 mp -66.93 -31.29 71.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.344 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.3 tp -51.82 -49.28 63.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.08 -45.18 18.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.89 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -59.11 -48.84 80.14 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -70.12 -24.93 63.27 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.66 145.27 54.97 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.556 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -59.48 143.53 85.78 Favored Pre-proline 0 C--N 1.346 0.447 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.487 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.46 -44.33 47.83 Favored 'Trans proline' 0 N--CA 1.504 2.131 0 C-N-CA 122.786 2.324 . . . . 0.0 115.477 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.38 -46.41 90.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 118.766 -1.173 . . . . 0.0 110.437 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 42.5 t -66.16 -43.13 87.84 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -49.62 -27.27 4.38 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.74 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 91.1 m -59.65 -49.35 78.09 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.602 -0.839 . . . . 0.0 108.778 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 4.5 tp -77.3 -38.37 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.746 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -44.11 72.12 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.03 -38.08 89.7 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.732 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.69 68.12 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.966 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.31 -35.32 67.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.75 171.33 44.08 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.668 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.06 146.95 97.03 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 123.49 2.794 . . . . 0.0 113.357 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.16 1.28 87.78 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.43 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -64.62 136.02 56.55 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.259 0.552 . . . . 0.0 111.695 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.4 m -68.83 139.29 55.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.0 tp -57.03 -44.12 82.59 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.246 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.2 -45.38 87.69 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -58.69 -42.3 88.23 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.5 mtt -63.51 -43.84 96.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.944 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 60.3 ttm -62.16 -50.11 73.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.52 0.676 . . . . 0.0 110.162 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.2 m -64.75 -45.43 86.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.064 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.05 79.12 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.109 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 97.8 m -64.69 -36.68 85.07 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.6 -36.76 76.91 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.986 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.73 -42.15 91.03 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.21 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.56 -18.27 6.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 117.179 0.489 . . . . 0.0 111.325 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 128.39 88.03 0.56 Allowed Glycine 0 CA--C 1.528 0.886 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -112.03 -81.36 1.13 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -46.23 -29.25 6.46 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.376 2.05 . . . . 0.0 110.003 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -99.56 -135.12 8.78 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 1.6 p80 60.07 170.92 0.08 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.472 0.653 . . . . 0.0 111.724 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -90.57 -67.51 0.84 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.139 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -152.59 16.7 0.6 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.836 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -135.15 158.15 45.08 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.434 0.635 . . . . 0.0 111.873 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 2.9 p -49.22 -26.84 2.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.218 -0.555 0 CA-C-O 117.946 -1.025 . . . . 0.0 111.055 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo . . . . . 0 N--CA 1.482 0.794 0 N-CA-C 109.13 -1.142 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.1 pt -65.42 113.78 2.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 109.891 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.0 t -126.27 126.71 69.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.187 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -63.58 127.57 31.95 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -83.96 -172.69 4.3 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.52 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.85 -38.04 80.99 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -66.71 -22.9 66.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.131 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.69 -7.96 57.95 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -73.21 126.35 29.86 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.985 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.2 mtt -81.56 135.22 35.58 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.005 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.5 m -133.1 134.1 58.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.518 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -57.27 142.23 43.94 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.008 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -144.63 144.21 31.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.746 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.17 143.07 50.65 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.6 pt -61.87 142.42 16.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -61.07 118.68 38.23 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.23 -36.7 78.73 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 N-CA-C 109.734 -0.91 . . . . 0.0 109.734 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -58.44 -48.27 81.25 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.149 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.6 m -61.05 -46.18 91.73 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.96 -58.36 5.01 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.843 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -58.35 -39.19 78.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.843 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.4 98.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.511 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -58.74 -50.68 73.02 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.546 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.3 t -62.74 -42.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.492 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.99 -42.89 91.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.371 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.8 t -58.74 -44.32 89.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.29 -35.95 75.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.772 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -53.7 -46.71 70.83 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.679 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -92.28 -35.14 13.93 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.698 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.22 37.84 4.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.778 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.14 -53.62 3.94 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -96.96 -5.93 36.72 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -51.7 138.87 31.31 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.224 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.91 -31.89 46.4 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.392 2.061 . . . . 0.0 112.709 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.04 -18.75 26.44 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.935 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.82 -42.48 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.925 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 mt -44.86 -60.67 2.84 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.814 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.95 -42.4 67.06 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 CA-C-N 119.985 1.03 . . . . 0.0 111.857 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.1 mtp -61.17 -43.41 98.93 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.672 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -56.03 -47.77 77.22 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.9 t -58.6 -44.69 89.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.042 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.77 -44.77 93.71 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.518 0.675 . . . . 0.0 110.114 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.72 -25.12 63.7 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.022 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.4 m -87.04 6.4 32.67 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.612 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.84 125.33 23.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.562 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.41 11.22 76.12 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 116.35 -0.387 . . . . 0.0 112.605 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.52 149.57 40.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.7 p -99.99 148.93 35.5 Favored Pre-proline 0 C--O 1.215 -0.722 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.622 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -45.81 -38.2 17.43 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.543 1.495 . . . . 0.0 113.323 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -70.37 -62.78 1.26 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.649 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.471 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -58.15 -36.73 73.43 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.12 -45.36 93.8 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.429 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -57.91 -37.86 74.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 84.8 m -59.47 -41.86 90.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.652 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.9 mtt -49.69 -50.08 45.04 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.274 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.09 -42.75 68.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.798 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -60.68 -40.72 93.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.799 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.3 p -68.73 -26.53 65.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.89 158.54 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.87 -149.72 5.08 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.43 -127.54 45.43 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -51.21 -10.55 0.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.044 -0.578 . . . . 0.0 112.171 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -41.8 -24.34 0.04 OUTLIER 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.68 -42.97 75.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.91 94.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -56.92 -28.04 61.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.471 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -56.38 -35.41 67.69 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.8 ttp -58.07 -44.99 87.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.22 -40.71 86.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -54.26 -41.57 68.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.75 -41.53 95.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.7 m -59.28 -42.62 91.67 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.9 mm -60.01 -44.16 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -60.63 -41.87 95.77 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.194 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.71 -45.94 91.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.448 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.26 -39.25 94.07 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.23 -41.59 97.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.072 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.4 -50.46 69.76 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.447 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -64.23 -41.52 96.97 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.048 0.928 . . . . 0.0 108.94 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 78.5 t90 -60.37 -38.84 85.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 113.91 -1.496 . . . . 0.0 109.36 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -53.67 -45.33 70.25 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -66.64 -40.62 88.81 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.424 0.63 . . . . 0.0 110.946 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.49 -43.53 69.53 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -113.81 -63.91 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.85 -38.5 85.73 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 CA-C-N 121.24 1.479 . . . . 0.0 111.39 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.8 t -66.6 -12.19 14.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.758 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -49.28 -31.04 8.17 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.17 -10.18 0.38 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.43 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 53.57 -117.0 6.49 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.71 143.94 99.54 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 CA-C-N 119.27 1.535 . . . . 0.0 109.536 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.7 tt -130.64 154.01 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.321 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.43 149.36 83.79 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.415 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.79 168.16 25.31 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.785 2.323 . . . . 0.0 113.013 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.02 -4.35 71.22 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.91 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -125.21 159.23 32.09 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.773 0.321 . . . . 0.0 110.67 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 96.2 mmm -62.23 142.94 57.42 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.08 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -60.48 127.12 30.16 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.373 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -70.42 151.18 95.7 Favored Pre-proline 0 C--O 1.237 0.446 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.96 112.95 3.53 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.446 1.431 . . . . 0.0 113.675 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -73.4 171.52 12.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.23 -48.97 61.64 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 119.111 -1.518 . . . . 0.0 109.884 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.3 m -60.65 -38.04 83.51 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.579 0.704 . . . . 0.0 109.517 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -59.61 -38.74 82.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.592 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -31.39 28.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.78 -21.35 26.56 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.276 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.17 -6.93 82.37 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.7 p -57.6 -22.82 47.44 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.1 p -119.55 29.87 7.38 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.632 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.9 m -129.53 135.05 48.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.279 -0.569 . . . . 0.0 112.393 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.2 m -76.86 145.31 38.43 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tt -50.03 -45.96 52.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.154 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.07 -39.33 92.02 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.065 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.04 -40.36 96.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.289 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.37 -50.18 74.63 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.4 pt -70.67 -24.31 25.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.809 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.07 -65.91 2.65 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.451 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.437 ' C ' ' CD1' ' A' ' 117' ' ' TRP . 2.0 p90 -61.62 -31.44 71.53 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 118.125 -1.43 . . . . 0.0 109.137 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.6 ttt -63.59 -45.14 91.75 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.8 m -115.26 -26.7 7.52 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -58.87 -72.61 0.1 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.085 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -73.74 -177.01 0.54 Allowed Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.61 141.6 15.0 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 120.641 1.265 . . . . 0.0 109.459 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -46.16 123.94 6.99 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.671 1.58 . . . . 0.0 113.766 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.415 ' HB ' ' HD1' ' A' ' 117' ' ' TRP . 47.3 mm -114.91 107.97 49.38 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.84 60.13 4.06 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.909 1.739 . . . . 0.0 113.943 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.6 m -51.57 -37.34 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.73 99.67 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.423 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.46 -45.71 89.56 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.472 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 90.2 mt -64.71 -48.67 83.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.569 0.699 . . . . 0.0 110.17 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -59.01 -48.98 79.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.021 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -63.02 -39.03 93.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.886 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -57.43 -43.19 83.64 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -62.69 -43.2 99.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.837 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 78.9 mt -58.43 -42.84 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.525 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.03 -41.6 83.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.78 -44.24 93.98 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.26 -42.57 97.36 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.52 -35.7 81.33 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -58.09 -44.51 87.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.67 -37.89 87.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.415 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.2 mm -60.77 -48.32 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.75 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.8 m -59.27 -34.76 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 118.42 -1.312 . . . . 0.0 107.471 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -65.83 -39.18 90.56 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.4 ttt -58.88 -45.44 90.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -74.89 -15.32 60.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.321 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.1 t -49.3 115.67 5.01 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.72 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -84.12 -30.35 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.107 1.871 . . . . 0.0 113.812 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.3 p -138.01 170.94 15.17 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 39.1 t -105.68 148.22 27.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.638 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.4 tp -49.46 -38.41 12.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.549 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.7 tp -65.6 -39.33 91.43 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.556 0.693 . . . . 0.0 109.798 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -67.64 0.32 3.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.553 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.8 mt -100.65 119.0 48.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.025 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -145.93 132.04 19.35 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.8 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -84.41 134.17 34.48 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.407 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -90.86 159.25 26.59 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.82 -41.79 74.89 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.182 1.921 . . . . 0.0 111.867 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -81.2 -17.95 47.86 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.625 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -73.76 138.37 76.85 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.721 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.28 136.19 23.85 Favored 'Trans proline' 0 N--CA 1.512 2.579 0 C-N-CA 123.171 2.58 . . . . 0.0 113.613 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.419 ' HB3' ' HA ' ' A' ' 224' ' ' PRO . 11.8 t80 -61.51 -28.17 69.12 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -61.96 -50.94 70.09 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.775 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -64.92 -40.26 94.78 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -59.2 -50.86 72.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.395 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.76 -43.82 97.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.8 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.68 -59.16 5.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.058 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.44 -40.75 97.59 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.073 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -57.69 -47.1 83.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -62.5 -41.77 99.05 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.542 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -59.75 -40.29 87.65 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.092 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 93.6 m -62.63 -41.89 99.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 82.6 mt -60.69 -39.45 88.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -60.36 -40.25 90.11 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.002 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.45 -10.67 57.29 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.077 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -59.18 145.03 44.12 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.524 0.678 . . . . 0.0 112.203 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -70.23 -95.06 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.034 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -44.99 149.91 0.42 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.519 0.676 . . . . 0.0 112.39 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 82.4 p -74.17 179.32 4.52 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.638 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -47.43 -26.0 1.21 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.58 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -51.21 -49.68 60.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 47.0 t -89.83 -58.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.775 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -42.08 -53.39 3.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.691 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -59.37 -44.11 92.79 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.679 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -60.31 -50.58 73.07 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.648 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 74.0 mtm -62.84 -41.29 99.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.947 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 54.4 m -59.46 -46.05 89.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.148 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.46 -47.05 86.99 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.513 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.3 m -67.49 -49.54 63.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.315 0.579 . . . . 0.0 112.007 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.35 -32.29 73.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.876 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 62.9 tp -51.03 -46.36 61.57 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 85.2 t -85.79 -46.16 16.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.028 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -60.31 -49.44 77.61 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -70.37 -22.55 62.76 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.705 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.74 153.75 10.16 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.621 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -68.99 148.5 97.89 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.74 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.23 -41.98 67.7 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.377 2.051 . . . . 0.0 114.376 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.62 -50.0 75.56 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.447 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 10.5 t -70.0 -37.77 75.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -47.11 -26.89 1.21 Allowed 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.092 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 69.0 p -62.49 -55.06 31.11 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.421 -1.312 . . . . 0.0 108.455 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.0 mm -65.07 -45.66 93.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.154 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -51.5 65.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.057 0.932 . . . . 0.0 108.834 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.31 -36.55 78.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.71 82.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.747 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -57.46 -44.38 84.74 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 119.421 -0.911 . . . . 0.0 108.713 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 79.43 175.57 47.66 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.085 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.73 150.95 79.98 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 124.011 3.141 . . . . 0.0 113.38 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 81.06 0.27 88.54 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.6 119.2 13.48 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.178 0.513 . . . . 0.0 110.382 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.2 m -61.07 139.36 58.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.1 tp -54.82 -46.08 74.5 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.604 -0.838 . . . . 0.0 108.873 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -55.41 -48.11 74.88 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.482 0.658 . . . . 0.0 109.332 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -57.76 -42.47 84.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 58.9 ttm -63.01 -45.72 91.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.75 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 61.8 tpp -61.99 -45.64 92.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.9 m -62.54 -49.75 74.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.74 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.72 95.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.708 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 78.3 m -61.02 -40.81 94.99 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.67 -40.85 97.86 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.087 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.12 97.92 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 23.9 m -82.59 -23.61 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.675 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 104.57 14.28 24.0 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.844 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -58.65 -45.69 94.35 Favored Glycine 0 CA--C 1.545 1.943 0 CA-C-O 119.689 -0.506 . . . . 0.0 112.474 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.419 ' HA ' ' HB3' ' A' ' 161' ' ' PHE . 50.6 Cg_exo -55.64 -17.86 18.81 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.11 1.873 . . . . 0.0 111.989 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -90.56 -49.73 3.12 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 123.595 0.56 . . . . 0.0 112.093 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -152.69 -51.95 0.11 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 122.402 -0.47 . . . . 0.0 110.961 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -165.65 -175.57 3.55 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.467 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -32.45 -81.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.335 1.022 . . . . 0.0 111.531 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.47 152.68 37.75 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.943 0.401 . . . . 0.0 110.714 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 9.9 p -51.93 -27.99 9.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.797 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.35 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.485 0.984 0 N-CA-C 108.837 -1.255 . . . . 0.0 108.837 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.597 HD11 ' SD ' ' A' ' 118' ' ' MET . 18.6 pt -67.62 119.32 13.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 110.071 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.47 138.07 48.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.505 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -69.71 125.01 25.44 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.958 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -78.33 -172.46 2.85 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.201 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 6' ' ' LEU . 9.6 mp -58.77 -38.18 77.92 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.44 -22.87 65.48 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.594 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.33 -7.75 58.46 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.77 127.78 33.82 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 120.171 -0.611 . . . . 0.0 109.524 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.494 ' SD ' HG21 ' A' ' 119' ' ' THR . 66.3 mtt -77.14 127.19 32.21 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.763 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 82.3 t -126.27 128.61 71.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.553 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -61.75 142.55 57.19 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.035 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -145.34 146.83 31.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.218 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.82 143.04 49.62 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.265 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.505 HD12 ' HG ' ' A' ' 20' ' ' LEU . 33.4 pt -61.81 144.25 14.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 120.902 0.382 . . . . 0.0 110.609 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 t -62.05 120.35 56.94 Favored Pre-proline 0 N--CA 1.453 -0.313 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -53.56 -36.9 82.17 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 N-CA-C 109.492 -1.003 . . . . 0.0 109.492 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -57.8 -48.49 79.56 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.164 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 84.1 m -60.84 -47.15 87.67 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.231 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.505 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -50.51 -57.03 9.04 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.905 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -58.3 -39.31 79.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.778 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.03 98.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.197 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.413 ' O ' HG23 ' A' ' 27' ' ' VAL . 22.1 t-105 -59.06 -49.76 76.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.483 0.658 . . . . 0.0 109.505 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.39 -40.3 88.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.095 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.4 -49.02 79.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.554 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.3 m -61.95 -35.55 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.713 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 79.7 t -66.83 -36.22 76.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.0 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -53.61 -47.07 70.54 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.579 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -89.42 -37.47 14.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -120.68 38.06 4.12 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.954 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.9 -51.16 5.64 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -175.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -96.11 -4.59 42.51 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.8 m -55.05 145.93 41.7 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.741 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.25 -32.59 20.38 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.486 2.124 . . . . 0.0 112.437 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.61 -20.07 30.37 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.886 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.69 -41.88 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.754 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.427 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 6.7 mt -45.72 -61.22 2.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.872 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 76.2 Cg_exo -54.78 -41.61 76.47 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 CA-C-N 120.176 1.099 . . . . 0.0 111.729 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 58.8 ttm -59.69 -46.87 87.77 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.338 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -55.07 -47.49 74.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -58.2 -44.48 88.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.719 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.67 -44.77 93.46 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.097 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.6 -22.61 62.53 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.138 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.7 m -87.66 5.81 37.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.593 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.9 126.16 26.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.742 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.01 11.23 69.77 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 121.315 -0.469 . . . . 0.0 112.231 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.13 146.26 50.97 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 112.543 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.0 m -99.72 141.3 22.54 Favored Pre-proline 0 C--O 1.215 -0.727 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -46.36 -36.2 17.18 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 CA-C-N 120.789 1.318 . . . . 0.0 113.222 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -68.59 -63.9 0.97 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.301 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.483 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -59.82 -37.58 79.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.265 1.031 . . . . 0.0 108.737 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.07 -45.31 92.76 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.773 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -57.72 -39.69 77.87 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 86.3 m -59.91 -39.28 84.87 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.48 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 97.9 mtp -57.98 -48.27 80.48 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.153 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.421 HD11 HD13 ' A' ' 134' ' ' ILE . 87.6 mt -65.53 -41.78 92.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.826 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -61.54 -36.46 80.65 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.206 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.5 m -65.56 -34.45 78.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.924 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.7 141.72 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.026 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -130.6 -140.27 4.65 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.4 -127.89 46.06 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.743 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -53.08 -11.33 0.24 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.853 -0.673 . . . . 0.0 111.669 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -41.92 -22.78 0.02 OUTLIER 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.78 -41.52 70.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.78 98.1 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 57.7 ttm -57.28 -26.22 60.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.038 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -56.97 -35.24 68.92 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.3 ttp -58.01 -46.2 85.66 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -57.65 -37.88 74.13 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -56.26 -42.95 78.23 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.37 -40.15 93.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.294 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -58.88 -43.46 90.91 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.8 -43.04 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -59.99 -41.48 92.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.027 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.24 -47.07 84.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.869 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -61.79 -40.1 94.02 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.25 94.15 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.862 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.04 74.69 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.404 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.43 -38.56 90.26 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.903 0.859 . . . . 0.0 108.975 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.59 ' CH2' HD13 ' A' ' 129' ' ' ILE . 76.2 t-105 -58.2 -45.92 86.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.659 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -49.8 -47.44 51.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.856 0.722 . . . . 0.0 109.136 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -64.0 -39.87 95.08 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.301 0.572 . . . . 0.0 110.892 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -176.123 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 . . . . . 0 C--O 1.237 0.435 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -56.53 141.64 71.72 Favored Pre-proline 0 C--O 1.238 0.465 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.8 111.72 0.98 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.25 1.3 . . . . 0.0 113.035 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.39 167.32 21.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.28 -43.28 89.47 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 119.072 -1.537 . . . . 0.0 109.788 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.4 t -61.0 -41.9 97.41 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.539 0.685 . . . . 0.0 109.232 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -61.94 -37.84 86.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.013 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.62 HD13 HG12 ' A' ' 126' ' ' VAL . 12.4 mm -57.7 -45.67 86.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.53 -17.64 64.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.55 0.16 89.28 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.1 p -64.22 -21.77 66.7 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.986 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.2 p -127.41 33.27 4.89 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.4 p -137.88 145.74 42.54 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.651 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.0 m -82.91 145.41 29.42 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -49.74 -44.94 48.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.61 -40.93 96.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.545 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -63.7 -43.26 97.13 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.163 0.506 . . . . 0.0 111.152 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -58.4 -47.86 82.53 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.35 -40.6 88.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.306 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.68 -63.91 4.42 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.662 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.438 ' CD1' ' N ' ' A' ' 118' ' ' MET . 1.2 p90 -59.75 -29.25 68.03 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 117.731 -1.587 . . . . 0.0 109.654 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.597 ' SD ' HD11 ' A' ' 2' ' ' ILE . 26.2 ttt -65.72 -45.01 84.3 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.494 HG21 ' SD ' ' A' ' 10' ' ' MET . 82.3 p -119.55 -24.27 6.33 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -58.19 -70.72 0.13 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.776 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -76.54 -177.34 0.74 Allowed Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -48.23 136.3 24.77 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 CA-C-N 120.619 1.257 . . . . 0.0 109.541 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -38.26 119.84 0.4 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.874 2.383 . . . . 0.0 114.509 -176.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.0 mm -112.98 106.84 54.87 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.57 59.95 4.26 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.257 1.971 . . . . 0.0 113.712 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.62 HG12 HD13 ' A' ' 104' ' ' ILE . 2.8 m -48.99 -38.74 11.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.28 99.71 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.627 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.52 -47.18 85.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.308 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.59 HD13 ' CH2' ' A' ' 80' ' ' TRP . 89.6 mt -63.64 -48.76 85.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.511 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.761 ' CE2' HD11 ' A' ' 134' ' ' ILE . 89.8 t80 -59.05 -48.56 81.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.909 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.506 ' HA ' HD12 ' A' ' 134' ' ' ILE . 38.5 ttpt -62.38 -38.06 88.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.592 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -58.73 -42.09 87.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.488 ' CH2' HG21 ' A' ' 104' ' ' ILE . 47.1 m0 -62.3 -43.83 97.92 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.761 HD11 ' CE2' ' A' ' 130' ' ' TYR . 85.7 mt -59.64 -45.26 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.62 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.14 -41.85 84.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.87 -42.53 99.8 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.23 -42.26 98.61 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.98 -36.21 83.23 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -58.45 -44.49 89.22 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.37 -38.9 91.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.557 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.4 mm -60.49 -49.64 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.0 m -57.74 -35.56 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -65.1 -39.83 93.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -59.2 -45.12 91.91 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -70.71 -22.06 62.49 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.442 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.7 t -43.03 106.59 0.49 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.538 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.01 -32.88 8.21 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.107 1.872 . . . . 0.0 113.758 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.9 p -137.95 172.6 12.69 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.3 m -104.98 149.99 25.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.125 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.4 mm -49.92 -42.03 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.9 tp -60.33 -39.26 86.46 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.19 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.85 -11.43 55.59 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.633 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.8 mm -75.71 119.95 24.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.82 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -152.93 134.1 14.18 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 C--O 1.237 0.437 0 CA-C-O 121.007 0.432 . . . . 0.0 111.665 -179.596 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 CA--C 1.548 0.884 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.28 139.34 11.62 Favored 'Trans proline' 0 N--CA 1.507 2.271 0 C-N-CA 123.577 2.851 . . . . 0.0 114.267 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.408 ' O ' HG23 ' A' ' 165' ' ' VAL . 26.3 t80 -59.28 -26.72 65.2 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -62.67 -51.44 67.23 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.811 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.27 -37.93 86.62 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.713 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -60.24 -50.56 73.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.674 0.75 . . . . 0.0 109.857 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 161' ' ' PHE . 54.7 t -64.7 -45.0 96.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.304 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -60.49 -51.51 69.13 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.948 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -66.24 -39.37 89.48 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.672 ' CE2' HG23 ' A' ' 186' ' ' THR . 87.8 t80 -58.78 -49.49 77.48 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -66.36 -36.25 82.42 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.299 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -58.27 -47.89 82.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 96.6 m -68.5 -39.39 81.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.133 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.24 -39.38 72.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.025 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.307 179.279 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 . . . . . 0 C--O 1.241 0.61 0 CA-C-O 121.279 0.561 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 91.1 mmm -62.56 -43.89 97.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.177 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.672 HG23 ' CE2' ' A' ' 168' ' ' PHE . 62.1 m -61.09 -45.75 93.43 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.609 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.81 -48.29 80.17 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.205 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 96.7 m -67.35 -47.27 70.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.236 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.9 -31.55 71.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.838 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.439 ' CD1' HG22 ' A' ' 186' ' ' THR . 16.4 mt -52.38 -43.4 64.7 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.309 -0.957 . . . . 0.0 108.892 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.3 t -85.72 -47.82 16.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.817 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -61.06 -49.38 77.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -70.12 -22.7 62.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.704 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.52 150.86 25.74 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -68.97 153.71 95.81 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.184 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.419 ' HA ' ' HB3' ' A' ' 199' ' ' LYS . 52.3 Cg_exo -57.09 -45.68 34.06 Favored 'Trans proline' 0 N--CA 1.509 2.393 0 C-N-CA 122.544 2.162 . . . . 0.0 115.521 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.76 -50.22 74.68 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.554 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 36.4 t -69.4 -39.34 78.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 196' ' ' PRO . 40.3 ttmt -49.02 -32.12 8.8 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.427 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.9 m -59.71 -48.79 80.29 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.935 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.627 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 48.2 mm -67.67 -43.14 86.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.466 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.404 HD11 ' CE1' ' A' ' 161' ' ' PHE . 82.1 mt -59.87 -39.67 86.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -61.35 -38.99 88.94 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -59.73 -40.1 86.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.478 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.76 -41.23 90.57 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.911 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.77 -159.18 52.59 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.779 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.19 166.49 5.71 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 123.5 2.8 . . . . 0.0 112.557 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.76 -126.35 40.68 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 56.73 96.62 0.02 OUTLIER 'General case' 0 C--O 1.238 0.48 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.332 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 76.4 p -61.65 157.58 17.26 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.152 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.35 -34.84 61.95 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -61.64 -50.15 73.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.352 0.596 . . . . 0.0 109.799 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.99 -42.43 94.19 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.6 ttm -60.87 -46.84 89.03 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.415 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 1.7 mmt -64.11 -41.43 97.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.1 0.476 . . . . 0.0 109.753 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.8 m -63.36 -49.83 72.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.409 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.96 -43.75 94.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.51 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.4 m -60.48 -40.76 92.49 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -60.97 -41.82 97.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.11 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.0 -39.93 96.31 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.527 HG21 HG21 ' A' ' 201' ' ' ILE . 34.4 m -91.95 6.04 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.903 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.234 0 C-N-CA 120.27 -0.966 . . . . 0.0 111.842 179.273 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo . . . . . 0 N--CA 1.483 0.904 0 N-CA-C 109.349 -1.058 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.6 pt -77.78 125.06 37.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.5 t -127.63 127.4 68.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.457 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -63.66 126.15 26.62 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -81.43 -173.39 4.34 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.291 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 6' ' ' LEU . 86.7 mt -59.71 -38.54 81.9 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.39 -21.7 65.59 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.566 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.49 -7.73 58.17 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -72.15 124.86 25.91 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.695 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.0 mtt -79.52 130.98 35.9 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.735 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.96 138.91 50.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 120.174 -0.611 . . . . 0.0 111.396 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -57.5 142.23 44.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.219 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -144.91 140.37 28.25 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.606 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.56 139.84 51.59 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.785 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.443 HD12 ' HG ' ' A' ' 20' ' ' LEU . 38.0 pt -61.87 137.24 24.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.558 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.7 t -60.28 122.76 69.33 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.637 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.36 -38.55 73.48 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 120.852 1.035 . . . . 0.0 110.973 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -56.91 -43.35 81.32 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.279 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.4 m -63.11 -46.81 85.58 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.443 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -49.74 -60.51 2.82 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.328 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -57.74 -39.42 77.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.891 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -61.51 -43.1 99.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.491 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -58.93 -50.2 74.94 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.56 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.5 t -62.07 -42.23 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.206 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.99 -41.95 88.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.027 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 22' ' ' ALA . 49.3 t -58.74 -45.38 91.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 67.1 t -64.17 -37.12 79.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.844 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -55.56 -45.66 77.25 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.685 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -92.86 -27.75 16.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.85 38.25 3.56 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.697 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.82 -54.48 3.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -175.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -96.03 -5.75 40.33 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 t -51.81 139.2 31.86 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.208 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.98 -32.83 34.21 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.476 2.117 . . . . 0.0 112.959 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -57.98 -18.65 25.19 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.995 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.81 -42.74 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.834 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.422 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 8.0 mt -44.79 -61.18 2.36 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.853 -178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 71.3 Cg_exo -54.38 -42.0 71.6 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 120.081 1.065 . . . . 0.0 111.732 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.489 ' CE ' HG21 ' A' ' 26' ' ' VAL . 20.7 ttt -60.63 -44.94 95.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.349 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -55.42 -47.1 76.48 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -58.41 -44.84 89.2 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.997 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.59 94.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.53 0.681 . . . . 0.0 110.2 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -70.44 -24.8 62.96 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.097 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.1 m -89.43 6.45 40.7 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.601 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.33 125.47 23.88 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.565 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.64 10.83 76.73 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.598 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' A' ' 52' ' ' LEU . . . -70.42 150.26 46.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.344 0.592 . . . . 0.0 112.354 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.8 m -99.72 142.38 24.51 Favored Pre-proline 0 C--O 1.217 -0.649 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.38 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -42.71 -38.82 6.8 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.466 1.444 . . . . 0.0 113.365 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -73.88 -61.32 1.89 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.041 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.452 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.93 -38.36 75.8 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.401 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . 57.3 tp -64.9 -44.29 90.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.648 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -57.72 -39.97 78.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 92.9 m -63.09 -39.58 95.13 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.953 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.45 ' O ' HG22 ' A' ' 58' ' ' THR . 28.2 ttt -56.8 -49.37 75.55 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.99 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.9 mt -69.8 -40.38 76.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.518 0.675 . . . . 0.0 110.155 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.53 -37.75 79.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.987 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 55' ' ' MET . 0.6 OUTLIER -66.33 -20.32 66.06 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.792 -178.614 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.85 140.0 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.51 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.84 -151.84 7.88 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.1 -127.75 45.92 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.924 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -51.32 -10.0 0.08 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.813 -0.693 . . . . 0.0 112.287 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -42.99 -21.28 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.39 -40.46 71.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.11 97.78 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.435 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 11.3 tmm? -58.32 -20.17 41.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.488 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.3 tp-100 -58.22 -39.32 78.75 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.4 tmm? -59.56 -42.36 92.26 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 66' ' ' MET . 61.3 tp -57.68 -40.7 80.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -59.15 -41.81 89.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.2 -39.64 93.1 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.81 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.1 m -59.83 -44.06 94.26 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.465 HD11 ' CD1' ' A' ' 134' ' ' ILE . 91.5 mt -60.82 -43.87 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -60.34 -41.91 94.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.483 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 88.8 tt0 -62.06 -46.84 87.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.19 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -63.83 -38.6 91.69 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.86 -39.19 88.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 75' ' ' GLU . . . -64.53 -51.24 63.89 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.845 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -64.8 -43.29 93.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.048 0.928 . . . . 0.0 109.468 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.494 ' CZ2' HD13 ' A' ' 104' ' ' ILE . 83.2 t90 -61.2 -41.47 96.87 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.779 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -59.6 -43.07 93.84 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -60.53 -33.77 73.14 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.597 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -177.033 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 . . . . . 0 C--O 1.239 0.547 0 CA-C-O 121.357 0.598 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.78 156.42 86.93 Favored Pre-proline 0 C--O 1.24 0.565 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.096 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.24 128.76 14.86 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.921 1.748 . . . . 0.0 113.475 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.5 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 3.4 mtt85 -126.13 151.95 46.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.778 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.618 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -42.1 -61.32 2.38 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.479 -176.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 108' ' ' THR . 74.7 m -61.34 -37.88 84.88 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 122.073 -0.663 . . . . 0.0 110.844 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 6.7 m-20 -61.53 -38.1 86.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.865 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.624 HG21 ' CH2' ' A' ' 133' ' ' TRP . 7.0 tp -58.44 -31.47 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.578 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.24 -10.42 56.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.613 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.92 0.12 87.95 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 48.8 p -63.48 -23.99 67.63 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.06 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 102' ' ' SER . 20.8 p -123.92 18.75 9.33 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.746 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.5 m -119.21 131.17 55.79 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.34 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -70.94 147.54 48.62 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.3 tp -53.46 -44.69 69.12 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.287 -0.965 . . . . 0.0 108.448 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.43 -40.58 94.96 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.08 -43.51 98.67 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.19 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -62.78 -41.25 99.17 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.246 0.341 . . . . 0.0 110.979 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 34.7 pt -68.15 -41.83 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.924 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.99 -41.86 70.31 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -58.88 -46.16 88.48 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.013 -1.094 . . . . 0.0 109.102 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.9 ttt -71.39 -42.58 68.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.44 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.6 m -125.78 -26.9 3.42 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -58.43 -49.92 75.57 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 118.455 -1.298 . . . . 0.0 109.814 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -81.54 -177.88 1.05 Allowed Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.51 144.51 32.18 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 N-CA-C 107.105 -1.921 . . . . 0.0 107.105 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -45.86 124.0 6.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 121.348 1.365 . . . . 0.0 112.997 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.417 HG22 HG13 ' A' ' 126' ' ' VAL . 45.8 mm -113.47 108.33 52.28 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.408 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 72.0 Cg_endo -74.72 56.86 4.21 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.958 1.772 . . . . 0.0 113.111 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 127' ' ' GLY . 21.6 m -58.74 -45.75 91.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.481 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -63.63 -44.37 96.57 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.205 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 125' ' ' PRO . 88.7 tt0 -60.32 -44.63 95.29 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.973 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.09 -47.85 91.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.865 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -59.09 -50.13 75.26 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.912 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -61.91 -38.57 88.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.967 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -56.66 -43.67 80.61 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.624 ' CH2' HG21 ' A' ' 104' ' ' ILE . 44.4 m0 -63.35 -44.44 94.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.593 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.465 ' CD1' HD11 ' A' ' 73' ' ' ILE . 29.7 mm -58.33 -44.88 89.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.455 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.74 -42.44 88.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.16 -43.67 97.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.381 0.61 . . . . 0.0 109.615 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.32 -42.28 99.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.26 -35.9 81.88 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -58.32 -45.0 88.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.79 -38.64 91.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.473 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.4 mm -60.9 -49.8 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 16.7 m -58.28 -36.16 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -65.49 -38.79 90.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.822 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 63.7 tpp -59.74 -46.75 88.17 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -71.62 -15.62 62.25 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.215 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.3 t -49.07 116.94 5.98 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.846 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.46 -40.19 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.949 1.766 . . . . 0.0 113.539 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 58.3 p -138.38 169.04 18.49 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.2 t -92.26 148.53 22.07 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.471 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.628 HD11 ' CZ ' ' A' ' 168' ' ' PHE . 17.5 tt -51.28 -36.45 17.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.43 -39.45 92.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.238 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -66.8 -9.84 41.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.492 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.57 HD13 ' HA ' ' A' ' 168' ' ' PHE . 81.6 mt -81.87 120.31 33.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.945 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -142.33 123.55 14.67 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.56 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 . . . . . 0 C--O 1.236 0.353 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.34 179.944 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 160' ' ' PRO . 95.9 mt-10 . . . . . 0 CA--C 1.541 0.626 0 CA-C-O 119.822 -0.133 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 163' ' ' ASP . 5.4 Cg_exo -75.36 135.13 18.04 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.704 2.27 . . . . 0.0 114.019 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.4 ' O ' HG23 ' A' ' 165' ' ' VAL . 49.9 t80 -61.55 -36.27 80.12 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -61.83 -47.7 83.9 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.087 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.419 ' H ' ' HB2' ' A' ' 160' ' ' PRO . 50.4 t0 -61.33 -41.62 97.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.86 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -61.13 -50.4 73.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.788 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 161' ' ' PHE . 53.5 t -62.14 -47.7 91.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.618 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.43 -50.99 70.57 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.28 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -64.85 -39.12 93.05 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.252 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.628 ' CZ ' HD11 ' A' ' 150' ' ' ILE . 88.1 t80 -60.42 -50.21 74.5 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.08 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.45 ' OH ' HD22 ' A' ' 211' ' ' LEU . 21.7 m-85 -69.49 -41.61 75.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.305 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -60.38 -46.33 90.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.511 ' CB ' HD11 ' A' ' 153' ' ' ILE . 91.9 m -65.21 -37.68 88.04 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.595 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.55 -49.15 78.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.314 0.578 . . . . 0.0 110.049 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.515 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 . . . . . 0 C--O 1.238 0.5 0 CA-C-O 121.281 0.563 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.463 ' SD ' HG21 ' A' ' 150' ' ' ILE . 59.9 ttm -60.67 -46.05 91.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.575 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.516 HG23 ' HE2' ' A' ' 168' ' ' PHE . 65.8 m -59.35 -48.68 80.71 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.976 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.25 -47.68 84.95 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.702 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 97.1 m -63.15 -48.03 80.18 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.98 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.425 HD23 ' ND2' ' A' ' 193' ' ' ASN . 8.2 mp -68.4 -34.18 75.56 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.699 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 17.1 mt -50.01 -45.88 52.26 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.142 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.0 t -81.37 -47.38 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.852 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -61.92 -50.77 70.83 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ASN . . . . . 0.425 ' ND2' HD23 ' A' ' 189' ' ' LEU . 97.6 m-20 -73.21 -23.13 60.35 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.365 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 190' ' ' LEU . . . -57.02 155.09 8.67 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.787 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -72.58 155.68 90.83 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.72 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.19 -39.78 82.04 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 122.454 2.102 . . . . 0.0 113.72 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -59.3 -49.33 78.25 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.808 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -73.51 -36.79 65.78 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -47.14 -37.88 10.66 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.741 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.3 m -60.3 -50.22 74.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.293 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.624 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 40.4 mm -68.11 -44.02 84.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.45 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 81.9 mt -59.12 -44.11 91.99 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -63.41 -38.1 89.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -60.03 -39.46 85.97 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.976 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.34 -35.84 70.42 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.699 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.02 172.75 49.03 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.55 155.31 54.95 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 123.733 2.955 . . . . 0.0 113.459 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.39 1.78 88.81 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.469 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.42 128.15 34.7 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.279 0.561 . . . . 0.0 111.126 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 34.7 m -66.31 143.97 56.86 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.45 HD22 ' OH ' ' A' ' 169' ' ' TYR . 68.4 tp -54.32 -44.67 72.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -57.92 -46.96 84.2 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -58.12 -43.72 87.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 98.3 mtp -62.35 -46.14 90.03 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.957 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 98.3 mtp -65.22 -41.04 94.81 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.825 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.0 m -63.28 -50.02 71.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.512 0.672 . . . . 0.0 110.468 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.31 98.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.408 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 76.2 m -60.88 -40.35 92.67 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.29 -39.23 82.31 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.83 -38.83 92.98 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.3 m -94.59 4.52 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 120.713 -0.395 . . . . 0.0 112.022 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.831 179.424 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.459 ' HB3' HG23 ' A' ' 48' ' ' THR . 12.5 Cg_exo . . . . . 0 N--CA 1.49 1.268 0 N-CA-C 109.147 -1.136 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.497 HG21 ' CG2' ' A' ' 115' ' ' ILE . 8.0 pt -73.07 109.57 5.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.147 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.82 145.68 34.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -61.75 138.22 58.31 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.384 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -97.31 -170.8 2.08 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.482 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.08 -41.54 83.65 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -69.95 -17.86 63.33 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.867 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.5 -7.96 63.95 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -72.1 127.73 33.49 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.698 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.1 mtt -74.81 128.37 35.4 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -127.61 130.16 70.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.097 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -59.48 141.27 55.12 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.733 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -146.07 144.73 30.22 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.912 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.3 142.52 50.47 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.201 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.484 HD12 ' HG ' ' A' ' 20' ' ' LEU . 33.3 pt -62.24 141.83 17.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.83 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.0 t -60.68 119.76 46.83 Favored Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.0 -36.19 74.81 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 N-CA-C 109.434 -1.025 . . . . 0.0 109.434 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -57.18 -49.02 77.27 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.015 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.6 m -61.27 -47.12 87.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.266 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.484 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -49.54 -60.27 3.01 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.813 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -55.07 -40.7 70.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.687 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -61.57 -41.37 97.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.429 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -58.25 -50.44 73.57 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.187 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.8 t -62.67 -43.11 98.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.875 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.37 -44.04 92.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.891 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 22' ' ' ALA . 53.9 t -58.86 -45.88 91.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 69.8 t -63.51 -36.34 75.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.745 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -54.46 -46.41 73.33 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.384 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -87.88 -33.57 18.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' HG21 ' A' ' 36' ' ' VAL . 38.2 mttt -130.46 40.05 3.56 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.918 -176.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.36 -50.03 5.1 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -95.12 -4.93 45.28 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.5 m -56.42 146.72 52.4 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.98 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.25 -34.97 11.98 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 122.661 2.241 . . . . 0.0 112.949 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -58.02 -18.57 25.05 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.914 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 30' ' ' LYS . 60.3 t -64.0 -42.3 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.49 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.426 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 8.0 mt -47.16 -60.59 3.76 Favored Pre-proline 0 C--O 1.24 0.57 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.594 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.426 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 73.2 Cg_exo -53.36 -42.15 67.48 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 119.971 1.026 . . . . 0.0 111.727 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.6 mtt -60.38 -44.51 95.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.496 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.66 -48.09 75.61 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.9 m -58.87 -42.88 90.51 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.824 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.22 -44.42 95.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.349 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.61 -22.45 60.97 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.388 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.0 m -88.27 5.89 39.57 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -61.88 125.89 25.43 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.857 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.15 10.74 74.3 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.804 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.99 149.34 39.32 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 1' ' ' PRO . 82.1 p -99.76 147.78 33.88 Favored Pre-proline 0 C--O 1.213 -0.851 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.379 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.26 -38.1 19.59 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.391 1.394 . . . . 0.0 113.221 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -68.31 -63.46 1.05 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.367 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.7 m-20 -58.24 -35.85 72.33 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.501 1.144 . . . . 0.0 108.024 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.525 HD21 ' HG2' ' A' ' 131' ' ' LYS . 58.2 tp -62.3 -48.86 78.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.104 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -58.18 -37.23 74.33 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 58' ' ' THR . 88.3 m -59.56 -40.83 88.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.455 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.0 -46.9 84.5 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.769 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.85 -39.71 87.68 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.689 0.757 . . . . 0.0 109.514 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -60.68 -39.59 89.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.439 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 54' ' ' THR . 59.4 p -67.34 -23.99 65.67 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.815 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.65 135.66 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.917 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.8 -149.17 7.54 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.13 -125.82 38.88 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.723 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -49.57 -12.62 0.07 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.326 -0.437 . . . . 0.0 111.675 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -42.65 -21.57 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.139 0.576 . . . . 0.0 112.177 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.13 -42.56 77.09 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.52 92.66 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 47.1 ttp -60.62 -28.68 68.71 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -58.14 -39.78 79.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.0 tmm? -60.75 -41.84 96.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.28 -39.43 75.69 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.483 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -60.14 -40.62 90.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.41 -40.28 95.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.235 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.0 m -59.64 -50.53 73.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.615 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.431 HD12 ' CE1' ' A' ' 130' ' ' TYR . 45.5 pt -67.75 -27.6 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.767 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -62.73 -43.27 99.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -63.38 -44.28 95.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.147 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.02 -37.13 78.87 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.398 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.88 98.92 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.776 -0.77 . . . . 0.0 108.965 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.47 -50.32 65.79 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.549 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.28 -41.69 98.7 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.85 0.833 . . . . 0.0 108.998 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -61.55 -42.27 98.58 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.07 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.49 -39.16 75.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.71 -13.14 61.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.505 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -178.527 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 . . . . . 0 C--O 1.236 0.39 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.44 142.99 90.33 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.05 110.85 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.497 1.465 . . . . 0.0 113.498 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -83.15 169.92 15.31 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.463 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -57.47 -49.53 72.48 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.025 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.7 t -60.29 -40.55 90.87 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.746 0.784 . . . . 0.0 109.142 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.16 -34.43 76.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.428 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.52 HG21 ' CZ3' ' A' ' 133' ' ' TRP . 0.4 OUTLIER -53.78 -28.82 17.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.14 -14.11 26.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.347 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.86 -1.34 88.59 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.3 p -61.77 -20.28 63.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.7 p -127.96 33.06 4.83 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.503 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 t -134.66 131.69 38.04 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.935 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.6 m -65.82 146.14 55.11 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -53.25 -43.41 67.36 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -39.97 93.3 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.705 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -62.79 -44.54 95.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.971 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -53.58 -63.37 1.17 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.497 ' CG2' HG21 ' A' ' 2' ' ' ILE . 45.7 pt -59.2 -25.28 29.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.971 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.7 -64.56 3.74 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 118' ' ' MET . 1.4 p90 -64.13 -28.23 69.63 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.247 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.405 ' N ' ' CD1' ' A' ' 117' ' ' TRP . 33.1 mtm -68.22 -40.0 82.21 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.6 p -115.63 -23.11 8.88 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -63.83 -75.66 0.08 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.128 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.22 -176.21 0.45 Allowed Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.38 144.44 13.43 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 N-CA-C 108.779 -1.277 . . . . 0.0 108.779 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.4 127.33 13.24 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.678 1.586 . . . . 0.0 114.009 -175.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.6 mm -114.73 108.74 48.61 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 114.637 -1.165 . . . . 0.0 107.894 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -87.34 60.2 3.67 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.811 1.674 . . . . 0.0 113.553 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -50.1 -39.47 16.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.87 -42.94 99.58 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.037 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -60.44 -47.85 84.3 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.312 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.403 HG22 ' CE2' ' A' ' 133' ' ' TRP . 90.1 mt -64.17 -47.91 87.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.466 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.792 ' CE2' HD11 ' A' ' 134' ' ' ILE . 87.4 t80 -59.2 -49.21 78.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.38 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.525 ' HG2' HD21 ' A' ' 52' ' ' LEU . 57.6 mtmt -62.87 -37.96 88.95 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.659 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -57.83 -43.43 85.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.52 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 43.7 m0 -63.03 -42.72 99.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.645 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.792 HD11 ' CE2' ' A' ' 130' ' ' TYR . 80.8 mt -59.02 -43.9 90.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.112 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.06 -40.28 80.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.91 -45.11 90.78 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.223 0.535 . . . . 0.0 109.709 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.32 -43.31 97.41 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.12 -36.49 83.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -58.46 -46.48 86.5 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -64.79 -38.57 91.44 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.713 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mm -60.42 -49.87 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.8 m -58.23 -34.48 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -66.65 -38.27 86.52 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 67.7 ttp -60.07 -46.28 90.07 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -71.13 -16.72 62.57 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.1 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -47.97 112.31 2.14 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.52 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.72 -35.87 4.18 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.936 1.757 . . . . 0.0 113.818 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.3 p -140.24 172.32 12.9 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 44.5 t -98.7 151.04 21.18 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.852 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.6 mm -51.9 -41.92 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.29 -39.08 81.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.802 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -66.7 -10.05 42.68 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.494 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.8 mm -80.29 125.36 39.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.739 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -152.49 129.7 11.22 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.99 0.424 . . . . 0.0 110.089 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.218 -179.608 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 . . . . . 0 CA--C 1.547 0.841 0 N-CA-C 111.45 0.167 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -67.55 134.36 32.79 Favored 'Trans proline' 0 N--CA 1.508 2.364 0 C-N-CA 122.524 2.149 . . . . 0.0 113.174 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.418 ' O ' HG23 ' A' ' 165' ' ' VAL . 37.4 t80 -58.73 -28.19 65.62 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -63.76 -50.36 69.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.867 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -63.07 -40.23 97.06 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -58.65 -50.26 74.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.412 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 161' ' ' PHE . 54.2 t -64.21 -49.23 82.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.712 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -59.5 -51.43 69.89 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.641 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -63.07 -41.69 99.49 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.089 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.641 ' CE2' HG23 ' A' ' 186' ' ' THR . 88.2 t80 -56.41 -48.58 76.64 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.519 ' OH ' HD22 ' A' ' 211' ' ' LEU . 12.3 m-85 -63.71 -37.38 87.12 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.231 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -58.05 -49.5 76.67 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 93.0 m -67.18 -38.24 85.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.861 0.839 . . . . 0.0 108.831 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 22.6 tp -55.46 -42.03 73.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.606 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 . . . . . 0 N--CA 1.446 -0.636 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.535 179.225 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 . . . . . 0 C--O 1.242 0.705 0 CA-C-O 121.464 0.649 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 98.4 mtp -61.69 -40.68 95.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.441 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.641 HG23 ' CE2' ' A' ' 168' ' ' PHE . 58.1 m -61.3 -48.26 82.19 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.563 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.67 -49.06 78.02 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.278 0.561 . . . . 0.0 110.17 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 98.4 m -62.46 -48.69 78.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.16 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 81.8 mt -67.61 -35.83 79.68 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.79 -1.096 . . . . 0.0 112.898 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.1 mt -44.75 -49.19 10.72 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.17 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 11.3 p -81.27 -37.22 15.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.73 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -61.97 -50.03 73.75 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.12 -23.89 62.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.831 0.348 . . . . 0.0 111.767 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.15 145.75 25.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.638 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -66.1 152.6 93.58 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.31 -45.61 36.51 Favored 'Trans proline' 0 N--CA 1.508 2.367 0 C-N-CA 122.705 2.27 . . . . 0.0 115.727 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -59.68 -49.46 77.67 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 118.799 -1.16 . . . . 0.0 110.417 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' CYS . . . . . 0.459 ' SG ' HD23 ' A' ' 202' ' ' LEU . 37.9 t -66.66 -38.98 87.96 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -48.79 -34.54 12.5 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.008 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 97.5 m -58.42 -50.36 73.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.185 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 26.2 mm -65.41 -45.21 93.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.596 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.459 HD23 ' SG ' ' A' ' 198' ' ' CYS . 3.9 mm? -53.9 -49.36 68.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.111 0.958 . . . . 0.0 108.858 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.64 -38.16 86.65 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.729 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -59.04 -39.43 81.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.913 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.445 HD21 ' HB1' ' A' ' 217' ' ' ALA . 2.7 mm? -59.15 -36.4 75.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 81.44 174.19 48.88 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.65 154.43 59.57 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 123.484 2.789 . . . . 0.0 112.902 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 86.91 -7.71 79.11 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.69 129.58 41.15 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.442 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.9 p -75.38 161.96 28.8 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.652 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.519 HD22 ' OH ' ' A' ' 169' ' ' TYR . 65.4 tp -59.6 -44.23 93.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.32 -50.3 74.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.162 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.6 -39.05 86.7 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.979 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 25.9 tpp -62.39 -50.58 70.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.938 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 15.2 tpt -63.25 -45.1 93.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.323 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.8 m -62.92 -48.43 78.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.85 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.445 ' HB1' HD21 ' A' ' 205' ' ' LEU . . . -62.73 -50.54 70.71 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.768 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 29.5 p -61.95 -30.61 71.03 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -64.85 -42.74 94.65 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.031 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.74 -40.42 98.76 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.006 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.67 -35.31 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.262 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.221 -179.451 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 N--CA 1.488 1.191 0 N-CA-C 108.948 -1.212 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.528 HG21 HG22 ' A' ' 115' ' ' ILE . 12.8 pt -63.74 112.3 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.253 0.549 . . . . 0.0 110.169 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.37 140.8 45.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.65 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -65.81 124.07 21.47 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.968 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -81.72 -172.23 3.76 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.369 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.24 -38.96 85.05 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -66.85 -19.2 65.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.453 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.52 -8.14 68.79 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.41 127.01 31.96 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.497 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 89.1 mtp -72.2 128.1 34.6 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.8 t -126.61 128.84 71.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.747 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -64.8 139.19 58.74 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.351 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -141.62 155.08 45.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.246 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.28 146.33 34.88 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.238 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.3 pt -62.79 144.15 14.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.916 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.8 m -61.89 121.18 63.44 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.44 -38.86 83.31 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 N-CA-C 109.794 -0.887 . . . . 0.0 109.794 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -59.53 -47.91 83.69 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.871 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.0 m -61.11 -46.11 91.92 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.87 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.524 HD13 ' C ' ' A' ' 20' ' ' LEU . 3.3 tm? -58.04 -49.14 77.9 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.245 0.545 . . . . 0.0 109.991 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -58.28 -42.3 86.25 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -62.22 -41.58 98.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.25 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -57.78 -49.42 76.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.6 t -62.08 -44.88 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.92 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -59.24 -42.78 91.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.529 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 22' ' ' ALA . 50.4 t -57.6 -44.58 85.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 53.8 t -64.63 -38.25 82.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.982 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -55.18 -49.22 72.43 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.086 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -81.07 -44.6 17.76 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -120.46 39.52 3.72 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.73 -52.19 3.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -95.83 -4.79 43.12 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -55.52 146.28 44.96 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 118.951 0.796 . . . . 0.0 111.734 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.19 -32.19 17.23 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 122.47 2.114 . . . . 0.0 112.544 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.26 -21.62 35.61 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.269 0.557 . . . . 0.0 109.667 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.5 t -63.27 -40.77 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.487 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.8 mt -42.75 -61.27 1.77 Allowed Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.317 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.04 -33.12 52.03 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 120.799 1.0 . . . . 0.0 111.499 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.1 tpt -60.23 -48.15 82.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.374 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 134' ' ' ILE . 63.9 t80 -55.77 -47.33 77.2 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.2 t -58.68 -43.89 90.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.89 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.05 94.02 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.04 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.7 mt -70.62 -24.53 62.75 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -91.34 25.94 2.4 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.561 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.6 126.17 30.56 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.161 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.29 11.21 75.56 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.055 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.28 150.67 43.37 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 111.915 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.9 p -99.3 149.12 35.53 Favored Pre-proline 0 C--O 1.218 -0.574 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.821 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -47.17 -37.44 23.64 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.192 1.261 . . . . 0.0 112.528 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -74.95 -62.51 1.52 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.61 -0.436 . . . . 0.0 112.139 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.77 -38.29 75.16 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 52' ' ' LEU . 56.4 tp -64.36 -44.21 92.13 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.595 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -58.22 -38.72 77.37 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 87.7 m -61.07 -40.36 93.36 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.963 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.16 -47.96 81.74 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.865 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.6 -41.5 92.69 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.218 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -61.62 -38.31 87.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.117 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.28 -24.15 66.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.522 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.433 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 95.8 t -58.67 154.52 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.78 -149.49 5.21 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.7 -128.5 47.79 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.208 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.452 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 18.7 p80 -53.82 -10.87 0.34 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.99 -0.605 . . . . 0.0 111.756 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.433 ' NE2' ' O ' ' A' ' 59' ' ' VAL . 16.9 tt0 -43.57 -22.2 0.04 OUTLIER 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.22 -40.29 67.53 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.08 97.63 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.2 tmm? -57.32 -21.4 34.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.52 -37.15 72.55 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.1 tpt -58.17 -45.63 87.17 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -56.23 -38.14 70.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -43.51 71.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.6 -35.53 73.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.987 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -58.34 -48.74 79.6 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 pt -67.68 -28.51 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -62.28 -43.47 98.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.02 -42.33 97.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.121 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.66 -40.02 90.51 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.24 98.29 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.225 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.3 -50.3 72.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.064 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.9 -39.18 93.58 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.893 0.854 . . . . 0.0 108.768 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -58.39 -45.29 88.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.779 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -57.38 -40.49 78.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -71.88 -14.07 61.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.599 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -177.797 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 . . . . . 0 C--O 1.24 0.56 0 CA-C-O 121.256 0.55 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -65.25 152.44 91.77 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.3 80.44 0.22 Allowed 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.216 1.944 . . . . 0.0 114.43 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -66.23 163.77 17.17 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.11 -44.29 96.45 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.405 ' HB3' HG23 ' A' ' 108' ' ' THR . 68.6 m -61.38 -39.97 92.62 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.07 -41.37 92.27 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.49 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.55 HG21 ' CH2' ' A' ' 133' ' ' TRP . 37.3 mm -58.72 -45.95 90.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.08 -20.5 65.82 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.89 -0.75 89.45 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 76.1 p -60.01 -21.41 61.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.405 HG23 ' HB3' ' A' ' 102' ' ' SER . 14.4 p -123.68 20.97 9.34 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.0 p -125.22 132.06 53.04 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.731 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -73.13 145.81 46.15 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.6 tp -50.98 -46.97 61.53 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.356 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.76 -41.29 97.49 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.29 -38.48 89.53 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.354 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -63.07 -42.08 99.57 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.824 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.528 HG22 HG21 ' A' ' 2' ' ' ILE . 35.0 pt -67.86 -42.14 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 118.907 -1.117 . . . . 0.0 111.06 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.26 -42.16 58.01 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -58.48 -44.71 89.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.421 ' SD ' HD11 ' A' ' 2' ' ' ILE . 28.2 ttt -73.29 -42.22 62.68 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.245 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 66.0 p -126.62 -23.66 3.7 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -56.11 -51.03 69.39 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.993 1.269 . . . . 0.0 110.279 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -81.14 -179.07 1.32 Allowed Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.05 143.65 17.67 Favored 'Trans proline' 0 N--CA 1.485 1.002 0 N-CA-C 107.441 -1.792 . . . . 0.0 107.441 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.85 123.85 4.23 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.849 1.699 . . . . 0.0 113.599 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.9 mm -113.64 108.41 51.76 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.43 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 73.1 Cg_endo -74.79 57.34 4.4 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.273 1.982 . . . . 0.0 113.503 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 127' ' ' GLY . 27.0 m -60.5 -44.49 96.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.515 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -63.3 -43.06 99.0 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.759 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 125' ' ' PRO . 88.7 tt0 -63.03 -44.89 94.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.63 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.5 mm -61.28 -47.54 93.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -57.87 -47.44 82.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -58.93 -41.85 88.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.785 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -57.72 -43.86 85.56 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.55 ' CH2' HG21 ' A' ' 104' ' ' ILE . 48.7 m0 -62.32 -45.54 92.77 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.765 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.476 HG21 ' CE2' ' A' ' 40' ' ' PHE . 32.3 mm -60.25 -46.67 94.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.424 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.61 -41.47 85.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 65.6 tp -60.52 -45.6 93.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.06 -41.14 96.35 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.35 -36.39 83.55 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -58.63 -44.83 90.13 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.49 -40.17 95.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.802 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.74 -49.26 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.353 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.7 m -58.02 -32.68 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.1 ttm-85 -67.98 -38.0 82.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 58.9 ttm -58.57 -44.15 89.65 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -74.84 -17.56 60.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.705 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.8 p -43.1 104.96 0.4 Allowed Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.39 -32.66 6.19 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.943 1.762 . . . . 0.0 113.673 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 70.6 p -139.35 173.04 11.95 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.6 t -106.72 150.12 26.6 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.887 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.577 ' HA ' HD12 ' A' ' 153' ' ' ILE . 13.6 mm -50.88 -46.51 29.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -59.4 -37.98 79.39 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.461 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -65.96 -5.04 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.216 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' A' ' 150' ' ' ILE . 92.6 mt -97.14 126.01 50.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.86 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -152.22 134.57 15.18 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.496 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 -179.246 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 160' ' ' PRO . 96.7 mt-10 . . . . . 0 CA--C 1.544 0.712 0 CA-C-O 119.895 -0.097 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 159' ' ' GLU . 5.2 Cg_endo -81.46 135.82 9.53 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.654 2.236 . . . . 0.0 113.418 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -58.93 -36.8 75.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -59.86 -49.77 76.4 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.02 -40.65 94.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.517 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -58.92 -49.59 77.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.463 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.65 -45.77 98.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.473 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.01 -52.19 66.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.019 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.64 -39.75 91.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.666 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.683 ' CE2' HG23 ' A' ' 186' ' ' THR . 81.2 t80 -56.71 -47.89 78.95 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -64.7 -36.59 84.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.943 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -57.98 -48.77 79.02 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.545 ' OG1' HD11 ' A' ' 153' ' ' ILE . 96.6 m -66.62 -38.91 87.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.729 0.776 . . . . 0.0 109.061 177.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 29.2 tp -56.42 -39.82 73.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.926 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 . . . . . 0 C--N 1.321 -0.669 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.954 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 . . . . . 0 C--O 1.241 0.623 0 CA-C-O 121.436 0.636 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 98.3 mtp -60.67 -41.04 94.28 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.079 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.683 HG23 ' CE2' ' A' ' 168' ' ' PHE . 66.4 m -60.44 -48.84 80.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.143 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.03 -47.72 85.11 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.01 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 99.0 m -62.09 -48.42 80.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.684 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.17 -21.69 58.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.42 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 67.2 tp -54.06 -49.97 67.79 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.625 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.7 m -87.33 -38.24 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.646 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.63 -45.96 92.09 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.958 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -80.27 -9.87 59.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.23 155.7 34.24 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -70.4 151.22 95.72 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.119 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.41 -42.91 63.49 Favored 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 122.316 2.011 . . . . 0.0 115.072 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.16 -60.49 3.79 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.538 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 49.4 t -62.16 -38.93 90.94 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -48.58 -34.64 11.87 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.856 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 99.3 m -59.92 -49.48 77.53 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 118.813 -1.155 . . . . 0.0 108.708 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.638 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 2.2 mp -64.75 -45.01 96.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.016 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.79 -42.16 92.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.51 -38.9 91.75 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -58.69 -40.47 83.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.278 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 205' ' ' LEU . 85.5 mt -63.0 -40.38 97.58 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.536 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.16 -160.49 53.3 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.999 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.05 165.91 4.65 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 123.822 3.015 . . . . 0.0 113.398 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 209' ' ' ALA . . . 61.08 -123.85 33.7 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 208' ' ' GLY . . . 64.86 99.29 0.04 OUTLIER 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.139 0.495 . . . . 0.0 111.231 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 50.9 m -57.76 144.27 38.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.2 tp -50.36 -40.96 50.89 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.223 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -57.98 -45.58 86.52 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.43 -42.23 91.42 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 5.5 mmt -61.58 -50.85 70.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.101 0.476 . . . . 0.0 110.961 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 59.3 ttm -63.69 -46.29 86.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.349 0.595 . . . . 0.0 110.574 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.8 m -61.8 -48.1 82.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.48 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.426 ' O ' HG23 ' A' ' 221' ' ' VAL . . . -61.05 -45.13 96.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.994 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 92.1 m -61.35 -40.98 96.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -56.7 -38.65 72.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.23 -38.98 93.99 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -94.97 5.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.341 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.267 -179.586 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.437 ' HB3' HG23 ' A' ' 48' ' ' THR . 8.0 Cg_exo . . . . . 0 N--CA 1.487 1.141 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.7 pt -71.21 110.11 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.403 0.621 . . . . 0.0 110.575 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.6 t -129.54 126.37 63.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.573 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -56.6 115.57 2.61 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.359 0.599 . . . . 0.0 109.847 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.56 -176.09 1.83 Allowed 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.281 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.99 -38.49 82.74 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.26 -19.51 66.0 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.731 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.25 -7.72 62.26 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -80.07 124.2 28.53 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.4 mtt -75.64 131.61 40.05 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.8 t -126.66 129.23 71.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.553 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -66.84 136.16 55.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.531 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -137.78 153.72 49.65 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.955 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.28 148.15 37.76 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.392 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.8 pt -62.44 144.48 14.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.173 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 m -63.68 121.98 73.87 Favored Pre-proline 0 N--CA 1.451 -0.399 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.15 -36.52 77.38 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 N-CA-C 109.507 -0.997 . . . . 0.0 109.507 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -57.63 -49.69 75.62 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.124 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 95.0 m -61.46 -46.14 91.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.458 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 65.8 tp -57.68 -49.9 74.96 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.832 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -58.47 -41.87 86.21 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -62.44 -41.67 98.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.751 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -57.55 -50.97 71.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.374 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.42 -41.84 94.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.365 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.74 -40.68 84.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.172 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 22' ' ' ALA . 47.2 t -58.55 -44.09 88.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 75.8 t -62.41 -35.96 72.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.998 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -57.03 -43.7 82.15 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.403 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -93.65 -27.1 16.76 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.545 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 99.6 mttt -132.41 38.3 3.46 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.956 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.79 -54.13 3.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -96.63 -5.17 39.64 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 55.4 m -52.49 144.34 24.24 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 118.906 0.776 . . . . 0.0 111.508 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.26 -31.62 17.96 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.453 2.102 . . . . 0.0 112.706 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -59.08 -18.86 39.04 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.771 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 30' ' ' LYS . 54.1 t -65.23 -41.27 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.944 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.427 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 6.4 mt -45.7 -60.79 2.99 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.237 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 77.8 Cg_exo -54.23 -41.22 77.92 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 CA-C-N 120.001 1.036 . . . . 0.0 111.795 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.9 mtt -60.86 -44.21 97.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.798 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -56.92 -49.44 75.62 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.779 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.4 p -60.86 -38.88 87.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.721 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.66 -46.08 91.7 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.067 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.61 -27.13 62.9 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.221 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -85.84 12.32 9.37 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.216 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -64.76 122.54 17.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.522 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.99 10.47 84.05 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 121.428 -0.415 . . . . 0.0 112.896 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.96 149.1 41.56 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.165 0.507 . . . . 0.0 112.117 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.437 HG23 ' HB3' ' A' ' 1' ' ' PRO . 81.3 p -99.19 148.69 34.97 Favored Pre-proline 0 C--O 1.212 -0.901 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.412 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -45.74 -37.17 15.76 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.477 1.451 . . . . 0.0 113.558 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -70.29 -63.35 1.1 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.254 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.509 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -57.88 -35.81 71.51 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.41 HD23 ' HD2' ' A' ' 130' ' ' TYR . 55.9 tp -62.4 -44.15 97.13 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.297 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -58.26 -38.05 76.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.53 ' O ' HG23 ' A' ' 58' ' ' THR . 88.3 m -61.21 -40.13 92.82 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.101 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 83.9 mmm -56.08 -46.49 78.99 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.581 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.78 -44.62 48.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.451 0.644 . . . . 0.0 111.145 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.25 -39.09 78.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.064 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 54' ' ' THR . 45.2 p -67.2 -19.69 65.6 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.999 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 60' ' ' GLY . 76.2 t -61.79 154.48 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.741 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 59' ' ' VAL . . . -140.65 -151.9 5.68 Favored Glycine 0 CA--C 1.535 1.338 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.96 -128.12 46.74 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.123 -1.037 . . . . 0.0 110.934 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -51.5 -10.59 0.1 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.956 -0.622 . . . . 0.0 112.11 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -43.46 -21.98 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.27 -41.09 68.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.13 96.36 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.3 tpp -56.78 -21.11 26.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.12 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -58.65 -38.4 78.03 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -58.58 -45.36 89.21 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -53.11 -43.04 66.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.086 178.707 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -59.62 -40.65 88.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -64.61 -40.78 96.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.593 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.7 m -60.17 -44.05 95.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.6 mt -60.33 -43.93 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -60.43 -42.13 95.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.444 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.23 -46.24 91.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.055 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.59 -39.21 93.81 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.66 98.51 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.435 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.29 -49.33 74.44 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.179 0.514 . . . . 0.0 111.186 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.22 -41.62 99.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 122.122 0.963 . . . . 0.0 109.1 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.469 ' CZ2' HD13 ' A' ' 104' ' ' ILE . 71.9 t90 -59.62 -44.42 93.44 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.083 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -53.87 -42.53 68.69 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.4 -26.75 68.13 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.477 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.351 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -60.62 158.92 27.97 Favored Pre-proline 0 C--O 1.239 0.541 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.069 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -48.17 130.44 20.52 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.718 1.612 . . . . 0.0 112.207 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.73 154.06 34.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.557 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -44.09 -61.28 3.16 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.605 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.569 ' OG ' HG23 ' A' ' 108' ' ' THR . 34.9 t -60.85 -39.03 87.59 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.667 0.746 . . . . 0.0 110.136 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -35.94 77.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.005 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.613 HG21 ' CZ3' ' A' ' 133' ' ' TRP . 6.5 tp -59.37 -33.35 50.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 102' ' ' SER . . . -70.59 -28.06 64.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.21 -8.1 79.82 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.7 p -57.78 -23.71 53.68 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.569 HG23 ' OG ' ' A' ' 102' ' ' SER . 23.0 p -114.79 8.51 16.09 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.684 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 62.0 m -111.79 131.34 55.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.078 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.0 m -71.04 156.03 40.11 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.8 tp -58.67 -47.83 83.16 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.244 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -61.61 -43.83 98.14 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.904 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.3 -39.38 86.75 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.192 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.619 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.5 pt -71.09 -39.76 74.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.952 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.33 -43.34 79.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -59.34 -45.15 92.16 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.915 -1.143 . . . . 0.0 109.084 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.2 ttt -72.04 -41.32 67.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.475 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.2 m -127.16 -26.4 3.11 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -57.4 -50.39 73.15 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 118.336 -1.346 . . . . 0.0 110.269 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.88 -178.23 1.13 Allowed Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 134.49 30.08 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 120.665 1.273 . . . . 0.0 109.224 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -36.77 116.72 0.16 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.681 2.254 . . . . 0.0 113.601 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.447 HG22 HG13 ' A' ' 126' ' ' VAL . 44.7 mm -108.83 108.54 60.82 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 87.4 Cg_endo -76.5 58.92 6.0 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.146 1.897 . . . . 0.0 112.692 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.47 HG23 ' N ' ' A' ' 127' ' ' GLY . 27.3 m -58.86 -45.08 91.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.956 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.47 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -64.18 -42.05 98.12 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.208 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 125' ' ' PRO . 88.4 tt0 -60.85 -45.89 92.74 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.415 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.84 -47.99 86.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.318 0.58 . . . . 0.0 110.415 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.7 ' CE2' HD11 ' A' ' 134' ' ' ILE . 86.7 t80 -58.59 -48.48 80.8 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.825 0.821 . . . . 0.0 108.858 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.491 ' HA ' HD12 ' A' ' 134' ' ' ILE . 60.2 mtpt -62.89 -38.16 89.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.035 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.7 tpp180 -57.79 -43.18 85.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.613 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 44.4 m0 -62.71 -43.74 98.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.885 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.7 HD11 ' CE2' ' A' ' 130' ' ' TYR . 84.4 mt -59.32 -44.57 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.933 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.37 -41.79 85.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.86 -42.42 99.75 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.25 -42.86 98.89 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.13 -36.47 84.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.7 -44.63 90.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.28 -39.5 92.67 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.607 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mm -60.58 -49.65 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.6 m -57.47 -35.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -65.15 -40.39 94.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 94.2 mmm -60.62 -43.09 97.9 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.329 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -71.61 -19.68 62.09 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.889 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.4 t -48.42 117.39 5.85 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.625 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -85.15 -25.03 1.87 Allowed 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 122.174 1.916 . . . . 0.0 113.67 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.1 p -138.97 169.66 17.39 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 40.8 t -107.43 148.9 28.54 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.985 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.444 HD11 ' CE1' ' A' ' 168' ' ' PHE . 4.9 tp -48.94 -36.38 8.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.5 tp -66.55 -39.48 88.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.609 0.719 . . . . 0.0 109.581 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -64.63 -26.36 68.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.153 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.21 108.36 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.071 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -144.85 122.62 11.9 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 C--N 1.328 -0.331 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.217 -179.067 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 119.877 -0.106 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.07 155.94 23.03 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.62 2.213 . . . . 0.0 114.598 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 165' ' ' VAL . 20.7 t80 -60.16 -39.68 87.26 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.453 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -62.99 -47.54 82.7 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.742 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -61.0 -43.34 99.03 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.907 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -62.15 -50.15 73.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.277 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 161' ' ' PHE . 55.1 t -61.07 -44.53 98.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.545 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -62.11 -53.88 49.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.6 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 61.5 mtm-85 -64.62 -41.0 96.46 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.173 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.615 ' CE2' HG23 ' A' ' 186' ' ' THR . 82.5 t80 -58.45 -48.8 79.54 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.55 ' OH ' HD22 ' A' ' 211' ' ' LEU . 8.9 m-85 -64.92 -36.9 85.88 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.538 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -59.62 -48.1 82.99 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 97.3 m -64.89 -39.6 93.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.579 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 17.0 tp -58.37 -38.26 76.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.103 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 27.9 ttt-85 . . . . . 0 N--CA 1.444 -0.741 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.656 179.76 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 . . . . . 0 C--O 1.242 0.677 0 CA-C-O 121.603 0.715 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.402 ' O ' HD13 ' A' ' 189' ' ' LEU . 98.7 mtp -61.62 -40.33 94.46 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.027 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.615 HG23 ' CE2' ' A' ' 168' ' ' PHE . 60.4 m -59.69 -46.92 87.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.283 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.68 -47.71 84.55 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.797 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 98.0 m -64.23 -47.54 79.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.596 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 185' ' ' MET . 8.7 mp -66.82 -33.81 76.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.327 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.572 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 13.2 mt -49.43 -44.95 45.85 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.964 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.6 -47.52 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.553 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -61.48 -50.28 73.39 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -72.08 -25.9 61.95 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.311 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 190' ' ' LEU . . . -59.08 156.97 10.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.304 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -70.63 152.88 95.22 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.081 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.28 -45.9 31.83 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 122.778 2.319 . . . . 0.0 114.708 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -54.6 -62.11 1.87 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.032 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 46.5 t -58.5 -45.09 89.44 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.857 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -48.95 -31.06 6.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.578 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.9 m -59.76 -50.59 73.24 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.679 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.472 ' HA ' ' HB3' ' A' ' 204' ' ' ALA . 3.5 mm -79.3 -30.14 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.697 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -55.1 39.02 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.58 -39.28 90.61 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 201' ' ' ILE . . . -57.22 -32.5 66.58 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.92 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 205' ' ' LEU . 56.2 tp -56.34 -38.47 71.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 96.61 160.1 32.0 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.778 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.0 156.05 66.45 Favored 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 123.594 2.863 . . . . 0.0 113.215 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 81.15 -0.34 87.64 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.532 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.405 ' HB1' HD21 ' A' ' 205' ' ' LEU . . . -68.37 136.82 53.96 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.458 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.6 p -76.22 160.81 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.886 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.55 HD22 ' OH ' ' A' ' 169' ' ' TYR . 63.3 tp -60.41 -44.03 96.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.94 -48.97 79.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.808 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.28 -43.43 92.52 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.0 ttm -60.33 -48.88 79.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.524 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 94.9 mmm -62.86 -39.07 93.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.5 m -61.69 -50.27 73.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.215 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.36 96.5 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.94 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 97.0 m -60.45 -40.44 91.17 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -68.62 -39.31 80.86 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.995 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.28 -40.66 92.21 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 12.4 t -95.09 -25.15 4.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-O 121.189 0.519 . . . . 0.0 110.598 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.125 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.441 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.486 1.049 0 N-CA-C 108.987 -1.197 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.467 HD11 ' SD ' ' A' ' 118' ' ' MET . 9.5 pt -62.31 109.85 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.494 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.1 t -128.88 123.58 59.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.486 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -57.13 110.63 0.87 Allowed 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.346 0.593 . . . . 0.0 110.003 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -68.5 177.78 2.28 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.011 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 pp -58.27 -33.45 69.42 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -63.18 -26.8 68.97 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.641 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.49 -7.19 53.55 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -85.73 124.72 32.56 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.894 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.0 mtt -73.75 134.49 43.47 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -128.62 130.07 68.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.813 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -68.19 136.27 53.35 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.518 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -137.9 153.6 49.52 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.254 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.86 142.95 40.0 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.985 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.432 ' CD1' HD21 ' A' ' 20' ' ' LEU . 37.9 pt -63.67 139.7 20.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.086 0.469 . . . . 0.0 110.488 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.0 t -61.01 126.09 85.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.82 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.09 -32.79 50.58 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 120.929 1.086 . . . . 0.0 109.884 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -58.76 -39.88 82.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 95.9 m -60.93 -46.2 91.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.732 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.432 HD21 ' CD1' ' A' ' 15' ' ' ILE . 68.1 mt -59.9 -45.02 93.87 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.64 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -60.55 -40.86 93.11 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.068 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.551 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -64.94 -46.65 80.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.284 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 42.3 t-105 -60.47 -50.69 72.57 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.878 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.89 -45.94 97.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.6 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.48 -43.5 98.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.364 0.602 . . . . 0.0 110.852 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 22' ' ' ALA . 46.7 t -59.27 -46.56 92.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.165 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 2.0 t -69.52 -25.94 29.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.393 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -58.98 -45.13 91.33 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.738 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -91.62 -36.35 13.71 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.412 ' O ' HG21 ' A' ' 36' ' ' VAL . 98.3 mttt -120.92 38.12 4.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.147 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.08 -51.64 4.49 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -96.11 -5.07 41.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.2 m -54.62 140.57 57.6 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 118.874 0.761 . . . . 0.0 112.22 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -59.93 -39.55 70.25 Favored 'Trans proline' 0 N--CA 1.507 2.265 0 C-N-CA 122.489 2.126 . . . . 0.0 112.817 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -54.15 -20.25 6.42 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.554 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.412 HG21 ' O ' ' A' ' 30' ' ' LYS . 52.9 t -62.57 -43.56 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.62 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.424 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 8.4 mt -46.97 -61.38 2.83 Favored Pre-proline 0 C--O 1.24 0.578 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.084 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 73.8 Cg_exo -53.62 -42.08 68.78 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 120.273 1.133 . . . . 0.0 111.781 176.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.0 mtp -61.41 -42.84 99.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.845 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -56.52 -48.84 76.37 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.8 t -59.23 -43.86 92.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.983 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.08 92.86 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.47 0.653 . . . . 0.0 110.069 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.4 mt -70.77 -25.64 62.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.459 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.9 m -89.53 7.76 34.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.785 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.22 128.41 35.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.573 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.76 10.54 76.79 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.58 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.67 149.86 38.05 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 111.973 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.9 p -99.05 150.29 36.56 Favored Pre-proline 0 C--O 1.218 -0.568 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.626 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.8 -39.55 18.82 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.492 1.461 . . . . 0.0 112.795 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -69.29 -63.35 1.08 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.349 -0.54 . . . . 0.0 112.018 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.492 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.96 -36.15 72.16 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.27 1.034 . . . . 0.0 108.405 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -62.18 -46.45 88.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.879 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -59.08 -37.46 77.16 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 85.5 m -58.6 -41.0 84.83 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.225 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.15 -46.07 89.33 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.298 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.439 HD11 HD13 ' A' ' 134' ' ' ILE . 90.8 mt -66.14 -41.84 89.91 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.814 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.97 -26.94 68.51 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.403 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 m -65.7 -34.64 78.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.238 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 60' ' ' GLY . 4.3 t -59.13 163.54 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.199 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.441 ' N ' HG12 ' A' ' 59' ' ' VAL . . . -157.6 -161.98 11.31 Favored Glycine 0 N--CA 1.473 1.109 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.43 -125.28 38.99 Favored Glycine 0 C--N 1.342 0.868 0 C-N-CA 118.867 -1.635 . . . . 0.0 109.774 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -48.37 -17.05 0.12 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.58 -0.31 . . . . 0.0 110.866 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -45.77 -21.71 0.14 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.324 0.25 . . . . 0.0 111.302 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.91 64.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.31 -40.55 96.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.0 mtt -63.74 -16.51 61.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.514 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -59.55 -39.05 82.73 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -60.62 -42.09 96.18 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -57.65 -39.28 76.67 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.096 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -60.63 -39.31 87.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.54 -40.48 95.68 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -59.39 -43.44 92.93 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 84.9 mt -60.78 -42.33 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -60.13 -41.8 93.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.486 -0.779 . . . . 0.0 108.97 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.32 -43.47 97.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.504 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.77 -40.47 97.39 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.73 98.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.564 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.1 -50.15 71.67 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.309 0.576 . . . . 0.0 110.87 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.81 -39.55 94.5 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.515 ' CH2' HD13 ' A' ' 129' ' ' ILE . 62.8 t-105 -58.12 -46.32 85.8 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.678 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -55.71 -41.79 74.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -72.26 -14.18 61.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.095 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -177.75 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 . . . . . 0 C--O 1.239 0.509 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -62.35 159.2 42.28 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.936 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.551 ' HB3' HD11 ' A' ' 104' ' ' ILE . 71.4 Cg_exo -51.24 141.31 39.79 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.437 2.092 . . . . 0.0 114.043 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.496 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 97.8 mtt180 -138.44 160.14 40.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.292 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.11 -47.64 85.96 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 118.348 -1.882 . . . . 0.0 109.63 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.1 p -64.78 -39.04 92.95 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.992 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.496 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 99.0 m-20 -63.91 -43.21 96.64 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.961 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.564 HG21 ' CZ3' ' A' ' 133' ' ' TRP . 0.8 OUTLIER -60.98 -37.89 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.69 -22.75 67.05 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.426 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.61 -3.26 69.31 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.4 p -67.53 -23.42 65.44 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.4 p -117.33 -2.32 11.61 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.154 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.0 m -105.45 131.42 52.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.726 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.8 m -70.65 151.47 44.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.82 -49.73 74.52 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.039 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.91 -40.43 88.79 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.69 -41.74 86.96 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -61.8 -37.68 85.29 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.5 mm -57.75 -62.03 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.291 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.71 -40.69 97.64 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -56.33 -44.94 80.47 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.467 ' SD ' HD11 ' A' ' 2' ' ' ILE . 27.4 ttt -72.67 -42.02 64.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.356 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 75.5 p -125.52 -23.89 4.0 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -51.72 -64.34 0.84 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.852 1.205 . . . . 0.0 110.429 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -76.71 -175.89 0.55 Allowed Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.24 143.82 14.06 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 N-CA-C 108.28 -1.469 . . . . 0.0 108.28 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.23 129.71 16.03 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.813 1.676 . . . . 0.0 113.526 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.454 HG22 HG13 ' A' ' 126' ' ' VAL . 42.7 mm -113.82 108.57 51.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.1 55.87 2.99 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.17 1.914 . . . . 0.0 113.431 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 127' ' ' GLY . 17.7 m -61.1 -48.19 90.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.926 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.482 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -63.59 -42.51 98.8 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.603 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -62.18 -46.26 89.73 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.389 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.515 HD13 ' CH2' ' A' ' 80' ' ' TRP . 89.8 mt -63.61 -48.77 85.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.372 0.606 . . . . 0.0 110.517 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.666 ' CE2' HD11 ' A' ' 134' ' ' ILE . 85.7 t80 -58.25 -47.1 84.64 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.417 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -61.53 -39.99 93.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.486 -1.233 . . . . 0.0 109.596 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.29 -41.74 89.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.564 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 47.9 m0 -62.08 -43.8 98.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.666 HD11 ' CE2' ' A' ' 130' ' ' TYR . 85.8 mt -60.47 -44.44 96.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.973 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.56 -41.27 81.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.729 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.8 -45.13 94.08 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.609 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.93 96.96 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -63.41 -36.41 83.65 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -58.05 -44.73 87.59 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.26 -38.62 90.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.778 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.66 -49.49 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.2 -36.06 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -65.81 -38.79 89.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.6 tpt -59.13 -47.39 85.45 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -72.93 -12.75 61.07 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.195 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.4 t -51.09 117.47 8.87 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.578 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -78.4 -35.04 1.29 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.956 1.771 . . . . 0.0 113.555 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.1 p -139.81 172.47 12.73 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.7 m -105.62 151.54 24.24 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.861 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.7 mm -49.35 -43.4 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 tt -58.79 -39.86 82.35 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.78 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -67.71 -14.49 62.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.081 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.2 mm -80.04 113.67 19.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.388 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -144.0 128.31 17.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.763 -179.45 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 119.658 -0.211 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 148.53 54.1 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.247 1.965 . . . . 0.0 114.116 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.74 -43.09 94.39 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.836 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.1 ttp85 -60.58 -46.61 89.59 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.68 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -59.86 -41.42 91.42 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.962 -1.095 . . . . 0.0 108.313 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -61.52 -50.45 72.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.126 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.32 -43.95 97.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.763 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.59 -56.37 20.59 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.63 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -62.24 -39.54 93.18 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.664 ' CE2' HG23 ' A' ' 186' ' ' THR . 90.1 t80 -57.32 -47.62 81.06 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -64.39 -37.66 88.3 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.624 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -61.07 -45.35 95.11 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.719 0.771 . . . . 0.0 109.6 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 94.7 m -66.1 -40.2 90.59 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 16.7 tp -58.51 -38.98 78.84 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.323 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 . . . . . 0 N--CA 1.445 -0.678 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.991 179.435 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 . . . . . 0 C--O 1.244 0.785 0 CA-C-O 121.577 0.703 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.4 -41.21 96.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.289 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.664 HG23 ' CE2' ' A' ' 168' ' ' PHE . 66.7 m -60.54 -45.5 93.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.029 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -59.36 -49.86 76.2 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.813 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 97.6 m -64.62 -47.36 78.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.591 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.59 -37.56 87.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.28 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.539 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 9.4 mt -43.23 -54.0 4.79 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.013 0.435 . . . . 0.0 110.722 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 71.8 t -86.92 -40.62 14.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.947 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -59.76 -49.36 78.04 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 49.3 p30 -89.32 -4.96 57.91 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 119.074 -1.051 . . . . 0.0 112.087 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 190' ' ' LEU . . . -68.31 162.98 24.0 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -66.85 150.83 97.48 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.624 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.402 ' HA ' ' HB3' ' A' ' 199' ' ' LYS . 31.7 Cg_endo -64.2 -38.74 34.12 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.407 2.072 . . . . 0.0 113.588 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -59.51 -50.54 73.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.21 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 202' ' ' LEU . 53.2 t -64.19 -43.59 94.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.035 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 196' ' ' PRO . 88.6 tttt -48.31 -30.27 4.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.847 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 92.6 m -59.47 -49.05 79.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.925 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 0.8 OUTLIER -82.67 -30.23 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.156 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.446 HD11 ' SG ' ' A' ' 198' ' ' CYS . 79.3 mt -60.94 -45.14 95.9 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.2 -39.45 94.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.001 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -59.05 -37.46 77.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.962 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 72.6 mt -59.78 -38.99 83.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.27 167.76 43.97 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.649 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.1 154.36 67.88 Favored 'Trans proline' 0 N--CA 1.507 2.32 0 C-N-CA 123.936 3.091 . . . . 0.0 113.871 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.19 16.3 80.8 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.749 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -79.9 135.54 36.45 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.094 0.473 . . . . 0.0 111.353 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 212' ' ' GLU . 42.0 m -73.35 137.37 44.71 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -51.64 -39.32 57.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.484 ' H ' HG22 ' A' ' 210' ' ' THR . 88.8 tt0 -59.25 -45.76 90.31 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.18 -42.18 90.24 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.7 mtt -62.7 -43.06 99.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.206 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 59.8 mtt -63.8 -43.54 95.98 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.682 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.1 m -65.86 -49.65 67.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.561 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.16 -44.53 95.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.031 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 81.0 m -61.32 -39.29 89.94 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.13 -36.68 83.79 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.174 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.37 94.35 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.49 -16.58 7.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.199 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.67 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 N--CA 1.486 1.077 0 N-CA-C 109.408 -1.035 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.2 pt -75.85 125.61 35.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.481 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -127.18 130.0 71.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.877 -178.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.42 121.58 13.03 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -84.04 -174.12 5.1 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.349 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 6' ' ' LEU . 87.3 mt -59.86 -38.32 81.83 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -66.82 -23.37 66.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.353 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.42 -7.14 56.02 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -71.85 132.54 44.56 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.371 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.1 mtt -85.04 109.49 18.25 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.8 t -109.73 130.22 63.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.805 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -61.29 137.38 58.24 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.841 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -138.55 152.34 48.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.006 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.86 143.59 49.36 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.029 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mm -64.42 138.46 23.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.2 t -58.69 121.58 54.78 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.44 -35.21 64.85 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 120.87 1.047 . . . . 0.0 110.029 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -59.42 -43.65 93.03 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.0 m -62.01 -46.19 90.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.97 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.7 mt -57.96 -50.17 74.3 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.311 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.11 -40.59 90.2 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.571 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -63.24 -43.4 98.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.693 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -59.75 -50.39 74.0 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.531 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.5 t -62.4 -42.66 96.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.175 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.82 -43.19 90.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 22' ' ' ALA . 49.2 t -58.79 -44.41 90.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 76.1 t -64.79 -35.92 76.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.636 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -54.07 -46.94 72.14 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.515 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -91.09 -39.47 12.15 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.675 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -116.83 38.17 3.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.001 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.6 -54.37 3.24 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -175.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -97.06 -5.69 36.95 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -50.83 140.4 20.13 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.399 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.3 -32.46 41.53 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 122.432 2.088 . . . . 0.0 112.7 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -57.84 -18.9 25.16 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.002 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.47 -42.76 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.766 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.424 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 7.2 mt -45.96 -61.5 2.47 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.731 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 77.8 Cg_exo -54.39 -41.53 75.86 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 CA-C-N 120.115 1.077 . . . . 0.0 111.569 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.5 tpt -59.66 -46.88 87.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.36 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -54.64 -48.65 72.02 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.2 m -59.48 -41.52 89.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.677 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.84 -44.67 93.97 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.094 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.58 -18.52 59.72 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.427 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -95.66 26.35 4.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.224 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -78.49 125.89 30.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.061 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.42 11.4 71.84 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.926 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 52' ' ' LEU . . . -68.21 149.08 49.96 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.301 0.572 . . . . 0.0 112.036 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.2 m -99.55 142.74 25.16 Favored Pre-proline 0 C--O 1.218 -0.569 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.482 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -43.64 -38.69 9.39 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.328 1.352 . . . . 0.0 112.852 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -71.54 -63.72 1.06 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.9 m-20 -58.91 -38.58 79.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.988 0.899 . . . . 0.0 108.917 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.479 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . 56.0 tp -63.95 -49.31 73.07 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.597 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -57.74 -39.83 78.24 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 96.9 m -61.17 -41.93 97.65 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.799 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 41.9 ttp -59.32 -48.16 82.66 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.888 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.49 ' H ' HD12 ' A' ' 56' ' ' LEU . 6.6 mp -63.3 -41.93 98.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.095 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -59.07 -33.8 71.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.374 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.4 m -65.37 -32.94 74.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.238 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.5 t -58.96 142.85 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.525 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.07 -151.88 6.95 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.79 -128.27 40.19 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -53.47 -12.85 0.5 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.817 -0.192 . . . . 0.0 111.414 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -44.38 -21.54 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.54 -39.26 70.35 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.67 93.79 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.5 ttm -57.54 -21.59 39.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.777 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -56.38 -37.35 69.98 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.2 ttp -58.55 -45.92 87.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 tt -58.19 -39.9 80.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -56.84 -41.56 78.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.007 -1.077 . . . . 0.0 108.377 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.9 -40.18 94.68 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -59.74 -43.95 94.01 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.79 -43.03 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -60.76 -40.02 90.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.949 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.55 -43.57 98.48 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -61.67 -39.48 91.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.83 -42.87 99.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.693 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.2 84.4 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.393 0.616 . . . . 0.0 110.393 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.48 -39.78 95.36 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -58.53 -47.98 82.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.259 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -55.07 -41.0 70.97 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.82 -22.89 64.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.745 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 CA--C 1.544 0.721 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -177.49 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 C--O 1.238 0.458 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -63.31 158.08 59.37 Favored Pre-proline 0 C--O 1.24 0.563 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.425 ' HB3' HD11 ' A' ' 104' ' ' ILE . 52.2 Cg_exo -50.01 136.8 36.94 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.584 1.522 . . . . 0.0 112.872 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.603 ' O ' HD12 ' A' ' 104' ' ' ILE . 43.7 ttm180 -134.67 139.11 45.01 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -43.22 -49.71 6.57 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.223 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -61.72 -41.21 97.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.325 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.87 -43.68 98.35 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.037 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.603 HD12 ' O ' ' A' ' 100' ' ' ARG . 1.5 mp -59.17 -41.5 83.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.4 -27.4 68.98 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.79 -7.89 80.59 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.3 p -60.13 -29.85 68.9 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.6 p -116.94 -7.69 11.36 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.981 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.1 t -99.28 129.15 45.48 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.205 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.7 m -72.85 146.29 46.33 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.5 tp -54.36 -47.44 72.6 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.375 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.4 -39.37 87.12 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.49 -40.62 97.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.199 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.2 -41.35 96.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.192 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 24.9 pt -63.77 -47.66 89.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 118.342 -1.343 . . . . 0.0 111.388 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.41 -41.67 66.66 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.416 ' CZ2' HG11 ' A' ' 126' ' ' VAL . 13.1 t90 -57.78 -45.03 86.59 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.8 ttt -71.86 -43.77 64.92 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.451 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.8 p -125.92 -23.62 3.93 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -57.44 -50.77 71.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 118.535 -1.266 . . . . 0.0 110.206 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -83.57 -178.12 1.12 Allowed Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.79 144.04 21.48 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 N-CA-C 107.785 -1.659 . . . . 0.0 107.785 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.54 126.8 10.84 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.43 1.42 . . . . 0.0 113.421 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.461 HG22 HG13 ' A' ' 126' ' ' VAL . 42.1 mm -114.24 108.07 50.79 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.24 55.68 4.15 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.834 1.689 . . . . 0.0 113.341 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.461 HG13 HG22 ' A' ' 124' ' ' ILE . 23.6 m -59.44 -42.47 87.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.454 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -62.67 -45.05 96.6 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.768 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.63 -43.9 97.64 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.153 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.58 -48.07 89.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.443 0.64 . . . . 0.0 110.071 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.741 ' CE2' HD11 ' A' ' 134' ' ' ILE . 78.4 t80 -59.48 -46.85 87.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.522 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -60.69 -39.37 88.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.392 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -59.13 -43.09 91.96 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.469 ' CH2' HG21 ' A' ' 104' ' ' ILE . 50.6 m0 -62.4 -43.66 98.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.186 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.741 HD11 ' CE2' ' A' ' 130' ' ' TYR . 84.7 mt -61.76 -45.52 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.035 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.19 -42.6 87.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.25 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.38 -43.05 99.74 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.6 98.46 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.43 -36.75 84.78 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -58.29 -44.03 88.33 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.69 -38.31 88.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.748 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.6 mm -60.84 -49.37 84.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.611 -0.436 . . . . 0.0 112.031 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.6 m -58.34 -35.9 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -65.16 -38.99 92.32 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.3 tmm? -60.41 -47.51 85.79 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.443 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -71.44 -15.2 62.33 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.202 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.9 t -48.11 115.16 3.85 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.717 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.66 -41.85 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.979 1.786 . . . . 0.0 113.801 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 43.1 p -140.83 170.17 16.26 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 39.9 t -90.84 148.19 22.68 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.98 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 tp -50.17 -34.35 10.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.8 tp -65.06 -39.42 93.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.724 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.7 -11.3 44.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.837 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.485 HD11 ' CB ' ' A' ' 171' ' ' THR . 88.2 mt -79.16 125.99 38.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.862 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -144.46 133.16 22.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.095 0.474 . . . . 0.0 111.016 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.634 178.512 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 . . . . . 0 C--O 1.24 0.588 0 CA-C-O 119.593 -0.242 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.86 136.55 16.84 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.203 1.936 . . . . 0.0 112.873 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 165' ' ' VAL . 53.4 t80 -59.56 -34.74 73.06 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -60.19 -52.45 65.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.111 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.52 -41.47 98.5 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.874 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -59.49 -50.09 75.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.634 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 161' ' ' PHE . 56.1 t -61.76 -46.66 96.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.13 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -58.47 -49.63 76.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.121 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.23 -41.58 99.12 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.581 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.455 ' HA ' HD13 ' A' ' 153' ' ' ILE . 85.8 t80 -56.53 -49.35 75.03 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.924 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.53 ' OH ' HD22 ' A' ' 211' ' ' LEU . 28.8 m-85 -67.29 -37.43 83.37 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.825 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -58.6 -49.96 75.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.696 0.76 . . . . 0.0 108.974 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.485 ' CB ' HD11 ' A' ' 153' ' ' ILE . 94.6 m -66.83 -37.35 84.32 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.88 178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 64.6 tp -59.28 -48.65 80.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.318 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.592 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 . . . . . 0 C--O 1.239 0.52 0 CA-C-O 121.25 0.548 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 57.4 mtt -63.54 -45.33 91.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.7 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 73.0 m -60.65 -50.15 74.66 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.818 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.58 -49.4 76.8 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.187 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.5 m -64.41 -48.31 75.85 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.906 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.37 -37.85 88.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.992 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.596 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 14.2 mt -48.92 -47.88 43.08 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.467 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.1 m -86.18 -38.17 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.077 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.55 -50.12 72.59 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -74.79 -21.83 59.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.979 0.419 . . . . 0.0 111.347 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 190' ' ' LEU . . . -59.56 150.84 25.99 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.222 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.94 138.8 97.6 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 199' ' ' LYS . 78.1 Cg_exo -52.36 -50.06 15.29 Favored 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 122.354 2.036 . . . . 0.0 116.145 -176.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -63.32 -44.02 96.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.982 -176.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 37.0 t -67.96 -42.14 81.36 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 196' ' ' PRO . 87.6 tttt -52.11 -28.57 18.21 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.105 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 87.7 m -59.09 -48.59 81.05 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 0.8 OUTLIER -68.52 -43.93 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.865 178.172 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.46 HD11 ' SD ' ' A' ' 214' ' ' MET . 0.0 OUTLIER -50.6 -52.73 36.59 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.57 -39.82 95.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.923 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -55.17 -35.0 64.33 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.346 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.461 ' CD2' ' HB1' ' A' ' 209' ' ' ALA . 58.6 tp -58.73 -39.84 82.02 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 104.9 163.66 24.05 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.63 155.08 54.77 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.301 2.667 . . . . 0.0 113.321 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 71.81 15.19 75.84 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.461 ' HB1' ' CD2' ' A' ' 205' ' ' LEU . . . -72.31 138.1 47.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.035 0.445 . . . . 0.0 111.201 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 212' ' ' GLU . 88.7 m -62.61 139.29 58.63 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.53 HD22 ' OH ' ' A' ' 169' ' ' TYR . 67.6 tp -54.86 -44.22 73.8 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.442 ' H ' HG22 ' A' ' 210' ' ' THR . 88.6 tt0 -58.04 -46.52 85.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.03 -40.86 86.35 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.46 ' SD ' HD11 ' A' ' 202' ' ' LEU . 56.0 ttm -61.65 -50.02 74.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.124 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 63.8 tpp -62.1 -47.42 84.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.584 0.707 . . . . 0.0 110.171 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.5 m -61.56 -47.17 86.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.126 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.8 -46.35 90.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.987 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.68 -40.57 97.5 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -58.2 -38.33 76.55 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.862 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.67 -37.5 89.64 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 35.9 m -97.22 -4.71 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.824 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.985 179.444 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.486 1.043 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.501 HG21 HG22 ' A' ' 115' ' ' ILE . 5.6 pt -57.42 108.26 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.342 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.01 133.54 19.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.18 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -60.97 136.42 58.08 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.38 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -98.38 -168.07 1.6 Allowed 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.657 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 6' ' ' LEU . 10.3 mp -58.67 -38.97 79.34 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -66.71 -23.32 66.1 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.237 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.4 -8.04 62.13 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.57 132.1 40.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 119' ' ' THR . 64.1 mtt -83.78 134.23 34.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.146 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.0 t -128.26 130.1 69.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.507 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.463 ' CD2' HD21 ' A' ' 111' ' ' LEU . 81.2 t60 -74.95 110.46 9.27 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.293 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -113.26 143.32 44.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.613 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.2 143.09 56.73 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.376 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.469 HD12 ' HG ' ' A' ' 20' ' ' LEU . 32.0 pt -60.57 144.57 13.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.721 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 m -62.76 122.76 76.38 Favored Pre-proline 0 N--CA 1.454 -0.26 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.877 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.58 -36.74 81.76 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 120.722 0.948 . . . . 0.0 109.738 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -56.75 -48.82 76.96 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.933 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.3 m -61.02 -46.94 88.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.042 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.469 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -48.9 -60.52 2.69 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.289 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -57.65 -38.79 75.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.821 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -61.77 -42.35 98.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.457 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -59.05 -51.06 71.66 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.829 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.7 t -63.18 -41.84 94.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.379 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.07 -43.68 91.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.372 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 22' ' ' ALA . 50.7 t -59.02 -44.98 92.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 60.7 t -62.45 -37.0 77.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.94 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -54.31 -46.72 72.89 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.528 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -89.42 -30.7 18.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' O ' HG21 ' A' ' 36' ' ' VAL . 98.9 mttt -130.91 38.44 3.69 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.871 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.51 -51.26 5.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -96.02 -4.65 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 67.2 m -54.97 147.22 34.36 Favored Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 118.866 0.757 . . . . 0.0 111.772 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.72 -34.71 10.98 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 122.663 2.242 . . . . 0.0 112.831 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.64 -19.36 25.85 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.904 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 30' ' ' LYS . 53.9 t -64.2 -41.77 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.608 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.427 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 7.1 mt -46.54 -61.31 2.76 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.279 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 78.4 Cg_exo -54.74 -40.61 83.86 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 CA-C-N 120.111 1.075 . . . . 0.0 111.557 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.0 tpt -59.0 -48.13 82.71 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.25 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -56.0 -46.77 78.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m -57.72 -44.2 85.79 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.858 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.27 99.17 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.462 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.91 -26.5 64.19 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.926 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.4 p -87.44 1.18 54.16 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -54.56 126.16 22.59 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.734 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.12 10.95 78.93 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.597 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.33 149.23 46.29 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.327 0.585 . . . . 0.0 112.564 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.7 m -99.96 141.7 23.25 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.135 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -41.74 -38.68 4.62 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.436 1.424 . . . . 0.0 113.056 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -71.05 -64.12 0.97 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.196 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.5 m-20 -59.18 -37.61 77.79 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.327 1.06 . . . . 0.0 108.503 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.08 -47.89 82.65 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.826 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -58.12 -39.27 78.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 58' ' ' THR . 91.6 m -60.65 -39.93 90.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.404 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 97.8 mtp -57.39 -48.08 80.01 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.654 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.521 HD11 HD13 ' A' ' 134' ' ' ILE . 88.1 mt -65.09 -40.62 94.86 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.799 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -60.54 -39.33 87.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.515 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 54' ' ' THR . 58.6 p -67.45 -19.04 65.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.896 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.2 t -61.18 152.97 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.587 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.54 -153.09 5.92 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.99 -128.16 46.85 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 120.363 -0.923 . . . . 0.0 111.018 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -51.93 -10.29 0.11 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.846 -0.677 . . . . 0.0 112.113 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -42.95 -21.7 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.14 66.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.6 96.29 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.6 tpp -57.09 -22.12 37.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.03 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -58.42 -38.11 76.75 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -58.85 -42.91 90.44 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.61 -40.86 76.07 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.498 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -58.18 -41.33 83.65 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.736 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.92 -40.4 95.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.499 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.5 m -59.61 -46.43 88.99 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.38 -41.06 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.305 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -60.33 -42.17 95.07 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.902 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.69 -46.03 90.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.996 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 133' ' ' TRP . 81.2 mm-40 -61.43 -38.54 87.51 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.68 90.93 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.54 66.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.891 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.46 -43.75 96.47 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.015 0.912 . . . . 0.0 108.854 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.648 ' CZ2' HD13 ' A' ' 104' ' ' ILE . 83.4 t90 -60.5 -39.82 89.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.613 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -54.32 -41.0 68.5 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -69.55 -20.56 63.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.832 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -177.831 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 . . . . . 0 C--O 1.238 0.454 0 CA-C-O 121.337 0.589 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.83 154.36 67.68 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.777 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.15 126.29 6.23 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.661 1.574 . . . . 0.0 113.118 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.564 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 1.1 mpt_? -115.55 151.32 35.1 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 113.773 -1.558 . . . . 0.0 107.774 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.549 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -49.35 -54.29 16.57 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.3 p -63.65 -33.94 76.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.875 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.564 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 82.9 m-20 -63.08 -39.86 95.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.857 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.648 HD13 ' CZ2' ' A' ' 80' ' ' TRP . 4.5 tp -56.8 -31.92 36.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.72 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.1 -27.8 61.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.204 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.88 -8.2 80.22 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 108.441 -1.863 . . . . 0.0 108.441 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 71.4 p -62.31 -19.24 63.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.0 p -122.96 10.57 9.5 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.003 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.1 m -114.81 130.77 56.92 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.271 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 m -73.0 151.14 41.9 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.463 HD21 ' CD2' ' A' ' 12' ' ' HIS . 68.3 tp -54.54 -46.03 73.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -61.01 -40.63 94.29 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -61.87 -45.85 91.98 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.277 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -62.29 -41.94 98.93 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.142 0.276 . . . . 0.0 111.38 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.501 HG22 HG21 ' A' ' 2' ' ' ILE . 47.1 pt -65.84 -43.26 93.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.931 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 120' ' ' HIS . . . -71.52 -41.05 58.63 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -58.56 -45.9 88.01 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.247 -0.976 . . . . 0.0 108.717 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.473 ' SD ' HD11 ' A' ' 2' ' ' ILE . 27.7 ttt -72.98 -41.1 64.71 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.377 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.529 HG21 ' SD ' ' A' ' 10' ' ' MET . 72.2 p -125.96 -24.26 3.8 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.406 ' HB2' ' HA2' ' A' ' 116' ' ' GLY . 50.3 t-80 -53.54 -64.78 0.71 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.93 1.241 . . . . 0.0 110.54 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -77.14 -177.4 0.78 Allowed Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.54 137.41 25.87 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 N-CA-C 108.276 -1.471 . . . . 0.0 108.276 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.59 127.31 3.32 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.627 2.218 . . . . 0.0 114.415 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.406 HG22 HG13 ' A' ' 126' ' ' VAL . 46.7 mm -113.34 108.26 52.65 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.99 57.31 4.52 Favored 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.309 2.006 . . . . 0.0 113.725 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 127' ' ' GLY . 19.3 m -59.48 -46.09 93.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-O 121.145 0.497 . . . . 0.0 109.975 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -62.92 -42.86 99.59 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.089 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.42 -45.24 95.13 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.339 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 mm -63.77 -48.63 85.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-O 121.318 0.58 . . . . 0.0 110.415 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.726 ' CE2' HD11 ' A' ' 134' ' ' ILE . 83.0 t80 -58.49 -49.45 77.32 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.142 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.495 ' HA ' HD12 ' A' ' 134' ' ' ILE . 38.0 ttpt -62.41 -39.24 92.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.402 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -56.58 -43.34 79.93 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.603 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 45.0 m0 -62.73 -43.45 98.78 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.293 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.726 HD11 ' CE2' ' A' ' 130' ' ' TYR . 82.2 mt -58.25 -44.05 87.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.809 -178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.7 mt -59.23 -41.97 85.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.308 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.82 -42.63 99.8 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.57 98.42 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.55 -35.68 81.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -58.01 -45.35 87.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.55 -39.19 93.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.684 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.5 mm -60.55 -49.74 83.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.168 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.2 m -58.74 -36.0 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -64.73 -39.52 93.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 60.8 ttm -60.08 -47.27 86.59 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -68.82 -22.08 64.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.062 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 p -43.09 114.84 1.65 Allowed Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.357 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.25 -41.79 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.93 1.753 . . . . 0.0 113.943 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.9 p -138.53 167.56 21.67 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 40.1 t -87.4 146.92 25.67 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.308 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.465 HD11 ' CE1' ' A' ' 168' ' ' PHE . 9.8 tp -52.66 -35.55 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.35 -38.61 90.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.029 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -64.57 -27.44 68.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.263 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.479 HD13 HG21 ' A' ' 171' ' ' THR . 1.3 mp -64.82 121.31 13.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.364 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 85.9 mtp180 -142.56 132.38 24.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.754 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--O 1.235 0.34 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.647 -179.603 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.59 136.89 52.15 Favored 'Trans proline' 0 N--CA 1.508 2.33 0 C-N-CA 122.626 2.217 . . . . 0.0 114.223 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.403 ' CE2' HG21 ' A' ' 165' ' ' VAL . 72.4 t80 -60.38 -38.52 84.17 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -60.19 -50.12 74.92 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.674 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -61.48 -39.5 91.16 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.146 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -60.29 -50.61 72.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.753 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.403 HG21 ' CE2' ' A' ' 161' ' ' PHE . 55.8 t -62.62 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.501 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -58.32 -51.23 70.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.345 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.27 -38.91 91.73 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.498 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.465 ' CE1' HD11 ' A' ' 150' ' ' ILE . 83.9 t80 -57.8 -48.69 78.98 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -67.87 -38.8 83.54 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.235 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -58.71 -47.49 84.39 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.479 HG21 HD13 ' A' ' 153' ' ' ILE . 98.2 m -64.94 -38.38 90.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.85 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.48 -47.8 84.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.716 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 . . . . . 0 CA--C 1.514 -0.421 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.182 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 99.2 m95 . . . . . 0 C--O 1.235 0.336 0 CA-C-O 121.159 0.504 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 54.8 mtt -63.1 -47.22 83.75 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.547 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 86.5 m -60.45 -48.81 80.16 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.478 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.04 -49.22 78.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.996 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 74.8 p -70.66 -44.81 66.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.148 0.499 . . . . 0.0 111.493 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.34 -36.41 84.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.975 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.44 HD21 ' SD ' ' A' ' 214' ' ' MET . 65.0 tp -46.86 -51.52 16.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.651 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.06 -40.39 13.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.166 0.508 . . . . 0.0 111.859 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.8 -48.2 82.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -86.8 -1.57 57.88 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.541 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.74 158.87 33.83 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.814 0.34 . . . . 0.0 111.677 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -69.85 152.77 95.92 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.147 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 199' ' ' LYS . 20.8 Cg_endo -60.81 -43.37 31.85 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 122.751 2.301 . . . . 0.0 115.993 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.2 -45.27 93.74 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.871 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 41.1 t -71.88 -40.07 69.18 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 196' ' ' PRO . 88.0 tttt -49.83 -34.32 19.4 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.888 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.2 m -58.87 -49.97 75.78 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.606 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 46.6 mm -66.4 -46.3 87.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.654 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 202' ' ' LEU . 1.0 OUTLIER -55.08 -50.72 68.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.203 1.001 . . . . 0.0 108.609 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.38 -37.03 79.46 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.385 -1.279 . . . . 0.0 107.777 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -58.2 -40.01 80.49 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.176 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 205' ' ' LEU . 88.9 mt -61.97 -36.72 82.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.74 -164.9 41.6 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.82 171.93 11.45 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.188 2.592 . . . . 0.0 112.463 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.63 -130.35 48.14 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.562 ' HB3' ' HE2' ' A' ' 214' ' ' MET . . . 59.88 109.8 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.274 0.559 . . . . 0.0 110.435 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.1 p -62.49 158.4 17.96 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.289 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 65.9 tp -56.77 -38.44 72.47 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -57.19 -49.25 76.55 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -59.96 -42.4 93.99 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 119.626 -0.83 . . . . 0.0 108.966 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.562 ' HE2' ' HB3' ' A' ' 209' ' ' ALA . 60.9 mtt -62.43 -45.73 91.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.199 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 25.9 ttt -65.84 -44.93 84.03 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.24 0.543 . . . . 0.0 110.355 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.2 m -62.78 -47.63 82.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.53 0.681 . . . . 0.0 110.201 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.89 -44.19 97.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.326 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 92.6 m -61.54 -39.43 91.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -58.11 -38.55 76.68 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.088 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.79 -39.11 93.34 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.1 m -92.65 3.42 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.609 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.257 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.661 179.211 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.423 ' O ' HG23 ' A' ' 3' ' ' VAL . 1.9 Cg_endo . . . . . 0 N--CA 1.486 1.047 0 N-CA-C 108.949 -1.212 . . . . 0.0 108.949 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.527 HD11 ' SD ' ' A' ' 118' ' ' MET . 11.9 pt -54.9 109.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.504 0.668 . . . . 0.0 110.837 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 1' ' ' PRO . 93.5 t -132.44 126.84 55.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.345 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -65.33 121.5 14.96 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -74.0 -170.07 0.86 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.182 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.85 -39.41 85.08 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.35 -23.41 66.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.365 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.61 -7.78 57.99 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -71.79 125.65 27.7 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.421 ' SD ' HG21 ' A' ' 119' ' ' THR . 66.7 mtt -75.71 133.69 40.7 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.312 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.4 t -127.98 129.91 69.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.804 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.45 ' CE1' ' OD2' ' A' ' 51' ' ' ASP . 53.6 t-80 -78.14 109.87 12.61 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.04 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -107.71 157.09 18.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.11 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.63 150.08 38.07 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.051 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.7 pt -65.51 143.02 16.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 120.966 0.412 . . . . 0.0 110.435 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.0 t -62.14 120.3 56.78 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.53 -36.07 69.16 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 120.763 0.976 . . . . 0.0 110.104 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -58.85 -48.28 81.91 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.723 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.7 p -66.64 -39.03 88.07 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.035 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.9 tp -59.0 -50.09 75.44 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.072 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -59.16 -41.81 89.28 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.405 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.518 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -62.13 -42.1 98.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.588 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.1 t-105 -58.16 -48.73 79.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.44 -44.3 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.336 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.84 -40.02 83.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.255 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.527 HG21 ' CE ' ' A' ' 39' ' ' MET . 53.8 t -58.08 -45.19 88.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 54.3 t -64.48 -37.72 80.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.126 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -53.94 -46.94 71.7 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.641 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -89.53 -39.24 13.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.442 ' O ' HG21 ' A' ' 36' ' ' VAL . 99.6 mttt -120.65 38.23 4.08 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.78 -54.19 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -95.76 -5.74 41.29 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -53.94 140.23 51.45 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 118.561 0.618 . . . . 0.0 111.571 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.82 -29.68 34.83 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 122.563 2.175 . . . . 0.0 113.275 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -59.32 -21.69 60.13 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.542 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 30' ' ' LYS . 53.8 t -62.73 -43.35 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.131 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.43 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 8.7 mt -45.09 -61.19 2.44 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.844 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 73.9 Cg_exo -53.43 -42.25 66.97 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 120.072 1.062 . . . . 0.0 111.803 176.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.527 ' CE ' HG21 ' A' ' 26' ' ' VAL . 24.2 ttt -61.53 -44.14 97.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.726 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.423 ' CE2' HG21 ' A' ' 134' ' ' ILE . 62.9 t80 -54.82 -47.74 73.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -58.79 -43.54 90.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.809 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.85 -46.23 89.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.379 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.67 -26.11 64.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.254 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.0 m -88.14 6.7 35.25 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.483 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -62.65 125.1 22.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.617 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.66 10.67 83.08 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.961 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.1 150.74 35.62 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.12 0.486 . . . . 0.0 112.221 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.1 p -98.91 148.75 34.99 Favored Pre-proline 0 C--O 1.216 -0.677 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.694 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -45.08 -36.63 11.94 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 121.577 1.518 . . . . 0.0 112.923 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -69.74 -64.55 0.86 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.792 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.504 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -59.69 -37.37 78.63 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 122.378 1.085 . . . . 0.0 108.565 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 52' ' ' LEU . 56.2 tp -61.78 -46.81 87.97 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.243 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -59.19 -38.59 80.2 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 84.9 m -60.38 -40.12 89.74 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.045 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.72 -48.4 81.27 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.046 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.84 -41.46 95.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.229 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.49 -37.74 84.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.14 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.3 m -65.22 -34.81 79.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.327 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.5 t -55.34 151.3 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.44 -144.51 4.49 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.69 -127.65 45.74 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 119.926 -1.131 . . . . 0.0 110.545 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.473 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 22.3 p80 -54.26 -11.12 0.45 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.636 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -43.57 -24.36 0.11 Allowed 'General case' 0 C--O 1.234 0.286 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.33 -44.09 68.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.58 97.86 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.781 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 58.0 ttm -56.14 -22.39 28.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.397 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -57.04 -35.06 68.86 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 63.3 ttp -56.71 -46.9 80.99 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 tt -58.38 -38.31 77.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -55.68 -42.58 75.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.73 -40.19 88.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.699 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.656 HG22 ' OE2' ' A' ' 76' ' ' GLU . 99.9 m -57.75 -45.59 85.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.99 -41.57 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.093 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -59.96 -41.82 92.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.399 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.34 -47.3 86.52 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.235 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.656 ' OE2' HG22 ' A' ' 72' ' ' THR . 1.3 mp0 -62.74 -37.24 85.82 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.428 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.44 -42.38 91.81 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.223 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.91 -51.58 57.44 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.88 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.53 -43.23 94.67 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.592 0.71 . . . . 0.0 110.203 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.594 ' CZ2' HD13 ' A' ' 104' ' ' ILE . 66.7 t90 -60.77 -50.52 73.14 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.955 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -58.42 -37.68 75.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -63.14 -43.68 97.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.096 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -176.487 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 . . . . . 0 C--O 1.238 0.495 0 CA-C-O 121.201 0.524 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -88.9 155.35 50.06 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.468 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -39.99 103.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.136 0 C-N-CA 122.477 2.118 . . . . 0.0 114.386 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.413 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 69.4 ttt180 -99.05 158.45 15.65 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.571 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -54.99 -52.7 44.99 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.772 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.445 ' HB3' HG23 ' A' ' 108' ' ' THR . 66.8 m -63.46 -36.63 84.38 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 117.553 0.676 . . . . 0.0 109.701 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 94.8 m-20 -59.31 -38.75 81.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.022 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.594 HD13 ' CZ2' ' A' ' 80' ' ' TRP . 4.4 tp -58.23 -30.82 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 119.487 -0.885 . . . . 0.0 108.938 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.28 -20.53 37.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.158 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.97 -0.97 89.44 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.2 p -63.95 -25.89 68.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.445 HG23 ' HB3' ' A' ' 102' ' ' SER . 20.5 p -117.13 4.46 12.7 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.146 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 t -110.75 130.26 55.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.532 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.6 p -74.82 164.37 26.64 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.5 tp -59.38 -46.66 88.03 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.48 -41.78 94.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 117' ' ' TRP . 54.2 tp10 -61.51 -46.34 90.39 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.882 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -61.66 -43.21 99.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.398 0.436 . . . . 0.0 111.289 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.8 tt -66.03 -44.07 92.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.048 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.76 -42.37 79.66 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.416 ' CB ' ' O ' ' A' ' 113' ' ' GLU . 12.4 t90 -58.49 -45.77 88.04 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.165 -1.018 . . . . 0.0 109.275 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.527 ' SD ' HD11 ' A' ' 2' ' ' ILE . 27.9 ttt -72.5 -41.91 65.44 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.582 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.421 HG21 ' SD ' ' A' ' 10' ' ' MET . 66.6 p -125.32 -24.85 3.88 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -58.81 -49.06 79.09 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 118.317 -1.353 . . . . 0.0 109.324 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.18 179.52 1.86 Allowed Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.91 135.5 36.11 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -35.84 114.74 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.866 2.378 . . . . 0.0 113.5 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mm -106.88 109.04 62.89 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 72.8 Cg_endo -75.47 57.75 4.96 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.951 1.767 . . . . 0.0 112.872 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 127' ' ' GLY . 28.4 m -58.78 -43.28 87.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -64.09 -42.49 98.09 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.442 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 125' ' ' PRO . 88.8 tt0 -63.21 -45.15 93.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.322 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 89.0 mt -63.47 -49.47 82.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.05 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.661 ' CE2' HD11 ' A' ' 134' ' ' ILE . 86.8 t80 -59.3 -48.2 82.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.219 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.426 ' HA ' HD12 ' A' ' 134' ' ' ILE . 40.6 ttmt -61.17 -40.43 93.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.687 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -57.41 -43.08 83.44 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.589 ' CH2' HG21 ' A' ' 104' ' ' ILE . 46.3 m0 -60.8 -44.63 96.59 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.04 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.661 HD11 ' CE2' ' A' ' 130' ' ' TYR . 84.7 mt -58.52 -43.86 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.286 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.99 -41.69 87.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.759 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.63 -45.49 86.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.308 0.575 . . . . 0.0 110.044 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.74 -43.1 98.15 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.16 -36.79 84.81 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -58.67 -45.28 89.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.81 -39.69 94.85 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.494 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.1 mm -61.1 -49.97 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.9 m -58.09 -36.81 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.2 ttm105 -65.51 -38.67 90.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.803 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -60.58 -46.36 90.53 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -67.78 -25.49 65.63 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.73 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.3 t -43.78 111.93 1.22 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.972 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.74 -21.43 7.12 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.96 1.773 . . . . 0.0 113.761 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 70.8 p -138.18 167.57 21.56 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.1 m -107.18 149.47 27.67 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.949 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.534 ' HA ' HD12 ' A' ' 153' ' ' ILE . 5.1 tp -48.98 -36.54 8.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.589 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.1 tp -66.76 -39.62 87.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.43 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.61 -12.37 57.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.609 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 150' ' ' ILE . 90.1 mt -79.45 123.33 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.411 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -152.5 154.95 36.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.077 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 . . . . . 0 C--N 1.327 -0.372 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.321 -179.631 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -62.36 143.09 93.15 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.15 1.9 . . . . 0.0 111.218 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -57.44 -33.47 67.96 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -61.32 -45.91 92.49 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -60.29 -45.35 93.67 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.74 -50.57 71.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.341 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.7 -46.75 95.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.421 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -61.57 -51.97 66.36 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.203 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -63.05 -43.69 97.94 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.048 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.572 ' CE2' HG23 ' A' ' 186' ' ' THR . 85.5 t80 -58.55 -48.11 81.97 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.559 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -63.36 -37.33 86.87 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.625 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -59.42 -48.67 80.77 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.534 ' CB ' HD11 ' A' ' 153' ' ' ILE . 95.4 m -66.28 -39.5 89.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.442 HD12 ' CE2' ' A' ' 168' ' ' PHE . 7.7 tt -55.89 -37.81 69.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.137 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.9 ttt-85 . . . . . 0 N--CA 1.443 -0.789 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.049 179.593 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 44.9 m0 . . . . . 0 C--O 1.242 0.699 0 CA-C-O 121.408 0.623 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 61.9 mtt -61.98 -41.6 98.21 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.204 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.572 HG23 ' CE2' ' A' ' 168' ' ' PHE . 61.1 m -60.0 -43.5 95.14 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.855 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -57.92 -48.33 80.2 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.694 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 77.5 p -72.08 -43.55 64.65 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.833 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.2 mp -66.93 -31.29 71.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.344 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.411 HD21 ' SD ' ' A' ' 214' ' ' MET . 68.3 tp -51.82 -49.28 63.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.08 -45.18 18.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.89 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -59.11 -48.84 80.14 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -70.12 -24.93 63.27 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.66 145.27 54.97 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.556 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -59.48 143.53 85.78 Favored Pre-proline 0 C--N 1.346 0.447 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.487 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.46 -44.33 47.83 Favored 'Trans proline' 0 N--CA 1.504 2.131 0 C-N-CA 122.786 2.324 . . . . 0.0 115.477 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.38 -46.41 90.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 118.766 -1.173 . . . . 0.0 110.437 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 42.5 t -66.16 -43.13 87.84 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -49.62 -27.27 4.38 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.74 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 91.1 m -59.65 -49.35 78.09 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.602 -0.839 . . . . 0.0 108.778 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 4.5 tp -77.3 -38.37 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.746 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.425 HD22 ' SG ' ' A' ' 218' ' ' CYS . 0.1 OUTLIER -54.42 -44.11 72.12 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.03 -38.08 89.7 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.732 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -55.47 -37.69 68.12 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.966 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.31 -35.32 67.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.75 171.33 44.08 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.668 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.06 146.95 97.03 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 123.49 2.794 . . . . 0.0 113.357 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.16 1.28 87.78 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.43 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.749 ' HB3' ' CE ' ' A' ' 214' ' ' MET . . . -64.62 136.02 56.55 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.259 0.552 . . . . 0.0 111.695 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 212' ' ' GLU . 90.4 m -68.83 139.29 55.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.0 tp -57.03 -44.12 82.59 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.246 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.444 ' H ' HG22 ' A' ' 210' ' ' THR . 88.7 tt0 -58.2 -45.38 87.69 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -58.69 -42.3 88.23 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.749 ' CE ' ' HB3' ' A' ' 209' ' ' ALA . 60.5 mtt -63.51 -43.84 96.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.944 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 60.3 ttm -62.16 -50.11 73.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.52 0.676 . . . . 0.0 110.162 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.2 m -64.75 -45.43 86.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.064 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.05 79.12 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.109 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.425 ' SG ' HD22 ' A' ' 202' ' ' LEU . 97.8 m -64.69 -36.68 85.07 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.6 -36.76 76.91 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.986 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.73 -42.15 91.03 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.21 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.56 -18.27 6.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 117.179 0.489 . . . . 0.0 111.325 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -178.329 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo . . . . . 0 N--CA 1.482 0.794 0 N-CA-C 109.13 -1.142 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.456 HD11 ' SD ' ' A' ' 118' ' ' MET . 14.1 pt -65.42 113.78 2.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 109.891 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.0 t -126.27 126.71 69.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.187 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -63.58 127.57 31.95 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -83.96 -172.69 4.3 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.52 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.85 -38.04 80.99 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -66.71 -22.9 66.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.131 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.69 -7.96 57.95 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -73.21 126.35 29.86 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.985 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.2 mtt -81.56 135.22 35.58 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.005 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.5 m -133.1 134.1 58.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.518 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.414 ' NE2' HD11 ' A' ' 111' ' ' LEU . 62.2 t-80 -57.27 142.23 43.94 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.008 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -144.63 144.21 31.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.746 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.17 143.07 50.65 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.466 HD12 ' HG ' ' A' ' 20' ' ' LEU . 38.6 pt -61.87 142.42 16.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -61.07 118.68 38.23 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.23 -36.7 78.73 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 N-CA-C 109.734 -0.91 . . . . 0.0 109.734 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -58.44 -48.27 81.25 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.149 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.6 m -61.05 -46.18 91.73 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -48.96 -58.36 5.01 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.843 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -58.35 -39.19 78.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.843 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -61.6 -42.4 98.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.511 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -58.74 -50.68 73.02 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.546 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.3 t -62.74 -42.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.492 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.99 -42.89 91.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.371 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 22' ' ' ALA . 50.8 t -58.74 -44.32 89.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 76.9 t -64.29 -35.95 75.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.772 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -53.7 -46.71 70.83 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.679 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -92.28 -35.14 13.93 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.698 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' O ' HG21 ' A' ' 36' ' ' VAL . 98.9 mttt -121.22 37.84 4.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.778 -176.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.14 -53.62 3.94 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -96.96 -5.93 36.72 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -51.7 138.87 31.31 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.224 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.91 -31.89 46.4 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.392 2.061 . . . . 0.0 112.709 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.04 -18.75 26.44 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.935 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 30' ' ' LYS . 54.1 t -64.82 -42.48 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.925 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.426 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 6.9 mt -44.86 -60.67 2.84 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.814 -177.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.426 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 76.9 Cg_exo -53.95 -42.4 67.06 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 CA-C-N 119.985 1.03 . . . . 0.0 111.857 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.1 mtp -61.17 -43.41 98.93 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.672 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -56.03 -47.77 77.22 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.9 t -58.6 -44.69 89.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.042 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.77 -44.77 93.71 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.518 0.675 . . . . 0.0 110.114 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.72 -25.12 63.7 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.022 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.4 m -87.04 6.4 32.67 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.612 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.84 125.33 23.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.562 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.41 11.22 76.12 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 116.35 -0.387 . . . . 0.0 112.605 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.52 149.57 40.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.7 p -99.99 148.93 35.5 Favored Pre-proline 0 C--O 1.215 -0.722 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.622 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -45.81 -38.2 17.43 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.543 1.495 . . . . 0.0 113.323 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -70.37 -62.78 1.26 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.649 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.502 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -58.15 -36.73 73.43 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 52' ' ' LEU . 56.1 tp -62.12 -45.36 93.8 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -57.91 -37.86 74.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 84.8 m -59.47 -41.86 90.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.652 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.9 mtt -49.69 -50.08 45.04 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.274 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.09 -42.75 68.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.798 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -60.68 -40.72 93.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.799 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.413 HG23 HG22 ' A' ' 54' ' ' THR . 54.3 p -68.73 -26.53 65.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.89 158.54 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.87 -149.72 5.08 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.43 -127.54 45.43 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -51.21 -10.55 0.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.044 -0.578 . . . . 0.0 112.171 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -41.8 -24.34 0.04 OUTLIER 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.68 -42.97 75.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.91 94.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -56.92 -28.04 61.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.471 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -56.38 -35.41 67.69 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.8 ttp -58.07 -44.99 87.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.22 -40.71 86.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -54.26 -41.57 68.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.75 -41.53 95.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.7 m -59.28 -42.62 91.67 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.498 HD11 HG12 ' A' ' 134' ' ' ILE . 15.9 mm -60.01 -44.16 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -60.63 -41.87 95.77 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.194 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.71 -45.94 91.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.448 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.26 -39.25 94.07 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.23 -41.59 97.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.072 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.4 -50.46 69.76 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.447 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -64.23 -41.52 96.97 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.048 0.928 . . . . 0.0 108.94 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 78.5 t90 -60.37 -38.84 85.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 113.91 -1.496 . . . . 0.0 109.36 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -53.67 -45.33 70.25 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -66.64 -40.62 88.81 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.424 0.63 . . . . 0.0 110.946 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -176.427 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 . . . . . 0 C--O 1.237 0.443 0 CA-C-O 120.951 0.405 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -70.42 151.18 95.7 Favored Pre-proline 0 C--O 1.237 0.446 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.96 112.95 3.53 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.446 1.431 . . . . 0.0 113.675 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -73.4 171.52 12.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.493 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -54.23 -48.97 61.64 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 119.111 -1.518 . . . . 0.0 109.884 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.493 ' HB3' HG23 ' A' ' 108' ' ' THR . 70.3 m -60.65 -38.04 83.51 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.579 0.704 . . . . 0.0 109.517 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -59.61 -38.74 82.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.592 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.562 HG21 ' CZ3' ' A' ' 133' ' ' TRP . 0.4 OUTLIER -55.55 -31.39 28.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.78 -21.35 26.56 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.276 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.17 -6.93 82.37 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.7 p -57.6 -22.82 47.44 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.493 HG23 ' HB3' ' A' ' 102' ' ' SER . 36.1 p -119.55 29.87 7.38 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.632 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.9 m -129.53 135.05 48.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.279 -0.569 . . . . 0.0 112.393 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.2 m -76.86 145.31 38.43 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.414 HD11 ' NE2' ' A' ' 12' ' ' HIS . 6.8 tt -50.03 -45.96 52.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.154 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.07 -39.33 92.02 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.065 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.04 -40.36 96.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.289 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.37 -50.18 74.63 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.4 pt -70.67 -24.31 25.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.809 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.07 -65.91 2.65 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.451 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.437 ' C ' ' CD1' ' A' ' 117' ' ' TRP . 2.0 p90 -61.62 -31.44 71.53 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 118.125 -1.43 . . . . 0.0 109.137 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.456 ' SD ' HD11 ' A' ' 2' ' ' ILE . 27.6 ttt -63.59 -45.14 91.75 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.8 m -115.26 -26.7 7.52 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -58.87 -72.61 0.1 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.085 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -73.74 -177.01 0.54 Allowed Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.61 141.6 15.0 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 120.641 1.265 . . . . 0.0 109.459 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -46.16 123.94 6.99 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.671 1.58 . . . . 0.0 113.766 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.429 ' HB ' ' HD1' ' A' ' 117' ' ' TRP . 47.3 mm -114.91 107.97 49.38 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.84 60.13 4.06 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.909 1.739 . . . . 0.0 113.943 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.6 m -51.57 -37.34 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.73 99.67 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.423 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.46 -45.71 89.56 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.472 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 90.2 mt -64.71 -48.67 83.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.569 0.699 . . . . 0.0 110.17 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.699 ' CE2' HD11 ' A' ' 134' ' ' ILE . 84.4 t80 -59.01 -48.98 79.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.021 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.415 ' HA ' HD12 ' A' ' 134' ' ' ILE . 39.1 ttpt -63.02 -39.03 93.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.886 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -57.43 -43.19 83.64 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.562 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 44.1 m0 -62.69 -43.2 99.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.837 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.699 HD11 ' CE2' ' A' ' 130' ' ' TYR . 78.9 mt -58.43 -42.84 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.525 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.03 -41.6 83.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.78 -44.24 93.98 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.26 -42.57 97.36 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.52 -35.7 81.33 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -58.09 -44.51 87.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.67 -37.89 87.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.415 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.2 mm -60.77 -48.32 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.75 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.8 m -59.27 -34.76 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 118.42 -1.312 . . . . 0.0 107.471 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -65.83 -39.18 90.56 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.4 ttt -58.88 -45.44 90.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -74.89 -15.32 60.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.321 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.1 t -49.3 115.67 5.01 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.72 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -84.12 -30.35 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.107 1.871 . . . . 0.0 113.812 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.3 p -138.01 170.94 15.17 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 39.1 t -105.68 148.22 27.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.638 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.654 ' HA ' HD12 ' A' ' 153' ' ' ILE . 5.4 tp -49.46 -38.41 12.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.549 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.7 tp -65.6 -39.33 91.43 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.556 0.693 . . . . 0.0 109.798 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -67.64 0.32 3.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.553 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 150' ' ' ILE . 96.8 mt -100.65 119.0 48.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.025 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -145.93 132.04 19.35 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.8 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 . . . . . 0 C--O 1.237 0.428 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.407 -179.491 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.28 136.19 23.85 Favored 'Trans proline' 0 N--CA 1.512 2.579 0 C-N-CA 123.171 2.58 . . . . 0.0 113.613 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.404 ' O ' HG23 ' A' ' 165' ' ' VAL . 11.8 t80 -61.51 -28.17 69.12 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -61.96 -50.94 70.09 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.775 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -64.92 -40.26 94.78 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -59.2 -50.86 72.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.395 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 161' ' ' PHE . 54.5 t -61.76 -43.82 97.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.8 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.68 -59.16 5.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.058 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.44 -40.75 97.59 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.073 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.626 ' HE2' HG23 ' A' ' 186' ' ' THR . 76.0 t80 -57.69 -47.1 83.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -62.5 -41.77 99.05 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.542 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -59.75 -40.29 87.65 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.092 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.595 ' OG1' HD11 ' A' ' 153' ' ' ILE . 93.6 m -62.63 -41.89 99.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.58 HD11 ' CE2' ' A' ' 168' ' ' PHE . 82.6 mt -60.69 -39.45 88.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 . . . . . 0 N--CA 1.448 -0.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.002 -179.648 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 . . . . . 0 C--O 1.242 0.693 0 CA-C-O 121.243 0.544 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 74.0 mtm -62.84 -41.29 99.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.947 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.626 HG23 ' HE2' ' A' ' 168' ' ' PHE . 54.4 m -59.46 -46.05 89.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.148 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.46 -47.05 86.99 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.513 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.3 m -67.49 -49.54 63.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.315 0.579 . . . . 0.0 112.007 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.35 -32.29 73.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.876 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.602 HD21 ' SD ' ' A' ' 214' ' ' MET . 62.9 tp -51.03 -46.36 61.57 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.504 HG22 HD12 ' A' ' 202' ' ' LEU . 85.2 t -85.79 -46.16 16.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.028 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -60.31 -49.44 77.61 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -70.37 -22.55 62.76 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.705 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.74 153.75 10.16 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.621 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -68.99 148.5 97.89 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.74 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.23 -41.98 67.7 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.377 2.051 . . . . 0.0 114.376 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.62 -50.0 75.56 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.447 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 10.5 t -70.0 -37.77 75.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -47.11 -26.89 1.21 Allowed 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.092 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 69.0 p -62.49 -55.06 31.11 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.421 -1.312 . . . . 0.0 108.455 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 40.0 mm -65.07 -45.66 93.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.154 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.504 HD12 HG22 ' A' ' 191' ' ' VAL . 0.1 OUTLIER -54.82 -51.5 65.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.057 0.932 . . . . 0.0 108.834 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.31 -36.55 78.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -59.0 -39.71 82.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.747 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -57.46 -44.38 84.74 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 119.421 -0.911 . . . . 0.0 108.713 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 79.43 175.57 47.66 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.085 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.73 150.95 79.98 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 124.011 3.141 . . . . 0.0 113.38 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 81.06 0.27 88.54 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.6 119.2 13.48 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.178 0.513 . . . . 0.0 110.382 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 212' ' ' GLU . 94.2 m -61.07 139.36 58.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.1 tp -54.82 -46.08 74.5 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.604 -0.838 . . . . 0.0 108.873 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.401 ' H ' HG22 ' A' ' 210' ' ' THR . 80.8 tt0 -55.41 -48.11 74.88 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.482 0.658 . . . . 0.0 109.332 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -57.76 -42.47 84.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.602 ' SD ' HD21 ' A' ' 190' ' ' LEU . 58.9 ttm -63.01 -45.72 91.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.75 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 61.8 tpp -61.99 -45.64 92.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.9 m -62.54 -49.75 74.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.74 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.72 95.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.708 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 78.3 m -61.02 -40.81 94.99 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.67 -40.85 97.86 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.087 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.12 97.92 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 23.9 m -82.59 -23.61 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.675 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.567 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.844 178.788 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.485 0.984 0 N-CA-C 108.837 -1.255 . . . . 0.0 108.837 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.597 HD11 ' SD ' ' A' ' 118' ' ' MET . 18.6 pt -67.62 119.32 13.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 110.071 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.47 138.07 48.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.505 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -69.71 125.01 25.44 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.958 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -78.33 -172.46 2.85 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.201 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 6' ' ' LEU . 9.6 mp -58.77 -38.18 77.92 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.44 -22.87 65.48 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.594 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.33 -7.75 58.46 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.77 127.78 33.82 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 120.171 -0.611 . . . . 0.0 109.524 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.494 ' SD ' HG21 ' A' ' 119' ' ' THR . 66.3 mtt -77.14 127.19 32.21 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.763 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 82.3 t -126.27 128.61 71.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.553 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -61.75 142.55 57.19 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.035 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -145.34 146.83 31.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.218 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.82 143.04 49.62 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.265 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.505 HD12 ' HG ' ' A' ' 20' ' ' LEU . 33.4 pt -61.81 144.25 14.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 120.902 0.382 . . . . 0.0 110.609 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 t -62.05 120.35 56.94 Favored Pre-proline 0 N--CA 1.453 -0.313 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -53.56 -36.9 82.17 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 N-CA-C 109.492 -1.003 . . . . 0.0 109.492 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -57.8 -48.49 79.56 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.164 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 84.1 m -60.84 -47.15 87.67 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.231 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.505 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -50.51 -57.03 9.04 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.905 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -58.3 -39.31 79.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.778 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.03 98.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.197 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.413 ' O ' HG23 ' A' ' 27' ' ' VAL . 22.1 t-105 -59.06 -49.76 76.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.483 0.658 . . . . 0.0 109.505 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.39 -40.3 88.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.095 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.4 -49.02 79.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.554 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.3 m -61.95 -35.55 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.713 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 79.7 t -66.83 -36.22 76.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.0 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -53.61 -47.07 70.54 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.579 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -89.42 -37.47 14.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -120.68 38.06 4.12 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.954 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.9 -51.16 5.64 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -175.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -96.11 -4.59 42.51 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.8 m -55.05 145.93 41.7 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.741 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.25 -32.59 20.38 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.486 2.124 . . . . 0.0 112.437 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.61 -20.07 30.37 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.886 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.69 -41.88 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.754 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.427 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 6.7 mt -45.72 -61.22 2.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.872 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 76.2 Cg_exo -54.78 -41.61 76.47 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 CA-C-N 120.176 1.099 . . . . 0.0 111.729 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 58.8 ttm -59.69 -46.87 87.77 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.338 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -55.07 -47.49 74.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -58.2 -44.48 88.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.719 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.67 -44.77 93.46 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.097 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.6 -22.61 62.53 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.138 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.7 m -87.66 5.81 37.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.593 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.9 126.16 26.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.742 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.01 11.23 69.77 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 121.315 -0.469 . . . . 0.0 112.231 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.13 146.26 50.97 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 112.543 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.0 m -99.72 141.3 22.54 Favored Pre-proline 0 C--O 1.215 -0.727 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -46.36 -36.2 17.18 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 CA-C-N 120.789 1.318 . . . . 0.0 113.222 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -68.59 -63.9 0.97 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.301 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.483 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -59.82 -37.58 79.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.265 1.031 . . . . 0.0 108.737 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.07 -45.31 92.76 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.773 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -57.72 -39.69 77.87 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 86.3 m -59.91 -39.28 84.87 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.48 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 97.9 mtp -57.98 -48.27 80.48 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.153 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.421 HD11 HD13 ' A' ' 134' ' ' ILE . 87.6 mt -65.53 -41.78 92.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.826 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -61.54 -36.46 80.65 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.206 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.5 m -65.56 -34.45 78.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.924 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.7 141.72 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.026 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -130.6 -140.27 4.65 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.4 -127.89 46.06 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.743 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -53.08 -11.33 0.24 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.853 -0.673 . . . . 0.0 111.669 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -41.92 -22.78 0.02 OUTLIER 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.78 -41.52 70.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.78 98.1 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 57.7 ttm -57.28 -26.22 60.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.038 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -56.97 -35.24 68.92 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.3 ttp -58.01 -46.2 85.66 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -57.65 -37.88 74.13 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -56.26 -42.95 78.23 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.37 -40.15 93.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.294 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -58.88 -43.46 90.91 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.8 -43.04 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -59.99 -41.48 92.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.027 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.24 -47.07 84.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.869 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -61.79 -40.1 94.02 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.25 94.15 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.862 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.04 74.69 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.404 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.43 -38.56 90.26 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.903 0.859 . . . . 0.0 108.975 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.59 ' CH2' HD13 ' A' ' 129' ' ' ILE . 76.2 t-105 -58.2 -45.92 86.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.659 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -49.8 -47.44 51.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.856 0.722 . . . . 0.0 109.136 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -64.0 -39.87 95.08 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.301 0.572 . . . . 0.0 110.892 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.14 -44.56 68.63 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -121.04 -60.6 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.229 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 85.1 Cg_exo -52.08 -33.08 51.77 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 CA-C-N 120.85 1.339 . . . . 0.0 111.343 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -77.88 -16.89 14.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.103 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -45.83 -30.01 1.54 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.52 -16.84 0.43 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.731 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.8 -114.03 4.1 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 106.437 -2.665 . . . . 0.0 106.437 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.82 141.12 97.65 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 119.347 1.573 . . . . 0.0 109.606 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.455 HD13 ' OE1' ' A' ' 98' ' ' GLU . 20.3 tt -137.09 158.53 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.49 148.72 89.84 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-O 120.488 0.185 . . . . 0.0 111.363 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.39 168.27 25.19 Favored 'Trans proline' 0 N--CA 1.504 2.129 0 C-N-CA 122.976 2.451 . . . . 0.0 113.019 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.44 -7.41 68.7 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.974 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -123.95 152.74 42.14 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 122.618 -0.342 . . . . 0.0 110.589 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -60.28 136.47 58.05 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.525 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -56.14 121.09 8.63 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.455 ' OE1' HD13 ' A' ' 91' ' ' ILE . 23.3 mp0 -56.53 141.64 71.72 Favored Pre-proline 0 C--O 1.238 0.465 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.8 111.72 0.98 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.25 1.3 . . . . 0.0 113.035 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.39 167.32 21.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.28 -43.28 89.47 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 119.072 -1.537 . . . . 0.0 109.788 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.4 t -61.0 -41.9 97.41 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.539 0.685 . . . . 0.0 109.232 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -61.94 -37.84 86.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.013 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.62 HD13 HG12 ' A' ' 126' ' ' VAL . 12.4 mm -57.7 -45.67 86.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.53 -17.64 64.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.55 0.16 89.28 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.1 p -64.22 -21.77 66.7 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.986 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.2 p -127.41 33.27 4.89 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.4 p -137.88 145.74 42.54 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.651 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.0 m -82.91 145.41 29.42 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -49.74 -44.94 48.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.61 -40.93 96.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.545 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -63.7 -43.26 97.13 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.163 0.506 . . . . 0.0 111.152 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -58.4 -47.86 82.53 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.35 -40.6 88.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.306 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.68 -63.91 4.42 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.662 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.438 ' CD1' ' N ' ' A' ' 118' ' ' MET . 1.2 p90 -59.75 -29.25 68.03 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 117.731 -1.587 . . . . 0.0 109.654 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.597 ' SD ' HD11 ' A' ' 2' ' ' ILE . 26.2 ttt -65.72 -45.01 84.3 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.494 HG21 ' SD ' ' A' ' 10' ' ' MET . 82.3 p -119.55 -24.27 6.33 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -58.19 -70.72 0.13 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.776 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -76.54 -177.34 0.74 Allowed Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -48.23 136.3 24.77 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 CA-C-N 120.619 1.257 . . . . 0.0 109.541 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -38.26 119.84 0.4 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.874 2.383 . . . . 0.0 114.509 -176.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.0 mm -112.98 106.84 54.87 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.57 59.95 4.26 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.257 1.971 . . . . 0.0 113.712 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.62 HG12 HD13 ' A' ' 104' ' ' ILE . 2.8 m -48.99 -38.74 11.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.28 99.71 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.627 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.52 -47.18 85.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.308 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.59 HD13 ' CH2' ' A' ' 80' ' ' TRP . 89.6 mt -63.64 -48.76 85.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.511 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.761 ' CE2' HD11 ' A' ' 134' ' ' ILE . 89.8 t80 -59.05 -48.56 81.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.909 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.506 ' HA ' HD12 ' A' ' 134' ' ' ILE . 38.5 ttpt -62.38 -38.06 88.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.592 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -58.73 -42.09 87.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.488 ' CH2' HG21 ' A' ' 104' ' ' ILE . 47.1 m0 -62.3 -43.83 97.92 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.761 HD11 ' CE2' ' A' ' 130' ' ' TYR . 85.7 mt -59.64 -45.26 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.62 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.14 -41.85 84.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.87 -42.53 99.8 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.23 -42.26 98.61 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.98 -36.21 83.23 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -58.45 -44.49 89.22 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.37 -38.9 91.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.557 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.4 mm -60.49 -49.64 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.0 m -57.74 -35.56 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -65.1 -39.83 93.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -59.2 -45.12 91.91 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -70.71 -22.06 62.49 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.442 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.7 t -43.03 106.59 0.49 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.538 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.01 -32.88 8.21 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.107 1.872 . . . . 0.0 113.758 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.9 p -137.95 172.6 12.69 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.3 m -104.98 149.99 25.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.125 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.4 mm -49.92 -42.03 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.9 tp -60.33 -39.26 86.46 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.19 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.85 -11.43 55.59 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.633 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.8 mm -75.71 119.95 24.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.82 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -152.93 134.1 14.18 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -94.79 134.25 37.61 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.007 0.432 . . . . 0.0 111.665 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -90.7 158.17 25.96 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.7 -33.44 96.48 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.64 1.56 . . . . 0.0 111.275 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -81.13 -17.76 48.76 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.164 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -79.39 146.63 66.64 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.28 139.34 11.62 Favored 'Trans proline' 0 N--CA 1.507 2.271 0 C-N-CA 123.577 2.851 . . . . 0.0 114.267 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.408 ' O ' HG23 ' A' ' 165' ' ' VAL . 26.3 t80 -59.28 -26.72 65.2 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.422 ' H ' ' HA ' ' A' ' 224' ' ' PRO . 40.7 ttm180 -62.67 -51.44 67.23 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.811 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.27 -37.93 86.62 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.713 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -60.24 -50.56 73.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.674 0.75 . . . . 0.0 109.857 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 161' ' ' PHE . 54.7 t -64.7 -45.0 96.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.304 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -60.49 -51.51 69.13 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.948 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -66.24 -39.37 89.48 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.672 ' CE2' HG23 ' A' ' 186' ' ' THR . 87.8 t80 -58.78 -49.49 77.48 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -66.36 -36.25 82.42 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.299 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -58.27 -47.89 82.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 96.6 m -68.5 -39.39 81.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.133 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.24 -39.38 72.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.025 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -59.3 -41.72 89.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.307 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -80.87 -11.2 59.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.03 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -57.88 140.45 51.91 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.179 0.514 . . . . 0.0 111.705 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -71.93 -93.72 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.432 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -43.29 139.47 1.93 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.805 0.812 . . . . 0.0 112.082 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 70.8 m -64.8 178.11 0.84 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.955 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -48.8 -21.73 0.68 Allowed 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.025 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -56.15 -46.88 79.12 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 86.8 t -89.45 -56.51 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.921 176.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -42.33 -51.22 4.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.167 -1.378 . . . . 0.0 112.448 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -59.58 -44.55 93.31 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.741 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -60.9 -50.11 74.76 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.724 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 91.1 mmm -62.56 -43.89 97.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.177 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.672 HG23 ' CE2' ' A' ' 168' ' ' PHE . 62.1 m -61.09 -45.75 93.43 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.609 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.81 -48.29 80.17 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.205 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 96.7 m -67.35 -47.27 70.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.236 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.9 -31.55 71.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.838 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.439 ' CD1' HG22 ' A' ' 186' ' ' THR . 16.4 mt -52.38 -43.4 64.7 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.309 -0.957 . . . . 0.0 108.892 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.3 t -85.72 -47.82 16.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.817 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -61.06 -49.38 77.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -70.12 -22.7 62.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.704 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.52 150.86 25.74 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -68.97 153.71 95.81 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.184 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.419 ' HA ' ' HB3' ' A' ' 199' ' ' LYS . 52.3 Cg_exo -57.09 -45.68 34.06 Favored 'Trans proline' 0 N--CA 1.509 2.393 0 C-N-CA 122.544 2.162 . . . . 0.0 115.521 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.76 -50.22 74.68 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.554 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 36.4 t -69.4 -39.34 78.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 196' ' ' PRO . 40.3 ttmt -49.02 -32.12 8.8 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.427 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.9 m -59.71 -48.79 80.29 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.935 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.627 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 48.2 mm -67.67 -43.14 86.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.466 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.404 HD11 ' CE1' ' A' ' 161' ' ' PHE . 82.1 mt -59.87 -39.67 86.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -61.35 -38.99 88.94 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -59.73 -40.1 86.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.478 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.76 -41.23 90.57 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.911 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.77 -159.18 52.59 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.779 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.19 166.49 5.71 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 123.5 2.8 . . . . 0.0 112.557 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.76 -126.35 40.68 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 56.73 96.62 0.02 OUTLIER 'General case' 0 C--O 1.238 0.48 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.332 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 76.4 p -61.65 157.58 17.26 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.152 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.35 -34.84 61.95 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -61.64 -50.15 73.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.352 0.596 . . . . 0.0 109.799 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.99 -42.43 94.19 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.6 ttm -60.87 -46.84 89.03 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.415 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 1.7 mmt -64.11 -41.43 97.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.1 0.476 . . . . 0.0 109.753 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.8 m -63.36 -49.83 72.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.409 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.96 -43.75 94.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.51 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.4 m -60.48 -40.76 92.49 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -60.97 -41.82 97.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.11 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.0 -39.93 96.31 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.527 HG21 HG21 ' A' ' 201' ' ' ILE . 34.4 m -91.95 6.04 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.903 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 70.34 18.85 75.51 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 120.27 -0.966 . . . . 0.0 111.842 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.453 ' N ' ' HD2' ' A' ' 224' ' ' PRO . . . -58.85 -42.16 96.48 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-O 119.038 -0.868 . . . . 0.0 112.128 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 223' ' ' GLY . 44.2 Cg_endo -69.04 -1.9 8.7 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.615 2.207 . . . . 0.0 112.809 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -98.85 -48.27 1.79 Allowed Glycine 0 CA--C 1.535 1.335 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -156.3 -49.0 0.08 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.263 0.554 . . . . 0.0 110.123 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -173.28 -158.85 0.1 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.453 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.23 -13.71 3.47 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.629 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 221' ' ' VAL . 66.7 mtp180 -50.67 128.39 20.41 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.732 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.8 m -37.43 -33.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 123.897 0.748 . . . . 0.0 112.568 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.431 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo . . . . . 0 N--CA 1.483 0.904 0 N-CA-C 109.349 -1.058 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.6 pt -77.78 125.06 37.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.5 t -127.63 127.4 68.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.457 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -63.66 126.15 26.62 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -81.43 -173.39 4.34 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.291 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 6' ' ' LEU . 86.7 mt -59.71 -38.54 81.9 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.39 -21.7 65.59 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.566 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.49 -7.73 58.17 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -72.15 124.86 25.91 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.695 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.0 mtt -79.52 130.98 35.9 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.735 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.96 138.91 50.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 120.174 -0.611 . . . . 0.0 111.396 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -57.5 142.23 44.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.219 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -144.91 140.37 28.25 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.606 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.56 139.84 51.59 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.785 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.443 HD12 ' HG ' ' A' ' 20' ' ' LEU . 38.0 pt -61.87 137.24 24.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.558 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.7 t -60.28 122.76 69.33 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.637 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.36 -38.55 73.48 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 120.852 1.035 . . . . 0.0 110.973 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -56.91 -43.35 81.32 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.279 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.4 m -63.11 -46.81 85.58 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.443 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -49.74 -60.51 2.82 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.328 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -57.74 -39.42 77.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.891 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -61.51 -43.1 99.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.491 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -58.93 -50.2 74.94 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.56 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.5 t -62.07 -42.23 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.206 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.99 -41.95 88.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.027 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 22' ' ' ALA . 49.3 t -58.74 -45.38 91.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 67.1 t -64.17 -37.12 79.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.844 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -55.56 -45.66 77.25 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.685 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -92.86 -27.75 16.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.85 38.25 3.56 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.697 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.82 -54.48 3.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -175.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -96.03 -5.75 40.33 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 t -51.81 139.2 31.86 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.208 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.98 -32.83 34.21 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.476 2.117 . . . . 0.0 112.959 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -57.98 -18.65 25.19 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.995 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.81 -42.74 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.834 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.422 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 8.0 mt -44.79 -61.18 2.36 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.853 -178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 71.3 Cg_exo -54.38 -42.0 71.6 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 120.081 1.065 . . . . 0.0 111.732 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.489 ' CE ' HG21 ' A' ' 26' ' ' VAL . 20.7 ttt -60.63 -44.94 95.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.349 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -55.42 -47.1 76.48 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -58.41 -44.84 89.2 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.997 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.59 94.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.53 0.681 . . . . 0.0 110.2 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -70.44 -24.8 62.96 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.097 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.1 m -89.43 6.45 40.7 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.601 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.33 125.47 23.88 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.565 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.64 10.83 76.73 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.598 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' A' ' 52' ' ' LEU . . . -70.42 150.26 46.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.344 0.592 . . . . 0.0 112.354 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.8 m -99.72 142.38 24.51 Favored Pre-proline 0 C--O 1.217 -0.649 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.38 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -42.71 -38.82 6.8 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.466 1.444 . . . . 0.0 113.365 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -73.88 -61.32 1.89 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.041 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.452 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.93 -38.36 75.8 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.401 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . 57.3 tp -64.9 -44.29 90.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.648 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -57.72 -39.97 78.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 92.9 m -63.09 -39.58 95.13 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.953 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.45 ' O ' HG22 ' A' ' 58' ' ' THR . 28.2 ttt -56.8 -49.37 75.55 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.99 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.9 mt -69.8 -40.38 76.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.518 0.675 . . . . 0.0 110.155 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.53 -37.75 79.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.987 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 55' ' ' MET . 0.6 OUTLIER -66.33 -20.32 66.06 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.792 -178.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.85 140.0 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.51 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.84 -151.84 7.88 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.1 -127.75 45.92 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.924 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -51.32 -10.0 0.08 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.813 -0.693 . . . . 0.0 112.287 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -42.99 -21.28 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.39 -40.46 71.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.11 97.78 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.435 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 11.3 tmm? -58.32 -20.17 41.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.488 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.3 tp-100 -58.22 -39.32 78.75 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.4 tmm? -59.56 -42.36 92.26 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 66' ' ' MET . 61.3 tp -57.68 -40.7 80.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -59.15 -41.81 89.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.2 -39.64 93.1 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.81 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.1 m -59.83 -44.06 94.26 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.465 HD11 ' CD1' ' A' ' 134' ' ' ILE . 91.5 mt -60.82 -43.87 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -60.34 -41.91 94.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.483 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 88.8 tt0 -62.06 -46.84 87.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.19 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -63.83 -38.6 91.69 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.86 -39.19 88.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 75' ' ' GLU . . . -64.53 -51.24 63.89 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.845 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -64.8 -43.29 93.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.048 0.928 . . . . 0.0 109.468 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.494 ' CZ2' HD13 ' A' ' 104' ' ' ILE . 83.2 t90 -61.2 -41.47 96.87 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.779 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -59.6 -43.07 93.84 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -60.53 -33.77 73.14 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.597 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt -108.53 -48.41 3.33 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.434 ' CB ' ' HD3' ' A' ' 85' ' ' PRO . 3.4 m80 -72.28 -69.08 0.37 Allowed Pre-proline 0 N--CA 1.473 0.709 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -177.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HD3' ' CB ' ' A' ' 84' ' ' HIS . 51.5 Cg_exo -58.24 -37.6 94.62 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 CA-C-N 121.578 1.599 . . . . 0.0 110.254 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.93 -14.66 3.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.724 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -45.98 -31.66 2.35 Favored 'General case' 0 C--N 1.348 0.503 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.71 -2.64 0.16 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.542 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 53.1 -116.22 5.38 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 107.776 -2.13 . . . . 0.0 107.776 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.36 145.75 92.52 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 CA-C-N 119.269 1.534 . . . . 0.0 110.405 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.2 tp -132.2 148.77 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.72 148.7 94.03 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -63.73 165.83 17.42 Favored 'Trans proline' 0 N--CA 1.508 2.357 0 C-N-CA 122.823 2.349 . . . . 0.0 113.048 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.37 -7.35 63.87 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.143 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -123.82 153.09 41.52 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.902 0.382 . . . . 0.0 111.085 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.1 mmt -63.17 146.34 53.54 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.498 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 -52.06 115.61 1.78 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.357 0.598 . . . . 0.0 109.555 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.78 156.42 86.93 Favored Pre-proline 0 C--O 1.24 0.565 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.096 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.24 128.76 14.86 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.921 1.748 . . . . 0.0 113.475 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.5 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 3.4 mtt85 -126.13 151.95 46.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.778 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.618 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -42.1 -61.32 2.38 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.479 -176.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 108' ' ' THR . 74.7 m -61.34 -37.88 84.88 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 122.073 -0.663 . . . . 0.0 110.844 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 6.7 m-20 -61.53 -38.1 86.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.865 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.624 HG21 ' CH2' ' A' ' 133' ' ' TRP . 7.0 tp -58.44 -31.47 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.578 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.24 -10.42 56.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.613 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.92 0.12 87.95 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 48.8 p -63.48 -23.99 67.63 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.06 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 102' ' ' SER . 20.8 p -123.92 18.75 9.33 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.746 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.5 m -119.21 131.17 55.79 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.34 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -70.94 147.54 48.62 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.3 tp -53.46 -44.69 69.12 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.287 -0.965 . . . . 0.0 108.448 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.43 -40.58 94.96 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.08 -43.51 98.67 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.19 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -62.78 -41.25 99.17 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.246 0.341 . . . . 0.0 110.979 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 34.7 pt -68.15 -41.83 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.924 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.99 -41.86 70.31 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -58.88 -46.16 88.48 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.013 -1.094 . . . . 0.0 109.102 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.9 ttt -71.39 -42.58 68.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.44 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.6 m -125.78 -26.9 3.42 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -58.43 -49.92 75.57 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 118.455 -1.298 . . . . 0.0 109.814 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -81.54 -177.88 1.05 Allowed Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.51 144.51 32.18 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 N-CA-C 107.105 -1.921 . . . . 0.0 107.105 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -45.86 124.0 6.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 121.348 1.365 . . . . 0.0 112.997 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.417 HG22 HG13 ' A' ' 126' ' ' VAL . 45.8 mm -113.47 108.33 52.28 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.408 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 72.0 Cg_endo -74.72 56.86 4.21 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.958 1.772 . . . . 0.0 113.111 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 127' ' ' GLY . 21.6 m -58.74 -45.75 91.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.481 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -63.63 -44.37 96.57 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.205 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 125' ' ' PRO . 88.7 tt0 -60.32 -44.63 95.29 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.973 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.09 -47.85 91.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.865 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -59.09 -50.13 75.26 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.912 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -61.91 -38.57 88.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.967 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -56.66 -43.67 80.61 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.624 ' CH2' HG21 ' A' ' 104' ' ' ILE . 44.4 m0 -63.35 -44.44 94.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.593 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.465 ' CD1' HD11 ' A' ' 73' ' ' ILE . 29.7 mm -58.33 -44.88 89.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.455 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.74 -42.44 88.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.16 -43.67 97.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.381 0.61 . . . . 0.0 109.615 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.32 -42.28 99.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.26 -35.9 81.88 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -58.32 -45.0 88.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.79 -38.64 91.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.473 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.4 mm -60.9 -49.8 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 16.7 m -58.28 -36.16 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -65.49 -38.79 90.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.822 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 63.7 tpp -59.74 -46.75 88.17 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -71.62 -15.62 62.25 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.215 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.3 t -49.07 116.94 5.98 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.846 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.46 -40.19 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.949 1.766 . . . . 0.0 113.539 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 58.3 p -138.38 169.04 18.49 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.2 t -92.26 148.53 22.07 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.471 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.628 HD11 ' CZ ' ' A' ' 168' ' ' PHE . 17.5 tt -51.28 -36.45 17.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.43 -39.45 92.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.238 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -66.8 -9.84 41.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.492 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.57 HD13 ' HA ' ' A' ' 168' ' ' PHE . 81.6 mt -81.87 120.31 33.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.945 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -142.33 123.55 14.67 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.56 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -83.12 128.53 34.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.34 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -90.25 164.17 30.69 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -62.17 -28.19 79.36 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.041 1.827 . . . . 0.0 110.572 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.64 1.35 55.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.491 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 160' ' ' PRO . 95.9 mt-10 -99.02 146.88 32.43 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.842 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 163' ' ' ASP . 5.4 Cg_exo -75.36 135.13 18.04 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.704 2.27 . . . . 0.0 114.019 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.4 ' O ' HG23 ' A' ' 165' ' ' VAL . 49.9 t80 -61.55 -36.27 80.12 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.433 ' N ' ' HA ' ' A' ' 224' ' ' PRO . 42.5 ttm180 -61.83 -47.7 83.9 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.087 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.419 ' H ' ' HB2' ' A' ' 160' ' ' PRO . 50.4 t0 -61.33 -41.62 97.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.86 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -61.13 -50.4 73.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.788 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 161' ' ' PHE . 53.5 t -62.14 -47.7 91.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.618 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.43 -50.99 70.57 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.28 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -64.85 -39.12 93.05 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.252 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.628 ' CZ ' HD11 ' A' ' 150' ' ' ILE . 88.1 t80 -60.42 -50.21 74.5 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.08 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.45 ' OH ' HD22 ' A' ' 211' ' ' LEU . 21.7 m-85 -69.49 -41.61 75.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.305 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -60.38 -46.33 90.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.511 ' CB ' HD11 ' A' ' 153' ' ' ILE . 91.9 m -65.21 -37.68 88.04 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.595 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.55 -49.15 78.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.314 0.578 . . . . 0.0 110.049 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -60.72 -43.77 97.45 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.69 -37.5 78.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.379 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -61.18 168.59 2.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.865 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -59.85 -163.52 0.01 OUTLIER 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -109.73 112.67 24.88 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 119.4 -0.92 . . . . 0.0 113.246 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.511 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 67.4 m -98.47 134.79 40.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -86.7 -65.49 1.01 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 117.033 -1.867 . . . . 0.0 110.366 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -88.48 -40.75 13.21 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.427 ' HB ' ' HB3' ' A' ' 178' ' ' SER . 25.0 t -55.74 -29.08 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 113.239 -1.801 . . . . 0.0 109.82 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 178' ' ' SER . 87.1 tttt -59.73 -50.11 75.13 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 118.236 -1.386 . . . . 0.0 108.953 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -70.0 -43.32 71.65 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.987 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -64.07 -50.89 66.59 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.281 0.563 . . . . 0.0 112.257 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.463 ' SD ' HG21 ' A' ' 150' ' ' ILE . 59.9 ttm -60.67 -46.05 91.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.575 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.516 HG23 ' HE2' ' A' ' 168' ' ' PHE . 65.8 m -59.35 -48.68 80.71 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.976 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.25 -47.68 84.95 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.702 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 97.1 m -63.15 -48.03 80.18 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.98 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.425 HD23 ' ND2' ' A' ' 193' ' ' ASN . 8.2 mp -68.4 -34.18 75.56 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.699 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 17.1 mt -50.01 -45.88 52.26 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.142 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.0 t -81.37 -47.38 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.852 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -61.92 -50.77 70.83 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.425 ' ND2' HD23 ' A' ' 189' ' ' LEU . 97.6 m-20 -73.21 -23.13 60.35 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.365 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 190' ' ' LEU . . . -57.02 155.09 8.67 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.787 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -72.58 155.68 90.83 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.72 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.19 -39.78 82.04 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 122.454 2.102 . . . . 0.0 113.72 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.535 ' CB ' ' HB3' ' A' ' 228' ' ' ALA . 98.7 m-20 -59.3 -49.33 78.25 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.808 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -73.51 -36.79 65.78 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -47.14 -37.88 10.66 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.741 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.3 m -60.3 -50.22 74.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.293 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.624 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 40.4 mm -68.11 -44.02 84.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.45 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 81.9 mt -59.12 -44.11 91.99 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -63.41 -38.1 89.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -60.03 -39.46 85.97 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.976 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.34 -35.84 70.42 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.699 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.02 172.75 49.03 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.55 155.31 54.95 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 123.733 2.955 . . . . 0.0 113.459 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.39 1.78 88.81 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.469 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.42 128.15 34.7 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.279 0.561 . . . . 0.0 111.126 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 34.7 m -66.31 143.97 56.86 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.45 HD22 ' OH ' ' A' ' 169' ' ' TYR . 68.4 tp -54.32 -44.67 72.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -57.92 -46.96 84.2 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -58.12 -43.72 87.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 98.3 mtp -62.35 -46.14 90.03 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.957 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 98.3 mtp -65.22 -41.04 94.81 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.825 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.0 m -63.28 -50.02 71.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.512 0.672 . . . . 0.0 110.468 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.31 98.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.408 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 76.2 m -60.88 -40.35 92.67 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.29 -39.23 82.31 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.83 -38.83 92.98 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.3 m -94.59 4.52 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 120.713 -0.395 . . . . 0.0 112.022 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.29 19.54 79.8 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.831 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.41 ' N ' ' CD ' ' A' ' 224' ' ' PRO . . . -58.43 -43.81 95.62 Favored Glycine 0 CA--C 1.542 1.723 0 CA-C-O 119.376 -0.68 . . . . 0.0 111.929 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.433 ' HA ' ' N ' ' A' ' 162' ' ' ARG . 86.3 Cg_exo -47.26 -37.58 24.51 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.951 1.767 . . . . 0.0 111.047 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -79.32 164.97 49.92 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.346 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -46.84 -23.42 0.43 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -96.44 165.16 12.31 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.535 ' HB3' ' CB ' ' A' ' 197' ' ' ASP . . . -147.7 148.2 30.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.314 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.425 ' HG3' HD11 ' A' ' 201' ' ' ILE . 55.7 ttp180 69.64 -71.07 0.13 Allowed 'General case' 0 C--O 1.238 0.487 0 O-C-N 123.758 0.661 . . . . 0.0 110.076 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.14 -46.01 95.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.4 tp . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.064 179.333 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.459 ' HB3' HG23 ' A' ' 48' ' ' THR . 12.5 Cg_exo . . . . . 0 N--CA 1.49 1.268 0 N-CA-C 109.147 -1.136 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.497 HG21 ' CG2' ' A' ' 115' ' ' ILE . 8.0 pt -73.07 109.57 5.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.147 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.82 145.68 34.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -61.75 138.22 58.31 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.384 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -97.31 -170.8 2.08 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.482 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.08 -41.54 83.65 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -69.95 -17.86 63.33 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.867 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.5 -7.96 63.95 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -72.1 127.73 33.49 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.698 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.1 mtt -74.81 128.37 35.4 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -127.61 130.16 70.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.097 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -59.48 141.27 55.12 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.733 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -146.07 144.73 30.22 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.912 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.3 142.52 50.47 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.201 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.484 HD12 ' HG ' ' A' ' 20' ' ' LEU . 33.3 pt -62.24 141.83 17.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.83 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.0 t -60.68 119.76 46.83 Favored Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.0 -36.19 74.81 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 N-CA-C 109.434 -1.025 . . . . 0.0 109.434 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -57.18 -49.02 77.27 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.015 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.6 m -61.27 -47.12 87.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.266 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.484 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -49.54 -60.27 3.01 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.813 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -55.07 -40.7 70.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.687 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -61.57 -41.37 97.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.429 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -58.25 -50.44 73.57 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.187 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.8 t -62.67 -43.11 98.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.875 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.37 -44.04 92.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.891 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 22' ' ' ALA . 53.9 t -58.86 -45.88 91.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 69.8 t -63.51 -36.34 75.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.745 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -54.46 -46.41 73.33 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.384 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -87.88 -33.57 18.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' HG21 ' A' ' 36' ' ' VAL . 38.2 mttt -130.46 40.05 3.56 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.918 -176.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.36 -50.03 5.1 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -95.12 -4.93 45.28 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.5 m -56.42 146.72 52.4 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.98 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.25 -34.97 11.98 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 122.661 2.241 . . . . 0.0 112.949 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -58.02 -18.57 25.05 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.914 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 30' ' ' LYS . 60.3 t -64.0 -42.3 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.49 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.426 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 8.0 mt -47.16 -60.59 3.76 Favored Pre-proline 0 C--O 1.24 0.57 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.594 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.426 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 73.2 Cg_exo -53.36 -42.15 67.48 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 119.971 1.026 . . . . 0.0 111.727 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.6 mtt -60.38 -44.51 95.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.496 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.66 -48.09 75.61 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.9 m -58.87 -42.88 90.51 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.824 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.22 -44.42 95.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.349 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.61 -22.45 60.97 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.388 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.0 m -88.27 5.89 39.57 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -61.88 125.89 25.43 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.857 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.15 10.74 74.3 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.804 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.99 149.34 39.32 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 1' ' ' PRO . 82.1 p -99.76 147.78 33.88 Favored Pre-proline 0 C--O 1.213 -0.851 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.379 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.26 -38.1 19.59 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.391 1.394 . . . . 0.0 113.221 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -68.31 -63.46 1.05 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.367 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.7 m-20 -58.24 -35.85 72.33 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.501 1.144 . . . . 0.0 108.024 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.525 HD21 ' HG2' ' A' ' 131' ' ' LYS . 58.2 tp -62.3 -48.86 78.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.104 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -58.18 -37.23 74.33 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 58' ' ' THR . 88.3 m -59.56 -40.83 88.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.455 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.0 -46.9 84.5 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.769 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.85 -39.71 87.68 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.689 0.757 . . . . 0.0 109.514 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -60.68 -39.59 89.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.439 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 54' ' ' THR . 59.4 p -67.34 -23.99 65.67 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.815 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.65 135.66 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.917 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.8 -149.17 7.54 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.13 -125.82 38.88 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.723 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -49.57 -12.62 0.07 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.326 -0.437 . . . . 0.0 111.675 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -42.65 -21.57 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.139 0.576 . . . . 0.0 112.177 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.13 -42.56 77.09 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.52 92.66 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 47.1 ttp -60.62 -28.68 68.71 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -58.14 -39.78 79.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.0 tmm? -60.75 -41.84 96.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.28 -39.43 75.69 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.483 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -60.14 -40.62 90.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.41 -40.28 95.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.235 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.0 m -59.64 -50.53 73.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.615 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.431 HD12 ' CE1' ' A' ' 130' ' ' TYR . 45.5 pt -67.75 -27.6 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.767 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -62.73 -43.27 99.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -63.38 -44.28 95.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.147 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.02 -37.13 78.87 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.398 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.88 98.92 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.776 -0.77 . . . . 0.0 108.965 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.47 -50.32 65.79 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.549 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.28 -41.69 98.7 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.85 0.833 . . . . 0.0 108.998 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.43 ' O ' ' HD2' ' A' ' 85' ' ' PRO . 77.8 t90 -61.55 -42.27 98.58 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.07 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.49 -39.16 75.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.71 -13.14 61.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.505 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.8 mt -106.85 -49.0 3.38 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -99.14 -68.96 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.563 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 98.7 Cg_exo -49.09 -26.88 11.26 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 CA-C-N 121.209 1.467 . . . . 0.0 111.029 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -54.02 -17.34 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.147 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.521 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 28.9 p80 -48.22 -38.5 18.55 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.148 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 87' ' ' HIS . . . 167.72 123.21 0.01 OUTLIER 'General case' 0 C--O 1.238 0.455 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.27 -61.53 6.81 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.27 148.72 92.74 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.159 2.572 . . . . 0.0 111.704 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.9 tt -156.65 149.09 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.942 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.25 133.89 94.49 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.416 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.06 160.3 22.86 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 122.053 1.835 . . . . 0.0 111.687 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.93 -4.9 59.33 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.812 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -120.36 147.59 44.84 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 117.127 0.464 . . . . 0.0 109.884 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 63.2 mtt -65.01 142.47 58.42 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 120.893 0.378 . . . . 0.0 110.686 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -51.96 115.5 1.72 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.44 142.99 90.33 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.05 110.85 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.497 1.465 . . . . 0.0 113.498 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -83.15 169.92 15.31 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.463 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -57.47 -49.53 72.48 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.025 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.7 t -60.29 -40.55 90.87 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.746 0.784 . . . . 0.0 109.142 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.16 -34.43 76.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.428 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.52 HG21 ' CZ3' ' A' ' 133' ' ' TRP . 0.4 OUTLIER -53.78 -28.82 17.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.14 -14.11 26.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.347 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.86 -1.34 88.59 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.3 p -61.77 -20.28 63.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.7 p -127.96 33.06 4.83 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.503 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 t -134.66 131.69 38.04 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.935 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.6 m -65.82 146.14 55.11 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -53.25 -43.41 67.36 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -39.97 93.3 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.705 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -62.79 -44.54 95.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.971 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -53.58 -63.37 1.17 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.497 ' CG2' HG21 ' A' ' 2' ' ' ILE . 45.7 pt -59.2 -25.28 29.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.971 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.7 -64.56 3.74 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 118' ' ' MET . 1.4 p90 -64.13 -28.23 69.63 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.247 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.405 ' N ' ' CD1' ' A' ' 117' ' ' TRP . 33.1 mtm -68.22 -40.0 82.21 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.6 p -115.63 -23.11 8.88 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -63.83 -75.66 0.08 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.128 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.22 -176.21 0.45 Allowed Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.38 144.44 13.43 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 N-CA-C 108.779 -1.277 . . . . 0.0 108.779 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.4 127.33 13.24 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.678 1.586 . . . . 0.0 114.009 -175.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.6 mm -114.73 108.74 48.61 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 114.637 -1.165 . . . . 0.0 107.894 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -87.34 60.2 3.67 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.811 1.674 . . . . 0.0 113.553 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -50.1 -39.47 16.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.87 -42.94 99.58 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.037 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -60.44 -47.85 84.3 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.312 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.403 HG22 ' CE2' ' A' ' 133' ' ' TRP . 90.1 mt -64.17 -47.91 87.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.466 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.792 ' CE2' HD11 ' A' ' 134' ' ' ILE . 87.4 t80 -59.2 -49.21 78.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.38 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.525 ' HG2' HD21 ' A' ' 52' ' ' LEU . 57.6 mtmt -62.87 -37.96 88.95 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.659 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -57.83 -43.43 85.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.52 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 43.7 m0 -63.03 -42.72 99.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.645 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.792 HD11 ' CE2' ' A' ' 130' ' ' TYR . 80.8 mt -59.02 -43.9 90.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.112 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.06 -40.28 80.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.91 -45.11 90.78 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.223 0.535 . . . . 0.0 109.709 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.32 -43.31 97.41 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.12 -36.49 83.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -58.46 -46.48 86.5 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -64.79 -38.57 91.44 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.713 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mm -60.42 -49.87 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.8 m -58.23 -34.48 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -66.65 -38.27 86.52 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 67.7 ttp -60.07 -46.28 90.07 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -71.13 -16.72 62.57 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.1 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -47.97 112.31 2.14 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.52 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.72 -35.87 4.18 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.936 1.757 . . . . 0.0 113.818 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.3 p -140.24 172.32 12.9 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 44.5 t -98.7 151.04 21.18 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.852 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.6 mm -51.9 -41.92 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.29 -39.08 81.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.802 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -66.7 -10.05 42.68 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.494 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.8 mm -80.29 125.36 39.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.739 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -152.49 129.7 11.22 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.99 0.424 . . . . 0.0 110.089 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -86.29 131.92 34.11 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.218 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -90.91 155.7 23.95 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -53.41 -37.26 81.62 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.33 2.02 . . . . 0.0 111.889 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -87.22 -10.16 53.26 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.371 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -81.64 131.75 56.96 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.45 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -67.55 134.36 32.79 Favored 'Trans proline' 0 N--CA 1.508 2.364 0 C-N-CA 122.524 2.149 . . . . 0.0 113.174 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.418 ' O ' HG23 ' A' ' 165' ' ' VAL . 37.4 t80 -58.73 -28.19 65.62 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.479 ' H ' ' HA ' ' A' ' 224' ' ' PRO . 41.9 ttm180 -63.76 -50.36 69.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.867 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -63.07 -40.23 97.06 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -58.65 -50.26 74.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.412 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 161' ' ' PHE . 54.2 t -64.21 -49.23 82.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.712 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -59.5 -51.43 69.89 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.641 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -63.07 -41.69 99.49 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.089 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.641 ' CE2' HG23 ' A' ' 186' ' ' THR . 88.2 t80 -56.41 -48.58 76.64 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.519 ' OH ' HD22 ' A' ' 211' ' ' LEU . 12.3 m-85 -63.71 -37.38 87.12 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.231 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -58.05 -49.5 76.67 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 93.0 m -67.18 -38.24 85.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.861 0.839 . . . . 0.0 108.831 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.462 HD11 ' CG ' ' A' ' 182' ' ' LYS . 22.6 tp -55.46 -42.03 73.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.606 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -61.69 -42.49 99.0 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.535 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -64.65 -27.01 68.64 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.528 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -46.91 150.07 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.295 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -81.19 -92.63 0.05 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.706 -1.133 . . . . 0.0 112.424 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -42.21 146.28 0.32 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.06 0.934 . . . . 0.0 112.808 -176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 69.0 m -64.42 179.11 0.63 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.094 -1.412 . . . . 0.0 112.126 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -57.49 -22.79 46.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.329 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -55.31 -48.55 73.96 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 118.782 -1.167 . . . . 0.0 108.392 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.3 t -89.94 -51.22 12.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.328 1.061 . . . . 0.0 110.092 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.462 ' CG ' HD11 ' A' ' 172' ' ' LEU . 39.9 ttpt -57.77 -46.51 84.46 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.19 -1.823 . . . . 0.0 112.991 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -60.3 -41.99 94.56 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.889 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -59.85 -48.52 81.37 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.464 0.649 . . . . 0.0 109.746 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 98.4 mtp -61.69 -40.68 95.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.441 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.641 HG23 ' CE2' ' A' ' 168' ' ' PHE . 58.1 m -61.3 -48.26 82.19 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.563 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.67 -49.06 78.02 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.278 0.561 . . . . 0.0 110.17 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 98.4 m -62.46 -48.69 78.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.16 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 81.8 mt -67.61 -35.83 79.68 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.79 -1.096 . . . . 0.0 112.898 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.1 mt -44.75 -49.19 10.72 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.17 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 11.3 p -81.27 -37.22 15.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.73 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -61.97 -50.03 73.75 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.12 -23.89 62.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.831 0.348 . . . . 0.0 111.767 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.15 145.75 25.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.638 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -66.1 152.6 93.58 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.31 -45.61 36.51 Favored 'Trans proline' 0 N--CA 1.508 2.367 0 C-N-CA 122.705 2.27 . . . . 0.0 115.727 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.688 ' O ' ' HB2' ' A' ' 228' ' ' ALA . 97.3 m-20 -59.68 -49.46 77.67 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 118.799 -1.16 . . . . 0.0 110.417 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' CYS . . . . . 0.459 ' SG ' HD23 ' A' ' 202' ' ' LEU . 37.9 t -66.66 -38.98 87.96 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -48.79 -34.54 12.5 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.008 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 97.5 m -58.42 -50.36 73.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.185 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.666 HG12 ' HB1' ' A' ' 228' ' ' ALA . 26.2 mm -65.41 -45.21 93.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.596 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.459 HD23 ' SG ' ' A' ' 198' ' ' CYS . 3.9 mm? -53.9 -49.36 68.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.111 0.958 . . . . 0.0 108.858 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.64 -38.16 86.65 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.729 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -59.04 -39.43 81.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.913 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.445 HD21 ' HB1' ' A' ' 217' ' ' ALA . 2.7 mm? -59.15 -36.4 75.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 81.44 174.19 48.88 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.65 154.43 59.57 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 123.484 2.789 . . . . 0.0 112.902 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 86.91 -7.71 79.11 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.69 129.58 41.15 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.442 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.9 p -75.38 161.96 28.8 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.652 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.519 HD22 ' OH ' ' A' ' 169' ' ' TYR . 65.4 tp -59.6 -44.23 93.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.32 -50.3 74.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.162 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.6 -39.05 86.7 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.979 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 25.9 tpp -62.39 -50.58 70.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.938 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 15.2 tpt -63.25 -45.1 93.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.323 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.8 m -62.92 -48.43 78.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.85 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.445 ' HB1' HD21 ' A' ' 205' ' ' LEU . . . -62.73 -50.54 70.71 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.768 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 29.5 p -61.95 -30.61 71.03 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -64.85 -42.74 94.65 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.031 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.74 -40.42 98.76 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.006 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 228' ' ' ALA . 2.7 t -83.67 -35.31 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 126.03 10.17 4.39 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.221 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -56.64 -47.64 83.23 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-O 119.114 -0.826 . . . . 0.0 113.498 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.479 ' HA ' ' H ' ' A' ' 162' ' ' ARG . 52.0 Cg_endo -70.29 -0.88 8.02 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 CA-C-N 120.274 2.037 . . . . 0.0 113.974 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -96.17 -51.25 1.77 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -156.11 -58.17 0.09 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.599 0.714 . . . . 0.0 109.71 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -140.25 -174.33 3.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.23 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' A' ' 197' ' ' ASP . . . -45.38 -51.05 11.79 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 123.153 0.283 . . . . 0.0 110.938 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -84.93 154.54 22.14 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.176 0.513 . . . . 0.0 111.599 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 9.6 p -55.53 -29.94 25.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.391 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.435 179.431 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 N--CA 1.488 1.191 0 N-CA-C 108.948 -1.212 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.528 HG21 HG22 ' A' ' 115' ' ' ILE . 12.8 pt -63.74 112.3 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.253 0.549 . . . . 0.0 110.169 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.37 140.8 45.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.65 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -65.81 124.07 21.47 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.968 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -81.72 -172.23 3.76 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.369 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.24 -38.96 85.05 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -66.85 -19.2 65.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.453 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.52 -8.14 68.79 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.41 127.01 31.96 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.497 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 89.1 mtp -72.2 128.1 34.6 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.8 t -126.61 128.84 71.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.747 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -64.8 139.19 58.74 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.351 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -141.62 155.08 45.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.246 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.28 146.33 34.88 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.238 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.3 pt -62.79 144.15 14.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.916 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.8 m -61.89 121.18 63.44 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.44 -38.86 83.31 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 N-CA-C 109.794 -0.887 . . . . 0.0 109.794 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -59.53 -47.91 83.69 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.871 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.0 m -61.11 -46.11 91.92 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.87 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.524 HD13 ' C ' ' A' ' 20' ' ' LEU . 3.3 tm? -58.04 -49.14 77.9 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.245 0.545 . . . . 0.0 109.991 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -58.28 -42.3 86.25 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -62.22 -41.58 98.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.25 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -57.78 -49.42 76.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.6 t -62.08 -44.88 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.92 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -59.24 -42.78 91.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.529 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 22' ' ' ALA . 50.4 t -57.6 -44.58 85.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 53.8 t -64.63 -38.25 82.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.982 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -55.18 -49.22 72.43 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.086 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -81.07 -44.6 17.76 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -120.46 39.52 3.72 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.73 -52.19 3.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -95.83 -4.79 43.12 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -55.52 146.28 44.96 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 118.951 0.796 . . . . 0.0 111.734 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.19 -32.19 17.23 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 122.47 2.114 . . . . 0.0 112.544 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.26 -21.62 35.61 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.269 0.557 . . . . 0.0 109.667 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.5 t -63.27 -40.77 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.487 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.8 mt -42.75 -61.27 1.77 Allowed Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.317 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.04 -33.12 52.03 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 120.799 1.0 . . . . 0.0 111.499 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.1 tpt -60.23 -48.15 82.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.374 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 134' ' ' ILE . 63.9 t80 -55.77 -47.33 77.2 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.2 t -58.68 -43.89 90.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.89 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.05 94.02 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.04 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.7 mt -70.62 -24.53 62.75 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -91.34 25.94 2.4 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.561 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.6 126.17 30.56 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.161 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.29 11.21 75.56 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.055 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.28 150.67 43.37 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 111.915 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.9 p -99.3 149.12 35.53 Favored Pre-proline 0 C--O 1.218 -0.574 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.821 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -47.17 -37.44 23.64 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.192 1.261 . . . . 0.0 112.528 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -74.95 -62.51 1.52 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.61 -0.436 . . . . 0.0 112.139 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.77 -38.29 75.16 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 52' ' ' LEU . 56.4 tp -64.36 -44.21 92.13 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.595 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -58.22 -38.72 77.37 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 87.7 m -61.07 -40.36 93.36 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.963 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.16 -47.96 81.74 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.865 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.6 -41.5 92.69 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.218 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -61.62 -38.31 87.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.117 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.28 -24.15 66.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.522 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.433 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 95.8 t -58.67 154.52 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.78 -149.49 5.21 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.7 -128.5 47.79 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.208 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.452 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 18.7 p80 -53.82 -10.87 0.34 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.99 -0.605 . . . . 0.0 111.756 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.433 ' NE2' ' O ' ' A' ' 59' ' ' VAL . 16.9 tt0 -43.57 -22.2 0.04 OUTLIER 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.22 -40.29 67.53 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.08 97.63 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.2 tmm? -57.32 -21.4 34.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.52 -37.15 72.55 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.1 tpt -58.17 -45.63 87.17 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -56.23 -38.14 70.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -43.51 71.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.6 -35.53 73.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.987 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -58.34 -48.74 79.6 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 pt -67.68 -28.51 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -62.28 -43.47 98.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.02 -42.33 97.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.121 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.66 -40.02 90.51 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.24 98.29 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.225 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.3 -50.3 72.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.064 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.9 -39.18 93.58 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.893 0.854 . . . . 0.0 108.768 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.526 ' O ' ' HD2' ' A' ' 85' ' ' PRO . 76.4 t-105 -58.39 -45.29 88.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.779 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -57.38 -40.49 78.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -71.88 -14.07 61.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.599 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.405 ' O ' HG12 ' A' ' 86' ' ' VAL . 6.3 mp -108.46 -48.95 3.25 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.408 ' CB ' ' HD3' ' A' ' 85' ' ' PRO . 0.6 OUTLIER -97.22 -65.42 0.09 OUTLIER Pre-proline 0 N--CA 1.467 0.389 0 C-N-CA 119.987 -0.685 . . . . 0.0 112.523 -178.158 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.526 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 82.9 Cg_exo -52.26 -29.41 38.01 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 CA-C-N 120.816 1.327 . . . . 0.0 110.212 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 83' ' ' LEU . 2.6 p -54.79 -20.17 5.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.999 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.498 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 21.9 p80 -48.9 -32.66 9.33 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.449 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 87' ' ' HIS . . . 168.76 107.15 0.01 OUTLIER 'General case' 0 C--O 1.238 0.448 0 O-C-N 123.415 0.447 . . . . 0.0 110.322 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.19 -62.9 5.78 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.17 143.51 90.14 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.88 2.386 . . . . 0.0 111.171 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.9 tp -150.22 144.53 17.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.84 149.4 93.2 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.915 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.12 161.24 46.73 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.66 2.24 . . . . 0.0 112.331 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.21 3.25 63.55 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.833 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -125.37 150.05 47.57 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 117.077 0.438 . . . . 0.0 110.682 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 53.6 mtt -67.33 152.66 45.32 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.353 0.597 . . . . 0.0 111.768 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -54.24 129.93 36.85 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.604 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -65.25 152.44 91.77 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.3 80.44 0.22 Allowed 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.216 1.944 . . . . 0.0 114.43 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -66.23 163.77 17.17 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.11 -44.29 96.45 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.405 ' HB3' HG23 ' A' ' 108' ' ' THR . 68.6 m -61.38 -39.97 92.62 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.07 -41.37 92.27 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.49 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.55 HG21 ' CH2' ' A' ' 133' ' ' TRP . 37.3 mm -58.72 -45.95 90.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.08 -20.5 65.82 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.89 -0.75 89.45 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 76.1 p -60.01 -21.41 61.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.405 HG23 ' HB3' ' A' ' 102' ' ' SER . 14.4 p -123.68 20.97 9.34 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.0 p -125.22 132.06 53.04 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.731 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -73.13 145.81 46.15 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.6 tp -50.98 -46.97 61.53 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.356 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.76 -41.29 97.49 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.29 -38.48 89.53 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.354 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -63.07 -42.08 99.57 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.824 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.528 HG22 HG21 ' A' ' 2' ' ' ILE . 35.0 pt -67.86 -42.14 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 118.907 -1.117 . . . . 0.0 111.06 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.26 -42.16 58.01 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -58.48 -44.71 89.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.421 ' SD ' HD11 ' A' ' 2' ' ' ILE . 28.2 ttt -73.29 -42.22 62.68 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.245 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 66.0 p -126.62 -23.66 3.7 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -56.11 -51.03 69.39 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.993 1.269 . . . . 0.0 110.279 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -81.14 -179.07 1.32 Allowed Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.05 143.65 17.67 Favored 'Trans proline' 0 N--CA 1.485 1.002 0 N-CA-C 107.441 -1.792 . . . . 0.0 107.441 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.85 123.85 4.23 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.849 1.699 . . . . 0.0 113.599 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.9 mm -113.64 108.41 51.76 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.43 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 73.1 Cg_endo -74.79 57.34 4.4 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.273 1.982 . . . . 0.0 113.503 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 127' ' ' GLY . 27.0 m -60.5 -44.49 96.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.515 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -63.3 -43.06 99.0 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.759 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 125' ' ' PRO . 88.7 tt0 -63.03 -44.89 94.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.63 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.5 mm -61.28 -47.54 93.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -57.87 -47.44 82.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -58.93 -41.85 88.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.785 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -57.72 -43.86 85.56 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.55 ' CH2' HG21 ' A' ' 104' ' ' ILE . 48.7 m0 -62.32 -45.54 92.77 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.765 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.476 HG21 ' CE2' ' A' ' 40' ' ' PHE . 32.3 mm -60.25 -46.67 94.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.424 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.61 -41.47 85.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 65.6 tp -60.52 -45.6 93.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.06 -41.14 96.35 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.35 -36.39 83.55 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -58.63 -44.83 90.13 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.49 -40.17 95.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.802 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.74 -49.26 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.353 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.7 m -58.02 -32.68 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.1 ttm-85 -67.98 -38.0 82.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 58.9 ttm -58.57 -44.15 89.65 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -74.84 -17.56 60.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.705 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.8 p -43.1 104.96 0.4 Allowed Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.39 -32.66 6.19 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.943 1.762 . . . . 0.0 113.673 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 70.6 p -139.35 173.04 11.95 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.6 t -106.72 150.12 26.6 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.887 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.577 ' HA ' HD12 ' A' ' 153' ' ' ILE . 13.6 mm -50.88 -46.51 29.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -59.4 -37.98 79.39 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.461 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -65.96 -5.04 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.216 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' A' ' 150' ' ' ILE . 92.6 mt -97.14 126.01 50.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.86 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -152.22 134.57 15.18 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.496 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -85.08 128.7 34.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -89.09 164.39 32.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.52 -36.18 78.07 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 121.831 1.687 . . . . 0.0 111.105 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -83.94 -17.15 41.6 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.497 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 160' ' ' PRO . 96.7 mt-10 -77.88 146.78 72.82 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.927 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 159' ' ' GLU . 5.2 Cg_endo -81.46 135.82 9.53 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.654 2.236 . . . . 0.0 113.418 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -58.93 -36.8 75.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 48.9 ttp180 -59.86 -49.77 76.4 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.02 -40.65 94.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.517 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -58.92 -49.59 77.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.463 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.65 -45.77 98.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.473 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.01 -52.19 66.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.019 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.64 -39.75 91.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.666 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.683 ' CE2' HG23 ' A' ' 186' ' ' THR . 81.2 t80 -56.71 -47.89 78.95 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -64.7 -36.59 84.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.943 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -57.98 -48.77 79.02 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.545 ' OG1' HD11 ' A' ' 153' ' ' ILE . 96.6 m -66.62 -38.91 87.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.729 0.776 . . . . 0.0 109.061 177.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 29.2 tp -56.42 -39.82 73.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.926 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -60.58 -38.87 86.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -76.53 -9.31 58.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.532 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -44.89 163.42 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.727 0.775 . . . . 0.0 112.573 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -104.73 -94.31 0.34 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.884 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -45.16 143.06 1.74 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.683 0.754 . . . . 0.0 111.643 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 67.9 m -51.77 166.74 0.13 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.002 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.71 -16.29 38.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.267 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.82 -45.23 82.43 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 43.9 t -89.33 -50.76 12.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.846 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -55.43 -46.74 76.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.897 -177.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -57.35 -43.31 83.37 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.897 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -60.81 -47.25 87.18 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.436 0.636 . . . . 0.0 109.917 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 98.3 mtp -60.67 -41.04 94.28 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.079 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.683 HG23 ' CE2' ' A' ' 168' ' ' PHE . 66.4 m -60.44 -48.84 80.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.143 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.03 -47.72 85.11 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.01 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 99.0 m -62.09 -48.42 80.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.684 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.17 -21.69 58.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.42 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 67.2 tp -54.06 -49.97 67.79 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.625 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.7 m -87.33 -38.24 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.646 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.63 -45.96 92.09 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.958 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -80.27 -9.87 59.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.23 155.7 34.24 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -70.4 151.22 95.72 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.119 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.41 -42.91 63.49 Favored 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 122.316 2.011 . . . . 0.0 115.072 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.16 -60.49 3.79 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.538 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' CYS . . . . . 0.758 ' HA ' ' HB2' ' A' ' 228' ' ' ALA . 49.4 t -62.16 -38.93 90.94 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -48.58 -34.64 11.87 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.856 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 99.3 m -59.92 -49.48 77.53 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 118.813 -1.155 . . . . 0.0 108.708 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.638 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 2.2 mp -64.75 -45.01 96.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.016 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.79 -42.16 92.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.51 -38.9 91.75 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -58.69 -40.47 83.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.278 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 205' ' ' LEU . 85.5 mt -63.0 -40.38 97.58 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.536 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.16 -160.49 53.3 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.999 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.05 165.91 4.65 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 123.822 3.015 . . . . 0.0 113.398 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 209' ' ' ALA . . . 61.08 -123.85 33.7 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 208' ' ' GLY . . . 64.86 99.29 0.04 OUTLIER 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.139 0.495 . . . . 0.0 111.231 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 50.9 m -57.76 144.27 38.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.2 tp -50.36 -40.96 50.89 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.223 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -57.98 -45.58 86.52 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.43 -42.23 91.42 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 5.5 mmt -61.58 -50.85 70.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.101 0.476 . . . . 0.0 110.961 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 59.3 ttm -63.69 -46.29 86.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.349 0.595 . . . . 0.0 110.574 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.8 m -61.8 -48.1 82.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.48 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.426 ' O ' HG23 ' A' ' 221' ' ' VAL . . . -61.05 -45.13 96.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.994 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 92.1 m -61.35 -40.98 96.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -56.7 -38.65 72.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.23 -38.98 93.99 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 228' ' ' ALA . 0.2 OUTLIER -94.97 5.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 72.75 20.04 79.55 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.267 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.429 ' N ' ' CD ' ' A' ' 224' ' ' PRO . . . -59.52 -40.87 96.82 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 119.212 -0.771 . . . . 0.0 112.394 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 223' ' ' GLY . 82.6 Cg_exo -48.97 -29.26 15.05 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 CA-C-N 120.016 1.908 . . . . 0.0 109.863 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -90.28 -178.98 44.17 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -57.66 141.7 47.47 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.017 -0.696 . . . . 0.0 109.811 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt 55.93 -172.18 0.07 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.92 0.391 . . . . 0.0 110.714 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.758 ' HB2' ' HA ' ' A' ' 198' ' ' CYS . . . -106.36 19.32 20.69 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.602 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -64.47 140.42 58.87 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.329 -0.549 . . . . 0.0 109.787 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 31.6 m -39.24 -31.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 O-C-N 123.848 0.717 . . . . 0.0 112.104 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.589 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.437 ' HB3' HG23 ' A' ' 48' ' ' THR . 8.0 Cg_exo . . . . . 0 N--CA 1.487 1.141 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.7 pt -71.21 110.11 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.403 0.621 . . . . 0.0 110.575 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.6 t -129.54 126.37 63.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.573 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -56.6 115.57 2.61 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.359 0.599 . . . . 0.0 109.847 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.56 -176.09 1.83 Allowed 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.281 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.99 -38.49 82.74 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.26 -19.51 66.0 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.731 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.25 -7.72 62.26 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -80.07 124.2 28.53 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.4 mtt -75.64 131.61 40.05 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.8 t -126.66 129.23 71.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.553 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -66.84 136.16 55.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.531 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -137.78 153.72 49.65 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.955 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.28 148.15 37.76 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.392 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.8 pt -62.44 144.48 14.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.173 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 m -63.68 121.98 73.87 Favored Pre-proline 0 N--CA 1.451 -0.399 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.15 -36.52 77.38 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 N-CA-C 109.507 -0.997 . . . . 0.0 109.507 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -57.63 -49.69 75.62 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.124 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 95.0 m -61.46 -46.14 91.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.458 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 65.8 tp -57.68 -49.9 74.96 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.832 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -58.47 -41.87 86.21 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -62.44 -41.67 98.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.751 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -57.55 -50.97 71.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.374 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.42 -41.84 94.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.365 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.74 -40.68 84.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.172 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 22' ' ' ALA . 47.2 t -58.55 -44.09 88.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 75.8 t -62.41 -35.96 72.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.998 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -57.03 -43.7 82.15 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.403 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -93.65 -27.1 16.76 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.545 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 99.6 mttt -132.41 38.3 3.46 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.956 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.79 -54.13 3.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -96.63 -5.17 39.64 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 55.4 m -52.49 144.34 24.24 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 118.906 0.776 . . . . 0.0 111.508 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.26 -31.62 17.96 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.453 2.102 . . . . 0.0 112.706 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -59.08 -18.86 39.04 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.771 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 30' ' ' LYS . 54.1 t -65.23 -41.27 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.944 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.427 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 6.4 mt -45.7 -60.79 2.99 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.237 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 77.8 Cg_exo -54.23 -41.22 77.92 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 CA-C-N 120.001 1.036 . . . . 0.0 111.795 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.9 mtt -60.86 -44.21 97.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.798 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -56.92 -49.44 75.62 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.779 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.4 p -60.86 -38.88 87.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.721 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.66 -46.08 91.7 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.067 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.61 -27.13 62.9 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.221 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -85.84 12.32 9.37 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.216 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -64.76 122.54 17.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.522 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.99 10.47 84.05 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 121.428 -0.415 . . . . 0.0 112.896 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.96 149.1 41.56 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.165 0.507 . . . . 0.0 112.117 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.437 HG23 ' HB3' ' A' ' 1' ' ' PRO . 81.3 p -99.19 148.69 34.97 Favored Pre-proline 0 C--O 1.212 -0.901 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.412 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -45.74 -37.17 15.76 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.477 1.451 . . . . 0.0 113.558 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -70.29 -63.35 1.1 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.254 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.509 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -57.88 -35.81 71.51 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.41 HD23 ' HD2' ' A' ' 130' ' ' TYR . 55.9 tp -62.4 -44.15 97.13 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.297 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -58.26 -38.05 76.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.53 ' O ' HG23 ' A' ' 58' ' ' THR . 88.3 m -61.21 -40.13 92.82 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.101 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 83.9 mmm -56.08 -46.49 78.99 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.581 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.78 -44.62 48.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.451 0.644 . . . . 0.0 111.145 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.25 -39.09 78.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.064 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 54' ' ' THR . 45.2 p -67.2 -19.69 65.6 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.999 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 60' ' ' GLY . 76.2 t -61.79 154.48 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.741 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 59' ' ' VAL . . . -140.65 -151.9 5.68 Favored Glycine 0 CA--C 1.535 1.338 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.96 -128.12 46.74 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.123 -1.037 . . . . 0.0 110.934 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -51.5 -10.59 0.1 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.956 -0.622 . . . . 0.0 112.11 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -43.46 -21.98 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.27 -41.09 68.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.13 96.36 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.3 tpp -56.78 -21.11 26.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.12 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -58.65 -38.4 78.03 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -58.58 -45.36 89.21 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -53.11 -43.04 66.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.086 178.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -59.62 -40.65 88.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -64.61 -40.78 96.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.593 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.7 m -60.17 -44.05 95.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.6 mt -60.33 -43.93 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -60.43 -42.13 95.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.444 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.23 -46.24 91.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.055 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.59 -39.21 93.81 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.66 98.51 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.435 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.29 -49.33 74.44 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.179 0.514 . . . . 0.0 111.186 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.22 -41.62 99.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 122.122 0.963 . . . . 0.0 109.1 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.469 ' CZ2' HD13 ' A' ' 104' ' ' ILE . 71.9 t90 -59.62 -44.42 93.44 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.083 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -53.87 -42.53 68.69 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.4 -26.75 68.13 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.477 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.452 ' O ' HG12 ' A' ' 86' ' ' VAL . 85.9 mt -98.3 -47.43 5.44 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -97.21 -69.52 0.05 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 119.003 0.82 . . . . 0.0 112.069 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.26 -23.5 6.98 Favored 'Trans proline' 0 N--CA 1.501 1.944 0 CA-C-N 121.316 1.506 . . . . 0.0 111.012 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 83' ' ' LEU . 5.6 p -54.57 -14.68 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.095 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.488 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 29.9 t60 -47.07 -50.82 19.11 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 87' ' ' HIS . . . 169.86 123.01 0.01 OUTLIER 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.528 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.58 -53.93 42.01 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -63.35 147.34 93.66 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.882 2.388 . . . . 0.0 112.606 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 tt -162.07 150.63 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.56 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.52 152.54 96.57 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.369 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.47 170.49 18.34 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.709 2.273 . . . . 0.0 112.066 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.42 -5.91 77.74 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -124.58 146.54 48.99 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.3 mtt -66.2 146.84 54.17 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.759 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -52.18 119.01 3.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -60.62 158.92 27.97 Favored Pre-proline 0 C--O 1.239 0.541 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.069 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -48.17 130.44 20.52 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.718 1.612 . . . . 0.0 112.207 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.73 154.06 34.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.557 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -44.09 -61.28 3.16 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.605 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.569 ' OG ' HG23 ' A' ' 108' ' ' THR . 34.9 t -60.85 -39.03 87.59 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.667 0.746 . . . . 0.0 110.136 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -35.94 77.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.005 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.613 HG21 ' CZ3' ' A' ' 133' ' ' TRP . 6.5 tp -59.37 -33.35 50.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 102' ' ' SER . . . -70.59 -28.06 64.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.21 -8.1 79.82 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.7 p -57.78 -23.71 53.68 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.569 HG23 ' OG ' ' A' ' 102' ' ' SER . 23.0 p -114.79 8.51 16.09 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.684 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 62.0 m -111.79 131.34 55.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.078 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.0 m -71.04 156.03 40.11 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.8 tp -58.67 -47.83 83.16 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.244 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -61.61 -43.83 98.14 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.904 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.3 -39.38 86.75 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.192 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.619 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.5 pt -71.09 -39.76 74.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.952 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.33 -43.34 79.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -59.34 -45.15 92.16 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.915 -1.143 . . . . 0.0 109.084 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.2 ttt -72.04 -41.32 67.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.475 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.2 m -127.16 -26.4 3.11 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -57.4 -50.39 73.15 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 118.336 -1.346 . . . . 0.0 110.269 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.88 -178.23 1.13 Allowed Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 134.49 30.08 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 120.665 1.273 . . . . 0.0 109.224 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -36.77 116.72 0.16 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.681 2.254 . . . . 0.0 113.601 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.447 HG22 HG13 ' A' ' 126' ' ' VAL . 44.7 mm -108.83 108.54 60.82 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 87.4 Cg_endo -76.5 58.92 6.0 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.146 1.897 . . . . 0.0 112.692 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.47 HG23 ' N ' ' A' ' 127' ' ' GLY . 27.3 m -58.86 -45.08 91.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.956 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.47 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -64.18 -42.05 98.12 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.208 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 125' ' ' PRO . 88.4 tt0 -60.85 -45.89 92.74 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.415 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.84 -47.99 86.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.318 0.58 . . . . 0.0 110.415 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.7 ' CE2' HD11 ' A' ' 134' ' ' ILE . 86.7 t80 -58.59 -48.48 80.8 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.825 0.821 . . . . 0.0 108.858 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.491 ' HA ' HD12 ' A' ' 134' ' ' ILE . 60.2 mtpt -62.89 -38.16 89.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.035 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.7 tpp180 -57.79 -43.18 85.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.613 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 44.4 m0 -62.71 -43.74 98.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.885 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.7 HD11 ' CE2' ' A' ' 130' ' ' TYR . 84.4 mt -59.32 -44.57 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.933 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.37 -41.79 85.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.86 -42.42 99.75 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.25 -42.86 98.89 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.13 -36.47 84.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.7 -44.63 90.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.28 -39.5 92.67 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.607 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mm -60.58 -49.65 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.6 m -57.47 -35.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -65.15 -40.39 94.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 94.2 mmm -60.62 -43.09 97.9 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.329 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -71.61 -19.68 62.09 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.889 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.4 t -48.42 117.39 5.85 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.625 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -85.15 -25.03 1.87 Allowed 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 122.174 1.916 . . . . 0.0 113.67 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.1 p -138.97 169.66 17.39 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 40.8 t -107.43 148.9 28.54 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.985 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.444 HD11 ' CE1' ' A' ' 168' ' ' PHE . 4.9 tp -48.94 -36.38 8.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.5 tp -66.55 -39.48 88.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.609 0.719 . . . . 0.0 109.581 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -64.63 -26.36 68.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.153 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.21 108.36 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.071 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -144.85 122.62 11.9 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -85.87 125.58 33.42 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.217 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -87.77 166.37 35.74 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.564 ' O ' ' HB2' ' A' ' 228' ' ' ALA . 26.0 Cg_endo -62.64 -25.82 75.4 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.19 1.927 . . . . 0.0 110.711 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -82.68 -18.57 40.51 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.875 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -90.22 137.01 28.01 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.07 155.94 23.03 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.62 2.213 . . . . 0.0 114.598 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 165' ' ' VAL . 20.7 t80 -60.16 -39.68 87.26 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.453 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.47 ' N ' ' HA ' ' A' ' 224' ' ' PRO . 56.0 ttp180 -62.99 -47.54 82.7 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.742 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -61.0 -43.34 99.03 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.907 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -62.15 -50.15 73.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.277 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 161' ' ' PHE . 55.1 t -61.07 -44.53 98.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.545 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -62.11 -53.88 49.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.6 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 61.5 mtm-85 -64.62 -41.0 96.46 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.173 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.615 ' CE2' HG23 ' A' ' 186' ' ' THR . 82.5 t80 -58.45 -48.8 79.54 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.55 ' OH ' HD22 ' A' ' 211' ' ' LEU . 8.9 m-85 -64.92 -36.9 85.88 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.538 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -59.62 -48.1 82.99 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 97.3 m -64.89 -39.6 93.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.579 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.442 HD11 ' HG2' ' A' ' 182' ' ' LYS . 17.0 tp -58.37 -38.26 76.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.103 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 27.9 ttt-85 -64.69 -38.23 90.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.656 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.55 -10.68 58.13 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.977 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -51.05 167.58 0.07 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.737 0.78 . . . . 0.0 112.405 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -93.7 -93.07 0.17 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.842 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -44.95 148.75 0.51 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.453 0.644 . . . . 0.0 111.36 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 70.1 m -74.79 179.0 5.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.661 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -47.23 -25.55 0.96 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.842 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.28 -62.03 1.76 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.014 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 49.4 t -87.57 -43.47 15.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.813 0.816 . . . . 0.0 109.931 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.442 ' HG2' HD11 ' A' ' 172' ' ' LEU . 39.3 ttpt -57.48 -48.59 78.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.13 -1.396 . . . . 0.0 112.806 -177.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -60.81 -41.64 96.09 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.332 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -59.79 -48.86 79.98 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.603 0.715 . . . . 0.0 109.671 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.402 ' O ' HD13 ' A' ' 189' ' ' LEU . 98.7 mtp -61.62 -40.33 94.46 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.027 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.615 HG23 ' CE2' ' A' ' 168' ' ' PHE . 60.4 m -59.69 -46.92 87.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.283 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.68 -47.71 84.55 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.797 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 98.0 m -64.23 -47.54 79.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.596 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 185' ' ' MET . 8.7 mp -66.82 -33.81 76.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.327 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.572 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 13.2 mt -49.43 -44.95 45.85 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.964 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.6 -47.52 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.553 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -61.48 -50.28 73.39 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -72.08 -25.9 61.95 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.311 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 190' ' ' LEU . . . -59.08 156.97 10.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.304 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -70.63 152.88 95.22 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.081 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.28 -45.9 31.83 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 122.778 2.319 . . . . 0.0 114.708 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.443 ' HB2' ' HB1' ' A' ' 228' ' ' ALA . 97.5 m-20 -54.6 -62.11 1.87 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.032 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' CYS . . . . . 0.601 ' SG ' HG11 ' A' ' 230' ' ' VAL . 46.5 t -58.5 -45.09 89.44 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.857 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -48.95 -31.06 6.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.578 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.9 m -59.76 -50.59 73.24 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.679 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.59 ' HB ' HG12 ' A' ' 230' ' ' VAL . 3.5 mm -79.3 -30.14 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.697 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -55.1 39.02 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.58 -39.28 90.61 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 201' ' ' ILE . . . -57.22 -32.5 66.58 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.92 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 205' ' ' LEU . 56.2 tp -56.34 -38.47 71.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 96.61 160.1 32.0 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.778 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.0 156.05 66.45 Favored 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 123.594 2.863 . . . . 0.0 113.215 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 81.15 -0.34 87.64 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.532 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.405 ' HB1' HD21 ' A' ' 205' ' ' LEU . . . -68.37 136.82 53.96 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.458 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.6 p -76.22 160.81 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.886 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.55 HD22 ' OH ' ' A' ' 169' ' ' TYR . 63.3 tp -60.41 -44.03 96.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.94 -48.97 79.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.808 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.28 -43.43 92.52 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.0 ttm -60.33 -48.88 79.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.524 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 94.9 mmm -62.86 -39.07 93.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.5 m -61.69 -50.27 73.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.215 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.36 96.5 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.94 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 97.0 m -60.45 -40.44 91.17 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -68.62 -39.31 80.86 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.995 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.28 -40.66 92.21 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.585 HG12 ' O ' ' A' ' 229' ' ' ARG . 12.4 t -95.09 -25.15 4.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-O 121.189 0.519 . . . . 0.0 110.598 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 230' ' ' VAL . . . 115.03 97.66 2.16 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.407 ' H ' ' HD2' ' A' ' 224' ' ' PRO . . . -139.78 -60.19 0.04 OUTLIER Glycine 0 N--CA 1.469 0.862 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.47 ' HA ' ' N ' ' A' ' 162' ' ' ARG . 34.6 Cg_exo -59.18 104.4 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.238 1.292 . . . . 0.0 109.674 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.435 ' H ' ' H ' ' A' ' 162' ' ' ARG . . . 87.98 -7.39 81.46 Favored Glycine 0 CA--C 1.54 1.599 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -106.15 116.3 31.7 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.02 0.41 . . . . 0.0 110.195 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 228' ' ' ALA . 63.8 pttt -36.37 -42.47 0.33 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 157' ' ' PRO . . . -178.31 31.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 118.991 -1.084 . . . . 0.0 112.939 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.585 ' O ' HG12 ' A' ' 221' ' ' VAL . 81.7 mtp180 -65.68 -14.35 61.06 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.024 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.601 HG11 ' SG ' ' A' ' 198' ' ' CYS . 72.9 t -59.99 -44.72 95.31 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.215 -0.751 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.929 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.486 1.049 0 N-CA-C 108.987 -1.197 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.467 HD11 ' SD ' ' A' ' 118' ' ' MET . 9.5 pt -62.31 109.85 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.494 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.1 t -128.88 123.58 59.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.486 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -57.13 110.63 0.87 Allowed 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.346 0.593 . . . . 0.0 110.003 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -68.5 177.78 2.28 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.011 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 pp -58.27 -33.45 69.42 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -63.18 -26.8 68.97 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.641 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.49 -7.19 53.55 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -85.73 124.72 32.56 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.894 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.0 mtt -73.75 134.49 43.47 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -128.62 130.07 68.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.813 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -68.19 136.27 53.35 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.518 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -137.9 153.6 49.52 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.254 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.86 142.95 40.0 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.985 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.432 ' CD1' HD21 ' A' ' 20' ' ' LEU . 37.9 pt -63.67 139.7 20.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.086 0.469 . . . . 0.0 110.488 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.0 t -61.01 126.09 85.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.82 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.09 -32.79 50.58 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 120.929 1.086 . . . . 0.0 109.884 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -58.76 -39.88 82.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 95.9 m -60.93 -46.2 91.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.732 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.432 HD21 ' CD1' ' A' ' 15' ' ' ILE . 68.1 mt -59.9 -45.02 93.87 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.64 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -60.55 -40.86 93.11 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.068 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.551 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -64.94 -46.65 80.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.284 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 42.3 t-105 -60.47 -50.69 72.57 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.878 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.89 -45.94 97.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.6 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.48 -43.5 98.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.364 0.602 . . . . 0.0 110.852 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 22' ' ' ALA . 46.7 t -59.27 -46.56 92.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.165 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 2.0 t -69.52 -25.94 29.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.393 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -58.98 -45.13 91.33 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.738 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -91.62 -36.35 13.71 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' O ' HG21 ' A' ' 36' ' ' VAL . 98.3 mttt -120.92 38.12 4.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.147 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.08 -51.64 4.49 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -96.11 -5.07 41.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.2 m -54.62 140.57 57.6 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 118.874 0.761 . . . . 0.0 112.22 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -59.93 -39.55 70.25 Favored 'Trans proline' 0 N--CA 1.507 2.265 0 C-N-CA 122.489 2.126 . . . . 0.0 112.817 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -54.15 -20.25 6.42 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.554 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.412 HG21 ' O ' ' A' ' 30' ' ' LYS . 52.9 t -62.57 -43.56 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.62 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.424 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 8.4 mt -46.97 -61.38 2.83 Favored Pre-proline 0 C--O 1.24 0.578 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.084 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 73.8 Cg_exo -53.62 -42.08 68.78 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 120.273 1.133 . . . . 0.0 111.781 176.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.0 mtp -61.41 -42.84 99.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.845 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -56.52 -48.84 76.37 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.8 t -59.23 -43.86 92.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.983 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.08 92.86 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.47 0.653 . . . . 0.0 110.069 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.4 mt -70.77 -25.64 62.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.459 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.9 m -89.53 7.76 34.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.785 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.22 128.41 35.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.573 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.76 10.54 76.79 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.58 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.67 149.86 38.05 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 111.973 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.9 p -99.05 150.29 36.56 Favored Pre-proline 0 C--O 1.218 -0.568 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.626 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.8 -39.55 18.82 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.492 1.461 . . . . 0.0 112.795 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -69.29 -63.35 1.08 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.349 -0.54 . . . . 0.0 112.018 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.492 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.96 -36.15 72.16 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.27 1.034 . . . . 0.0 108.405 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -62.18 -46.45 88.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.879 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -59.08 -37.46 77.16 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 85.5 m -58.6 -41.0 84.83 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.225 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.15 -46.07 89.33 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.298 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.439 HD11 HD13 ' A' ' 134' ' ' ILE . 90.8 mt -66.14 -41.84 89.91 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.814 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.97 -26.94 68.51 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.403 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 m -65.7 -34.64 78.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.238 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 60' ' ' GLY . 4.3 t -59.13 163.54 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.199 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.441 ' N ' HG12 ' A' ' 59' ' ' VAL . . . -157.6 -161.98 11.31 Favored Glycine 0 N--CA 1.473 1.109 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.43 -125.28 38.99 Favored Glycine 0 C--N 1.342 0.868 0 C-N-CA 118.867 -1.635 . . . . 0.0 109.774 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -48.37 -17.05 0.12 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.58 -0.31 . . . . 0.0 110.866 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -45.77 -21.71 0.14 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.324 0.25 . . . . 0.0 111.302 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.91 64.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.31 -40.55 96.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.0 mtt -63.74 -16.51 61.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.514 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -59.55 -39.05 82.73 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -60.62 -42.09 96.18 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -57.65 -39.28 76.67 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.096 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -60.63 -39.31 87.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.54 -40.48 95.68 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -59.39 -43.44 92.93 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 84.9 mt -60.78 -42.33 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -60.13 -41.8 93.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.486 -0.779 . . . . 0.0 108.97 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.32 -43.47 97.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.504 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.77 -40.47 97.39 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.73 98.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.564 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.1 -50.15 71.67 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.309 0.576 . . . . 0.0 110.87 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.81 -39.55 94.5 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.515 ' CH2' HD13 ' A' ' 129' ' ' ILE . 62.8 t-105 -58.12 -46.32 85.8 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.678 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -55.71 -41.79 74.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -72.26 -14.18 61.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.095 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt -105.1 -48.72 3.65 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.464 ' HB3' ' HD3' ' A' ' 85' ' ' PRO . 4.3 t-80 -102.5 -58.52 0.09 OUTLIER Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 119.696 -0.801 . . . . 0.0 112.913 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 51.7 Cg_exo -58.22 -25.58 72.62 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.125 1.216 . . . . 0.0 109.29 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.3 p -55.32 -17.44 2.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.356 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.536 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 17.8 p80 -48.09 -36.52 13.33 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.476 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 87' ' ' HIS . . . 163.12 117.06 0.0 OUTLIER 'General case' 0 C--O 1.239 0.505 0 O-C-N 123.621 0.575 . . . . 0.0 109.893 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.58 -54.62 36.35 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.04 148.57 91.46 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.934 2.423 . . . . 0.0 112.263 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.567 HD13 ' OE1' ' A' ' 98' ' ' GLU . 19.5 tt -155.6 152.75 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.929 0.395 . . . . 0.0 110.746 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.18 135.36 93.46 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.06 157.07 35.94 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 122.236 1.957 . . . . 0.0 112.36 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.1 5.98 60.49 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.307 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -125.06 146.58 49.38 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.068 0.461 . . . . 0.0 111.052 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -62.48 147.02 50.08 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.624 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 -56.97 114.56 2.16 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.567 ' OE1' HD13 ' A' ' 91' ' ' ILE . 17.6 mp0 -62.35 159.2 42.28 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.936 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.551 ' HB3' HD11 ' A' ' 104' ' ' ILE . 71.4 Cg_exo -51.24 141.31 39.79 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.437 2.092 . . . . 0.0 114.043 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.496 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 97.8 mtt180 -138.44 160.14 40.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.292 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.11 -47.64 85.96 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 118.348 -1.882 . . . . 0.0 109.63 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.1 p -64.78 -39.04 92.95 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.992 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.496 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 99.0 m-20 -63.91 -43.21 96.64 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.961 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.564 HG21 ' CZ3' ' A' ' 133' ' ' TRP . 0.8 OUTLIER -60.98 -37.89 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.69 -22.75 67.05 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.426 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.61 -3.26 69.31 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.4 p -67.53 -23.42 65.44 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.4 p -117.33 -2.32 11.61 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.154 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.0 m -105.45 131.42 52.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.726 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.8 m -70.65 151.47 44.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.82 -49.73 74.52 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.039 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.91 -40.43 88.79 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.69 -41.74 86.96 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -61.8 -37.68 85.29 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.5 mm -57.75 -62.03 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.291 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.71 -40.69 97.64 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -56.33 -44.94 80.47 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.467 ' SD ' HD11 ' A' ' 2' ' ' ILE . 27.4 ttt -72.67 -42.02 64.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.356 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 75.5 p -125.52 -23.89 4.0 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -51.72 -64.34 0.84 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.852 1.205 . . . . 0.0 110.429 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -76.71 -175.89 0.55 Allowed Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.24 143.82 14.06 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 N-CA-C 108.28 -1.469 . . . . 0.0 108.28 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.23 129.71 16.03 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.813 1.676 . . . . 0.0 113.526 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.454 HG22 HG13 ' A' ' 126' ' ' VAL . 42.7 mm -113.82 108.57 51.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.1 55.87 2.99 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.17 1.914 . . . . 0.0 113.431 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 127' ' ' GLY . 17.7 m -61.1 -48.19 90.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.926 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.482 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -63.59 -42.51 98.8 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.603 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -62.18 -46.26 89.73 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.389 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.515 HD13 ' CH2' ' A' ' 80' ' ' TRP . 89.8 mt -63.61 -48.77 85.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.372 0.606 . . . . 0.0 110.517 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.666 ' CE2' HD11 ' A' ' 134' ' ' ILE . 85.7 t80 -58.25 -47.1 84.64 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.417 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -61.53 -39.99 93.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.486 -1.233 . . . . 0.0 109.596 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.29 -41.74 89.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.564 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 47.9 m0 -62.08 -43.8 98.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.666 HD11 ' CE2' ' A' ' 130' ' ' TYR . 85.8 mt -60.47 -44.44 96.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.973 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.56 -41.27 81.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.729 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.8 -45.13 94.08 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.609 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.93 96.96 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -63.41 -36.41 83.65 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -58.05 -44.73 87.59 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.26 -38.62 90.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.778 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.66 -49.49 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.2 -36.06 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -65.81 -38.79 89.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.6 tpt -59.13 -47.39 85.45 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -72.93 -12.75 61.07 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.195 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.4 t -51.09 117.47 8.87 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.578 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -78.4 -35.04 1.29 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.956 1.771 . . . . 0.0 113.555 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.1 p -139.81 172.47 12.73 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.7 m -105.62 151.54 24.24 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.861 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.7 mm -49.35 -43.4 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 tt -58.79 -39.86 82.35 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.78 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -67.71 -14.49 62.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.081 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.2 mm -80.04 113.67 19.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.388 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -144.0 128.31 17.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -90.1 125.35 35.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.763 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -89.39 166.38 33.2 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.641 ' O ' ' HB2' ' A' ' 228' ' ' ALA . 22.0 Cg_endo -62.19 -35.46 74.58 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.666 1.578 . . . . 0.0 110.312 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -77.12 -17.41 58.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.484 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -84.62 127.3 66.03 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.662 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 148.53 54.1 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.247 1.965 . . . . 0.0 114.116 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.74 -43.09 94.39 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.836 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.522 ' H ' ' H ' ' A' ' 225' ' ' GLY . 36.1 ttp85 -60.58 -46.61 89.59 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.68 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -59.86 -41.42 91.42 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.962 -1.095 . . . . 0.0 108.313 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -61.52 -50.45 72.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.126 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.32 -43.95 97.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.763 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.59 -56.37 20.59 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.63 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -62.24 -39.54 93.18 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.664 ' CE2' HG23 ' A' ' 186' ' ' THR . 90.1 t80 -57.32 -47.62 81.06 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -64.39 -37.66 88.3 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.624 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -61.07 -45.35 95.11 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.719 0.771 . . . . 0.0 109.6 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 94.7 m -66.1 -40.2 90.59 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 16.7 tp -58.51 -38.98 78.84 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.323 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -61.51 -42.57 99.01 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.991 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -82.67 -10.65 58.83 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.205 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -49.78 167.73 0.04 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.592 0.71 . . . . 0.0 111.868 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -98.6 -93.57 0.25 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.494 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -44.57 143.8 1.25 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.675 0.75 . . . . 0.0 111.977 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 66.5 m -63.32 177.26 0.67 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.855 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -50.84 -27.28 7.05 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.051 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -51.65 -48.18 63.49 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 55.3 t -89.87 -61.23 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.175 0.988 . . . . 0.0 108.926 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -42.05 -53.08 4.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.552 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -59.46 -41.9 90.75 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.753 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -60.44 -48.87 79.87 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.577 0.703 . . . . 0.0 109.907 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.4 -41.21 96.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.289 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.664 HG23 ' CE2' ' A' ' 168' ' ' PHE . 66.7 m -60.54 -45.5 93.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.029 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -59.36 -49.86 76.2 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.813 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 97.6 m -64.62 -47.36 78.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.591 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.59 -37.56 87.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.28 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.539 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 9.4 mt -43.23 -54.0 4.79 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.013 0.435 . . . . 0.0 110.722 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 71.8 t -86.92 -40.62 14.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.947 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -59.76 -49.36 78.04 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 49.3 p30 -89.32 -4.96 57.91 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 119.074 -1.051 . . . . 0.0 112.087 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 190' ' ' LEU . . . -68.31 162.98 24.0 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -66.85 150.83 97.48 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.624 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.402 ' HA ' ' HB3' ' A' ' 199' ' ' LYS . 31.7 Cg_endo -64.2 -38.74 34.12 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.407 2.072 . . . . 0.0 113.588 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.539 ' HB2' ' HB1' ' A' ' 228' ' ' ALA . 98.6 m-20 -59.51 -50.54 73.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.21 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' CYS . . . . . 0.703 ' SG ' HG11 ' A' ' 230' ' ' VAL . 53.2 t -64.19 -43.59 94.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.035 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 196' ' ' PRO . 88.6 tttt -48.31 -30.27 4.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.847 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 92.6 m -59.47 -49.05 79.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.925 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.691 ' HB ' HG12 ' A' ' 230' ' ' VAL . 0.8 OUTLIER -82.67 -30.23 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.156 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.446 HD11 ' SG ' ' A' ' 198' ' ' CYS . 79.3 mt -60.94 -45.14 95.9 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.2 -39.45 94.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.001 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -59.05 -37.46 77.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.962 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 72.6 mt -59.78 -38.99 83.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.27 167.76 43.97 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.649 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.1 154.36 67.88 Favored 'Trans proline' 0 N--CA 1.507 2.32 0 C-N-CA 123.936 3.091 . . . . 0.0 113.871 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.19 16.3 80.8 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.749 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -79.9 135.54 36.45 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.094 0.473 . . . . 0.0 111.353 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 212' ' ' GLU . 42.0 m -73.35 137.37 44.71 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -51.64 -39.32 57.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.484 ' H ' HG22 ' A' ' 210' ' ' THR . 88.8 tt0 -59.25 -45.76 90.31 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.18 -42.18 90.24 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.7 mtt -62.7 -43.06 99.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.206 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 59.8 mtt -63.8 -43.54 95.98 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.682 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.1 m -65.86 -49.65 67.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.561 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.16 -44.53 95.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.031 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 81.0 m -61.32 -39.29 89.94 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.13 -36.68 83.79 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.174 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.37 94.35 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 229' ' ' ARG . 2.2 t -96.49 -16.58 7.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.199 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 109.98 105.32 2.92 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -147.84 -62.05 0.01 OUTLIER Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.629 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.449 ' HA ' ' N ' ' A' ' 162' ' ' ARG . 27.0 Cg_exo -59.71 90.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 121.945 1.763 . . . . 0.0 110.211 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.522 ' H ' ' H ' ' A' ' 162' ' ' ARG . . . 100.16 -7.17 58.44 Favored Glycine 0 CA--C 1.537 1.434 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -178.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -105.37 124.79 50.13 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 122.558 -0.378 . . . . 0.0 110.711 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -30.31 -66.4 0.1 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.436 1.085 . . . . 0.0 113.409 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 157' ' ' PRO . . . -163.11 28.13 0.09 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.056 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.454 ' O ' HG12 ' A' ' 221' ' ' VAL . 40.1 mmt180 -66.21 -6.57 14.06 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.76 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.703 HG11 ' SG ' ' A' ' 198' ' ' CYS . 53.2 t -59.04 -44.26 90.93 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.908 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.88 -179.666 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 N--CA 1.486 1.077 0 N-CA-C 109.408 -1.035 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.2 pt -75.85 125.61 35.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.481 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -127.18 130.0 71.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.877 -178.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.42 121.58 13.03 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -84.04 -174.12 5.1 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.349 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 6' ' ' LEU . 87.3 mt -59.86 -38.32 81.83 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -66.82 -23.37 66.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.353 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.42 -7.14 56.02 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -71.85 132.54 44.56 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.371 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.1 mtt -85.04 109.49 18.25 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.8 t -109.73 130.22 63.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.805 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -61.29 137.38 58.24 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.841 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -138.55 152.34 48.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.006 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.86 143.59 49.36 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.029 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mm -64.42 138.46 23.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.2 t -58.69 121.58 54.78 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.44 -35.21 64.85 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 120.87 1.047 . . . . 0.0 110.029 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -59.42 -43.65 93.03 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.0 m -62.01 -46.19 90.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.97 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.7 mt -57.96 -50.17 74.3 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.311 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.11 -40.59 90.2 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.571 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -63.24 -43.4 98.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.693 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -59.75 -50.39 74.0 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.531 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.5 t -62.4 -42.66 96.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.175 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.82 -43.19 90.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 22' ' ' ALA . 49.2 t -58.79 -44.41 90.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 76.1 t -64.79 -35.92 76.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.636 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -54.07 -46.94 72.14 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.515 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -91.09 -39.47 12.15 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.675 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -116.83 38.17 3.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.001 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.6 -54.37 3.24 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -175.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -97.06 -5.69 36.95 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -50.83 140.4 20.13 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.399 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.3 -32.46 41.53 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 122.432 2.088 . . . . 0.0 112.7 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -57.84 -18.9 25.16 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.002 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.47 -42.76 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.766 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.424 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 7.2 mt -45.96 -61.5 2.47 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.731 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 77.8 Cg_exo -54.39 -41.53 75.86 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 CA-C-N 120.115 1.077 . . . . 0.0 111.569 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.5 tpt -59.66 -46.88 87.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.36 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -54.64 -48.65 72.02 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.2 m -59.48 -41.52 89.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.677 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.84 -44.67 93.97 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.094 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.58 -18.52 59.72 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.427 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -95.66 26.35 4.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.224 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -78.49 125.89 30.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.061 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.42 11.4 71.84 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.926 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 52' ' ' LEU . . . -68.21 149.08 49.96 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.301 0.572 . . . . 0.0 112.036 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.2 m -99.55 142.74 25.16 Favored Pre-proline 0 C--O 1.218 -0.569 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.482 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -43.64 -38.69 9.39 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.328 1.352 . . . . 0.0 112.852 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -71.54 -63.72 1.06 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.9 m-20 -58.91 -38.58 79.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.988 0.899 . . . . 0.0 108.917 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.479 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . 56.0 tp -63.95 -49.31 73.07 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.597 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -57.74 -39.83 78.24 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 96.9 m -61.17 -41.93 97.65 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.799 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 41.9 ttp -59.32 -48.16 82.66 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.888 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.49 ' H ' HD12 ' A' ' 56' ' ' LEU . 6.6 mp -63.3 -41.93 98.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.095 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -59.07 -33.8 71.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.374 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.4 m -65.37 -32.94 74.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.238 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.5 t -58.96 142.85 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.525 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.07 -151.88 6.95 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.79 -128.27 40.19 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -53.47 -12.85 0.5 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.817 -0.192 . . . . 0.0 111.414 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -44.38 -21.54 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.54 -39.26 70.35 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.67 93.79 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.5 ttm -57.54 -21.59 39.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.777 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -56.38 -37.35 69.98 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.2 ttp -58.55 -45.92 87.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 tt -58.19 -39.9 80.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -56.84 -41.56 78.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.007 -1.077 . . . . 0.0 108.377 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.9 -40.18 94.68 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -59.74 -43.95 94.01 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.79 -43.03 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -60.76 -40.02 90.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.949 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.55 -43.57 98.48 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -61.67 -39.48 91.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.83 -42.87 99.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.693 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.2 84.4 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.393 0.616 . . . . 0.0 110.393 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.48 -39.78 95.36 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.606 ' O ' ' HD2' ' A' ' 85' ' ' PRO . 76.4 t-105 -58.53 -47.98 82.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.259 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -55.07 -41.0 70.97 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.82 -22.89 64.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.745 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.4 mt -101.01 -49.13 4.21 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.426 ' HB3' ' HD3' ' A' ' 85' ' ' PRO . 20.8 t60 -102.6 -62.56 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 119.668 -0.813 . . . . 0.0 112.777 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 68.4 Cg_exo -54.46 -20.86 21.89 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 CA-C-N 120.935 1.37 . . . . 0.0 109.841 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -50.94 -20.0 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.643 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -40.43 -68.51 0.17 Allowed 'General case' 0 C--N 1.347 0.457 0 O-C-N 123.37 0.419 . . . . 0.0 111.112 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -175.62 125.3 0.23 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.061 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.16 -52.11 55.21 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.64 146.06 38.15 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.569 1.513 . . . . 0.0 111.832 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.9 tt -156.28 153.24 7.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.789 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.7 152.56 96.19 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.811 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.04 162.49 42.48 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.483 2.122 . . . . 0.0 112.081 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.57 -4.39 69.36 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 121.108 -0.567 . . . . 0.0 111.783 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -118.16 141.52 48.4 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 116.883 0.341 . . . . 0.0 110.36 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.04 147.11 53.86 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.128 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -52.21 121.24 6.5 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -63.31 158.08 59.37 Favored Pre-proline 0 C--O 1.24 0.563 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.425 ' HB3' HD11 ' A' ' 104' ' ' ILE . 52.2 Cg_exo -50.01 136.8 36.94 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.584 1.522 . . . . 0.0 112.872 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.603 ' O ' HD12 ' A' ' 104' ' ' ILE . 43.7 ttm180 -134.67 139.11 45.01 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -43.22 -49.71 6.57 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.223 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -61.72 -41.21 97.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.325 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.87 -43.68 98.35 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.037 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.603 HD12 ' O ' ' A' ' 100' ' ' ARG . 1.5 mp -59.17 -41.5 83.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.4 -27.4 68.98 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.79 -7.89 80.59 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.3 p -60.13 -29.85 68.9 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.6 p -116.94 -7.69 11.36 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.981 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.1 t -99.28 129.15 45.48 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.205 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.7 m -72.85 146.29 46.33 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.5 tp -54.36 -47.44 72.6 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.375 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.4 -39.37 87.12 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.49 -40.62 97.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.199 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.2 -41.35 96.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.192 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 24.9 pt -63.77 -47.66 89.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 118.342 -1.343 . . . . 0.0 111.388 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.41 -41.67 66.66 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.416 ' CZ2' HG11 ' A' ' 126' ' ' VAL . 13.1 t90 -57.78 -45.03 86.59 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.8 ttt -71.86 -43.77 64.92 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.451 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.8 p -125.92 -23.62 3.93 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -57.44 -50.77 71.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 118.535 -1.266 . . . . 0.0 110.206 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -83.57 -178.12 1.12 Allowed Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.79 144.04 21.48 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 N-CA-C 107.785 -1.659 . . . . 0.0 107.785 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.54 126.8 10.84 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.43 1.42 . . . . 0.0 113.421 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.461 HG22 HG13 ' A' ' 126' ' ' VAL . 42.1 mm -114.24 108.07 50.79 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.24 55.68 4.15 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.834 1.689 . . . . 0.0 113.341 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.461 HG13 HG22 ' A' ' 124' ' ' ILE . 23.6 m -59.44 -42.47 87.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.454 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -62.67 -45.05 96.6 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.768 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.63 -43.9 97.64 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.153 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.58 -48.07 89.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.443 0.64 . . . . 0.0 110.071 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.741 ' CE2' HD11 ' A' ' 134' ' ' ILE . 78.4 t80 -59.48 -46.85 87.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.522 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -60.69 -39.37 88.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.392 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -59.13 -43.09 91.96 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.469 ' CH2' HG21 ' A' ' 104' ' ' ILE . 50.6 m0 -62.4 -43.66 98.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.186 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.741 HD11 ' CE2' ' A' ' 130' ' ' TYR . 84.7 mt -61.76 -45.52 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.035 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.19 -42.6 87.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.25 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.38 -43.05 99.74 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.6 98.46 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.43 -36.75 84.78 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -58.29 -44.03 88.33 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.69 -38.31 88.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.748 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.6 mm -60.84 -49.37 84.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.611 -0.436 . . . . 0.0 112.031 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.6 m -58.34 -35.9 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -65.16 -38.99 92.32 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.3 tmm? -60.41 -47.51 85.79 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.443 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -71.44 -15.2 62.33 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.202 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.9 t -48.11 115.16 3.85 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.717 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.66 -41.85 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.979 1.786 . . . . 0.0 113.801 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 43.1 p -140.83 170.17 16.26 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 39.9 t -90.84 148.19 22.68 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.98 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 tp -50.17 -34.35 10.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.8 tp -65.06 -39.42 93.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.724 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.7 -11.3 44.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.837 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.485 HD11 ' CB ' ' A' ' 171' ' ' THR . 88.2 mt -79.16 125.99 38.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.862 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -144.46 133.16 22.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.095 0.474 . . . . 0.0 111.016 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -66.86 105.5 1.62 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.634 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -69.64 159.91 53.09 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.977 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.814 ' HA ' ' HB2' ' A' ' 228' ' ' ALA . 68.9 Cg_exo -53.82 -37.69 85.03 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 123.026 2.484 . . . . 0.0 112.785 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -109.31 22.91 15.21 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -96.75 136.84 21.5 Favored Pre-proline 0 C--O 1.24 0.588 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.198 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.86 136.55 16.84 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.203 1.936 . . . . 0.0 112.873 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 165' ' ' VAL . 53.4 t80 -59.56 -34.74 73.06 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.406 ' N ' ' HA ' ' A' ' 224' ' ' PRO . 59.3 ttt85 -60.19 -52.45 65.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.111 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.52 -41.47 98.5 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.874 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -59.49 -50.09 75.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.634 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 161' ' ' PHE . 56.1 t -61.76 -46.66 96.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.13 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -58.47 -49.63 76.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.121 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.23 -41.58 99.12 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.581 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.455 ' HA ' HD13 ' A' ' 153' ' ' ILE . 85.8 t80 -56.53 -49.35 75.03 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.924 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.53 ' OH ' HD22 ' A' ' 211' ' ' LEU . 28.8 m-85 -67.29 -37.43 83.37 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.825 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -58.6 -49.96 75.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.696 0.76 . . . . 0.0 108.974 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.485 ' CB ' HD11 ' A' ' 153' ' ' ILE . 94.6 m -66.83 -37.35 84.32 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.88 178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 64.6 tp -59.28 -48.65 80.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.318 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -60.28 -45.56 92.91 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.81 77.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.236 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -54.11 164.46 0.63 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.725 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -60.66 -163.45 0.01 OUTLIER 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -109.4 110.29 21.39 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 118.866 -1.134 . . . . 0.0 113.271 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.445 ' HB3' ' HB ' ' A' ' 181' ' ' VAL . 66.3 m -101.22 133.48 45.73 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -87.33 -65.68 0.99 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 117.035 -1.866 . . . . 0.0 110.174 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -88.6 -40.76 13.11 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 178' ' ' SER . 24.9 t -52.3 -31.66 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.482 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 178' ' ' SER . 87.3 tttt -59.38 -46.8 87.65 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 119.444 -0.902 . . . . 0.0 108.683 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -64.54 -46.08 84.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.35 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -62.49 -51.12 68.69 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.25 0.548 . . . . 0.0 111.531 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 57.4 mtt -63.54 -45.33 91.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.7 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 73.0 m -60.65 -50.15 74.66 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.818 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.58 -49.4 76.8 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.187 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.5 m -64.41 -48.31 75.85 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.906 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.37 -37.85 88.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.992 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.596 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 14.2 mt -48.92 -47.88 43.08 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.467 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.1 m -86.18 -38.17 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.077 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.55 -50.12 72.59 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -74.79 -21.83 59.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.979 0.419 . . . . 0.0 111.347 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 190' ' ' LEU . . . -59.56 150.84 25.99 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.222 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.94 138.8 97.6 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 199' ' ' LYS . 78.1 Cg_exo -52.36 -50.06 15.29 Favored 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 122.354 2.036 . . . . 0.0 116.145 -176.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -63.32 -44.02 96.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.982 -176.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' CYS . . . . . 0.428 ' N ' ' HA ' ' A' ' 229' ' ' ARG . 37.0 t -67.96 -42.14 81.36 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 196' ' ' PRO . 87.6 tttt -52.11 -28.57 18.21 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.105 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 87.7 m -59.09 -48.59 81.05 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 0.8 OUTLIER -68.52 -43.93 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.865 178.172 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.46 HD11 ' SD ' ' A' ' 214' ' ' MET . 0.0 OUTLIER -50.6 -52.73 36.59 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.57 -39.82 95.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.923 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -55.17 -35.0 64.33 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.346 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.461 ' CD2' ' HB1' ' A' ' 209' ' ' ALA . 58.6 tp -58.73 -39.84 82.02 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 104.9 163.66 24.05 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.63 155.08 54.77 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.301 2.667 . . . . 0.0 113.321 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 71.81 15.19 75.84 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.461 ' HB1' ' CD2' ' A' ' 205' ' ' LEU . . . -72.31 138.1 47.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.035 0.445 . . . . 0.0 111.201 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 212' ' ' GLU . 88.7 m -62.61 139.29 58.63 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.53 HD22 ' OH ' ' A' ' 169' ' ' TYR . 67.6 tp -54.86 -44.22 73.8 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.442 ' H ' HG22 ' A' ' 210' ' ' THR . 88.6 tt0 -58.04 -46.52 85.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.03 -40.86 86.35 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.46 ' SD ' HD11 ' A' ' 202' ' ' LEU . 56.0 ttm -61.65 -50.02 74.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.124 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 63.8 tpp -62.1 -47.42 84.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.584 0.707 . . . . 0.0 110.171 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.5 m -61.56 -47.17 86.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.126 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.8 -46.35 90.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.987 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.68 -40.57 97.5 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -58.2 -38.33 76.55 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.862 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.67 -37.5 89.64 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 35.9 m -97.22 -4.71 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.5 14.23 57.29 Favored Glycine 0 CA--C 1.543 1.824 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.985 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.426 ' N ' ' CD ' ' A' ' 224' ' ' PRO . . . -59.35 -41.91 97.16 Favored Glycine 0 CA--C 1.553 2.437 0 CA-C-N 117.187 0.493 . . . . 0.0 112.742 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 223' ' ' GLY . 87.5 Cg_exo -50.59 -31.68 32.6 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.246 1.964 . . . . 0.0 111.647 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -78.01 158.91 46.87 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.917 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -56.5 108.94 0.54 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.2 tttt 172.8 143.31 0.04 OUTLIER 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.537 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.814 ' HB2' ' HA ' ' A' ' 157' ' ' PRO . . . -72.41 -16.41 61.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.37 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.428 ' HA ' ' N ' ' A' ' 198' ' ' CYS . 16.2 ptp180 -109.75 -178.27 3.49 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -177.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 4.0 m -52.21 -30.97 14.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 113.347 -1.752 . . . . 0.0 109.723 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.595 179.883 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.486 1.043 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.501 HG21 HG22 ' A' ' 115' ' ' ILE . 5.6 pt -57.42 108.26 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.342 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.01 133.54 19.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.18 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -60.97 136.42 58.08 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.38 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -98.38 -168.07 1.6 Allowed 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.657 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 6' ' ' LEU . 10.3 mp -58.67 -38.97 79.34 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -66.71 -23.32 66.1 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.237 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.4 -8.04 62.13 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.57 132.1 40.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 119' ' ' THR . 64.1 mtt -83.78 134.23 34.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.146 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.0 t -128.26 130.1 69.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.507 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.463 ' CD2' HD21 ' A' ' 111' ' ' LEU . 81.2 t60 -74.95 110.46 9.27 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.293 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -113.26 143.32 44.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.613 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.2 143.09 56.73 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.376 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.469 HD12 ' HG ' ' A' ' 20' ' ' LEU . 32.0 pt -60.57 144.57 13.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.721 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 m -62.76 122.76 76.38 Favored Pre-proline 0 N--CA 1.454 -0.26 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.877 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.58 -36.74 81.76 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 120.722 0.948 . . . . 0.0 109.738 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -56.75 -48.82 76.96 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.933 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.3 m -61.02 -46.94 88.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.042 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.469 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -48.9 -60.52 2.69 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.289 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -57.65 -38.79 75.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.821 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -61.77 -42.35 98.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.457 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -59.05 -51.06 71.66 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.829 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.7 t -63.18 -41.84 94.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.379 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.07 -43.68 91.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.372 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 22' ' ' ALA . 50.7 t -59.02 -44.98 92.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 60.7 t -62.45 -37.0 77.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.94 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -54.31 -46.72 72.89 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.528 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -89.42 -30.7 18.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' O ' HG21 ' A' ' 36' ' ' VAL . 98.9 mttt -130.91 38.44 3.69 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.871 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.51 -51.26 5.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -96.02 -4.65 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 67.2 m -54.97 147.22 34.36 Favored Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 118.866 0.757 . . . . 0.0 111.772 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.72 -34.71 10.98 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 122.663 2.242 . . . . 0.0 112.831 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.64 -19.36 25.85 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.904 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 30' ' ' LYS . 53.9 t -64.2 -41.77 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.608 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.427 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 7.1 mt -46.54 -61.31 2.76 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.279 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 78.4 Cg_exo -54.74 -40.61 83.86 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 CA-C-N 120.111 1.075 . . . . 0.0 111.557 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.0 tpt -59.0 -48.13 82.71 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.25 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -56.0 -46.77 78.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m -57.72 -44.2 85.79 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.858 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.27 99.17 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.462 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.91 -26.5 64.19 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.926 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.4 p -87.44 1.18 54.16 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -54.56 126.16 22.59 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.734 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.12 10.95 78.93 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.597 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.33 149.23 46.29 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.327 0.585 . . . . 0.0 112.564 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.7 m -99.96 141.7 23.25 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.135 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -41.74 -38.68 4.62 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.436 1.424 . . . . 0.0 113.056 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -71.05 -64.12 0.97 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.196 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.5 m-20 -59.18 -37.61 77.79 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.327 1.06 . . . . 0.0 108.503 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.08 -47.89 82.65 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.826 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -58.12 -39.27 78.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 58' ' ' THR . 91.6 m -60.65 -39.93 90.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.404 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 97.8 mtp -57.39 -48.08 80.01 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.654 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.521 HD11 HD13 ' A' ' 134' ' ' ILE . 88.1 mt -65.09 -40.62 94.86 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.799 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -60.54 -39.33 87.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.515 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 54' ' ' THR . 58.6 p -67.45 -19.04 65.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.896 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.2 t -61.18 152.97 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.587 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.54 -153.09 5.92 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.99 -128.16 46.85 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 120.363 -0.923 . . . . 0.0 111.018 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -51.93 -10.29 0.11 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.846 -0.677 . . . . 0.0 112.113 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -42.95 -21.7 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.14 66.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.6 96.29 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.6 tpp -57.09 -22.12 37.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.03 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -58.42 -38.11 76.75 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -58.85 -42.91 90.44 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.61 -40.86 76.07 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.498 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -58.18 -41.33 83.65 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.736 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.92 -40.4 95.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.499 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.5 m -59.61 -46.43 88.99 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.38 -41.06 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.305 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -60.33 -42.17 95.07 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.902 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.69 -46.03 90.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.996 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 133' ' ' TRP . 81.2 mm-40 -61.43 -38.54 87.51 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.68 90.93 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.54 66.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.891 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.46 -43.75 96.47 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.015 0.912 . . . . 0.0 108.854 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.648 ' CZ2' HD13 ' A' ' 104' ' ' ILE . 83.4 t90 -60.5 -39.82 89.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.613 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -54.32 -41.0 68.5 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -69.55 -20.56 63.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.832 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.95 -48.09 4.36 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.419 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . 7.1 m80 -95.14 -67.14 0.08 OUTLIER Pre-proline 0 C--O 1.223 -0.34 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.676 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 85.6 Cg_exo -51.17 -37.46 58.75 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 CA-C-N 121.626 1.617 . . . . 0.0 111.687 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 t -79.9 -12.17 13.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -42.63 -31.72 0.49 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.557 0.218 . . . . 0.0 110.45 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.1 4.82 0.55 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.082 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.7 -127.1 39.61 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.37 145.13 98.82 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 CA-C-N 119.352 1.576 . . . . 0.0 110.627 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.2 tp -126.94 149.65 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.99 155.0 85.2 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.79 167.35 27.46 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 123.028 2.485 . . . . 0.0 112.837 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.9 -10.17 60.34 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -125.25 154.43 41.67 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 122.602 -0.352 . . . . 0.0 110.774 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 62.0 mtt -61.77 146.38 49.61 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.18 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -51.37 116.41 2.05 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.337 0.589 . . . . 0.0 109.47 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.83 154.36 67.68 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.777 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.15 126.29 6.23 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.661 1.574 . . . . 0.0 113.118 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.564 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 1.1 mpt_? -115.55 151.32 35.1 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 113.773 -1.558 . . . . 0.0 107.774 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.549 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -49.35 -54.29 16.57 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.3 p -63.65 -33.94 76.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.875 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.564 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 82.9 m-20 -63.08 -39.86 95.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.857 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.648 HD13 ' CZ2' ' A' ' 80' ' ' TRP . 4.5 tp -56.8 -31.92 36.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.72 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.1 -27.8 61.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.204 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.88 -8.2 80.22 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 108.441 -1.863 . . . . 0.0 108.441 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 71.4 p -62.31 -19.24 63.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.0 p -122.96 10.57 9.5 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.003 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.1 m -114.81 130.77 56.92 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.271 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 m -73.0 151.14 41.9 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.463 HD21 ' CD2' ' A' ' 12' ' ' HIS . 68.3 tp -54.54 -46.03 73.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -61.01 -40.63 94.29 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -61.87 -45.85 91.98 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.277 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -62.29 -41.94 98.93 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.142 0.276 . . . . 0.0 111.38 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.501 HG22 HG21 ' A' ' 2' ' ' ILE . 47.1 pt -65.84 -43.26 93.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.931 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 120' ' ' HIS . . . -71.52 -41.05 58.63 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -58.56 -45.9 88.01 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.247 -0.976 . . . . 0.0 108.717 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.473 ' SD ' HD11 ' A' ' 2' ' ' ILE . 27.7 ttt -72.98 -41.1 64.71 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.377 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.529 HG21 ' SD ' ' A' ' 10' ' ' MET . 72.2 p -125.96 -24.26 3.8 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.406 ' HB2' ' HA2' ' A' ' 116' ' ' GLY . 50.3 t-80 -53.54 -64.78 0.71 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.93 1.241 . . . . 0.0 110.54 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -77.14 -177.4 0.78 Allowed Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.54 137.41 25.87 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 N-CA-C 108.276 -1.471 . . . . 0.0 108.276 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.59 127.31 3.32 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.627 2.218 . . . . 0.0 114.415 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.406 HG22 HG13 ' A' ' 126' ' ' VAL . 46.7 mm -113.34 108.26 52.65 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.99 57.31 4.52 Favored 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.309 2.006 . . . . 0.0 113.725 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 127' ' ' GLY . 19.3 m -59.48 -46.09 93.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-O 121.145 0.497 . . . . 0.0 109.975 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -62.92 -42.86 99.59 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.089 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.42 -45.24 95.13 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.339 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 mm -63.77 -48.63 85.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-O 121.318 0.58 . . . . 0.0 110.415 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.726 ' CE2' HD11 ' A' ' 134' ' ' ILE . 83.0 t80 -58.49 -49.45 77.32 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.142 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.495 ' HA ' HD12 ' A' ' 134' ' ' ILE . 38.0 ttpt -62.41 -39.24 92.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.402 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -56.58 -43.34 79.93 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.603 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 45.0 m0 -62.73 -43.45 98.78 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.293 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.726 HD11 ' CE2' ' A' ' 130' ' ' TYR . 82.2 mt -58.25 -44.05 87.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.809 -178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.7 mt -59.23 -41.97 85.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.308 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.82 -42.63 99.8 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.57 98.42 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.55 -35.68 81.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -58.01 -45.35 87.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.55 -39.19 93.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.684 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.5 mm -60.55 -49.74 83.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.168 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.2 m -58.74 -36.0 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -64.73 -39.52 93.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 60.8 ttm -60.08 -47.27 86.59 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -68.82 -22.08 64.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.062 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 p -43.09 114.84 1.65 Allowed Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.357 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.25 -41.79 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.93 1.753 . . . . 0.0 113.943 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.9 p -138.53 167.56 21.67 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 40.1 t -87.4 146.92 25.67 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.308 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.465 HD11 ' CE1' ' A' ' 168' ' ' PHE . 9.8 tp -52.66 -35.55 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.35 -38.61 90.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.029 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -64.57 -27.44 68.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.263 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.479 HD13 HG21 ' A' ' 171' ' ' THR . 1.3 mp -64.82 121.31 13.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.364 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 85.9 mtp180 -142.56 132.38 24.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.754 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -94.28 131.37 39.96 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.647 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -95.6 157.43 21.82 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.97 -42.83 56.23 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.749 1.632 . . . . 0.0 111.508 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -73.74 -18.96 60.92 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.611 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.65 131.95 59.49 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.282 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.59 136.89 52.15 Favored 'Trans proline' 0 N--CA 1.508 2.33 0 C-N-CA 122.626 2.217 . . . . 0.0 114.223 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.403 ' CE2' HG21 ' A' ' 165' ' ' VAL . 72.4 t80 -60.38 -38.52 84.17 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.439 ' N ' ' HA ' ' A' ' 224' ' ' PRO . 79.8 ttt180 -60.19 -50.12 74.92 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.674 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -61.48 -39.5 91.16 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.146 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -60.29 -50.61 72.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.753 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.403 HG21 ' CE2' ' A' ' 161' ' ' PHE . 55.8 t -62.62 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.501 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -58.32 -51.23 70.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.345 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.27 -38.91 91.73 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.498 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.465 ' CE1' HD11 ' A' ' 150' ' ' ILE . 83.9 t80 -57.8 -48.69 78.98 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -67.87 -38.8 83.54 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.235 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -58.71 -47.49 84.39 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.479 HG21 HD13 ' A' ' 153' ' ' ILE . 98.2 m -64.94 -38.38 90.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.85 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.423 HD21 ' HE2' ' A' ' 182' ' ' LYS . 63.8 tp -59.48 -47.8 84.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.716 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -59.95 -44.29 94.49 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.71 79.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.051 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -53.02 158.74 1.36 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.171 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -62.87 -162.4 0.01 OUTLIER 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -104.38 110.35 22.57 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 118.804 -1.159 . . . . 0.0 112.802 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 70.7 m -100.01 132.84 45.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -87.88 -66.66 0.89 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 116.984 -1.886 . . . . 0.0 110.186 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -88.77 -40.04 13.49 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 178' ' ' SER . 37.1 t -52.47 -29.35 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.052 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 178' ' ' SER . 63.1 tttm -58.9 -47.02 86.46 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.229 -0.989 . . . . 0.0 108.523 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -68.92 -41.48 78.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.215 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -65.42 -50.68 64.52 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.159 0.504 . . . . 0.0 111.227 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 54.8 mtt -63.1 -47.22 83.75 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.547 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 86.5 m -60.45 -48.81 80.16 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.478 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.04 -49.22 78.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.996 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 74.8 p -70.66 -44.81 66.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.148 0.499 . . . . 0.0 111.493 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.34 -36.41 84.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.975 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.44 HD21 ' SD ' ' A' ' 214' ' ' MET . 65.0 tp -46.86 -51.52 16.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.651 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.06 -40.39 13.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.166 0.508 . . . . 0.0 111.859 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.8 -48.2 82.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -86.8 -1.57 57.88 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.541 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.74 158.87 33.83 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.814 0.34 . . . . 0.0 111.677 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ASN . . . . . 0.485 ' OD1' ' HB1' ' A' ' 228' ' ' ALA . 24.7 p30 -69.85 152.77 95.92 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.147 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 199' ' ' LYS . 20.8 Cg_endo -60.81 -43.37 31.85 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 122.751 2.301 . . . . 0.0 115.993 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.561 ' HB2' ' HB3' ' A' ' 228' ' ' ALA . 99.1 m-20 -60.2 -45.27 93.74 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.871 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 41.1 t -71.88 -40.07 69.18 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 196' ' ' PRO . 88.0 tttt -49.83 -34.32 19.4 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.888 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.2 m -58.87 -49.97 75.78 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.606 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 46.6 mm -66.4 -46.3 87.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.654 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 202' ' ' LEU . 1.0 OUTLIER -55.08 -50.72 68.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.203 1.001 . . . . 0.0 108.609 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.38 -37.03 79.46 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.385 -1.279 . . . . 0.0 107.777 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -58.2 -40.01 80.49 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.176 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 205' ' ' LEU . 88.9 mt -61.97 -36.72 82.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.74 -164.9 41.6 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.82 171.93 11.45 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.188 2.592 . . . . 0.0 112.463 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.63 -130.35 48.14 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.562 ' HB3' ' HE2' ' A' ' 214' ' ' MET . . . 59.88 109.8 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.274 0.559 . . . . 0.0 110.435 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.1 p -62.49 158.4 17.96 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.289 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 65.9 tp -56.77 -38.44 72.47 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -57.19 -49.25 76.55 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -59.96 -42.4 93.99 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 119.626 -0.83 . . . . 0.0 108.966 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.562 ' HE2' ' HB3' ' A' ' 209' ' ' ALA . 60.9 mtt -62.43 -45.73 91.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.199 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 25.9 ttt -65.84 -44.93 84.03 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.24 0.543 . . . . 0.0 110.355 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.2 m -62.78 -47.63 82.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.53 0.681 . . . . 0.0 110.201 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.89 -44.19 97.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.326 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 92.6 m -61.54 -39.43 91.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -58.11 -38.55 76.68 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.088 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.79 -39.11 93.34 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.1 m -92.65 3.42 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.609 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 75.19 17.11 80.27 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.661 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 224' ' ' PRO . . . -57.97 -44.48 94.5 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-O 119.515 -0.603 . . . . 0.0 111.808 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.439 ' HA ' ' N ' ' A' ' 162' ' ' ARG . 99.2 Cg_exo -47.76 -38.35 29.62 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.179 1.919 . . . . 0.0 110.64 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -80.22 169.52 52.86 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.989 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -46.4 -26.82 0.91 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.765 -0.218 . . . . 0.0 111.551 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.27 121.19 21.81 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 197' ' ' ASP . . . -88.49 30.09 0.93 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.422 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 176.31 174.33 0.35 Allowed 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 8.0 p -50.35 -27.86 4.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 231' ' ' LEU . 11.6 tp . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.039 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.423 ' O ' HG23 ' A' ' 3' ' ' VAL . 1.9 Cg_endo . . . . . 0 N--CA 1.486 1.047 0 N-CA-C 108.949 -1.212 . . . . 0.0 108.949 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.527 HD11 ' SD ' ' A' ' 118' ' ' MET . 11.9 pt -54.9 109.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.504 0.668 . . . . 0.0 110.837 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 1' ' ' PRO . 93.5 t -132.44 126.84 55.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.345 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -65.33 121.5 14.96 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -74.0 -170.07 0.86 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.182 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.85 -39.41 85.08 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.35 -23.41 66.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.365 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.61 -7.78 57.99 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -71.79 125.65 27.7 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.421 ' SD ' HG21 ' A' ' 119' ' ' THR . 66.7 mtt -75.71 133.69 40.7 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.312 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.4 t -127.98 129.91 69.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.804 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.45 ' CE1' ' OD2' ' A' ' 51' ' ' ASP . 53.6 t-80 -78.14 109.87 12.61 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.04 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -107.71 157.09 18.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.11 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.63 150.08 38.07 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.051 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.7 pt -65.51 143.02 16.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 120.966 0.412 . . . . 0.0 110.435 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.0 t -62.14 120.3 56.78 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.53 -36.07 69.16 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 120.763 0.976 . . . . 0.0 110.104 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -58.85 -48.28 81.91 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.723 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.7 p -66.64 -39.03 88.07 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.035 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.9 tp -59.0 -50.09 75.44 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.072 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -59.16 -41.81 89.28 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.405 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.518 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -62.13 -42.1 98.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.588 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.1 t-105 -58.16 -48.73 79.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.44 -44.3 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.336 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.84 -40.02 83.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.255 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.527 HG21 ' CE ' ' A' ' 39' ' ' MET . 53.8 t -58.08 -45.19 88.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 54.3 t -64.48 -37.72 80.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.126 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -53.94 -46.94 71.7 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.641 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -89.53 -39.24 13.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.442 ' O ' HG21 ' A' ' 36' ' ' VAL . 99.6 mttt -120.65 38.23 4.08 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.78 -54.19 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -95.76 -5.74 41.29 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -53.94 140.23 51.45 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 118.561 0.618 . . . . 0.0 111.571 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.82 -29.68 34.83 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 122.563 2.175 . . . . 0.0 113.275 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -59.32 -21.69 60.13 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.542 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 30' ' ' LYS . 53.8 t -62.73 -43.35 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.131 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.43 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 8.7 mt -45.09 -61.19 2.44 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.844 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 73.9 Cg_exo -53.43 -42.25 66.97 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 120.072 1.062 . . . . 0.0 111.803 176.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.527 ' CE ' HG21 ' A' ' 26' ' ' VAL . 24.2 ttt -61.53 -44.14 97.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.726 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.423 ' CE2' HG21 ' A' ' 134' ' ' ILE . 62.9 t80 -54.82 -47.74 73.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -58.79 -43.54 90.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.809 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.85 -46.23 89.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.379 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.67 -26.11 64.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.254 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.0 m -88.14 6.7 35.25 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.483 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -62.65 125.1 22.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.617 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.66 10.67 83.08 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.961 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.1 150.74 35.62 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.12 0.486 . . . . 0.0 112.221 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.1 p -98.91 148.75 34.99 Favored Pre-proline 0 C--O 1.216 -0.677 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.694 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -45.08 -36.63 11.94 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 121.577 1.518 . . . . 0.0 112.923 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -69.74 -64.55 0.86 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.792 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.504 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -59.69 -37.37 78.63 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 122.378 1.085 . . . . 0.0 108.565 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 52' ' ' LEU . 56.2 tp -61.78 -46.81 87.97 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.243 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -59.19 -38.59 80.2 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 84.9 m -60.38 -40.12 89.74 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.045 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.72 -48.4 81.27 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.046 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.84 -41.46 95.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.229 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.49 -37.74 84.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.14 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.3 m -65.22 -34.81 79.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.327 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.5 t -55.34 151.3 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.44 -144.51 4.49 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.69 -127.65 45.74 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 119.926 -1.131 . . . . 0.0 110.545 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.473 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 22.3 p80 -54.26 -11.12 0.45 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.636 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -43.57 -24.36 0.11 Allowed 'General case' 0 C--O 1.234 0.286 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.33 -44.09 68.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.58 97.86 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.781 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 58.0 ttm -56.14 -22.39 28.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.397 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -57.04 -35.06 68.86 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 63.3 ttp -56.71 -46.9 80.99 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 tt -58.38 -38.31 77.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -55.68 -42.58 75.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.73 -40.19 88.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.699 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.656 HG22 ' OE2' ' A' ' 76' ' ' GLU . 99.9 m -57.75 -45.59 85.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.99 -41.57 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.093 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -59.96 -41.82 92.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.399 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.34 -47.3 86.52 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.235 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.656 ' OE2' HG22 ' A' ' 72' ' ' THR . 1.3 mp0 -62.74 -37.24 85.82 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.428 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.44 -42.38 91.81 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.223 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.91 -51.58 57.44 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.88 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.53 -43.23 94.67 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.592 0.71 . . . . 0.0 110.203 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.594 ' CZ2' HD13 ' A' ' 104' ' ' ILE . 66.7 t90 -60.77 -50.52 73.14 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.955 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -58.42 -37.68 75.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.621 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 80.1 ttt180 -63.14 -43.68 97.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.096 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 84.2 mt -111.5 -36.42 5.52 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -176.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.17 -58.06 15.67 Favored Pre-proline 0 N--CA 1.47 0.556 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -176.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -52.78 157.42 7.7 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 120.994 1.129 . . . . 0.0 110.983 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.6 t -44.98 145.77 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.251 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.554 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 38.1 m80 53.85 36.47 24.19 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 82' ' ' ARG . . . 77.31 -55.34 0.54 Allowed 'General case' 0 C--O 1.241 0.608 0 O-C-N 124.026 0.829 . . . . 0.0 108.976 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.67 -66.9 0.06 OUTLIER Glycine 0 CA--C 1.54 1.615 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.86 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.23 140.17 26.36 Favored 'Trans proline' 0 N--CA 1.512 2.592 0 C-N-CA 123.813 3.009 . . . . 0.0 114.617 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 98' ' ' GLU . 78.6 mt -117.74 129.66 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 114.431 -1.258 . . . . 0.0 110.148 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.52 140.28 84.44 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.348 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.95 163.83 29.59 Favored 'Trans proline' 0 N--CA 1.514 2.698 0 C-N-CA 122.953 2.436 . . . . 0.0 114.268 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 93.09 5.47 63.96 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.768 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -126.75 167.79 15.28 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.948 0.374 . . . . 0.0 111.267 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 66.2 mtt -69.3 154.35 42.18 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.205 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -51.76 112.15 0.72 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.591 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.539 ' HB2' HD13 ' A' ' 91' ' ' ILE . 80.9 mm-40 -88.9 155.35 50.06 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.468 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -39.99 103.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.136 0 C-N-CA 122.477 2.118 . . . . 0.0 114.386 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.413 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 69.4 ttt180 -99.05 158.45 15.65 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.571 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -54.99 -52.7 44.99 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.772 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.445 ' HB3' HG23 ' A' ' 108' ' ' THR . 66.8 m -63.46 -36.63 84.38 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 117.553 0.676 . . . . 0.0 109.701 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 94.8 m-20 -59.31 -38.75 81.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.022 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.594 HD13 ' CZ2' ' A' ' 80' ' ' TRP . 4.4 tp -58.23 -30.82 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 119.487 -0.885 . . . . 0.0 108.938 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.28 -20.53 37.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.158 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.97 -0.97 89.44 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.2 p -63.95 -25.89 68.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.445 HG23 ' HB3' ' A' ' 102' ' ' SER . 20.5 p -117.13 4.46 12.7 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.146 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 t -110.75 130.26 55.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.532 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.6 p -74.82 164.37 26.64 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.5 tp -59.38 -46.66 88.03 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.48 -41.78 94.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 117' ' ' TRP . 54.2 tp10 -61.51 -46.34 90.39 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.882 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -61.66 -43.21 99.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.398 0.436 . . . . 0.0 111.289 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.8 tt -66.03 -44.07 92.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.048 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.76 -42.37 79.66 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.416 ' CB ' ' O ' ' A' ' 113' ' ' GLU . 12.4 t90 -58.49 -45.77 88.04 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.165 -1.018 . . . . 0.0 109.275 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.527 ' SD ' HD11 ' A' ' 2' ' ' ILE . 27.9 ttt -72.5 -41.91 65.44 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.582 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.421 HG21 ' SD ' ' A' ' 10' ' ' MET . 66.6 p -125.32 -24.85 3.88 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -58.81 -49.06 79.09 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 118.317 -1.353 . . . . 0.0 109.324 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.18 179.52 1.86 Allowed Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.91 135.5 36.11 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -35.84 114.74 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.866 2.378 . . . . 0.0 113.5 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mm -106.88 109.04 62.89 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 72.8 Cg_endo -75.47 57.75 4.96 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.951 1.767 . . . . 0.0 112.872 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 127' ' ' GLY . 28.4 m -58.78 -43.28 87.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -64.09 -42.49 98.09 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.442 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 125' ' ' PRO . 88.8 tt0 -63.21 -45.15 93.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.322 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 89.0 mt -63.47 -49.47 82.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.05 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.661 ' CE2' HD11 ' A' ' 134' ' ' ILE . 86.8 t80 -59.3 -48.2 82.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.219 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.426 ' HA ' HD12 ' A' ' 134' ' ' ILE . 40.6 ttmt -61.17 -40.43 93.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.687 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -57.41 -43.08 83.44 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.589 ' CH2' HG21 ' A' ' 104' ' ' ILE . 46.3 m0 -60.8 -44.63 96.59 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.04 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.661 HD11 ' CE2' ' A' ' 130' ' ' TYR . 84.7 mt -58.52 -43.86 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.286 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.99 -41.69 87.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.759 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.63 -45.49 86.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.308 0.575 . . . . 0.0 110.044 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.74 -43.1 98.15 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.16 -36.79 84.81 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -58.67 -45.28 89.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.81 -39.69 94.85 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.494 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.1 mm -61.1 -49.97 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.9 m -58.09 -36.81 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.2 ttm105 -65.51 -38.67 90.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.803 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -60.58 -46.36 90.53 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -67.78 -25.49 65.63 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.73 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.3 t -43.78 111.93 1.22 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.972 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.74 -21.43 7.12 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.96 1.773 . . . . 0.0 113.761 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 70.8 p -138.18 167.57 21.56 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.1 m -107.18 149.47 27.67 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.949 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.534 ' HA ' HD12 ' A' ' 153' ' ' ILE . 5.1 tp -48.98 -36.54 8.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.589 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.1 tp -66.76 -39.62 87.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.43 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.61 -12.37 57.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.609 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 150' ' ' ILE . 90.1 mt -79.45 123.33 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.411 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -152.5 154.95 36.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.077 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -81.95 119.79 24.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.321 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -74.13 160.92 53.59 Favored Glycine 0 CA--C 1.54 1.605 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.539 ' O ' ' HB2' ' A' ' 228' ' ' ALA . 72.7 Cg_exo -51.92 -38.0 67.84 Favored 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 123.181 2.588 . . . . 0.0 112.844 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -112.68 20.67 16.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.043 0.449 . . . . 0.0 109.801 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -82.65 115.41 58.17 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.398 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 225' ' ' GLY . 29.8 Cg_exo -62.36 143.09 93.15 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.15 1.9 . . . . 0.0 111.218 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -57.44 -33.47 67.96 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.484 ' N ' ' HA ' ' A' ' 224' ' ' PRO . 58.9 ttp180 -61.32 -45.91 92.49 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -60.29 -45.35 93.67 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.74 -50.57 71.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.341 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.7 -46.75 95.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.421 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -61.57 -51.97 66.36 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.203 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -63.05 -43.69 97.94 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.048 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.572 ' CE2' HG23 ' A' ' 186' ' ' THR . 85.5 t80 -58.55 -48.11 81.97 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.559 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -63.36 -37.33 86.87 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.625 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -59.42 -48.67 80.77 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.534 ' CB ' HD11 ' A' ' 153' ' ' ILE . 95.4 m -66.28 -39.5 89.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.442 HD12 ' CE2' ' A' ' 168' ' ' PHE . 7.7 tt -55.89 -37.81 69.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.137 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.9 ttt-85 -64.64 -38.36 90.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.049 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.74 -10.71 57.93 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.115 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -49.37 168.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.816 0.817 . . . . 0.0 112.433 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -98.75 -92.84 0.26 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.407 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.419 ' HB1' ' HB ' ' A' ' 181' ' ' VAL . . . -44.3 146.53 0.66 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.75 0.786 . . . . 0.0 112.042 -177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 70.3 m -65.76 169.23 6.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.525 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -47.33 -23.56 0.6 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.801 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.82 -46.93 81.35 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 118.578 -1.249 . . . . 0.0 107.906 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.419 ' HB ' ' HB1' ' A' ' 177' ' ' ALA . 25.3 t -89.82 -51.61 11.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 122.017 0.913 . . . . 0.0 110.19 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -57.42 -46.37 83.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.427 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -60.88 -41.7 96.49 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.279 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -60.98 -45.9 92.92 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.828 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 61.9 mtt -61.98 -41.6 98.21 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.204 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.572 HG23 ' CE2' ' A' ' 168' ' ' PHE . 61.1 m -60.0 -43.5 95.14 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.855 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -57.92 -48.33 80.2 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.694 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 77.5 p -72.08 -43.55 64.65 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.833 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.2 mp -66.93 -31.29 71.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.344 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.411 HD21 ' SD ' ' A' ' 214' ' ' MET . 68.3 tp -51.82 -49.28 63.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.08 -45.18 18.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.89 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -59.11 -48.84 80.14 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -70.12 -24.93 63.27 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.66 145.27 54.97 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.556 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ASN . . . . . 0.439 ' CG ' ' HB1' ' A' ' 228' ' ' ALA . 0.8 OUTLIER -59.48 143.53 85.78 Favored Pre-proline 0 C--N 1.346 0.447 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.487 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.46 -44.33 47.83 Favored 'Trans proline' 0 N--CA 1.504 2.131 0 C-N-CA 122.786 2.324 . . . . 0.0 115.477 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.38 -46.41 90.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 118.766 -1.173 . . . . 0.0 110.437 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 42.5 t -66.16 -43.13 87.84 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -49.62 -27.27 4.38 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.74 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 91.1 m -59.65 -49.35 78.09 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.602 -0.839 . . . . 0.0 108.778 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 4.5 tp -77.3 -38.37 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.746 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.425 HD22 ' SG ' ' A' ' 218' ' ' CYS . 0.1 OUTLIER -54.42 -44.11 72.12 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.03 -38.08 89.7 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.732 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -55.47 -37.69 68.12 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.966 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.31 -35.32 67.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.75 171.33 44.08 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.668 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.06 146.95 97.03 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 123.49 2.794 . . . . 0.0 113.357 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.16 1.28 87.78 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.43 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.749 ' HB3' ' CE ' ' A' ' 214' ' ' MET . . . -64.62 136.02 56.55 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.259 0.552 . . . . 0.0 111.695 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 212' ' ' GLU . 90.4 m -68.83 139.29 55.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.0 tp -57.03 -44.12 82.59 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.246 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.444 ' H ' HG22 ' A' ' 210' ' ' THR . 88.7 tt0 -58.2 -45.38 87.69 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -58.69 -42.3 88.23 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.749 ' CE ' ' HB3' ' A' ' 209' ' ' ALA . 60.5 mtt -63.51 -43.84 96.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.944 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 60.3 ttm -62.16 -50.11 73.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.52 0.676 . . . . 0.0 110.162 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.2 m -64.75 -45.43 86.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.064 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.05 79.12 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.109 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.425 ' SG ' HD22 ' A' ' 202' ' ' LEU . 97.8 m -64.69 -36.68 85.07 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLN . . . . . 0.4 ' HA ' ' H ' ' A' ' 223' ' ' GLY . 63.4 tt0 -59.6 -36.76 76.91 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.986 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.73 -42.15 91.03 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.21 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.56 -18.27 6.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 117.179 0.489 . . . . 0.0 111.325 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 128.39 88.03 0.56 Allowed Glycine 0 CA--C 1.528 0.886 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.4 ' H ' ' HA ' ' A' ' 219' ' ' GLN . . . -112.03 -81.36 1.13 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.484 ' HA ' ' N ' ' A' ' 162' ' ' ARG . 96.9 Cg_exo -46.23 -29.25 6.46 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.376 2.05 . . . . 0.0 110.003 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 160' ' ' PRO . . . -99.56 -135.12 8.78 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 1.6 p80 60.07 170.92 0.08 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.472 0.653 . . . . 0.0 111.724 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -90.57 -67.51 0.84 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.139 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 157' ' ' PRO . . . -152.59 16.7 0.6 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.836 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -135.15 158.15 45.08 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.434 0.635 . . . . 0.0 111.873 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 2.9 p -49.22 -26.84 2.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.218 -0.555 0 CA-C-O 117.946 -1.025 . . . . 0.0 111.055 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo . . . . . 0 N--CA 1.482 0.794 0 N-CA-C 109.13 -1.142 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.456 HD11 ' SD ' ' A' ' 118' ' ' MET . 14.1 pt -65.42 113.78 2.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 109.891 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.0 t -126.27 126.71 69.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.187 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -63.58 127.57 31.95 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -83.96 -172.69 4.3 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.52 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.85 -38.04 80.99 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -66.71 -22.9 66.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.131 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.69 -7.96 57.95 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -73.21 126.35 29.86 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.985 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.2 mtt -81.56 135.22 35.58 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.005 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.5 m -133.1 134.1 58.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.518 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.414 ' NE2' HD11 ' A' ' 111' ' ' LEU . 62.2 t-80 -57.27 142.23 43.94 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.008 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -144.63 144.21 31.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.746 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.17 143.07 50.65 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.466 HD12 ' HG ' ' A' ' 20' ' ' LEU . 38.6 pt -61.87 142.42 16.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -61.07 118.68 38.23 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.23 -36.7 78.73 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 N-CA-C 109.734 -0.91 . . . . 0.0 109.734 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -58.44 -48.27 81.25 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.149 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.6 m -61.05 -46.18 91.73 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -48.96 -58.36 5.01 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.843 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -58.35 -39.19 78.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.843 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -61.6 -42.4 98.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.511 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -58.74 -50.68 73.02 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.546 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.3 t -62.74 -42.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.492 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.99 -42.89 91.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.371 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 22' ' ' ALA . 50.8 t -58.74 -44.32 89.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 76.9 t -64.29 -35.95 75.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.772 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -53.7 -46.71 70.83 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.679 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -92.28 -35.14 13.93 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.698 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' O ' HG21 ' A' ' 36' ' ' VAL . 98.9 mttt -121.22 37.84 4.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.778 -176.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.14 -53.62 3.94 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -96.96 -5.93 36.72 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -51.7 138.87 31.31 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.224 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.91 -31.89 46.4 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.392 2.061 . . . . 0.0 112.709 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.04 -18.75 26.44 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.935 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 30' ' ' LYS . 54.1 t -64.82 -42.48 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.925 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.426 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 6.9 mt -44.86 -60.67 2.84 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.814 -177.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.426 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 76.9 Cg_exo -53.95 -42.4 67.06 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 CA-C-N 119.985 1.03 . . . . 0.0 111.857 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.1 mtp -61.17 -43.41 98.93 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.672 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -56.03 -47.77 77.22 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.9 t -58.6 -44.69 89.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.042 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.77 -44.77 93.71 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.518 0.675 . . . . 0.0 110.114 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.72 -25.12 63.7 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.022 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.4 m -87.04 6.4 32.67 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.612 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.84 125.33 23.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.562 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.41 11.22 76.12 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 116.35 -0.387 . . . . 0.0 112.605 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.52 149.57 40.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.7 p -99.99 148.93 35.5 Favored Pre-proline 0 C--O 1.215 -0.722 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.622 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -45.81 -38.2 17.43 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.543 1.495 . . . . 0.0 113.323 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -70.37 -62.78 1.26 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.649 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.502 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -58.15 -36.73 73.43 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 52' ' ' LEU . 56.1 tp -62.12 -45.36 93.8 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -57.91 -37.86 74.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 84.8 m -59.47 -41.86 90.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.652 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.9 mtt -49.69 -50.08 45.04 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.274 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.09 -42.75 68.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.798 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -60.68 -40.72 93.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.799 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.413 HG23 HG22 ' A' ' 54' ' ' THR . 54.3 p -68.73 -26.53 65.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.89 158.54 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.87 -149.72 5.08 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.43 -127.54 45.43 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -51.21 -10.55 0.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.044 -0.578 . . . . 0.0 112.171 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -41.8 -24.34 0.04 OUTLIER 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.68 -42.97 75.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.91 94.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -56.92 -28.04 61.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.471 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -56.38 -35.41 67.69 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.8 ttp -58.07 -44.99 87.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.22 -40.71 86.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -54.26 -41.57 68.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.75 -41.53 95.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.7 m -59.28 -42.62 91.67 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.498 HD11 HG12 ' A' ' 134' ' ' ILE . 15.9 mm -60.01 -44.16 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -60.63 -41.87 95.77 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.194 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.71 -45.94 91.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.448 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.26 -39.25 94.07 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.23 -41.59 97.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.072 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.4 -50.46 69.76 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.447 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -64.23 -41.52 96.97 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.048 0.928 . . . . 0.0 108.94 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.419 ' O ' ' HD2' ' A' ' 85' ' ' PRO . 78.5 t90 -60.37 -38.84 85.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 113.91 -1.496 . . . . 0.0 109.36 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -53.67 -45.33 70.25 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -66.64 -40.62 88.81 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.424 0.63 . . . . 0.0 110.946 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.49 -43.53 69.53 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -113.81 -63.91 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 72.4 Cg_exo -53.85 -38.5 85.73 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 CA-C-N 121.24 1.479 . . . . 0.0 111.39 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.8 t -66.6 -12.19 14.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.758 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -49.28 -31.04 8.17 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.17 -10.18 0.38 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.43 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 53.57 -117.0 6.49 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.71 143.94 99.54 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 CA-C-N 119.27 1.535 . . . . 0.0 109.536 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.4 HD12 ' CD ' ' A' ' 98' ' ' GLU . 16.7 tt -130.64 154.01 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.321 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.43 149.36 83.79 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.415 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.79 168.16 25.31 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.785 2.323 . . . . 0.0 113.013 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.02 -4.35 71.22 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.91 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -125.21 159.23 32.09 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.773 0.321 . . . . 0.0 110.67 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 96.2 mmm -62.23 142.94 57.42 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.08 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -60.48 127.12 30.16 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.373 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' CD ' HD12 ' A' ' 91' ' ' ILE . 64.6 mt-10 -70.42 151.18 95.7 Favored Pre-proline 0 C--O 1.237 0.446 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.96 112.95 3.53 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.446 1.431 . . . . 0.0 113.675 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -73.4 171.52 12.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.493 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -54.23 -48.97 61.64 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 119.111 -1.518 . . . . 0.0 109.884 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.493 ' HB3' HG23 ' A' ' 108' ' ' THR . 70.3 m -60.65 -38.04 83.51 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.579 0.704 . . . . 0.0 109.517 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -59.61 -38.74 82.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.592 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.562 HG21 ' CZ3' ' A' ' 133' ' ' TRP . 0.4 OUTLIER -55.55 -31.39 28.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.78 -21.35 26.56 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.276 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.17 -6.93 82.37 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.7 p -57.6 -22.82 47.44 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.493 HG23 ' HB3' ' A' ' 102' ' ' SER . 36.1 p -119.55 29.87 7.38 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.632 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.9 m -129.53 135.05 48.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.279 -0.569 . . . . 0.0 112.393 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.2 m -76.86 145.31 38.43 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.414 HD11 ' NE2' ' A' ' 12' ' ' HIS . 6.8 tt -50.03 -45.96 52.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.154 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.07 -39.33 92.02 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.065 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.04 -40.36 96.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.289 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.37 -50.18 74.63 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.4 pt -70.67 -24.31 25.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.809 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.07 -65.91 2.65 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.451 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.437 ' C ' ' CD1' ' A' ' 117' ' ' TRP . 2.0 p90 -61.62 -31.44 71.53 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 118.125 -1.43 . . . . 0.0 109.137 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.456 ' SD ' HD11 ' A' ' 2' ' ' ILE . 27.6 ttt -63.59 -45.14 91.75 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.8 m -115.26 -26.7 7.52 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -58.87 -72.61 0.1 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.085 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -73.74 -177.01 0.54 Allowed Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.61 141.6 15.0 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 120.641 1.265 . . . . 0.0 109.459 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -46.16 123.94 6.99 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.671 1.58 . . . . 0.0 113.766 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.429 ' HB ' ' HD1' ' A' ' 117' ' ' TRP . 47.3 mm -114.91 107.97 49.38 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.84 60.13 4.06 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.909 1.739 . . . . 0.0 113.943 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.6 m -51.57 -37.34 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.73 99.67 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.423 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.46 -45.71 89.56 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.472 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 90.2 mt -64.71 -48.67 83.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.569 0.699 . . . . 0.0 110.17 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.699 ' CE2' HD11 ' A' ' 134' ' ' ILE . 84.4 t80 -59.01 -48.98 79.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.021 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.415 ' HA ' HD12 ' A' ' 134' ' ' ILE . 39.1 ttpt -63.02 -39.03 93.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.886 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -57.43 -43.19 83.64 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.562 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 44.1 m0 -62.69 -43.2 99.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.837 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.699 HD11 ' CE2' ' A' ' 130' ' ' TYR . 78.9 mt -58.43 -42.84 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.525 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.03 -41.6 83.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.78 -44.24 93.98 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.26 -42.57 97.36 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.52 -35.7 81.33 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -58.09 -44.51 87.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.67 -37.89 87.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.415 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.2 mm -60.77 -48.32 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.75 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.8 m -59.27 -34.76 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 118.42 -1.312 . . . . 0.0 107.471 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -65.83 -39.18 90.56 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.4 ttt -58.88 -45.44 90.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -74.89 -15.32 60.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.321 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.1 t -49.3 115.67 5.01 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.72 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -84.12 -30.35 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.107 1.871 . . . . 0.0 113.812 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.3 p -138.01 170.94 15.17 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 39.1 t -105.68 148.22 27.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.638 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.654 ' HA ' HD12 ' A' ' 153' ' ' ILE . 5.4 tp -49.46 -38.41 12.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.549 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.7 tp -65.6 -39.33 91.43 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.556 0.693 . . . . 0.0 109.798 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -67.64 0.32 3.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.553 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 150' ' ' ILE . 96.8 mt -100.65 119.0 48.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.025 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -145.93 132.04 19.35 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.8 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -84.41 134.17 34.48 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.407 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -90.86 159.25 26.59 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.82 -41.79 74.89 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.182 1.921 . . . . 0.0 111.867 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -81.2 -17.95 47.86 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.625 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -73.76 138.37 76.85 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.721 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.28 136.19 23.85 Favored 'Trans proline' 0 N--CA 1.512 2.579 0 C-N-CA 123.171 2.58 . . . . 0.0 113.613 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.414 ' HB3' ' HA ' ' A' ' 224' ' ' PRO . 11.8 t80 -61.51 -28.17 69.12 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.401 ' H ' ' HA ' ' A' ' 224' ' ' PRO . 58.9 ttt85 -61.96 -50.94 70.09 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.775 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -64.92 -40.26 94.78 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -59.2 -50.86 72.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.395 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 161' ' ' PHE . 54.5 t -61.76 -43.82 97.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.8 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.68 -59.16 5.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.058 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.44 -40.75 97.59 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.073 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.626 ' HE2' HG23 ' A' ' 186' ' ' THR . 76.0 t80 -57.69 -47.1 83.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -62.5 -41.77 99.05 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.542 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -59.75 -40.29 87.65 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.092 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.595 ' OG1' HD11 ' A' ' 153' ' ' ILE . 93.6 m -62.63 -41.89 99.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.58 HD11 ' CE2' ' A' ' 168' ' ' PHE . 82.6 mt -60.69 -39.45 88.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -60.36 -40.25 90.11 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.002 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.45 -10.67 57.29 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.077 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -59.18 145.03 44.12 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.524 0.678 . . . . 0.0 112.203 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -70.23 -95.06 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.034 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -44.99 149.91 0.42 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.519 0.676 . . . . 0.0 112.39 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 82.4 p -74.17 179.32 4.52 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.638 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -47.43 -26.0 1.21 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.58 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -51.21 -49.68 60.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.418 HG12 ' CE ' ' A' ' 185' ' ' MET . 47.0 t -89.83 -58.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.775 176.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -42.08 -53.39 3.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.691 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -59.37 -44.11 92.79 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.679 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -60.31 -50.58 73.07 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.648 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.418 ' CE ' HG12 ' A' ' 181' ' ' VAL . 74.0 mtm -62.84 -41.29 99.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.947 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.626 HG23 ' HE2' ' A' ' 168' ' ' PHE . 54.4 m -59.46 -46.05 89.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.148 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.46 -47.05 86.99 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.513 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.3 m -67.49 -49.54 63.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.315 0.579 . . . . 0.0 112.007 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.35 -32.29 73.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.876 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.602 HD21 ' SD ' ' A' ' 214' ' ' MET . 62.9 tp -51.03 -46.36 61.57 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.504 HG22 HD12 ' A' ' 202' ' ' LEU . 85.2 t -85.79 -46.16 16.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.028 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -60.31 -49.44 77.61 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -70.37 -22.55 62.76 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.705 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.74 153.75 10.16 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.621 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -68.99 148.5 97.89 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.74 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.23 -41.98 67.7 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.377 2.051 . . . . 0.0 114.376 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.63 ' O ' ' HB2' ' A' ' 228' ' ' ALA . 97.8 m-20 -59.62 -50.0 75.56 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.447 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' CYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 228' ' ' ALA . 10.5 t -70.0 -37.77 75.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -47.11 -26.89 1.21 Allowed 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.092 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 69.0 p -62.49 -55.06 31.11 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.421 -1.312 . . . . 0.0 108.455 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 40.0 mm -65.07 -45.66 93.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.154 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.504 HD12 HG22 ' A' ' 191' ' ' VAL . 0.1 OUTLIER -54.82 -51.5 65.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.057 0.932 . . . . 0.0 108.834 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.31 -36.55 78.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -59.0 -39.71 82.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.747 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -57.46 -44.38 84.74 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 119.421 -0.911 . . . . 0.0 108.713 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 79.43 175.57 47.66 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.085 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.73 150.95 79.98 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 124.011 3.141 . . . . 0.0 113.38 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 81.06 0.27 88.54 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.6 119.2 13.48 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.178 0.513 . . . . 0.0 110.382 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 212' ' ' GLU . 94.2 m -61.07 139.36 58.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.1 tp -54.82 -46.08 74.5 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.604 -0.838 . . . . 0.0 108.873 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.401 ' H ' HG22 ' A' ' 210' ' ' THR . 80.8 tt0 -55.41 -48.11 74.88 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.482 0.658 . . . . 0.0 109.332 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -57.76 -42.47 84.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.602 ' SD ' HD21 ' A' ' 190' ' ' LEU . 58.9 ttm -63.01 -45.72 91.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.75 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 61.8 tpp -61.99 -45.64 92.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.9 m -62.54 -49.75 74.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.74 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.72 95.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.708 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 78.3 m -61.02 -40.81 94.99 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.67 -40.85 97.86 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.087 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.12 97.92 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 23.9 m -82.59 -23.61 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.675 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 104.57 14.28 24.0 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.844 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -58.65 -45.69 94.35 Favored Glycine 0 CA--C 1.545 1.943 0 CA-C-O 119.689 -0.506 . . . . 0.0 112.474 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.414 ' HA ' ' HB3' ' A' ' 161' ' ' PHE . 50.6 Cg_exo -55.64 -17.86 18.81 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.11 1.873 . . . . 0.0 111.989 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -90.56 -49.73 3.12 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 123.595 0.56 . . . . 0.0 112.093 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -152.69 -51.95 0.11 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 122.402 -0.47 . . . . 0.0 110.961 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -165.65 -175.57 3.55 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.467 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 197' ' ' ASP . . . -32.45 -81.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.335 1.022 . . . . 0.0 111.531 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.47 152.68 37.75 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.943 0.401 . . . . 0.0 110.714 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 9.9 p -51.93 -27.99 9.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.797 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.35 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.485 0.984 0 N-CA-C 108.837 -1.255 . . . . 0.0 108.837 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.597 HD11 ' SD ' ' A' ' 118' ' ' MET . 18.6 pt -67.62 119.32 13.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 110.071 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.47 138.07 48.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.505 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -69.71 125.01 25.44 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.958 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -78.33 -172.46 2.85 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.201 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 6' ' ' LEU . 9.6 mp -58.77 -38.18 77.92 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.44 -22.87 65.48 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.594 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.33 -7.75 58.46 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.77 127.78 33.82 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 120.171 -0.611 . . . . 0.0 109.524 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.494 ' SD ' HG21 ' A' ' 119' ' ' THR . 66.3 mtt -77.14 127.19 32.21 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.763 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 82.3 t -126.27 128.61 71.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.553 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -61.75 142.55 57.19 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.035 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -145.34 146.83 31.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.218 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.82 143.04 49.62 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.265 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.505 HD12 ' HG ' ' A' ' 20' ' ' LEU . 33.4 pt -61.81 144.25 14.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 120.902 0.382 . . . . 0.0 110.609 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 t -62.05 120.35 56.94 Favored Pre-proline 0 N--CA 1.453 -0.313 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -53.56 -36.9 82.17 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 N-CA-C 109.492 -1.003 . . . . 0.0 109.492 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -57.8 -48.49 79.56 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.164 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 84.1 m -60.84 -47.15 87.67 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.231 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.505 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -50.51 -57.03 9.04 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.905 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -58.3 -39.31 79.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.778 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.03 98.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.197 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.413 ' O ' HG23 ' A' ' 27' ' ' VAL . 22.1 t-105 -59.06 -49.76 76.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.483 0.658 . . . . 0.0 109.505 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.39 -40.3 88.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.095 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.4 -49.02 79.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.554 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.3 m -61.95 -35.55 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.713 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 79.7 t -66.83 -36.22 76.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.0 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -53.61 -47.07 70.54 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.579 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -89.42 -37.47 14.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -120.68 38.06 4.12 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.954 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.9 -51.16 5.64 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -175.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -96.11 -4.59 42.51 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.8 m -55.05 145.93 41.7 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.741 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.25 -32.59 20.38 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.486 2.124 . . . . 0.0 112.437 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.61 -20.07 30.37 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.886 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.69 -41.88 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.754 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.427 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 6.7 mt -45.72 -61.22 2.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.872 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 76.2 Cg_exo -54.78 -41.61 76.47 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 CA-C-N 120.176 1.099 . . . . 0.0 111.729 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 58.8 ttm -59.69 -46.87 87.77 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.338 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -55.07 -47.49 74.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -58.2 -44.48 88.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.719 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.67 -44.77 93.46 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.097 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.6 -22.61 62.53 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.138 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.7 m -87.66 5.81 37.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.593 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.9 126.16 26.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.742 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.01 11.23 69.77 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 121.315 -0.469 . . . . 0.0 112.231 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.13 146.26 50.97 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 112.543 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.0 m -99.72 141.3 22.54 Favored Pre-proline 0 C--O 1.215 -0.727 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -46.36 -36.2 17.18 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 CA-C-N 120.789 1.318 . . . . 0.0 113.222 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -68.59 -63.9 0.97 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.301 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.483 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -59.82 -37.58 79.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.265 1.031 . . . . 0.0 108.737 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.07 -45.31 92.76 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.773 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -57.72 -39.69 77.87 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 86.3 m -59.91 -39.28 84.87 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.48 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 97.9 mtp -57.98 -48.27 80.48 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.153 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.421 HD11 HD13 ' A' ' 134' ' ' ILE . 87.6 mt -65.53 -41.78 92.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.826 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -61.54 -36.46 80.65 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.206 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.5 m -65.56 -34.45 78.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.924 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.7 141.72 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.026 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -130.6 -140.27 4.65 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.4 -127.89 46.06 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.743 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -53.08 -11.33 0.24 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.853 -0.673 . . . . 0.0 111.669 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -41.92 -22.78 0.02 OUTLIER 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.78 -41.52 70.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.78 98.1 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 57.7 ttm -57.28 -26.22 60.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.038 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -56.97 -35.24 68.92 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.3 ttp -58.01 -46.2 85.66 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -57.65 -37.88 74.13 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -56.26 -42.95 78.23 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.37 -40.15 93.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.294 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -58.88 -43.46 90.91 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.8 -43.04 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -59.99 -41.48 92.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.027 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.24 -47.07 84.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.869 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -61.79 -40.1 94.02 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.25 94.15 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.862 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.04 74.69 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.404 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.43 -38.56 90.26 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.903 0.859 . . . . 0.0 108.975 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.59 ' CH2' HD13 ' A' ' 129' ' ' ILE . 76.2 t-105 -58.2 -45.92 86.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.659 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -49.8 -47.44 51.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.856 0.722 . . . . 0.0 109.136 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -64.0 -39.87 95.08 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.301 0.572 . . . . 0.0 110.892 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -176.123 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 . . . . . 0 C--O 1.237 0.435 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -56.53 141.64 71.72 Favored Pre-proline 0 C--O 1.238 0.465 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.8 111.72 0.98 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.25 1.3 . . . . 0.0 113.035 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.39 167.32 21.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.28 -43.28 89.47 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 119.072 -1.537 . . . . 0.0 109.788 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.4 t -61.0 -41.9 97.41 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.539 0.685 . . . . 0.0 109.232 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -61.94 -37.84 86.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.013 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.62 HD13 HG12 ' A' ' 126' ' ' VAL . 12.4 mm -57.7 -45.67 86.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.53 -17.64 64.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.55 0.16 89.28 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.1 p -64.22 -21.77 66.7 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.986 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.2 p -127.41 33.27 4.89 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.4 p -137.88 145.74 42.54 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.651 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.0 m -82.91 145.41 29.42 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -49.74 -44.94 48.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.61 -40.93 96.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.545 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -63.7 -43.26 97.13 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.163 0.506 . . . . 0.0 111.152 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -58.4 -47.86 82.53 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.35 -40.6 88.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.306 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.68 -63.91 4.42 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.662 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.438 ' CD1' ' N ' ' A' ' 118' ' ' MET . 1.2 p90 -59.75 -29.25 68.03 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 117.731 -1.587 . . . . 0.0 109.654 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.597 ' SD ' HD11 ' A' ' 2' ' ' ILE . 26.2 ttt -65.72 -45.01 84.3 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.494 HG21 ' SD ' ' A' ' 10' ' ' MET . 82.3 p -119.55 -24.27 6.33 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -58.19 -70.72 0.13 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.776 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -76.54 -177.34 0.74 Allowed Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -48.23 136.3 24.77 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 CA-C-N 120.619 1.257 . . . . 0.0 109.541 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -38.26 119.84 0.4 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.874 2.383 . . . . 0.0 114.509 -176.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.0 mm -112.98 106.84 54.87 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.57 59.95 4.26 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.257 1.971 . . . . 0.0 113.712 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.62 HG12 HD13 ' A' ' 104' ' ' ILE . 2.8 m -48.99 -38.74 11.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.28 99.71 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.627 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.52 -47.18 85.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.308 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.59 HD13 ' CH2' ' A' ' 80' ' ' TRP . 89.6 mt -63.64 -48.76 85.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.511 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.761 ' CE2' HD11 ' A' ' 134' ' ' ILE . 89.8 t80 -59.05 -48.56 81.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.909 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.506 ' HA ' HD12 ' A' ' 134' ' ' ILE . 38.5 ttpt -62.38 -38.06 88.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.592 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -58.73 -42.09 87.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.488 ' CH2' HG21 ' A' ' 104' ' ' ILE . 47.1 m0 -62.3 -43.83 97.92 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.761 HD11 ' CE2' ' A' ' 130' ' ' TYR . 85.7 mt -59.64 -45.26 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.62 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.14 -41.85 84.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.87 -42.53 99.8 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.23 -42.26 98.61 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.98 -36.21 83.23 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -58.45 -44.49 89.22 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.37 -38.9 91.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.557 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.4 mm -60.49 -49.64 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.0 m -57.74 -35.56 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -65.1 -39.83 93.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -59.2 -45.12 91.91 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -70.71 -22.06 62.49 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.442 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.7 t -43.03 106.59 0.49 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.538 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.01 -32.88 8.21 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.107 1.872 . . . . 0.0 113.758 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.9 p -137.95 172.6 12.69 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.3 m -104.98 149.99 25.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.125 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.4 mm -49.92 -42.03 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.9 tp -60.33 -39.26 86.46 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.19 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.85 -11.43 55.59 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.633 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.8 mm -75.71 119.95 24.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.82 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -152.93 134.1 14.18 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 C--O 1.237 0.437 0 CA-C-O 121.007 0.432 . . . . 0.0 111.665 -179.596 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 . . . . . 0 CA--C 1.548 0.884 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.28 139.34 11.62 Favored 'Trans proline' 0 N--CA 1.507 2.271 0 C-N-CA 123.577 2.851 . . . . 0.0 114.267 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.408 ' O ' HG23 ' A' ' 165' ' ' VAL . 26.3 t80 -59.28 -26.72 65.2 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -62.67 -51.44 67.23 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.811 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.27 -37.93 86.62 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.713 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -60.24 -50.56 73.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.674 0.75 . . . . 0.0 109.857 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 161' ' ' PHE . 54.7 t -64.7 -45.0 96.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.304 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -60.49 -51.51 69.13 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.948 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -66.24 -39.37 89.48 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.672 ' CE2' HG23 ' A' ' 186' ' ' THR . 87.8 t80 -58.78 -49.49 77.48 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -66.36 -36.25 82.42 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.299 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -58.27 -47.89 82.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 96.6 m -68.5 -39.39 81.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.133 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.24 -39.38 72.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.025 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.307 179.279 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 . . . . . 0 C--O 1.241 0.61 0 CA-C-O 121.279 0.561 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 91.1 mmm -62.56 -43.89 97.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.177 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.672 HG23 ' CE2' ' A' ' 168' ' ' PHE . 62.1 m -61.09 -45.75 93.43 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.609 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.81 -48.29 80.17 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.205 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 96.7 m -67.35 -47.27 70.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.236 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.9 -31.55 71.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.838 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.439 ' CD1' HG22 ' A' ' 186' ' ' THR . 16.4 mt -52.38 -43.4 64.7 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.309 -0.957 . . . . 0.0 108.892 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.3 t -85.72 -47.82 16.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.817 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -61.06 -49.38 77.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -70.12 -22.7 62.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.704 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.52 150.86 25.74 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -68.97 153.71 95.81 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.184 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.419 ' HA ' ' HB3' ' A' ' 199' ' ' LYS . 52.3 Cg_exo -57.09 -45.68 34.06 Favored 'Trans proline' 0 N--CA 1.509 2.393 0 C-N-CA 122.544 2.162 . . . . 0.0 115.521 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.76 -50.22 74.68 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.554 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 36.4 t -69.4 -39.34 78.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 196' ' ' PRO . 40.3 ttmt -49.02 -32.12 8.8 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.427 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.9 m -59.71 -48.79 80.29 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.935 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.627 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 48.2 mm -67.67 -43.14 86.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.466 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.404 HD11 ' CE1' ' A' ' 161' ' ' PHE . 82.1 mt -59.87 -39.67 86.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -61.35 -38.99 88.94 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -59.73 -40.1 86.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.478 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.76 -41.23 90.57 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.911 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.77 -159.18 52.59 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.779 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.19 166.49 5.71 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 123.5 2.8 . . . . 0.0 112.557 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.76 -126.35 40.68 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 56.73 96.62 0.02 OUTLIER 'General case' 0 C--O 1.238 0.48 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.332 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 76.4 p -61.65 157.58 17.26 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.152 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.35 -34.84 61.95 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -61.64 -50.15 73.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.352 0.596 . . . . 0.0 109.799 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.99 -42.43 94.19 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.6 ttm -60.87 -46.84 89.03 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.415 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 1.7 mmt -64.11 -41.43 97.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.1 0.476 . . . . 0.0 109.753 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.8 m -63.36 -49.83 72.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.409 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.96 -43.75 94.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.51 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.4 m -60.48 -40.76 92.49 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -60.97 -41.82 97.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.11 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.0 -39.93 96.31 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.527 HG21 HG21 ' A' ' 201' ' ' ILE . 34.4 m -91.95 6.04 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.903 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.234 0 C-N-CA 120.27 -0.966 . . . . 0.0 111.842 179.273 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo . . . . . 0 N--CA 1.483 0.904 0 N-CA-C 109.349 -1.058 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.6 pt -77.78 125.06 37.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.5 t -127.63 127.4 68.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.457 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -63.66 126.15 26.62 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -81.43 -173.39 4.34 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.291 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 6' ' ' LEU . 86.7 mt -59.71 -38.54 81.9 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.39 -21.7 65.59 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.566 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.49 -7.73 58.17 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -72.15 124.86 25.91 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.695 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.0 mtt -79.52 130.98 35.9 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.735 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.96 138.91 50.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 120.174 -0.611 . . . . 0.0 111.396 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -57.5 142.23 44.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.219 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -144.91 140.37 28.25 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.606 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.56 139.84 51.59 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.785 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.443 HD12 ' HG ' ' A' ' 20' ' ' LEU . 38.0 pt -61.87 137.24 24.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.558 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.7 t -60.28 122.76 69.33 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.637 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.36 -38.55 73.48 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 120.852 1.035 . . . . 0.0 110.973 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -56.91 -43.35 81.32 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.279 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.4 m -63.11 -46.81 85.58 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.443 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -49.74 -60.51 2.82 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.328 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -57.74 -39.42 77.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.891 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -61.51 -43.1 99.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.491 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -58.93 -50.2 74.94 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.56 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.5 t -62.07 -42.23 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.206 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.99 -41.95 88.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.027 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 22' ' ' ALA . 49.3 t -58.74 -45.38 91.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 67.1 t -64.17 -37.12 79.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.844 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -55.56 -45.66 77.25 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.685 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -92.86 -27.75 16.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.85 38.25 3.56 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.697 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.82 -54.48 3.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -175.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -96.03 -5.75 40.33 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 t -51.81 139.2 31.86 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.208 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.98 -32.83 34.21 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.476 2.117 . . . . 0.0 112.959 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -57.98 -18.65 25.19 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.995 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.81 -42.74 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.834 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.422 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 8.0 mt -44.79 -61.18 2.36 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.853 -178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 71.3 Cg_exo -54.38 -42.0 71.6 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 120.081 1.065 . . . . 0.0 111.732 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.489 ' CE ' HG21 ' A' ' 26' ' ' VAL . 20.7 ttt -60.63 -44.94 95.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.349 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -55.42 -47.1 76.48 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -58.41 -44.84 89.2 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.997 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.59 94.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.53 0.681 . . . . 0.0 110.2 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -70.44 -24.8 62.96 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.097 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.1 m -89.43 6.45 40.7 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.601 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.33 125.47 23.88 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.565 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.64 10.83 76.73 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.598 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' A' ' 52' ' ' LEU . . . -70.42 150.26 46.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.344 0.592 . . . . 0.0 112.354 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.8 m -99.72 142.38 24.51 Favored Pre-proline 0 C--O 1.217 -0.649 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.38 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -42.71 -38.82 6.8 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.466 1.444 . . . . 0.0 113.365 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -73.88 -61.32 1.89 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.041 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.452 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.93 -38.36 75.8 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.401 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . 57.3 tp -64.9 -44.29 90.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.648 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -57.72 -39.97 78.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 92.9 m -63.09 -39.58 95.13 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.953 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.45 ' O ' HG22 ' A' ' 58' ' ' THR . 28.2 ttt -56.8 -49.37 75.55 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.99 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.9 mt -69.8 -40.38 76.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.518 0.675 . . . . 0.0 110.155 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.53 -37.75 79.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.987 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 55' ' ' MET . 0.6 OUTLIER -66.33 -20.32 66.06 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.792 -178.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.85 140.0 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.51 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.84 -151.84 7.88 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.1 -127.75 45.92 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.924 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -51.32 -10.0 0.08 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.813 -0.693 . . . . 0.0 112.287 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -42.99 -21.28 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.39 -40.46 71.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.11 97.78 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.435 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 11.3 tmm? -58.32 -20.17 41.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.488 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.3 tp-100 -58.22 -39.32 78.75 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.4 tmm? -59.56 -42.36 92.26 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 66' ' ' MET . 61.3 tp -57.68 -40.7 80.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -59.15 -41.81 89.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.2 -39.64 93.1 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.81 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.1 m -59.83 -44.06 94.26 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.465 HD11 ' CD1' ' A' ' 134' ' ' ILE . 91.5 mt -60.82 -43.87 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -60.34 -41.91 94.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.483 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 88.8 tt0 -62.06 -46.84 87.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.19 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -63.83 -38.6 91.69 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.86 -39.19 88.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 75' ' ' GLU . . . -64.53 -51.24 63.89 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.845 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -64.8 -43.29 93.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.048 0.928 . . . . 0.0 109.468 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.494 ' CZ2' HD13 ' A' ' 104' ' ' ILE . 83.2 t90 -61.2 -41.47 96.87 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.779 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -59.6 -43.07 93.84 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -60.53 -33.77 73.14 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.597 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -177.033 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 . . . . . 0 C--O 1.239 0.547 0 CA-C-O 121.357 0.598 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.78 156.42 86.93 Favored Pre-proline 0 C--O 1.24 0.565 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.096 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.24 128.76 14.86 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.921 1.748 . . . . 0.0 113.475 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.5 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 3.4 mtt85 -126.13 151.95 46.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.778 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.618 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -42.1 -61.32 2.38 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.479 -176.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 108' ' ' THR . 74.7 m -61.34 -37.88 84.88 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 122.073 -0.663 . . . . 0.0 110.844 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 6.7 m-20 -61.53 -38.1 86.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.865 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.624 HG21 ' CH2' ' A' ' 133' ' ' TRP . 7.0 tp -58.44 -31.47 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.578 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.24 -10.42 56.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.613 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.92 0.12 87.95 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 48.8 p -63.48 -23.99 67.63 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.06 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 102' ' ' SER . 20.8 p -123.92 18.75 9.33 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.746 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.5 m -119.21 131.17 55.79 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.34 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -70.94 147.54 48.62 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.3 tp -53.46 -44.69 69.12 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.287 -0.965 . . . . 0.0 108.448 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.43 -40.58 94.96 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.08 -43.51 98.67 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.19 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -62.78 -41.25 99.17 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.246 0.341 . . . . 0.0 110.979 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 34.7 pt -68.15 -41.83 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.924 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.99 -41.86 70.31 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -58.88 -46.16 88.48 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.013 -1.094 . . . . 0.0 109.102 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.9 ttt -71.39 -42.58 68.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.44 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.6 m -125.78 -26.9 3.42 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -58.43 -49.92 75.57 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 118.455 -1.298 . . . . 0.0 109.814 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -81.54 -177.88 1.05 Allowed Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.51 144.51 32.18 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 N-CA-C 107.105 -1.921 . . . . 0.0 107.105 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -45.86 124.0 6.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 121.348 1.365 . . . . 0.0 112.997 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.417 HG22 HG13 ' A' ' 126' ' ' VAL . 45.8 mm -113.47 108.33 52.28 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.408 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 72.0 Cg_endo -74.72 56.86 4.21 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.958 1.772 . . . . 0.0 113.111 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 127' ' ' GLY . 21.6 m -58.74 -45.75 91.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.481 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -63.63 -44.37 96.57 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.205 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 125' ' ' PRO . 88.7 tt0 -60.32 -44.63 95.29 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.973 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.09 -47.85 91.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.865 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -59.09 -50.13 75.26 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.912 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -61.91 -38.57 88.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.967 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -56.66 -43.67 80.61 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.624 ' CH2' HG21 ' A' ' 104' ' ' ILE . 44.4 m0 -63.35 -44.44 94.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.593 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.465 ' CD1' HD11 ' A' ' 73' ' ' ILE . 29.7 mm -58.33 -44.88 89.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.455 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.74 -42.44 88.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.16 -43.67 97.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.381 0.61 . . . . 0.0 109.615 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.32 -42.28 99.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.26 -35.9 81.88 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -58.32 -45.0 88.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.79 -38.64 91.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.473 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.4 mm -60.9 -49.8 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 16.7 m -58.28 -36.16 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -65.49 -38.79 90.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.822 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 63.7 tpp -59.74 -46.75 88.17 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -71.62 -15.62 62.25 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.215 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.3 t -49.07 116.94 5.98 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.846 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.46 -40.19 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.949 1.766 . . . . 0.0 113.539 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 58.3 p -138.38 169.04 18.49 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.2 t -92.26 148.53 22.07 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.471 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.628 HD11 ' CZ ' ' A' ' 168' ' ' PHE . 17.5 tt -51.28 -36.45 17.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.43 -39.45 92.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.238 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -66.8 -9.84 41.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.492 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.57 HD13 ' HA ' ' A' ' 168' ' ' PHE . 81.6 mt -81.87 120.31 33.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.945 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -142.33 123.55 14.67 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.56 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 . . . . . 0 C--O 1.236 0.353 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.34 179.944 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 160' ' ' PRO . 95.9 mt-10 . . . . . 0 CA--C 1.541 0.626 0 CA-C-O 119.822 -0.133 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 163' ' ' ASP . 5.4 Cg_exo -75.36 135.13 18.04 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.704 2.27 . . . . 0.0 114.019 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.4 ' O ' HG23 ' A' ' 165' ' ' VAL . 49.9 t80 -61.55 -36.27 80.12 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -61.83 -47.7 83.9 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.087 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.419 ' H ' ' HB2' ' A' ' 160' ' ' PRO . 50.4 t0 -61.33 -41.62 97.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.86 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -61.13 -50.4 73.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.788 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 161' ' ' PHE . 53.5 t -62.14 -47.7 91.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.618 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.43 -50.99 70.57 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.28 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -64.85 -39.12 93.05 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.252 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.628 ' CZ ' HD11 ' A' ' 150' ' ' ILE . 88.1 t80 -60.42 -50.21 74.5 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.08 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.45 ' OH ' HD22 ' A' ' 211' ' ' LEU . 21.7 m-85 -69.49 -41.61 75.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.305 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -60.38 -46.33 90.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.511 ' CB ' HD11 ' A' ' 153' ' ' ILE . 91.9 m -65.21 -37.68 88.04 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.595 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.55 -49.15 78.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.314 0.578 . . . . 0.0 110.049 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.515 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 . . . . . 0 C--O 1.238 0.5 0 CA-C-O 121.281 0.563 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.463 ' SD ' HG21 ' A' ' 150' ' ' ILE . 59.9 ttm -60.67 -46.05 91.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.575 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.516 HG23 ' HE2' ' A' ' 168' ' ' PHE . 65.8 m -59.35 -48.68 80.71 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.976 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.25 -47.68 84.95 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.702 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 97.1 m -63.15 -48.03 80.18 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.98 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.425 HD23 ' ND2' ' A' ' 193' ' ' ASN . 8.2 mp -68.4 -34.18 75.56 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.699 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 17.1 mt -50.01 -45.88 52.26 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.142 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.0 t -81.37 -47.38 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.852 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -61.92 -50.77 70.83 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . 0.425 ' ND2' HD23 ' A' ' 189' ' ' LEU . 97.6 m-20 -73.21 -23.13 60.35 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.365 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 190' ' ' LEU . . . -57.02 155.09 8.67 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.787 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -72.58 155.68 90.83 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.72 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.19 -39.78 82.04 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 122.454 2.102 . . . . 0.0 113.72 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -59.3 -49.33 78.25 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.808 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -73.51 -36.79 65.78 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -47.14 -37.88 10.66 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.741 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.3 m -60.3 -50.22 74.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.293 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.624 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 40.4 mm -68.11 -44.02 84.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.45 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 81.9 mt -59.12 -44.11 91.99 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -63.41 -38.1 89.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -60.03 -39.46 85.97 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.976 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.34 -35.84 70.42 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.699 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.02 172.75 49.03 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.55 155.31 54.95 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 123.733 2.955 . . . . 0.0 113.459 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.39 1.78 88.81 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.469 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.42 128.15 34.7 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.279 0.561 . . . . 0.0 111.126 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 34.7 m -66.31 143.97 56.86 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.45 HD22 ' OH ' ' A' ' 169' ' ' TYR . 68.4 tp -54.32 -44.67 72.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -57.92 -46.96 84.2 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -58.12 -43.72 87.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 98.3 mtp -62.35 -46.14 90.03 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.957 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 98.3 mtp -65.22 -41.04 94.81 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.825 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.0 m -63.28 -50.02 71.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.512 0.672 . . . . 0.0 110.468 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.31 98.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.408 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 76.2 m -60.88 -40.35 92.67 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.29 -39.23 82.31 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.83 -38.83 92.98 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.3 m -94.59 4.52 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 120.713 -0.395 . . . . 0.0 112.022 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.831 179.424 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.459 ' HB3' HG23 ' A' ' 48' ' ' THR . 12.5 Cg_exo . . . . . 0 N--CA 1.49 1.268 0 N-CA-C 109.147 -1.136 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.497 HG21 ' CG2' ' A' ' 115' ' ' ILE . 8.0 pt -73.07 109.57 5.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.147 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.82 145.68 34.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -61.75 138.22 58.31 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.384 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -97.31 -170.8 2.08 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.482 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.08 -41.54 83.65 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -69.95 -17.86 63.33 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.867 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.5 -7.96 63.95 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -72.1 127.73 33.49 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.698 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.1 mtt -74.81 128.37 35.4 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -127.61 130.16 70.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.097 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -59.48 141.27 55.12 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.733 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -146.07 144.73 30.22 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.912 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.3 142.52 50.47 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.201 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.484 HD12 ' HG ' ' A' ' 20' ' ' LEU . 33.3 pt -62.24 141.83 17.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.83 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.0 t -60.68 119.76 46.83 Favored Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.0 -36.19 74.81 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 N-CA-C 109.434 -1.025 . . . . 0.0 109.434 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -57.18 -49.02 77.27 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.015 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.6 m -61.27 -47.12 87.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.266 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.484 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -49.54 -60.27 3.01 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.813 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -55.07 -40.7 70.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.687 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -61.57 -41.37 97.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.429 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -58.25 -50.44 73.57 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.187 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.8 t -62.67 -43.11 98.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.875 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.37 -44.04 92.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.891 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 22' ' ' ALA . 53.9 t -58.86 -45.88 91.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 69.8 t -63.51 -36.34 75.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.745 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -54.46 -46.41 73.33 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.384 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -87.88 -33.57 18.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' HG21 ' A' ' 36' ' ' VAL . 38.2 mttt -130.46 40.05 3.56 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.918 -176.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.36 -50.03 5.1 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -95.12 -4.93 45.28 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.5 m -56.42 146.72 52.4 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.98 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.25 -34.97 11.98 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 122.661 2.241 . . . . 0.0 112.949 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -58.02 -18.57 25.05 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.914 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 30' ' ' LYS . 60.3 t -64.0 -42.3 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.49 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.426 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 8.0 mt -47.16 -60.59 3.76 Favored Pre-proline 0 C--O 1.24 0.57 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.594 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.426 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 73.2 Cg_exo -53.36 -42.15 67.48 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 119.971 1.026 . . . . 0.0 111.727 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.6 mtt -60.38 -44.51 95.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.496 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.66 -48.09 75.61 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.9 m -58.87 -42.88 90.51 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.824 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.22 -44.42 95.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.349 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.61 -22.45 60.97 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.388 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.0 m -88.27 5.89 39.57 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -61.88 125.89 25.43 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.857 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.15 10.74 74.3 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.804 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.99 149.34 39.32 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 1' ' ' PRO . 82.1 p -99.76 147.78 33.88 Favored Pre-proline 0 C--O 1.213 -0.851 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.379 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.26 -38.1 19.59 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.391 1.394 . . . . 0.0 113.221 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -68.31 -63.46 1.05 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.367 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.7 m-20 -58.24 -35.85 72.33 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.501 1.144 . . . . 0.0 108.024 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.525 HD21 ' HG2' ' A' ' 131' ' ' LYS . 58.2 tp -62.3 -48.86 78.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.104 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -58.18 -37.23 74.33 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 58' ' ' THR . 88.3 m -59.56 -40.83 88.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.455 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.0 -46.9 84.5 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.769 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.85 -39.71 87.68 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.689 0.757 . . . . 0.0 109.514 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -60.68 -39.59 89.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.439 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 54' ' ' THR . 59.4 p -67.34 -23.99 65.67 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.815 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.65 135.66 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.917 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.8 -149.17 7.54 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.13 -125.82 38.88 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.723 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -49.57 -12.62 0.07 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.326 -0.437 . . . . 0.0 111.675 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -42.65 -21.57 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.139 0.576 . . . . 0.0 112.177 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.13 -42.56 77.09 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.52 92.66 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 47.1 ttp -60.62 -28.68 68.71 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -58.14 -39.78 79.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.0 tmm? -60.75 -41.84 96.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.28 -39.43 75.69 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.483 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -60.14 -40.62 90.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.41 -40.28 95.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.235 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.0 m -59.64 -50.53 73.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.615 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.431 HD12 ' CE1' ' A' ' 130' ' ' TYR . 45.5 pt -67.75 -27.6 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.767 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -62.73 -43.27 99.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -63.38 -44.28 95.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.147 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.02 -37.13 78.87 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.398 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.88 98.92 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.776 -0.77 . . . . 0.0 108.965 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.47 -50.32 65.79 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.549 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.28 -41.69 98.7 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.85 0.833 . . . . 0.0 108.998 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -61.55 -42.27 98.58 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.07 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.49 -39.16 75.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.71 -13.14 61.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.505 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -178.527 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 . . . . . 0 C--O 1.236 0.39 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.44 142.99 90.33 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.05 110.85 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.497 1.465 . . . . 0.0 113.498 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -83.15 169.92 15.31 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.463 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -57.47 -49.53 72.48 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.025 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.7 t -60.29 -40.55 90.87 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.746 0.784 . . . . 0.0 109.142 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.16 -34.43 76.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.428 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.52 HG21 ' CZ3' ' A' ' 133' ' ' TRP . 0.4 OUTLIER -53.78 -28.82 17.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.14 -14.11 26.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.347 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.86 -1.34 88.59 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.3 p -61.77 -20.28 63.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.7 p -127.96 33.06 4.83 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.503 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 t -134.66 131.69 38.04 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.935 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.6 m -65.82 146.14 55.11 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -53.25 -43.41 67.36 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -39.97 93.3 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.705 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -62.79 -44.54 95.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.971 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -53.58 -63.37 1.17 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.497 ' CG2' HG21 ' A' ' 2' ' ' ILE . 45.7 pt -59.2 -25.28 29.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.971 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.7 -64.56 3.74 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 118' ' ' MET . 1.4 p90 -64.13 -28.23 69.63 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.247 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.405 ' N ' ' CD1' ' A' ' 117' ' ' TRP . 33.1 mtm -68.22 -40.0 82.21 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.6 p -115.63 -23.11 8.88 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -63.83 -75.66 0.08 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.128 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.22 -176.21 0.45 Allowed Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.38 144.44 13.43 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 N-CA-C 108.779 -1.277 . . . . 0.0 108.779 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.4 127.33 13.24 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.678 1.586 . . . . 0.0 114.009 -175.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.6 mm -114.73 108.74 48.61 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 114.637 -1.165 . . . . 0.0 107.894 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -87.34 60.2 3.67 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.811 1.674 . . . . 0.0 113.553 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -50.1 -39.47 16.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.87 -42.94 99.58 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.037 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -60.44 -47.85 84.3 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.312 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.403 HG22 ' CE2' ' A' ' 133' ' ' TRP . 90.1 mt -64.17 -47.91 87.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.466 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.792 ' CE2' HD11 ' A' ' 134' ' ' ILE . 87.4 t80 -59.2 -49.21 78.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.38 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.525 ' HG2' HD21 ' A' ' 52' ' ' LEU . 57.6 mtmt -62.87 -37.96 88.95 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.659 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -57.83 -43.43 85.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.52 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 43.7 m0 -63.03 -42.72 99.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.645 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.792 HD11 ' CE2' ' A' ' 130' ' ' TYR . 80.8 mt -59.02 -43.9 90.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.112 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.06 -40.28 80.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.91 -45.11 90.78 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.223 0.535 . . . . 0.0 109.709 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.32 -43.31 97.41 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.12 -36.49 83.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -58.46 -46.48 86.5 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -64.79 -38.57 91.44 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.713 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mm -60.42 -49.87 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.8 m -58.23 -34.48 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -66.65 -38.27 86.52 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 67.7 ttp -60.07 -46.28 90.07 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -71.13 -16.72 62.57 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.1 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -47.97 112.31 2.14 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.52 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.72 -35.87 4.18 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.936 1.757 . . . . 0.0 113.818 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.3 p -140.24 172.32 12.9 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 44.5 t -98.7 151.04 21.18 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.852 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.6 mm -51.9 -41.92 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.29 -39.08 81.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.802 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -66.7 -10.05 42.68 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.494 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.8 mm -80.29 125.36 39.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.739 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -152.49 129.7 11.22 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.99 0.424 . . . . 0.0 110.089 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.218 -179.608 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 . . . . . 0 CA--C 1.547 0.841 0 N-CA-C 111.45 0.167 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -67.55 134.36 32.79 Favored 'Trans proline' 0 N--CA 1.508 2.364 0 C-N-CA 122.524 2.149 . . . . 0.0 113.174 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.418 ' O ' HG23 ' A' ' 165' ' ' VAL . 37.4 t80 -58.73 -28.19 65.62 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -63.76 -50.36 69.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.867 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -63.07 -40.23 97.06 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -58.65 -50.26 74.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.412 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 161' ' ' PHE . 54.2 t -64.21 -49.23 82.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.712 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -59.5 -51.43 69.89 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.641 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -63.07 -41.69 99.49 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.089 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.641 ' CE2' HG23 ' A' ' 186' ' ' THR . 88.2 t80 -56.41 -48.58 76.64 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.519 ' OH ' HD22 ' A' ' 211' ' ' LEU . 12.3 m-85 -63.71 -37.38 87.12 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.231 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -58.05 -49.5 76.67 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 93.0 m -67.18 -38.24 85.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.861 0.839 . . . . 0.0 108.831 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 22.6 tp -55.46 -42.03 73.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.606 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 . . . . . 0 N--CA 1.446 -0.636 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.535 179.225 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 . . . . . 0 C--O 1.242 0.705 0 CA-C-O 121.464 0.649 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 98.4 mtp -61.69 -40.68 95.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.441 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.641 HG23 ' CE2' ' A' ' 168' ' ' PHE . 58.1 m -61.3 -48.26 82.19 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.563 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.67 -49.06 78.02 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.278 0.561 . . . . 0.0 110.17 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 98.4 m -62.46 -48.69 78.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.16 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 81.8 mt -67.61 -35.83 79.68 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.79 -1.096 . . . . 0.0 112.898 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.1 mt -44.75 -49.19 10.72 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.17 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 11.3 p -81.27 -37.22 15.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.73 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -61.97 -50.03 73.75 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.12 -23.89 62.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.831 0.348 . . . . 0.0 111.767 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.15 145.75 25.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.638 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -66.1 152.6 93.58 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.31 -45.61 36.51 Favored 'Trans proline' 0 N--CA 1.508 2.367 0 C-N-CA 122.705 2.27 . . . . 0.0 115.727 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -59.68 -49.46 77.67 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 118.799 -1.16 . . . . 0.0 110.417 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . 0.459 ' SG ' HD23 ' A' ' 202' ' ' LEU . 37.9 t -66.66 -38.98 87.96 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -48.79 -34.54 12.5 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.008 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 97.5 m -58.42 -50.36 73.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.185 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 26.2 mm -65.41 -45.21 93.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.596 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.459 HD23 ' SG ' ' A' ' 198' ' ' CYS . 3.9 mm? -53.9 -49.36 68.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.111 0.958 . . . . 0.0 108.858 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.64 -38.16 86.65 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.729 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -59.04 -39.43 81.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.913 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.445 HD21 ' HB1' ' A' ' 217' ' ' ALA . 2.7 mm? -59.15 -36.4 75.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 81.44 174.19 48.88 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.65 154.43 59.57 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 123.484 2.789 . . . . 0.0 112.902 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 86.91 -7.71 79.11 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.69 129.58 41.15 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.442 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.9 p -75.38 161.96 28.8 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.652 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.519 HD22 ' OH ' ' A' ' 169' ' ' TYR . 65.4 tp -59.6 -44.23 93.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.32 -50.3 74.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.162 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.6 -39.05 86.7 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.979 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 25.9 tpp -62.39 -50.58 70.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.938 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 15.2 tpt -63.25 -45.1 93.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.323 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.8 m -62.92 -48.43 78.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.85 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.445 ' HB1' HD21 ' A' ' 205' ' ' LEU . . . -62.73 -50.54 70.71 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.768 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 29.5 p -61.95 -30.61 71.03 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -64.85 -42.74 94.65 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.031 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.74 -40.42 98.76 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.006 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.67 -35.31 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.262 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.221 -179.451 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 N--CA 1.488 1.191 0 N-CA-C 108.948 -1.212 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.528 HG21 HG22 ' A' ' 115' ' ' ILE . 12.8 pt -63.74 112.3 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.253 0.549 . . . . 0.0 110.169 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.37 140.8 45.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.65 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -65.81 124.07 21.47 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.968 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -81.72 -172.23 3.76 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.369 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.24 -38.96 85.05 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -66.85 -19.2 65.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.453 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.52 -8.14 68.79 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.41 127.01 31.96 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.497 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 89.1 mtp -72.2 128.1 34.6 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.8 t -126.61 128.84 71.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.747 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -64.8 139.19 58.74 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.351 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -141.62 155.08 45.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.246 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.28 146.33 34.88 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.238 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.3 pt -62.79 144.15 14.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.916 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.8 m -61.89 121.18 63.44 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.44 -38.86 83.31 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 N-CA-C 109.794 -0.887 . . . . 0.0 109.794 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -59.53 -47.91 83.69 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.871 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.0 m -61.11 -46.11 91.92 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.87 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.524 HD13 ' C ' ' A' ' 20' ' ' LEU . 3.3 tm? -58.04 -49.14 77.9 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.245 0.545 . . . . 0.0 109.991 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -58.28 -42.3 86.25 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -62.22 -41.58 98.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.25 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -57.78 -49.42 76.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.6 t -62.08 -44.88 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.92 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -59.24 -42.78 91.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.529 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 22' ' ' ALA . 50.4 t -57.6 -44.58 85.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 53.8 t -64.63 -38.25 82.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.982 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -55.18 -49.22 72.43 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.086 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -81.07 -44.6 17.76 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -120.46 39.52 3.72 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.73 -52.19 3.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -95.83 -4.79 43.12 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -55.52 146.28 44.96 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 118.951 0.796 . . . . 0.0 111.734 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.19 -32.19 17.23 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 122.47 2.114 . . . . 0.0 112.544 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.26 -21.62 35.61 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.269 0.557 . . . . 0.0 109.667 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.5 t -63.27 -40.77 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.487 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.8 mt -42.75 -61.27 1.77 Allowed Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.317 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.04 -33.12 52.03 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 120.799 1.0 . . . . 0.0 111.499 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.1 tpt -60.23 -48.15 82.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.374 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 134' ' ' ILE . 63.9 t80 -55.77 -47.33 77.2 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.2 t -58.68 -43.89 90.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.89 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.05 94.02 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.04 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.7 mt -70.62 -24.53 62.75 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -91.34 25.94 2.4 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.561 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.6 126.17 30.56 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.161 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.29 11.21 75.56 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.055 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.28 150.67 43.37 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 111.915 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.9 p -99.3 149.12 35.53 Favored Pre-proline 0 C--O 1.218 -0.574 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.821 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -47.17 -37.44 23.64 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.192 1.261 . . . . 0.0 112.528 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -74.95 -62.51 1.52 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.61 -0.436 . . . . 0.0 112.139 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.77 -38.29 75.16 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 52' ' ' LEU . 56.4 tp -64.36 -44.21 92.13 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.595 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -58.22 -38.72 77.37 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 87.7 m -61.07 -40.36 93.36 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.963 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.16 -47.96 81.74 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.865 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.6 -41.5 92.69 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.218 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -61.62 -38.31 87.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.117 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.28 -24.15 66.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.522 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.8 t -58.67 154.52 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.78 -149.49 5.21 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.7 -128.5 47.79 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.208 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.452 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 18.7 p80 -53.82 -10.87 0.34 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.99 -0.605 . . . . 0.0 111.756 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -43.57 -22.2 0.04 OUTLIER 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.22 -40.29 67.53 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.08 97.63 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.2 tmm? -57.32 -21.4 34.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.52 -37.15 72.55 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.1 tpt -58.17 -45.63 87.17 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -56.23 -38.14 70.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -43.51 71.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.6 -35.53 73.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.987 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -58.34 -48.74 79.6 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 pt -67.68 -28.51 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -62.28 -43.47 98.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.02 -42.33 97.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.121 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.66 -40.02 90.51 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.24 98.29 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.225 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.3 -50.3 72.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.064 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.9 -39.18 93.58 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.893 0.854 . . . . 0.0 108.768 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -58.39 -45.29 88.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.779 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -57.38 -40.49 78.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -71.88 -14.07 61.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.599 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -177.797 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 . . . . . 0 C--O 1.24 0.56 0 CA-C-O 121.256 0.55 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -65.25 152.44 91.77 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.3 80.44 0.22 Allowed 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.216 1.944 . . . . 0.0 114.43 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -66.23 163.77 17.17 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.11 -44.29 96.45 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.405 ' HB3' HG23 ' A' ' 108' ' ' THR . 68.6 m -61.38 -39.97 92.62 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.07 -41.37 92.27 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.49 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.55 HG21 ' CH2' ' A' ' 133' ' ' TRP . 37.3 mm -58.72 -45.95 90.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.08 -20.5 65.82 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.89 -0.75 89.45 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 76.1 p -60.01 -21.41 61.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.405 HG23 ' HB3' ' A' ' 102' ' ' SER . 14.4 p -123.68 20.97 9.34 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.0 p -125.22 132.06 53.04 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.731 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -73.13 145.81 46.15 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.6 tp -50.98 -46.97 61.53 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.356 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.76 -41.29 97.49 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.29 -38.48 89.53 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.354 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -63.07 -42.08 99.57 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.824 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.528 HG22 HG21 ' A' ' 2' ' ' ILE . 35.0 pt -67.86 -42.14 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 118.907 -1.117 . . . . 0.0 111.06 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.26 -42.16 58.01 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -58.48 -44.71 89.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.421 ' SD ' HD11 ' A' ' 2' ' ' ILE . 28.2 ttt -73.29 -42.22 62.68 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.245 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 66.0 p -126.62 -23.66 3.7 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -56.11 -51.03 69.39 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.993 1.269 . . . . 0.0 110.279 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -81.14 -179.07 1.32 Allowed Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.05 143.65 17.67 Favored 'Trans proline' 0 N--CA 1.485 1.002 0 N-CA-C 107.441 -1.792 . . . . 0.0 107.441 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.85 123.85 4.23 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.849 1.699 . . . . 0.0 113.599 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.9 mm -113.64 108.41 51.76 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.43 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 73.1 Cg_endo -74.79 57.34 4.4 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.273 1.982 . . . . 0.0 113.503 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 127' ' ' GLY . 27.0 m -60.5 -44.49 96.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.515 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -63.3 -43.06 99.0 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.759 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 125' ' ' PRO . 88.7 tt0 -63.03 -44.89 94.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.63 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.5 mm -61.28 -47.54 93.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -57.87 -47.44 82.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -58.93 -41.85 88.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.785 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -57.72 -43.86 85.56 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.55 ' CH2' HG21 ' A' ' 104' ' ' ILE . 48.7 m0 -62.32 -45.54 92.77 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.765 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.476 HG21 ' CE2' ' A' ' 40' ' ' PHE . 32.3 mm -60.25 -46.67 94.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.424 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.61 -41.47 85.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 65.6 tp -60.52 -45.6 93.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.06 -41.14 96.35 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.35 -36.39 83.55 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -58.63 -44.83 90.13 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.49 -40.17 95.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.802 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.74 -49.26 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.353 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.7 m -58.02 -32.68 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.1 ttm-85 -67.98 -38.0 82.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 58.9 ttm -58.57 -44.15 89.65 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -74.84 -17.56 60.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.705 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.8 p -43.1 104.96 0.4 Allowed Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.39 -32.66 6.19 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.943 1.762 . . . . 0.0 113.673 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 70.6 p -139.35 173.04 11.95 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.6 t -106.72 150.12 26.6 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.887 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.577 ' HA ' HD12 ' A' ' 153' ' ' ILE . 13.6 mm -50.88 -46.51 29.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -59.4 -37.98 79.39 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.461 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -65.96 -5.04 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.216 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' A' ' 150' ' ' ILE . 92.6 mt -97.14 126.01 50.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.86 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -152.22 134.57 15.18 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.496 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 -179.246 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 160' ' ' PRO . 96.7 mt-10 . . . . . 0 CA--C 1.544 0.712 0 CA-C-O 119.895 -0.097 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 159' ' ' GLU . 5.2 Cg_endo -81.46 135.82 9.53 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.654 2.236 . . . . 0.0 113.418 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -58.93 -36.8 75.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -59.86 -49.77 76.4 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.02 -40.65 94.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.517 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -58.92 -49.59 77.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.463 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.65 -45.77 98.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.473 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.01 -52.19 66.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.019 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.64 -39.75 91.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.666 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.683 ' CE2' HG23 ' A' ' 186' ' ' THR . 81.2 t80 -56.71 -47.89 78.95 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -64.7 -36.59 84.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.943 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -57.98 -48.77 79.02 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.545 ' OG1' HD11 ' A' ' 153' ' ' ILE . 96.6 m -66.62 -38.91 87.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.729 0.776 . . . . 0.0 109.061 177.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 29.2 tp -56.42 -39.82 73.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.926 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 . . . . . 0 C--N 1.321 -0.669 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.954 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 . . . . . 0 C--O 1.241 0.623 0 CA-C-O 121.436 0.636 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 98.3 mtp -60.67 -41.04 94.28 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.079 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.683 HG23 ' CE2' ' A' ' 168' ' ' PHE . 66.4 m -60.44 -48.84 80.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.143 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.03 -47.72 85.11 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.01 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 99.0 m -62.09 -48.42 80.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.684 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.17 -21.69 58.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.42 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 67.2 tp -54.06 -49.97 67.79 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.625 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.7 m -87.33 -38.24 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.646 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.63 -45.96 92.09 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.958 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -80.27 -9.87 59.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.23 155.7 34.24 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -70.4 151.22 95.72 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.119 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.41 -42.91 63.49 Favored 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 122.316 2.011 . . . . 0.0 115.072 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.16 -60.49 3.79 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.538 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 49.4 t -62.16 -38.93 90.94 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -48.58 -34.64 11.87 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.856 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 99.3 m -59.92 -49.48 77.53 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 118.813 -1.155 . . . . 0.0 108.708 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.638 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 2.2 mp -64.75 -45.01 96.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.016 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.79 -42.16 92.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.51 -38.9 91.75 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -58.69 -40.47 83.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.278 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 205' ' ' LEU . 85.5 mt -63.0 -40.38 97.58 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.536 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.16 -160.49 53.3 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.999 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.05 165.91 4.65 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 123.822 3.015 . . . . 0.0 113.398 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 209' ' ' ALA . . . 61.08 -123.85 33.7 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 208' ' ' GLY . . . 64.86 99.29 0.04 OUTLIER 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.139 0.495 . . . . 0.0 111.231 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 50.9 m -57.76 144.27 38.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.2 tp -50.36 -40.96 50.89 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.223 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -57.98 -45.58 86.52 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.43 -42.23 91.42 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 5.5 mmt -61.58 -50.85 70.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.101 0.476 . . . . 0.0 110.961 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 59.3 ttm -63.69 -46.29 86.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.349 0.595 . . . . 0.0 110.574 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.8 m -61.8 -48.1 82.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.48 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.426 ' O ' HG23 ' A' ' 221' ' ' VAL . . . -61.05 -45.13 96.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.994 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 92.1 m -61.35 -40.98 96.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -56.7 -38.65 72.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.23 -38.98 93.99 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -94.97 5.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.341 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.267 -179.586 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.437 ' HB3' HG23 ' A' ' 48' ' ' THR . 8.0 Cg_exo . . . . . 0 N--CA 1.487 1.141 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.7 pt -71.21 110.11 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.403 0.621 . . . . 0.0 110.575 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.6 t -129.54 126.37 63.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.573 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -56.6 115.57 2.61 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.359 0.599 . . . . 0.0 109.847 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.56 -176.09 1.83 Allowed 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.281 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.99 -38.49 82.74 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.26 -19.51 66.0 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.731 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.25 -7.72 62.26 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -80.07 124.2 28.53 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.4 mtt -75.64 131.61 40.05 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.8 t -126.66 129.23 71.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.553 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -66.84 136.16 55.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.531 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -137.78 153.72 49.65 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.955 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.28 148.15 37.76 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.392 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.8 pt -62.44 144.48 14.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.173 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 m -63.68 121.98 73.87 Favored Pre-proline 0 N--CA 1.451 -0.399 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.15 -36.52 77.38 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 N-CA-C 109.507 -0.997 . . . . 0.0 109.507 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -57.63 -49.69 75.62 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.124 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 95.0 m -61.46 -46.14 91.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.458 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 65.8 tp -57.68 -49.9 74.96 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.832 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -58.47 -41.87 86.21 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -62.44 -41.67 98.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.751 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -57.55 -50.97 71.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.374 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.42 -41.84 94.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.365 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.74 -40.68 84.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.172 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 22' ' ' ALA . 47.2 t -58.55 -44.09 88.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 75.8 t -62.41 -35.96 72.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.998 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -57.03 -43.7 82.15 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.403 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -93.65 -27.1 16.76 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.545 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 99.6 mttt -132.41 38.3 3.46 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.956 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.79 -54.13 3.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -96.63 -5.17 39.64 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 55.4 m -52.49 144.34 24.24 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 118.906 0.776 . . . . 0.0 111.508 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.26 -31.62 17.96 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.453 2.102 . . . . 0.0 112.706 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -59.08 -18.86 39.04 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.771 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 30' ' ' LYS . 54.1 t -65.23 -41.27 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.944 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.427 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 6.4 mt -45.7 -60.79 2.99 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.237 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 77.8 Cg_exo -54.23 -41.22 77.92 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 CA-C-N 120.001 1.036 . . . . 0.0 111.795 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.9 mtt -60.86 -44.21 97.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.798 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -56.92 -49.44 75.62 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.779 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.4 p -60.86 -38.88 87.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.721 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.66 -46.08 91.7 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.067 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.61 -27.13 62.9 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.221 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -85.84 12.32 9.37 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.216 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -64.76 122.54 17.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.522 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.99 10.47 84.05 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 121.428 -0.415 . . . . 0.0 112.896 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.96 149.1 41.56 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.165 0.507 . . . . 0.0 112.117 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.437 HG23 ' HB3' ' A' ' 1' ' ' PRO . 81.3 p -99.19 148.69 34.97 Favored Pre-proline 0 C--O 1.212 -0.901 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.412 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -45.74 -37.17 15.76 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.477 1.451 . . . . 0.0 113.558 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -70.29 -63.35 1.1 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.254 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.509 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -57.88 -35.81 71.51 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.41 HD23 ' HD2' ' A' ' 130' ' ' TYR . 55.9 tp -62.4 -44.15 97.13 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.297 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -58.26 -38.05 76.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.53 ' O ' HG23 ' A' ' 58' ' ' THR . 88.3 m -61.21 -40.13 92.82 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.101 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 83.9 mmm -56.08 -46.49 78.99 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.581 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.78 -44.62 48.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.451 0.644 . . . . 0.0 111.145 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.25 -39.09 78.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.064 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 54' ' ' THR . 45.2 p -67.2 -19.69 65.6 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.999 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 60' ' ' GLY . 76.2 t -61.79 154.48 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.741 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 59' ' ' VAL . . . -140.65 -151.9 5.68 Favored Glycine 0 CA--C 1.535 1.338 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.96 -128.12 46.74 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.123 -1.037 . . . . 0.0 110.934 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -51.5 -10.59 0.1 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.956 -0.622 . . . . 0.0 112.11 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -43.46 -21.98 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.27 -41.09 68.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.13 96.36 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.3 tpp -56.78 -21.11 26.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.12 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -58.65 -38.4 78.03 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -58.58 -45.36 89.21 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -53.11 -43.04 66.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.086 178.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -59.62 -40.65 88.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -64.61 -40.78 96.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.593 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.7 m -60.17 -44.05 95.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.6 mt -60.33 -43.93 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -60.43 -42.13 95.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.444 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.23 -46.24 91.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.055 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.59 -39.21 93.81 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.66 98.51 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.435 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.29 -49.33 74.44 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.179 0.514 . . . . 0.0 111.186 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.22 -41.62 99.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 122.122 0.963 . . . . 0.0 109.1 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.469 ' CZ2' HD13 ' A' ' 104' ' ' ILE . 71.9 t90 -59.62 -44.42 93.44 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.083 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -53.87 -42.53 68.69 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.4 -26.75 68.13 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.477 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.351 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -60.62 158.92 27.97 Favored Pre-proline 0 C--O 1.239 0.541 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.069 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -48.17 130.44 20.52 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.718 1.612 . . . . 0.0 112.207 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.73 154.06 34.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.557 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -44.09 -61.28 3.16 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.605 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.569 ' OG ' HG23 ' A' ' 108' ' ' THR . 34.9 t -60.85 -39.03 87.59 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.667 0.746 . . . . 0.0 110.136 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -35.94 77.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.005 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.613 HG21 ' CZ3' ' A' ' 133' ' ' TRP . 6.5 tp -59.37 -33.35 50.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 102' ' ' SER . . . -70.59 -28.06 64.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.21 -8.1 79.82 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.7 p -57.78 -23.71 53.68 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.569 HG23 ' OG ' ' A' ' 102' ' ' SER . 23.0 p -114.79 8.51 16.09 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.684 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 62.0 m -111.79 131.34 55.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.078 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.0 m -71.04 156.03 40.11 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.8 tp -58.67 -47.83 83.16 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.244 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -61.61 -43.83 98.14 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.904 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.3 -39.38 86.75 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.192 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.619 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.5 pt -71.09 -39.76 74.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.952 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.33 -43.34 79.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -59.34 -45.15 92.16 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.915 -1.143 . . . . 0.0 109.084 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.2 ttt -72.04 -41.32 67.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.475 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.2 m -127.16 -26.4 3.11 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -57.4 -50.39 73.15 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 118.336 -1.346 . . . . 0.0 110.269 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.88 -178.23 1.13 Allowed Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 134.49 30.08 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 120.665 1.273 . . . . 0.0 109.224 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -36.77 116.72 0.16 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.681 2.254 . . . . 0.0 113.601 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.447 HG22 HG13 ' A' ' 126' ' ' VAL . 44.7 mm -108.83 108.54 60.82 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 87.4 Cg_endo -76.5 58.92 6.0 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.146 1.897 . . . . 0.0 112.692 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.47 HG23 ' N ' ' A' ' 127' ' ' GLY . 27.3 m -58.86 -45.08 91.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.956 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.47 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -64.18 -42.05 98.12 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.208 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 125' ' ' PRO . 88.4 tt0 -60.85 -45.89 92.74 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.415 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.84 -47.99 86.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.318 0.58 . . . . 0.0 110.415 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.7 ' CE2' HD11 ' A' ' 134' ' ' ILE . 86.7 t80 -58.59 -48.48 80.8 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.825 0.821 . . . . 0.0 108.858 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.491 ' HA ' HD12 ' A' ' 134' ' ' ILE . 60.2 mtpt -62.89 -38.16 89.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.035 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.7 tpp180 -57.79 -43.18 85.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.613 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 44.4 m0 -62.71 -43.74 98.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.885 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.7 HD11 ' CE2' ' A' ' 130' ' ' TYR . 84.4 mt -59.32 -44.57 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.933 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.37 -41.79 85.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.86 -42.42 99.75 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.25 -42.86 98.89 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.13 -36.47 84.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.7 -44.63 90.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.28 -39.5 92.67 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.607 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mm -60.58 -49.65 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.6 m -57.47 -35.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -65.15 -40.39 94.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 94.2 mmm -60.62 -43.09 97.9 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.329 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -71.61 -19.68 62.09 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.889 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.4 t -48.42 117.39 5.85 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.625 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -85.15 -25.03 1.87 Allowed 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 122.174 1.916 . . . . 0.0 113.67 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.1 p -138.97 169.66 17.39 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 40.8 t -107.43 148.9 28.54 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.985 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.444 HD11 ' CE1' ' A' ' 168' ' ' PHE . 4.9 tp -48.94 -36.38 8.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.5 tp -66.55 -39.48 88.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.609 0.719 . . . . 0.0 109.581 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -64.63 -26.36 68.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.153 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.21 108.36 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.071 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -144.85 122.62 11.9 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 C--N 1.328 -0.331 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.217 -179.067 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 119.877 -0.106 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.07 155.94 23.03 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.62 2.213 . . . . 0.0 114.598 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 165' ' ' VAL . 20.7 t80 -60.16 -39.68 87.26 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.453 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -62.99 -47.54 82.7 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.742 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -61.0 -43.34 99.03 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.907 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -62.15 -50.15 73.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.277 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 161' ' ' PHE . 55.1 t -61.07 -44.53 98.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.545 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -62.11 -53.88 49.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.6 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 61.5 mtm-85 -64.62 -41.0 96.46 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.173 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.615 ' CE2' HG23 ' A' ' 186' ' ' THR . 82.5 t80 -58.45 -48.8 79.54 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.55 ' OH ' HD22 ' A' ' 211' ' ' LEU . 8.9 m-85 -64.92 -36.9 85.88 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.538 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -59.62 -48.1 82.99 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 97.3 m -64.89 -39.6 93.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.579 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 17.0 tp -58.37 -38.26 76.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.103 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 27.9 ttt-85 . . . . . 0 N--CA 1.444 -0.741 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.656 179.76 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 . . . . . 0 C--O 1.242 0.677 0 CA-C-O 121.603 0.715 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.402 ' O ' HD13 ' A' ' 189' ' ' LEU . 98.7 mtp -61.62 -40.33 94.46 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.027 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.615 HG23 ' CE2' ' A' ' 168' ' ' PHE . 60.4 m -59.69 -46.92 87.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.283 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.68 -47.71 84.55 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.797 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 98.0 m -64.23 -47.54 79.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.596 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 185' ' ' MET . 8.7 mp -66.82 -33.81 76.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.327 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.572 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 13.2 mt -49.43 -44.95 45.85 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.964 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.6 -47.52 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.553 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -61.48 -50.28 73.39 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -72.08 -25.9 61.95 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.311 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 190' ' ' LEU . . . -59.08 156.97 10.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.304 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -70.63 152.88 95.22 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.081 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.28 -45.9 31.83 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 122.778 2.319 . . . . 0.0 114.708 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -54.6 -62.11 1.87 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.032 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 46.5 t -58.5 -45.09 89.44 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.857 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -48.95 -31.06 6.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.578 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.9 m -59.76 -50.59 73.24 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.679 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.472 ' HA ' ' HB3' ' A' ' 204' ' ' ALA . 3.5 mm -79.3 -30.14 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.697 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -55.1 39.02 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.58 -39.28 90.61 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 201' ' ' ILE . . . -57.22 -32.5 66.58 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.92 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 205' ' ' LEU . 56.2 tp -56.34 -38.47 71.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 96.61 160.1 32.0 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.778 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.0 156.05 66.45 Favored 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 123.594 2.863 . . . . 0.0 113.215 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 81.15 -0.34 87.64 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.532 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.405 ' HB1' HD21 ' A' ' 205' ' ' LEU . . . -68.37 136.82 53.96 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.458 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.6 p -76.22 160.81 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.886 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.55 HD22 ' OH ' ' A' ' 169' ' ' TYR . 63.3 tp -60.41 -44.03 96.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.94 -48.97 79.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.808 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.28 -43.43 92.52 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.0 ttm -60.33 -48.88 79.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.524 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 94.9 mmm -62.86 -39.07 93.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.5 m -61.69 -50.27 73.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.215 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.36 96.5 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.94 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 97.0 m -60.45 -40.44 91.17 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -68.62 -39.31 80.86 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.995 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.28 -40.66 92.21 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 12.4 t -95.09 -25.15 4.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-O 121.189 0.519 . . . . 0.0 110.598 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.125 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.441 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.486 1.049 0 N-CA-C 108.987 -1.197 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.467 HD11 ' SD ' ' A' ' 118' ' ' MET . 9.5 pt -62.31 109.85 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.494 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.1 t -128.88 123.58 59.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.486 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -57.13 110.63 0.87 Allowed 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.346 0.593 . . . . 0.0 110.003 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -68.5 177.78 2.28 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.011 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 pp -58.27 -33.45 69.42 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -63.18 -26.8 68.97 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.641 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.49 -7.19 53.55 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -85.73 124.72 32.56 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.894 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.0 mtt -73.75 134.49 43.47 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -128.62 130.07 68.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.813 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -68.19 136.27 53.35 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.518 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -137.9 153.6 49.52 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.254 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.86 142.95 40.0 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.985 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.432 ' CD1' HD21 ' A' ' 20' ' ' LEU . 37.9 pt -63.67 139.7 20.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.086 0.469 . . . . 0.0 110.488 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.0 t -61.01 126.09 85.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.82 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.09 -32.79 50.58 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 120.929 1.086 . . . . 0.0 109.884 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -58.76 -39.88 82.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 95.9 m -60.93 -46.2 91.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.732 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.432 HD21 ' CD1' ' A' ' 15' ' ' ILE . 68.1 mt -59.9 -45.02 93.87 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.64 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -60.55 -40.86 93.11 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.068 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.551 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -64.94 -46.65 80.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.284 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 42.3 t-105 -60.47 -50.69 72.57 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.878 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.89 -45.94 97.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.6 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.48 -43.5 98.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.364 0.602 . . . . 0.0 110.852 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 22' ' ' ALA . 46.7 t -59.27 -46.56 92.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.165 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 2.0 t -69.52 -25.94 29.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.393 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -58.98 -45.13 91.33 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.738 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -91.62 -36.35 13.71 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.412 ' O ' HG21 ' A' ' 36' ' ' VAL . 98.3 mttt -120.92 38.12 4.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.147 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.08 -51.64 4.49 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -96.11 -5.07 41.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.2 m -54.62 140.57 57.6 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 118.874 0.761 . . . . 0.0 112.22 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -59.93 -39.55 70.25 Favored 'Trans proline' 0 N--CA 1.507 2.265 0 C-N-CA 122.489 2.126 . . . . 0.0 112.817 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -54.15 -20.25 6.42 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.554 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.412 HG21 ' O ' ' A' ' 30' ' ' LYS . 52.9 t -62.57 -43.56 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.62 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.424 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 8.4 mt -46.97 -61.38 2.83 Favored Pre-proline 0 C--O 1.24 0.578 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.084 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 73.8 Cg_exo -53.62 -42.08 68.78 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 120.273 1.133 . . . . 0.0 111.781 176.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.0 mtp -61.41 -42.84 99.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.845 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -56.52 -48.84 76.37 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.8 t -59.23 -43.86 92.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.983 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.08 92.86 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.47 0.653 . . . . 0.0 110.069 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.4 mt -70.77 -25.64 62.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.459 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.9 m -89.53 7.76 34.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.785 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.22 128.41 35.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.573 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.76 10.54 76.79 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.58 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.67 149.86 38.05 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 111.973 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.9 p -99.05 150.29 36.56 Favored Pre-proline 0 C--O 1.218 -0.568 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.626 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.8 -39.55 18.82 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.492 1.461 . . . . 0.0 112.795 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -69.29 -63.35 1.08 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.349 -0.54 . . . . 0.0 112.018 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.492 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.96 -36.15 72.16 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.27 1.034 . . . . 0.0 108.405 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -62.18 -46.45 88.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.879 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -59.08 -37.46 77.16 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 85.5 m -58.6 -41.0 84.83 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.225 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.15 -46.07 89.33 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.298 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.439 HD11 HD13 ' A' ' 134' ' ' ILE . 90.8 mt -66.14 -41.84 89.91 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.814 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.97 -26.94 68.51 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.403 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 m -65.7 -34.64 78.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.238 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 60' ' ' GLY . 4.3 t -59.13 163.54 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.199 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.441 ' N ' HG12 ' A' ' 59' ' ' VAL . . . -157.6 -161.98 11.31 Favored Glycine 0 N--CA 1.473 1.109 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.43 -125.28 38.99 Favored Glycine 0 C--N 1.342 0.868 0 C-N-CA 118.867 -1.635 . . . . 0.0 109.774 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -48.37 -17.05 0.12 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.58 -0.31 . . . . 0.0 110.866 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -45.77 -21.71 0.14 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.324 0.25 . . . . 0.0 111.302 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.91 64.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.31 -40.55 96.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.0 mtt -63.74 -16.51 61.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.514 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -59.55 -39.05 82.73 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -60.62 -42.09 96.18 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -57.65 -39.28 76.67 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.096 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -60.63 -39.31 87.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.54 -40.48 95.68 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -59.39 -43.44 92.93 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 84.9 mt -60.78 -42.33 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -60.13 -41.8 93.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.486 -0.779 . . . . 0.0 108.97 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.32 -43.47 97.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.504 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.77 -40.47 97.39 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.73 98.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.564 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.1 -50.15 71.67 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.309 0.576 . . . . 0.0 110.87 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.81 -39.55 94.5 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.515 ' CH2' HD13 ' A' ' 129' ' ' ILE . 62.8 t-105 -58.12 -46.32 85.8 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.678 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -55.71 -41.79 74.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -72.26 -14.18 61.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.095 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -177.75 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 . . . . . 0 C--O 1.239 0.509 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -62.35 159.2 42.28 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.936 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.551 ' HB3' HD11 ' A' ' 104' ' ' ILE . 71.4 Cg_exo -51.24 141.31 39.79 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.437 2.092 . . . . 0.0 114.043 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.496 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 97.8 mtt180 -138.44 160.14 40.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.292 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.11 -47.64 85.96 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 118.348 -1.882 . . . . 0.0 109.63 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.1 p -64.78 -39.04 92.95 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.992 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.496 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 99.0 m-20 -63.91 -43.21 96.64 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.961 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.564 HG21 ' CZ3' ' A' ' 133' ' ' TRP . 0.8 OUTLIER -60.98 -37.89 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.69 -22.75 67.05 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.426 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.61 -3.26 69.31 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.4 p -67.53 -23.42 65.44 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.4 p -117.33 -2.32 11.61 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.154 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.0 m -105.45 131.42 52.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.726 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.8 m -70.65 151.47 44.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.82 -49.73 74.52 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.039 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.91 -40.43 88.79 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.69 -41.74 86.96 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -61.8 -37.68 85.29 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.5 mm -57.75 -62.03 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.291 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.71 -40.69 97.64 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -56.33 -44.94 80.47 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.467 ' SD ' HD11 ' A' ' 2' ' ' ILE . 27.4 ttt -72.67 -42.02 64.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.356 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 75.5 p -125.52 -23.89 4.0 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -51.72 -64.34 0.84 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.852 1.205 . . . . 0.0 110.429 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -76.71 -175.89 0.55 Allowed Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.24 143.82 14.06 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 N-CA-C 108.28 -1.469 . . . . 0.0 108.28 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.23 129.71 16.03 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.813 1.676 . . . . 0.0 113.526 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.454 HG22 HG13 ' A' ' 126' ' ' VAL . 42.7 mm -113.82 108.57 51.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.1 55.87 2.99 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.17 1.914 . . . . 0.0 113.431 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 127' ' ' GLY . 17.7 m -61.1 -48.19 90.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.926 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.482 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -63.59 -42.51 98.8 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.603 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -62.18 -46.26 89.73 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.389 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.515 HD13 ' CH2' ' A' ' 80' ' ' TRP . 89.8 mt -63.61 -48.77 85.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.372 0.606 . . . . 0.0 110.517 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.666 ' CE2' HD11 ' A' ' 134' ' ' ILE . 85.7 t80 -58.25 -47.1 84.64 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.417 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -61.53 -39.99 93.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.486 -1.233 . . . . 0.0 109.596 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.29 -41.74 89.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.564 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 47.9 m0 -62.08 -43.8 98.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.666 HD11 ' CE2' ' A' ' 130' ' ' TYR . 85.8 mt -60.47 -44.44 96.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.973 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.56 -41.27 81.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.729 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.8 -45.13 94.08 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.609 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.93 96.96 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -63.41 -36.41 83.65 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -58.05 -44.73 87.59 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.26 -38.62 90.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.778 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.66 -49.49 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.2 -36.06 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -65.81 -38.79 89.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.6 tpt -59.13 -47.39 85.45 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -72.93 -12.75 61.07 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.195 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.4 t -51.09 117.47 8.87 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.578 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -78.4 -35.04 1.29 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.956 1.771 . . . . 0.0 113.555 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.1 p -139.81 172.47 12.73 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.7 m -105.62 151.54 24.24 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.861 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.7 mm -49.35 -43.4 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 tt -58.79 -39.86 82.35 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.78 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -67.71 -14.49 62.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.081 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.2 mm -80.04 113.67 19.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.388 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -144.0 128.31 17.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.763 -179.45 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 119.658 -0.211 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 148.53 54.1 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.247 1.965 . . . . 0.0 114.116 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.74 -43.09 94.39 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.836 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.1 ttp85 -60.58 -46.61 89.59 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.68 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -59.86 -41.42 91.42 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.962 -1.095 . . . . 0.0 108.313 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -61.52 -50.45 72.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.126 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.32 -43.95 97.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.763 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.59 -56.37 20.59 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.63 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -62.24 -39.54 93.18 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.664 ' CE2' HG23 ' A' ' 186' ' ' THR . 90.1 t80 -57.32 -47.62 81.06 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -64.39 -37.66 88.3 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.624 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -61.07 -45.35 95.11 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.719 0.771 . . . . 0.0 109.6 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 94.7 m -66.1 -40.2 90.59 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 16.7 tp -58.51 -38.98 78.84 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.323 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 . . . . . 0 N--CA 1.445 -0.678 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.991 179.435 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 . . . . . 0 C--O 1.244 0.785 0 CA-C-O 121.577 0.703 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.4 -41.21 96.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.289 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.664 HG23 ' CE2' ' A' ' 168' ' ' PHE . 66.7 m -60.54 -45.5 93.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.029 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -59.36 -49.86 76.2 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.813 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 97.6 m -64.62 -47.36 78.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.591 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.59 -37.56 87.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.28 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.539 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 9.4 mt -43.23 -54.0 4.79 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.013 0.435 . . . . 0.0 110.722 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 71.8 t -86.92 -40.62 14.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.947 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -59.76 -49.36 78.04 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 49.3 p30 -89.32 -4.96 57.91 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 119.074 -1.051 . . . . 0.0 112.087 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 190' ' ' LEU . . . -68.31 162.98 24.0 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -66.85 150.83 97.48 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.624 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.402 ' HA ' ' HB3' ' A' ' 199' ' ' LYS . 31.7 Cg_endo -64.2 -38.74 34.12 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.407 2.072 . . . . 0.0 113.588 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -59.51 -50.54 73.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.21 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 202' ' ' LEU . 53.2 t -64.19 -43.59 94.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.035 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 196' ' ' PRO . 88.6 tttt -48.31 -30.27 4.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.847 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 92.6 m -59.47 -49.05 79.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.925 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 0.8 OUTLIER -82.67 -30.23 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.156 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.446 HD11 ' SG ' ' A' ' 198' ' ' CYS . 79.3 mt -60.94 -45.14 95.9 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.2 -39.45 94.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.001 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -59.05 -37.46 77.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.962 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 72.6 mt -59.78 -38.99 83.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.27 167.76 43.97 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.649 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.1 154.36 67.88 Favored 'Trans proline' 0 N--CA 1.507 2.32 0 C-N-CA 123.936 3.091 . . . . 0.0 113.871 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.19 16.3 80.8 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.749 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -79.9 135.54 36.45 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.094 0.473 . . . . 0.0 111.353 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 212' ' ' GLU . 42.0 m -73.35 137.37 44.71 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -51.64 -39.32 57.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.484 ' H ' HG22 ' A' ' 210' ' ' THR . 88.8 tt0 -59.25 -45.76 90.31 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.18 -42.18 90.24 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.7 mtt -62.7 -43.06 99.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.206 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 59.8 mtt -63.8 -43.54 95.98 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.682 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.1 m -65.86 -49.65 67.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.561 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.16 -44.53 95.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.031 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 81.0 m -61.32 -39.29 89.94 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.13 -36.68 83.79 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.174 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.37 94.35 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.49 -16.58 7.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.199 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.67 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 N--CA 1.486 1.077 0 N-CA-C 109.408 -1.035 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.2 pt -75.85 125.61 35.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.481 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -127.18 130.0 71.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.877 -178.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.42 121.58 13.03 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -84.04 -174.12 5.1 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.349 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 6' ' ' LEU . 87.3 mt -59.86 -38.32 81.83 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -66.82 -23.37 66.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.353 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.42 -7.14 56.02 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -71.85 132.54 44.56 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.371 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.1 mtt -85.04 109.49 18.25 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.8 t -109.73 130.22 63.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.805 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -61.29 137.38 58.24 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.841 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -138.55 152.34 48.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.006 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.86 143.59 49.36 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.029 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mm -64.42 138.46 23.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.2 t -58.69 121.58 54.78 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.44 -35.21 64.85 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 120.87 1.047 . . . . 0.0 110.029 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -59.42 -43.65 93.03 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.0 m -62.01 -46.19 90.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.97 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.7 mt -57.96 -50.17 74.3 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.311 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.11 -40.59 90.2 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.571 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -63.24 -43.4 98.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.693 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -59.75 -50.39 74.0 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.531 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.5 t -62.4 -42.66 96.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.175 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.82 -43.19 90.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 22' ' ' ALA . 49.2 t -58.79 -44.41 90.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 76.1 t -64.79 -35.92 76.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.636 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -54.07 -46.94 72.14 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.515 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -91.09 -39.47 12.15 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.675 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -116.83 38.17 3.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.001 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.6 -54.37 3.24 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -175.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -97.06 -5.69 36.95 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -50.83 140.4 20.13 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.399 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.3 -32.46 41.53 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 122.432 2.088 . . . . 0.0 112.7 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -57.84 -18.9 25.16 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.002 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.47 -42.76 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.766 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.424 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 7.2 mt -45.96 -61.5 2.47 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.731 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 77.8 Cg_exo -54.39 -41.53 75.86 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 CA-C-N 120.115 1.077 . . . . 0.0 111.569 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.5 tpt -59.66 -46.88 87.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.36 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -54.64 -48.65 72.02 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.2 m -59.48 -41.52 89.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.677 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.84 -44.67 93.97 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.094 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.58 -18.52 59.72 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.427 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -95.66 26.35 4.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.224 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -78.49 125.89 30.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.061 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.42 11.4 71.84 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.926 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 52' ' ' LEU . . . -68.21 149.08 49.96 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.301 0.572 . . . . 0.0 112.036 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.2 m -99.55 142.74 25.16 Favored Pre-proline 0 C--O 1.218 -0.569 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.482 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -43.64 -38.69 9.39 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.328 1.352 . . . . 0.0 112.852 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -71.54 -63.72 1.06 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.9 m-20 -58.91 -38.58 79.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.988 0.899 . . . . 0.0 108.917 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.479 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . 56.0 tp -63.95 -49.31 73.07 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.597 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -57.74 -39.83 78.24 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 96.9 m -61.17 -41.93 97.65 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.799 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 41.9 ttp -59.32 -48.16 82.66 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.888 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.49 ' H ' HD12 ' A' ' 56' ' ' LEU . 6.6 mp -63.3 -41.93 98.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.095 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -59.07 -33.8 71.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.374 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.4 m -65.37 -32.94 74.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.238 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.5 t -58.96 142.85 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.525 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.07 -151.88 6.95 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.79 -128.27 40.19 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -53.47 -12.85 0.5 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.817 -0.192 . . . . 0.0 111.414 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -44.38 -21.54 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.54 -39.26 70.35 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.67 93.79 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.5 ttm -57.54 -21.59 39.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.777 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -56.38 -37.35 69.98 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.2 ttp -58.55 -45.92 87.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 tt -58.19 -39.9 80.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -56.84 -41.56 78.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.007 -1.077 . . . . 0.0 108.377 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.9 -40.18 94.68 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -59.74 -43.95 94.01 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.79 -43.03 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -60.76 -40.02 90.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.949 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.55 -43.57 98.48 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -61.67 -39.48 91.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.83 -42.87 99.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.693 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.2 84.4 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.393 0.616 . . . . 0.0 110.393 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.48 -39.78 95.36 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -58.53 -47.98 82.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.259 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -55.07 -41.0 70.97 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.82 -22.89 64.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.745 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 CA--C 1.544 0.721 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -177.49 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 C--O 1.238 0.458 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -63.31 158.08 59.37 Favored Pre-proline 0 C--O 1.24 0.563 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.425 ' HB3' HD11 ' A' ' 104' ' ' ILE . 52.2 Cg_exo -50.01 136.8 36.94 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.584 1.522 . . . . 0.0 112.872 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.603 ' O ' HD12 ' A' ' 104' ' ' ILE . 43.7 ttm180 -134.67 139.11 45.01 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -43.22 -49.71 6.57 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.223 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -61.72 -41.21 97.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.325 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.87 -43.68 98.35 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.037 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.603 HD12 ' O ' ' A' ' 100' ' ' ARG . 1.5 mp -59.17 -41.5 83.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.4 -27.4 68.98 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.79 -7.89 80.59 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.3 p -60.13 -29.85 68.9 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.6 p -116.94 -7.69 11.36 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.981 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.1 t -99.28 129.15 45.48 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.205 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.7 m -72.85 146.29 46.33 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.5 tp -54.36 -47.44 72.6 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.375 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.4 -39.37 87.12 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.49 -40.62 97.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.199 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.2 -41.35 96.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.192 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 24.9 pt -63.77 -47.66 89.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 118.342 -1.343 . . . . 0.0 111.388 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.41 -41.67 66.66 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.416 ' CZ2' HG11 ' A' ' 126' ' ' VAL . 13.1 t90 -57.78 -45.03 86.59 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.8 ttt -71.86 -43.77 64.92 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.451 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.8 p -125.92 -23.62 3.93 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -57.44 -50.77 71.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 118.535 -1.266 . . . . 0.0 110.206 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -83.57 -178.12 1.12 Allowed Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.79 144.04 21.48 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 N-CA-C 107.785 -1.659 . . . . 0.0 107.785 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.54 126.8 10.84 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.43 1.42 . . . . 0.0 113.421 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.461 HG22 HG13 ' A' ' 126' ' ' VAL . 42.1 mm -114.24 108.07 50.79 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.24 55.68 4.15 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.834 1.689 . . . . 0.0 113.341 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.461 HG13 HG22 ' A' ' 124' ' ' ILE . 23.6 m -59.44 -42.47 87.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.454 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -62.67 -45.05 96.6 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.768 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.63 -43.9 97.64 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.153 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.58 -48.07 89.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.443 0.64 . . . . 0.0 110.071 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.741 ' CE2' HD11 ' A' ' 134' ' ' ILE . 78.4 t80 -59.48 -46.85 87.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.522 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -60.69 -39.37 88.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.392 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -59.13 -43.09 91.96 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.469 ' CH2' HG21 ' A' ' 104' ' ' ILE . 50.6 m0 -62.4 -43.66 98.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.186 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.741 HD11 ' CE2' ' A' ' 130' ' ' TYR . 84.7 mt -61.76 -45.52 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.035 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.19 -42.6 87.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.25 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.38 -43.05 99.74 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.6 98.46 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.43 -36.75 84.78 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -58.29 -44.03 88.33 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.69 -38.31 88.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.748 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.6 mm -60.84 -49.37 84.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.611 -0.436 . . . . 0.0 112.031 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.6 m -58.34 -35.9 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -65.16 -38.99 92.32 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.3 tmm? -60.41 -47.51 85.79 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.443 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -71.44 -15.2 62.33 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.202 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.9 t -48.11 115.16 3.85 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.717 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.66 -41.85 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.979 1.786 . . . . 0.0 113.801 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 43.1 p -140.83 170.17 16.26 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 39.9 t -90.84 148.19 22.68 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.98 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 tp -50.17 -34.35 10.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.8 tp -65.06 -39.42 93.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.724 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.7 -11.3 44.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.837 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.485 HD11 ' CB ' ' A' ' 171' ' ' THR . 88.2 mt -79.16 125.99 38.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.862 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -144.46 133.16 22.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.095 0.474 . . . . 0.0 111.016 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.634 178.512 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 . . . . . 0 C--O 1.24 0.588 0 CA-C-O 119.593 -0.242 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.86 136.55 16.84 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.203 1.936 . . . . 0.0 112.873 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 165' ' ' VAL . 53.4 t80 -59.56 -34.74 73.06 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -60.19 -52.45 65.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.111 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.52 -41.47 98.5 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.874 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -59.49 -50.09 75.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.634 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 161' ' ' PHE . 56.1 t -61.76 -46.66 96.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.13 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -58.47 -49.63 76.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.121 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.23 -41.58 99.12 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.581 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.455 ' HA ' HD13 ' A' ' 153' ' ' ILE . 85.8 t80 -56.53 -49.35 75.03 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.924 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.53 ' OH ' HD22 ' A' ' 211' ' ' LEU . 28.8 m-85 -67.29 -37.43 83.37 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.825 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -58.6 -49.96 75.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.696 0.76 . . . . 0.0 108.974 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.485 ' CB ' HD11 ' A' ' 153' ' ' ILE . 94.6 m -66.83 -37.35 84.32 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.88 178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 64.6 tp -59.28 -48.65 80.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.318 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.592 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 . . . . . 0 C--O 1.239 0.52 0 CA-C-O 121.25 0.548 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 57.4 mtt -63.54 -45.33 91.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.7 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 73.0 m -60.65 -50.15 74.66 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.818 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.58 -49.4 76.8 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.187 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.5 m -64.41 -48.31 75.85 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.906 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.37 -37.85 88.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.992 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.596 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 14.2 mt -48.92 -47.88 43.08 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.467 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.1 m -86.18 -38.17 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.077 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.55 -50.12 72.59 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -74.79 -21.83 59.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.979 0.419 . . . . 0.0 111.347 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 190' ' ' LEU . . . -59.56 150.84 25.99 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.222 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.94 138.8 97.6 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 199' ' ' LYS . 78.1 Cg_exo -52.36 -50.06 15.29 Favored 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 122.354 2.036 . . . . 0.0 116.145 -176.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -63.32 -44.02 96.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.982 -176.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 37.0 t -67.96 -42.14 81.36 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 196' ' ' PRO . 87.6 tttt -52.11 -28.57 18.21 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.105 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 87.7 m -59.09 -48.59 81.05 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 0.8 OUTLIER -68.52 -43.93 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.865 178.172 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.46 HD11 ' SD ' ' A' ' 214' ' ' MET . 0.0 OUTLIER -50.6 -52.73 36.59 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.57 -39.82 95.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.923 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -55.17 -35.0 64.33 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.346 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.461 ' CD2' ' HB1' ' A' ' 209' ' ' ALA . 58.6 tp -58.73 -39.84 82.02 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 104.9 163.66 24.05 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.63 155.08 54.77 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.301 2.667 . . . . 0.0 113.321 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 71.81 15.19 75.84 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.461 ' HB1' ' CD2' ' A' ' 205' ' ' LEU . . . -72.31 138.1 47.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.035 0.445 . . . . 0.0 111.201 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 212' ' ' GLU . 88.7 m -62.61 139.29 58.63 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.53 HD22 ' OH ' ' A' ' 169' ' ' TYR . 67.6 tp -54.86 -44.22 73.8 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.442 ' H ' HG22 ' A' ' 210' ' ' THR . 88.6 tt0 -58.04 -46.52 85.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.03 -40.86 86.35 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.46 ' SD ' HD11 ' A' ' 202' ' ' LEU . 56.0 ttm -61.65 -50.02 74.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.124 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 63.8 tpp -62.1 -47.42 84.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.584 0.707 . . . . 0.0 110.171 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.5 m -61.56 -47.17 86.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.126 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.8 -46.35 90.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.987 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.68 -40.57 97.5 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -58.2 -38.33 76.55 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.862 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.67 -37.5 89.64 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 35.9 m -97.22 -4.71 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.824 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.985 179.444 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.486 1.043 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.501 HG21 HG22 ' A' ' 115' ' ' ILE . 5.6 pt -57.42 108.26 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.342 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.01 133.54 19.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.18 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -60.97 136.42 58.08 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.38 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -98.38 -168.07 1.6 Allowed 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.657 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 6' ' ' LEU . 10.3 mp -58.67 -38.97 79.34 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -66.71 -23.32 66.1 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.237 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.4 -8.04 62.13 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.57 132.1 40.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 119' ' ' THR . 64.1 mtt -83.78 134.23 34.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.146 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.0 t -128.26 130.1 69.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.507 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.463 ' CD2' HD21 ' A' ' 111' ' ' LEU . 81.2 t60 -74.95 110.46 9.27 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.293 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -113.26 143.32 44.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.613 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.2 143.09 56.73 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.376 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.469 HD12 ' HG ' ' A' ' 20' ' ' LEU . 32.0 pt -60.57 144.57 13.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.721 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 m -62.76 122.76 76.38 Favored Pre-proline 0 N--CA 1.454 -0.26 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.877 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.58 -36.74 81.76 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 120.722 0.948 . . . . 0.0 109.738 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -56.75 -48.82 76.96 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.933 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.3 m -61.02 -46.94 88.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.042 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.469 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -48.9 -60.52 2.69 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.289 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -57.65 -38.79 75.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.821 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -61.77 -42.35 98.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.457 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -59.05 -51.06 71.66 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.829 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.7 t -63.18 -41.84 94.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.379 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.07 -43.68 91.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.372 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 22' ' ' ALA . 50.7 t -59.02 -44.98 92.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 60.7 t -62.45 -37.0 77.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.94 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -54.31 -46.72 72.89 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.528 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -89.42 -30.7 18.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' O ' HG21 ' A' ' 36' ' ' VAL . 98.9 mttt -130.91 38.44 3.69 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.871 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.51 -51.26 5.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -96.02 -4.65 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 67.2 m -54.97 147.22 34.36 Favored Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 118.866 0.757 . . . . 0.0 111.772 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.72 -34.71 10.98 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 122.663 2.242 . . . . 0.0 112.831 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.64 -19.36 25.85 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.904 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 30' ' ' LYS . 53.9 t -64.2 -41.77 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.608 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.427 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 7.1 mt -46.54 -61.31 2.76 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.279 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 78.4 Cg_exo -54.74 -40.61 83.86 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 CA-C-N 120.111 1.075 . . . . 0.0 111.557 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.0 tpt -59.0 -48.13 82.71 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.25 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -56.0 -46.77 78.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m -57.72 -44.2 85.79 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.858 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.27 99.17 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.462 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.91 -26.5 64.19 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.926 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.4 p -87.44 1.18 54.16 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -54.56 126.16 22.59 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.734 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.12 10.95 78.93 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.597 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.33 149.23 46.29 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.327 0.585 . . . . 0.0 112.564 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.7 m -99.96 141.7 23.25 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.135 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -41.74 -38.68 4.62 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.436 1.424 . . . . 0.0 113.056 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -71.05 -64.12 0.97 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.196 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.5 m-20 -59.18 -37.61 77.79 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.327 1.06 . . . . 0.0 108.503 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.08 -47.89 82.65 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.826 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -58.12 -39.27 78.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 58' ' ' THR . 91.6 m -60.65 -39.93 90.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.404 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 97.8 mtp -57.39 -48.08 80.01 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.654 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.521 HD11 HD13 ' A' ' 134' ' ' ILE . 88.1 mt -65.09 -40.62 94.86 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.799 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -60.54 -39.33 87.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.515 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 54' ' ' THR . 58.6 p -67.45 -19.04 65.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.896 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.2 t -61.18 152.97 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.587 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.54 -153.09 5.92 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.99 -128.16 46.85 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 120.363 -0.923 . . . . 0.0 111.018 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -51.93 -10.29 0.11 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.846 -0.677 . . . . 0.0 112.113 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -42.95 -21.7 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.14 66.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.6 96.29 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.6 tpp -57.09 -22.12 37.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.03 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -58.42 -38.11 76.75 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -58.85 -42.91 90.44 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.61 -40.86 76.07 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.498 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -58.18 -41.33 83.65 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.736 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.92 -40.4 95.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.499 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.5 m -59.61 -46.43 88.99 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.38 -41.06 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.305 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -60.33 -42.17 95.07 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.902 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.69 -46.03 90.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.996 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 133' ' ' TRP . 81.2 mm-40 -61.43 -38.54 87.51 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.68 90.93 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.54 66.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.891 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.46 -43.75 96.47 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.015 0.912 . . . . 0.0 108.854 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.648 ' CZ2' HD13 ' A' ' 104' ' ' ILE . 83.4 t90 -60.5 -39.82 89.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.613 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -54.32 -41.0 68.5 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -69.55 -20.56 63.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.832 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -177.831 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 . . . . . 0 C--O 1.238 0.454 0 CA-C-O 121.337 0.589 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.83 154.36 67.68 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.777 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.15 126.29 6.23 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.661 1.574 . . . . 0.0 113.118 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.564 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 1.1 mpt_? -115.55 151.32 35.1 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 113.773 -1.558 . . . . 0.0 107.774 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.549 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -49.35 -54.29 16.57 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.3 p -63.65 -33.94 76.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.875 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.564 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 82.9 m-20 -63.08 -39.86 95.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.857 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.648 HD13 ' CZ2' ' A' ' 80' ' ' TRP . 4.5 tp -56.8 -31.92 36.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.72 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.1 -27.8 61.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.204 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.88 -8.2 80.22 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 108.441 -1.863 . . . . 0.0 108.441 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 71.4 p -62.31 -19.24 63.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.0 p -122.96 10.57 9.5 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.003 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.1 m -114.81 130.77 56.92 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.271 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 m -73.0 151.14 41.9 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.463 HD21 ' CD2' ' A' ' 12' ' ' HIS . 68.3 tp -54.54 -46.03 73.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -61.01 -40.63 94.29 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -61.87 -45.85 91.98 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.277 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -62.29 -41.94 98.93 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.142 0.276 . . . . 0.0 111.38 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.501 HG22 HG21 ' A' ' 2' ' ' ILE . 47.1 pt -65.84 -43.26 93.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.931 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 120' ' ' HIS . . . -71.52 -41.05 58.63 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -58.56 -45.9 88.01 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.247 -0.976 . . . . 0.0 108.717 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.473 ' SD ' HD11 ' A' ' 2' ' ' ILE . 27.7 ttt -72.98 -41.1 64.71 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.377 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.529 HG21 ' SD ' ' A' ' 10' ' ' MET . 72.2 p -125.96 -24.26 3.8 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.406 ' HB2' ' HA2' ' A' ' 116' ' ' GLY . 50.3 t-80 -53.54 -64.78 0.71 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.93 1.241 . . . . 0.0 110.54 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -77.14 -177.4 0.78 Allowed Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.54 137.41 25.87 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 N-CA-C 108.276 -1.471 . . . . 0.0 108.276 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.59 127.31 3.32 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.627 2.218 . . . . 0.0 114.415 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.406 HG22 HG13 ' A' ' 126' ' ' VAL . 46.7 mm -113.34 108.26 52.65 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.99 57.31 4.52 Favored 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.309 2.006 . . . . 0.0 113.725 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 127' ' ' GLY . 19.3 m -59.48 -46.09 93.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-O 121.145 0.497 . . . . 0.0 109.975 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -62.92 -42.86 99.59 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.089 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.42 -45.24 95.13 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.339 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 mm -63.77 -48.63 85.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-O 121.318 0.58 . . . . 0.0 110.415 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.726 ' CE2' HD11 ' A' ' 134' ' ' ILE . 83.0 t80 -58.49 -49.45 77.32 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.142 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.495 ' HA ' HD12 ' A' ' 134' ' ' ILE . 38.0 ttpt -62.41 -39.24 92.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.402 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -56.58 -43.34 79.93 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.603 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 45.0 m0 -62.73 -43.45 98.78 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.293 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.726 HD11 ' CE2' ' A' ' 130' ' ' TYR . 82.2 mt -58.25 -44.05 87.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.809 -178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.7 mt -59.23 -41.97 85.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.308 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.82 -42.63 99.8 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.57 98.42 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.55 -35.68 81.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -58.01 -45.35 87.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.55 -39.19 93.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.684 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.5 mm -60.55 -49.74 83.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.168 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.2 m -58.74 -36.0 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -64.73 -39.52 93.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 60.8 ttm -60.08 -47.27 86.59 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -68.82 -22.08 64.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.062 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 p -43.09 114.84 1.65 Allowed Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.357 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.25 -41.79 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.93 1.753 . . . . 0.0 113.943 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.9 p -138.53 167.56 21.67 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 40.1 t -87.4 146.92 25.67 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.308 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.465 HD11 ' CE1' ' A' ' 168' ' ' PHE . 9.8 tp -52.66 -35.55 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.35 -38.61 90.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.029 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -64.57 -27.44 68.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.263 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.479 HD13 HG21 ' A' ' 171' ' ' THR . 1.3 mp -64.82 121.31 13.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.364 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 85.9 mtp180 -142.56 132.38 24.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.754 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--O 1.235 0.34 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.647 -179.603 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.59 136.89 52.15 Favored 'Trans proline' 0 N--CA 1.508 2.33 0 C-N-CA 122.626 2.217 . . . . 0.0 114.223 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.403 ' CE2' HG21 ' A' ' 165' ' ' VAL . 72.4 t80 -60.38 -38.52 84.17 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -60.19 -50.12 74.92 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.674 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -61.48 -39.5 91.16 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.146 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -60.29 -50.61 72.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.753 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.403 HG21 ' CE2' ' A' ' 161' ' ' PHE . 55.8 t -62.62 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.501 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -58.32 -51.23 70.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.345 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.27 -38.91 91.73 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.498 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.465 ' CE1' HD11 ' A' ' 150' ' ' ILE . 83.9 t80 -57.8 -48.69 78.98 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -67.87 -38.8 83.54 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.235 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -58.71 -47.49 84.39 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.479 HG21 HD13 ' A' ' 153' ' ' ILE . 98.2 m -64.94 -38.38 90.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.85 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.48 -47.8 84.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.716 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 . . . . . 0 CA--C 1.514 -0.421 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.182 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 99.2 m95 . . . . . 0 C--O 1.235 0.336 0 CA-C-O 121.159 0.504 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 54.8 mtt -63.1 -47.22 83.75 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.547 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 86.5 m -60.45 -48.81 80.16 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.478 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.04 -49.22 78.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.996 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 74.8 p -70.66 -44.81 66.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.148 0.499 . . . . 0.0 111.493 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.34 -36.41 84.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.975 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.44 HD21 ' SD ' ' A' ' 214' ' ' MET . 65.0 tp -46.86 -51.52 16.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.651 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.06 -40.39 13.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.166 0.508 . . . . 0.0 111.859 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.8 -48.2 82.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -86.8 -1.57 57.88 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.541 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.74 158.87 33.83 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.814 0.34 . . . . 0.0 111.677 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -69.85 152.77 95.92 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.147 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 199' ' ' LYS . 20.8 Cg_endo -60.81 -43.37 31.85 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 122.751 2.301 . . . . 0.0 115.993 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.2 -45.27 93.74 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.871 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 41.1 t -71.88 -40.07 69.18 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 196' ' ' PRO . 88.0 tttt -49.83 -34.32 19.4 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.888 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.2 m -58.87 -49.97 75.78 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.606 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 46.6 mm -66.4 -46.3 87.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.654 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 202' ' ' LEU . 1.0 OUTLIER -55.08 -50.72 68.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.203 1.001 . . . . 0.0 108.609 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.38 -37.03 79.46 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.385 -1.279 . . . . 0.0 107.777 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -58.2 -40.01 80.49 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.176 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 205' ' ' LEU . 88.9 mt -61.97 -36.72 82.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.74 -164.9 41.6 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.82 171.93 11.45 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.188 2.592 . . . . 0.0 112.463 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.63 -130.35 48.14 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.562 ' HB3' ' HE2' ' A' ' 214' ' ' MET . . . 59.88 109.8 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.274 0.559 . . . . 0.0 110.435 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.1 p -62.49 158.4 17.96 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.289 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 65.9 tp -56.77 -38.44 72.47 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -57.19 -49.25 76.55 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -59.96 -42.4 93.99 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 119.626 -0.83 . . . . 0.0 108.966 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.562 ' HE2' ' HB3' ' A' ' 209' ' ' ALA . 60.9 mtt -62.43 -45.73 91.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.199 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 25.9 ttt -65.84 -44.93 84.03 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.24 0.543 . . . . 0.0 110.355 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.2 m -62.78 -47.63 82.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.53 0.681 . . . . 0.0 110.201 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.89 -44.19 97.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.326 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 92.6 m -61.54 -39.43 91.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -58.11 -38.55 76.68 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.088 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.79 -39.11 93.34 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.1 m -92.65 3.42 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.609 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.257 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.661 179.211 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.423 ' O ' HG23 ' A' ' 3' ' ' VAL . 1.9 Cg_endo . . . . . 0 N--CA 1.486 1.047 0 N-CA-C 108.949 -1.212 . . . . 0.0 108.949 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.527 HD11 ' SD ' ' A' ' 118' ' ' MET . 11.9 pt -54.9 109.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.504 0.668 . . . . 0.0 110.837 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 1' ' ' PRO . 93.5 t -132.44 126.84 55.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.345 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -65.33 121.5 14.96 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -74.0 -170.07 0.86 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.182 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.85 -39.41 85.08 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.35 -23.41 66.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.365 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.61 -7.78 57.99 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -71.79 125.65 27.7 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.421 ' SD ' HG21 ' A' ' 119' ' ' THR . 66.7 mtt -75.71 133.69 40.7 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.312 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.4 t -127.98 129.91 69.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.804 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.422 ' CD2' HD21 ' A' ' 111' ' ' LEU . 84.3 t60 -78.14 109.87 12.61 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.04 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -107.71 157.09 18.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.11 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.63 150.08 38.07 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.051 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.7 pt -65.51 143.02 16.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 120.966 0.412 . . . . 0.0 110.435 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.0 t -62.14 120.3 56.78 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.53 -36.07 69.16 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 120.763 0.976 . . . . 0.0 110.104 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -58.85 -48.28 81.91 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.723 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.7 p -66.64 -39.03 88.07 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.035 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.9 tp -59.0 -50.09 75.44 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.072 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -59.16 -41.81 89.28 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.405 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.518 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -62.13 -42.1 98.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.588 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.1 t-105 -58.16 -48.73 79.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.44 -44.3 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.336 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.84 -40.02 83.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.255 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.527 HG21 ' CE ' ' A' ' 39' ' ' MET . 53.8 t -58.08 -45.19 88.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 54.3 t -64.48 -37.72 80.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.126 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -53.94 -46.94 71.7 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.641 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -89.53 -39.24 13.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.442 ' O ' HG21 ' A' ' 36' ' ' VAL . 99.6 mttt -120.65 38.23 4.08 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.78 -54.19 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -95.76 -5.74 41.29 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -53.94 140.23 51.45 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 118.561 0.618 . . . . 0.0 111.571 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.82 -29.68 34.83 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 122.563 2.175 . . . . 0.0 113.275 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -59.32 -21.69 60.13 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.542 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 30' ' ' LYS . 53.8 t -62.73 -43.35 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.131 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.43 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 8.7 mt -45.09 -61.19 2.44 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.844 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 73.9 Cg_exo -53.43 -42.25 66.97 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 120.072 1.062 . . . . 0.0 111.803 176.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.527 ' CE ' HG21 ' A' ' 26' ' ' VAL . 24.2 ttt -61.53 -44.14 97.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.726 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.423 ' CE2' HG21 ' A' ' 134' ' ' ILE . 62.9 t80 -54.82 -47.74 73.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -58.79 -43.54 90.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.809 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.85 -46.23 89.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.379 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.67 -26.11 64.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.254 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.0 m -88.14 6.7 35.25 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.483 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -62.65 125.1 22.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.617 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.66 10.67 83.08 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.961 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.1 150.74 35.62 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.12 0.486 . . . . 0.0 112.221 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.1 p -98.91 148.75 34.99 Favored Pre-proline 0 C--O 1.216 -0.677 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.694 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -45.08 -36.63 11.94 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 121.577 1.518 . . . . 0.0 112.923 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -69.74 -64.55 0.86 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.792 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.504 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -59.69 -37.37 78.63 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 122.378 1.085 . . . . 0.0 108.565 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 52' ' ' LEU . 56.2 tp -61.78 -46.81 87.97 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.243 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -59.19 -38.59 80.2 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 84.9 m -60.38 -40.12 89.74 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.045 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.72 -48.4 81.27 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.046 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.84 -41.46 95.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.229 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.49 -37.74 84.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.14 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.3 m -65.22 -34.81 79.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.327 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.5 t -55.34 151.3 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.44 -144.51 4.49 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.69 -127.65 45.74 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 119.926 -1.131 . . . . 0.0 110.545 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.473 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 22.3 p80 -54.26 -11.12 0.45 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.636 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -43.57 -24.36 0.11 Allowed 'General case' 0 C--O 1.234 0.286 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.33 -44.09 68.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.58 97.86 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.781 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 58.0 ttm -56.14 -22.39 28.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.397 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -57.04 -35.06 68.86 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 63.3 ttp -56.71 -46.9 80.99 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 tt -58.38 -38.31 77.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -55.68 -42.58 75.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.73 -40.19 88.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.699 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.656 HG22 ' OE2' ' A' ' 76' ' ' GLU . 99.9 m -57.75 -45.59 85.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.99 -41.57 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.093 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -59.96 -41.82 92.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.399 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.34 -47.3 86.52 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.235 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.656 ' OE2' HG22 ' A' ' 72' ' ' THR . 1.3 mp0 -62.74 -37.24 85.82 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.428 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.44 -42.38 91.81 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.223 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.91 -51.58 57.44 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.88 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.53 -43.23 94.67 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.592 0.71 . . . . 0.0 110.203 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.594 ' CZ2' HD13 ' A' ' 104' ' ' ILE . 66.7 t90 -60.77 -50.52 73.14 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.955 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -58.42 -37.68 75.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -63.14 -43.68 97.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.096 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -176.487 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 . . . . . 0 C--O 1.238 0.495 0 CA-C-O 121.201 0.524 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -88.9 155.35 50.06 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.468 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -39.99 103.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.136 0 C-N-CA 122.477 2.118 . . . . 0.0 114.386 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.413 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 69.4 ttt180 -99.05 158.45 15.65 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.571 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -54.99 -52.7 44.99 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.772 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.445 ' HB3' HG23 ' A' ' 108' ' ' THR . 66.8 m -63.46 -36.63 84.38 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 117.553 0.676 . . . . 0.0 109.701 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 94.8 m-20 -59.31 -38.75 81.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.022 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.594 HD13 ' CZ2' ' A' ' 80' ' ' TRP . 4.4 tp -58.23 -30.82 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 119.487 -0.885 . . . . 0.0 108.938 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.28 -20.53 37.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.158 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.97 -0.97 89.44 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.2 p -63.95 -25.89 68.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.445 HG23 ' HB3' ' A' ' 102' ' ' SER . 20.5 p -117.13 4.46 12.7 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.146 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 t -110.75 130.26 55.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.532 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.6 p -74.82 164.37 26.64 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.422 HD21 ' CD2' ' A' ' 12' ' ' HIS . 66.5 tp -59.38 -46.66 88.03 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.48 -41.78 94.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 117' ' ' TRP . 54.2 tp10 -61.51 -46.34 90.39 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.882 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -61.66 -43.21 99.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.398 0.436 . . . . 0.0 111.289 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.8 tt -66.03 -44.07 92.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.048 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.76 -42.37 79.66 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.416 ' CB ' ' O ' ' A' ' 113' ' ' GLU . 12.4 t90 -58.49 -45.77 88.04 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.165 -1.018 . . . . 0.0 109.275 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.527 ' SD ' HD11 ' A' ' 2' ' ' ILE . 27.9 ttt -72.5 -41.91 65.44 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.582 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.421 HG21 ' SD ' ' A' ' 10' ' ' MET . 66.6 p -125.32 -24.85 3.88 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -58.81 -49.06 79.09 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 118.317 -1.353 . . . . 0.0 109.324 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.18 179.52 1.86 Allowed Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.91 135.5 36.11 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -35.84 114.74 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.866 2.378 . . . . 0.0 113.5 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mm -106.88 109.04 62.89 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 72.8 Cg_endo -75.47 57.75 4.96 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.951 1.767 . . . . 0.0 112.872 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 127' ' ' GLY . 28.4 m -58.78 -43.28 87.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -64.09 -42.49 98.09 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.442 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 125' ' ' PRO . 88.8 tt0 -63.21 -45.15 93.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.322 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 89.0 mt -63.47 -49.47 82.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.05 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.661 ' CE2' HD11 ' A' ' 134' ' ' ILE . 86.8 t80 -59.3 -48.2 82.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.219 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.426 ' HA ' HD12 ' A' ' 134' ' ' ILE . 40.6 ttmt -61.17 -40.43 93.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.687 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -57.41 -43.08 83.44 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.589 ' CH2' HG21 ' A' ' 104' ' ' ILE . 46.3 m0 -60.8 -44.63 96.59 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.04 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.661 HD11 ' CE2' ' A' ' 130' ' ' TYR . 84.7 mt -58.52 -43.86 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.286 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.99 -41.69 87.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.759 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.63 -45.49 86.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.308 0.575 . . . . 0.0 110.044 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.74 -43.1 98.15 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.16 -36.79 84.81 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -58.67 -45.28 89.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.81 -39.69 94.85 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.494 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.1 mm -61.1 -49.97 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.9 m -58.09 -36.81 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.2 ttm105 -65.51 -38.67 90.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.803 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -60.58 -46.36 90.53 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -67.78 -25.49 65.63 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.73 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.3 t -43.78 111.93 1.22 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.972 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.74 -21.43 7.12 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.96 1.773 . . . . 0.0 113.761 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 70.8 p -138.18 167.57 21.56 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.1 m -107.18 149.47 27.67 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.949 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.534 ' HA ' HD12 ' A' ' 153' ' ' ILE . 5.1 tp -48.98 -36.54 8.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.589 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.1 tp -66.76 -39.62 87.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.43 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.61 -12.37 57.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.609 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 150' ' ' ILE . 90.1 mt -79.45 123.33 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.411 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -152.5 154.95 36.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.077 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 . . . . . 0 C--N 1.327 -0.372 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.321 -179.631 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -62.36 143.09 93.15 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.15 1.9 . . . . 0.0 111.218 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -57.44 -33.47 67.96 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -61.32 -45.91 92.49 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -60.29 -45.35 93.67 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.74 -50.57 71.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.341 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.7 -46.75 95.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.421 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -61.57 -51.97 66.36 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.203 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -63.05 -43.69 97.94 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.048 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.572 ' CE2' HG23 ' A' ' 186' ' ' THR . 85.5 t80 -58.55 -48.11 81.97 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.559 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -63.36 -37.33 86.87 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.625 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -59.42 -48.67 80.77 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.534 ' CB ' HD11 ' A' ' 153' ' ' ILE . 95.4 m -66.28 -39.5 89.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.442 HD12 ' CE2' ' A' ' 168' ' ' PHE . 7.7 tt -55.89 -37.81 69.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.137 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.9 ttt-85 . . . . . 0 N--CA 1.443 -0.789 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.049 179.593 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 44.9 m0 . . . . . 0 C--O 1.242 0.699 0 CA-C-O 121.408 0.623 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 61.9 mtt -61.98 -41.6 98.21 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.204 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.572 HG23 ' CE2' ' A' ' 168' ' ' PHE . 61.1 m -60.0 -43.5 95.14 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.855 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -57.92 -48.33 80.2 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.694 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 77.5 p -72.08 -43.55 64.65 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.833 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.2 mp -66.93 -31.29 71.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.344 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.411 HD21 ' SD ' ' A' ' 214' ' ' MET . 68.3 tp -51.82 -49.28 63.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.08 -45.18 18.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.89 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -59.11 -48.84 80.14 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -70.12 -24.93 63.27 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.66 145.27 54.97 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.556 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -59.48 143.53 85.78 Favored Pre-proline 0 C--N 1.346 0.447 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.487 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.46 -44.33 47.83 Favored 'Trans proline' 0 N--CA 1.504 2.131 0 C-N-CA 122.786 2.324 . . . . 0.0 115.477 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.38 -46.41 90.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 118.766 -1.173 . . . . 0.0 110.437 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 42.5 t -66.16 -43.13 87.84 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -49.62 -27.27 4.38 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.74 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 91.1 m -59.65 -49.35 78.09 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.602 -0.839 . . . . 0.0 108.778 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 4.5 tp -77.3 -38.37 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.746 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.425 HD22 ' SG ' ' A' ' 218' ' ' CYS . 0.1 OUTLIER -54.42 -44.11 72.12 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.03 -38.08 89.7 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.732 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -55.47 -37.69 68.12 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.966 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.31 -35.32 67.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.75 171.33 44.08 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.668 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.06 146.95 97.03 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 123.49 2.794 . . . . 0.0 113.357 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.16 1.28 87.78 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.43 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.749 ' HB3' ' CE ' ' A' ' 214' ' ' MET . . . -64.62 136.02 56.55 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.259 0.552 . . . . 0.0 111.695 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 212' ' ' GLU . 90.4 m -68.83 139.29 55.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.0 tp -57.03 -44.12 82.59 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.246 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.444 ' H ' HG22 ' A' ' 210' ' ' THR . 88.7 tt0 -58.2 -45.38 87.69 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -58.69 -42.3 88.23 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.749 ' CE ' ' HB3' ' A' ' 209' ' ' ALA . 60.5 mtt -63.51 -43.84 96.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.944 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 60.3 ttm -62.16 -50.11 73.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.52 0.676 . . . . 0.0 110.162 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.2 m -64.75 -45.43 86.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.064 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.05 79.12 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.109 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.425 ' SG ' HD22 ' A' ' 202' ' ' LEU . 97.8 m -64.69 -36.68 85.07 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.6 -36.76 76.91 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.986 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.73 -42.15 91.03 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.21 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.56 -18.27 6.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 117.179 0.489 . . . . 0.0 111.325 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -178.329 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo . . . . . 0 N--CA 1.482 0.794 0 N-CA-C 109.13 -1.142 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.456 HD11 ' SD ' ' A' ' 118' ' ' MET . 14.1 pt -65.42 113.78 2.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 109.891 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.0 t -126.27 126.71 69.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.187 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -63.58 127.57 31.95 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -83.96 -172.69 4.3 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.52 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.85 -38.04 80.99 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -66.71 -22.9 66.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.131 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.69 -7.96 57.95 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -73.21 126.35 29.86 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.985 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.2 mtt -81.56 135.22 35.58 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.005 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.5 m -133.1 134.1 58.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.518 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.414 ' NE2' HD11 ' A' ' 111' ' ' LEU . 62.2 t-80 -57.27 142.23 43.94 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.008 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -144.63 144.21 31.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.746 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.17 143.07 50.65 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.466 HD12 ' HG ' ' A' ' 20' ' ' LEU . 38.6 pt -61.87 142.42 16.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -61.07 118.68 38.23 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.23 -36.7 78.73 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 N-CA-C 109.734 -0.91 . . . . 0.0 109.734 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -58.44 -48.27 81.25 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.149 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.6 m -61.05 -46.18 91.73 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -48.96 -58.36 5.01 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.843 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -58.35 -39.19 78.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.843 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -61.6 -42.4 98.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.511 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -58.74 -50.68 73.02 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.546 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.3 t -62.74 -42.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.492 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.99 -42.89 91.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.371 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 22' ' ' ALA . 50.8 t -58.74 -44.32 89.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 76.9 t -64.29 -35.95 75.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.772 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -53.7 -46.71 70.83 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.679 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -92.28 -35.14 13.93 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.698 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' O ' HG21 ' A' ' 36' ' ' VAL . 98.9 mttt -121.22 37.84 4.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.778 -176.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.14 -53.62 3.94 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -96.96 -5.93 36.72 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -51.7 138.87 31.31 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.224 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.91 -31.89 46.4 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.392 2.061 . . . . 0.0 112.709 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.04 -18.75 26.44 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.935 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 30' ' ' LYS . 54.1 t -64.82 -42.48 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.925 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.426 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 6.9 mt -44.86 -60.67 2.84 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.814 -177.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.426 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 76.9 Cg_exo -53.95 -42.4 67.06 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 CA-C-N 119.985 1.03 . . . . 0.0 111.857 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.1 mtp -61.17 -43.41 98.93 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.672 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -56.03 -47.77 77.22 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.9 t -58.6 -44.69 89.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.042 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.77 -44.77 93.71 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.518 0.675 . . . . 0.0 110.114 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.72 -25.12 63.7 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.022 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.4 m -87.04 6.4 32.67 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.612 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.84 125.33 23.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.562 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.41 11.22 76.12 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 116.35 -0.387 . . . . 0.0 112.605 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.52 149.57 40.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.7 p -99.99 148.93 35.5 Favored Pre-proline 0 C--O 1.215 -0.722 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.622 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -45.81 -38.2 17.43 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.543 1.495 . . . . 0.0 113.323 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -70.37 -62.78 1.26 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.649 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.502 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -58.15 -36.73 73.43 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 52' ' ' LEU . 56.1 tp -62.12 -45.36 93.8 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -57.91 -37.86 74.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 84.8 m -59.47 -41.86 90.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.652 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.9 mtt -49.69 -50.08 45.04 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.274 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.09 -42.75 68.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.798 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -60.68 -40.72 93.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.799 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.413 HG23 HG22 ' A' ' 54' ' ' THR . 54.3 p -68.73 -26.53 65.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.89 158.54 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.87 -149.72 5.08 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.43 -127.54 45.43 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -51.21 -10.55 0.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.044 -0.578 . . . . 0.0 112.171 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -41.8 -24.34 0.04 OUTLIER 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.68 -42.97 75.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.91 94.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -56.92 -28.04 61.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.471 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -56.38 -35.41 67.69 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.8 ttp -58.07 -44.99 87.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.22 -40.71 86.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -54.26 -41.57 68.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.75 -41.53 95.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.7 m -59.28 -42.62 91.67 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.498 HD11 HG12 ' A' ' 134' ' ' ILE . 15.9 mm -60.01 -44.16 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -60.63 -41.87 95.77 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.194 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.71 -45.94 91.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.448 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.26 -39.25 94.07 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.23 -41.59 97.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.072 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.4 -50.46 69.76 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.447 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -64.23 -41.52 96.97 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.048 0.928 . . . . 0.0 108.94 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 78.5 t90 -60.37 -38.84 85.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 113.91 -1.496 . . . . 0.0 109.36 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -53.67 -45.33 70.25 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -66.64 -40.62 88.81 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.424 0.63 . . . . 0.0 110.946 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -176.427 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 . . . . . 0 C--O 1.237 0.443 0 CA-C-O 120.951 0.405 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -70.42 151.18 95.7 Favored Pre-proline 0 C--O 1.237 0.446 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.96 112.95 3.53 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.446 1.431 . . . . 0.0 113.675 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -73.4 171.52 12.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.493 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -54.23 -48.97 61.64 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 119.111 -1.518 . . . . 0.0 109.884 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.493 ' HB3' HG23 ' A' ' 108' ' ' THR . 70.3 m -60.65 -38.04 83.51 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.579 0.704 . . . . 0.0 109.517 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -59.61 -38.74 82.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.592 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.562 HG21 ' CZ3' ' A' ' 133' ' ' TRP . 0.4 OUTLIER -55.55 -31.39 28.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.78 -21.35 26.56 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.276 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.17 -6.93 82.37 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.7 p -57.6 -22.82 47.44 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.493 HG23 ' HB3' ' A' ' 102' ' ' SER . 36.1 p -119.55 29.87 7.38 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.632 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.9 m -129.53 135.05 48.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.279 -0.569 . . . . 0.0 112.393 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.2 m -76.86 145.31 38.43 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.414 HD11 ' NE2' ' A' ' 12' ' ' HIS . 6.8 tt -50.03 -45.96 52.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.154 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.07 -39.33 92.02 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.065 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.04 -40.36 96.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.289 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.37 -50.18 74.63 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.4 pt -70.67 -24.31 25.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.809 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.07 -65.91 2.65 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.451 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.437 ' C ' ' CD1' ' A' ' 117' ' ' TRP . 2.0 p90 -61.62 -31.44 71.53 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 118.125 -1.43 . . . . 0.0 109.137 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.456 ' SD ' HD11 ' A' ' 2' ' ' ILE . 27.6 ttt -63.59 -45.14 91.75 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.8 m -115.26 -26.7 7.52 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -58.87 -72.61 0.1 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.085 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -73.74 -177.01 0.54 Allowed Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.61 141.6 15.0 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 120.641 1.265 . . . . 0.0 109.459 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -46.16 123.94 6.99 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.671 1.58 . . . . 0.0 113.766 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.429 ' HB ' ' HD1' ' A' ' 117' ' ' TRP . 47.3 mm -114.91 107.97 49.38 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.84 60.13 4.06 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.909 1.739 . . . . 0.0 113.943 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.6 m -51.57 -37.34 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.73 99.67 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.423 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.46 -45.71 89.56 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.472 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 90.2 mt -64.71 -48.67 83.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.569 0.699 . . . . 0.0 110.17 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.699 ' CE2' HD11 ' A' ' 134' ' ' ILE . 84.4 t80 -59.01 -48.98 79.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.021 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.415 ' HA ' HD12 ' A' ' 134' ' ' ILE . 39.1 ttpt -63.02 -39.03 93.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.886 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -57.43 -43.19 83.64 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.562 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 44.1 m0 -62.69 -43.2 99.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.837 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.699 HD11 ' CE2' ' A' ' 130' ' ' TYR . 78.9 mt -58.43 -42.84 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.525 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.03 -41.6 83.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.78 -44.24 93.98 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.26 -42.57 97.36 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.52 -35.7 81.33 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -58.09 -44.51 87.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.67 -37.89 87.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.415 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.2 mm -60.77 -48.32 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.75 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.8 m -59.27 -34.76 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 118.42 -1.312 . . . . 0.0 107.471 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -65.83 -39.18 90.56 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.4 ttt -58.88 -45.44 90.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -74.89 -15.32 60.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.321 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.1 t -49.3 115.67 5.01 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.72 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -84.12 -30.35 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.107 1.871 . . . . 0.0 113.812 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.3 p -138.01 170.94 15.17 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 39.1 t -105.68 148.22 27.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.638 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.654 ' HA ' HD12 ' A' ' 153' ' ' ILE . 5.4 tp -49.46 -38.41 12.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.549 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.7 tp -65.6 -39.33 91.43 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.556 0.693 . . . . 0.0 109.798 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -67.64 0.32 3.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.553 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 150' ' ' ILE . 96.8 mt -100.65 119.0 48.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.025 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -145.93 132.04 19.35 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.8 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 . . . . . 0 C--O 1.237 0.428 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.407 -179.491 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.28 136.19 23.85 Favored 'Trans proline' 0 N--CA 1.512 2.579 0 C-N-CA 123.171 2.58 . . . . 0.0 113.613 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.404 ' O ' HG23 ' A' ' 165' ' ' VAL . 11.8 t80 -61.51 -28.17 69.12 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -61.96 -50.94 70.09 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.775 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -64.92 -40.26 94.78 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -59.2 -50.86 72.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.395 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 161' ' ' PHE . 54.5 t -61.76 -43.82 97.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.8 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.68 -59.16 5.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.058 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.44 -40.75 97.59 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.073 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.626 ' HE2' HG23 ' A' ' 186' ' ' THR . 76.0 t80 -57.69 -47.1 83.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -62.5 -41.77 99.05 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.542 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -59.75 -40.29 87.65 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.092 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.595 ' OG1' HD11 ' A' ' 153' ' ' ILE . 93.6 m -62.63 -41.89 99.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.58 HD11 ' CE2' ' A' ' 168' ' ' PHE . 82.6 mt -60.69 -39.45 88.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 . . . . . 0 N--CA 1.448 -0.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.002 -179.648 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 . . . . . 0 C--O 1.242 0.693 0 CA-C-O 121.243 0.544 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 74.0 mtm -62.84 -41.29 99.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.947 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.626 HG23 ' HE2' ' A' ' 168' ' ' PHE . 54.4 m -59.46 -46.05 89.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.148 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.46 -47.05 86.99 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.513 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.3 m -67.49 -49.54 63.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.315 0.579 . . . . 0.0 112.007 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.35 -32.29 73.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.876 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.602 HD21 ' SD ' ' A' ' 214' ' ' MET . 62.9 tp -51.03 -46.36 61.57 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.504 HG22 HD12 ' A' ' 202' ' ' LEU . 85.2 t -85.79 -46.16 16.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.028 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -60.31 -49.44 77.61 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -70.37 -22.55 62.76 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.705 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.74 153.75 10.16 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.621 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -68.99 148.5 97.89 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.74 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.23 -41.98 67.7 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.377 2.051 . . . . 0.0 114.376 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.62 -50.0 75.56 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.447 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 10.5 t -70.0 -37.77 75.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -47.11 -26.89 1.21 Allowed 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.092 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 69.0 p -62.49 -55.06 31.11 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.421 -1.312 . . . . 0.0 108.455 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 40.0 mm -65.07 -45.66 93.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.154 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.504 HD12 HG22 ' A' ' 191' ' ' VAL . 0.1 OUTLIER -54.82 -51.5 65.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.057 0.932 . . . . 0.0 108.834 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.31 -36.55 78.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -59.0 -39.71 82.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.747 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -57.46 -44.38 84.74 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 119.421 -0.911 . . . . 0.0 108.713 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 79.43 175.57 47.66 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.085 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.73 150.95 79.98 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 124.011 3.141 . . . . 0.0 113.38 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 81.06 0.27 88.54 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.6 119.2 13.48 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.178 0.513 . . . . 0.0 110.382 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 212' ' ' GLU . 94.2 m -61.07 139.36 58.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.1 tp -54.82 -46.08 74.5 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.604 -0.838 . . . . 0.0 108.873 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.401 ' H ' HG22 ' A' ' 210' ' ' THR . 80.8 tt0 -55.41 -48.11 74.88 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.482 0.658 . . . . 0.0 109.332 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -57.76 -42.47 84.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.602 ' SD ' HD21 ' A' ' 190' ' ' LEU . 58.9 ttm -63.01 -45.72 91.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.75 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 61.8 tpp -61.99 -45.64 92.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.9 m -62.54 -49.75 74.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.74 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.72 95.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.708 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 78.3 m -61.02 -40.81 94.99 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.67 -40.85 97.86 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.087 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.12 97.92 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 23.9 m -82.59 -23.61 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.675 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.567 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.844 178.788 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.485 0.984 0 N-CA-C 108.837 -1.255 . . . . 0.0 108.837 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.597 HD11 ' SD ' ' A' ' 118' ' ' MET . 18.6 pt -67.62 119.32 13.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 110.071 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.47 138.07 48.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.505 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -69.71 125.01 25.44 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.958 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -78.33 -172.46 2.85 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.201 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 6' ' ' LEU . 9.6 mp -58.77 -38.18 77.92 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.44 -22.87 65.48 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.594 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.33 -7.75 58.46 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.77 127.78 33.82 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 120.171 -0.611 . . . . 0.0 109.524 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.494 ' SD ' HG21 ' A' ' 119' ' ' THR . 66.3 mtt -77.14 127.19 32.21 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.763 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 82.3 t -126.27 128.61 71.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.553 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -61.75 142.55 57.19 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.035 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -145.34 146.83 31.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.218 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.82 143.04 49.62 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.265 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.505 HD12 ' HG ' ' A' ' 20' ' ' LEU . 33.4 pt -61.81 144.25 14.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 120.902 0.382 . . . . 0.0 110.609 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 t -62.05 120.35 56.94 Favored Pre-proline 0 N--CA 1.453 -0.313 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -53.56 -36.9 82.17 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 N-CA-C 109.492 -1.003 . . . . 0.0 109.492 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -57.8 -48.49 79.56 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.164 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 84.1 m -60.84 -47.15 87.67 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.231 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.505 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -50.51 -57.03 9.04 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.905 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -58.3 -39.31 79.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.778 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.03 98.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.197 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.413 ' O ' HG23 ' A' ' 27' ' ' VAL . 22.1 t-105 -59.06 -49.76 76.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.483 0.658 . . . . 0.0 109.505 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.39 -40.3 88.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.095 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.4 -49.02 79.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.554 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.3 m -61.95 -35.55 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.713 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 79.7 t -66.83 -36.22 76.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.0 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -53.61 -47.07 70.54 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.579 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -89.42 -37.47 14.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -120.68 38.06 4.12 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.954 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.9 -51.16 5.64 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -175.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -96.11 -4.59 42.51 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.8 m -55.05 145.93 41.7 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.741 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.25 -32.59 20.38 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.486 2.124 . . . . 0.0 112.437 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.61 -20.07 30.37 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.886 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.69 -41.88 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.754 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.427 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 6.7 mt -45.72 -61.22 2.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.872 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 76.2 Cg_exo -54.78 -41.61 76.47 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 CA-C-N 120.176 1.099 . . . . 0.0 111.729 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 58.8 ttm -59.69 -46.87 87.77 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.338 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -55.07 -47.49 74.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -58.2 -44.48 88.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.719 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.67 -44.77 93.46 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.097 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.6 -22.61 62.53 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.138 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.7 m -87.66 5.81 37.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.593 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -60.9 126.16 26.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.742 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.01 11.23 69.77 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 121.315 -0.469 . . . . 0.0 112.231 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.13 146.26 50.97 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 112.543 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.0 m -99.72 141.3 22.54 Favored Pre-proline 0 C--O 1.215 -0.727 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -46.36 -36.2 17.18 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 CA-C-N 120.789 1.318 . . . . 0.0 113.222 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -68.59 -63.9 0.97 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.301 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.483 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -59.82 -37.58 79.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.265 1.031 . . . . 0.0 108.737 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.07 -45.31 92.76 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.773 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -57.72 -39.69 77.87 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 86.3 m -59.91 -39.28 84.87 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.48 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 97.9 mtp -57.98 -48.27 80.48 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.153 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.421 HD11 HD13 ' A' ' 134' ' ' ILE . 87.6 mt -65.53 -41.78 92.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.826 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -61.54 -36.46 80.65 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.206 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.5 m -65.56 -34.45 78.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.924 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.7 141.72 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.026 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -130.6 -140.27 4.65 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.4 -127.89 46.06 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.743 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -53.08 -11.33 0.24 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.853 -0.673 . . . . 0.0 111.669 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -41.92 -22.78 0.02 OUTLIER 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.78 -41.52 70.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.78 98.1 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 57.7 ttm -57.28 -26.22 60.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.038 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -56.97 -35.24 68.92 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.3 ttp -58.01 -46.2 85.66 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -57.65 -37.88 74.13 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -56.26 -42.95 78.23 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.37 -40.15 93.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.294 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.8 m -58.88 -43.46 90.91 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.0 mt -60.8 -43.04 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -59.99 -41.48 92.13 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.027 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.24 -47.07 84.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.869 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -61.79 -40.1 94.02 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.25 94.15 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.862 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.04 74.69 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.404 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.43 -38.56 90.26 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.903 0.859 . . . . 0.0 108.975 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.59 ' CH2' HD13 ' A' ' 129' ' ' ILE . 76.2 t-105 -58.2 -45.92 86.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.659 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -49.8 -47.44 51.3 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.856 0.722 . . . . 0.0 109.136 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -64.0 -39.87 95.08 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.301 0.572 . . . . 0.0 110.892 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.14 -44.56 68.63 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -121.04 -60.6 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.229 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 85.1 Cg_exo -52.08 -33.08 51.77 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 CA-C-N 120.85 1.339 . . . . 0.0 111.343 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 t -77.88 -16.89 14.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.103 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -45.83 -30.01 1.54 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.52 -16.84 0.43 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.731 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.8 -114.03 4.1 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 106.437 -2.665 . . . . 0.0 106.437 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.82 141.12 97.65 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 119.347 1.573 . . . . 0.0 109.606 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.455 HD13 ' OE1' ' A' ' 98' ' ' GLU . 20.3 tt -137.09 158.53 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.49 148.72 89.84 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-O 120.488 0.185 . . . . 0.0 111.363 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.39 168.27 25.19 Favored 'Trans proline' 0 N--CA 1.504 2.129 0 C-N-CA 122.976 2.451 . . . . 0.0 113.019 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.44 -7.41 68.7 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.974 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -123.95 152.74 42.14 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 122.618 -0.342 . . . . 0.0 110.589 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -60.28 136.47 58.05 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.525 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -56.14 121.09 8.63 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.455 ' OE1' HD13 ' A' ' 91' ' ' ILE . 23.3 mp0 -56.53 141.64 71.72 Favored Pre-proline 0 C--O 1.238 0.465 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.8 111.72 0.98 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.25 1.3 . . . . 0.0 113.035 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.39 167.32 21.51 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.28 -43.28 89.47 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 119.072 -1.537 . . . . 0.0 109.788 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.4 t -61.0 -41.9 97.41 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.539 0.685 . . . . 0.0 109.232 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -61.94 -37.84 86.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.013 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.62 HD13 HG12 ' A' ' 126' ' ' VAL . 12.4 mm -57.7 -45.67 86.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.53 -17.64 64.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.55 0.16 89.28 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.1 p -64.22 -21.77 66.7 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.986 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.2 p -127.41 33.27 4.89 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.4 p -137.88 145.74 42.54 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.651 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.0 m -82.91 145.41 29.42 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -49.74 -44.94 48.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.61 -40.93 96.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.545 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -63.7 -43.26 97.13 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.163 0.506 . . . . 0.0 111.152 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -58.4 -47.86 82.53 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.35 -40.6 88.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.306 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.68 -63.91 4.42 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.662 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.438 ' CD1' ' N ' ' A' ' 118' ' ' MET . 1.2 p90 -59.75 -29.25 68.03 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 117.731 -1.587 . . . . 0.0 109.654 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.597 ' SD ' HD11 ' A' ' 2' ' ' ILE . 26.2 ttt -65.72 -45.01 84.3 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.494 HG21 ' SD ' ' A' ' 10' ' ' MET . 82.3 p -119.55 -24.27 6.33 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -58.19 -70.72 0.13 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.776 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -76.54 -177.34 0.74 Allowed Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -48.23 136.3 24.77 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 CA-C-N 120.619 1.257 . . . . 0.0 109.541 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -38.26 119.84 0.4 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.874 2.383 . . . . 0.0 114.509 -176.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.0 mm -112.98 106.84 54.87 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.57 59.95 4.26 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.257 1.971 . . . . 0.0 113.712 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.62 HG12 HD13 ' A' ' 104' ' ' ILE . 2.8 m -48.99 -38.74 11.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.28 99.71 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.627 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.52 -47.18 85.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.308 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.59 HD13 ' CH2' ' A' ' 80' ' ' TRP . 89.6 mt -63.64 -48.76 85.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.511 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.761 ' CE2' HD11 ' A' ' 134' ' ' ILE . 89.8 t80 -59.05 -48.56 81.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.909 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.506 ' HA ' HD12 ' A' ' 134' ' ' ILE . 38.5 ttpt -62.38 -38.06 88.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.592 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -58.73 -42.09 87.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.488 ' CH2' HG21 ' A' ' 104' ' ' ILE . 47.1 m0 -62.3 -43.83 97.92 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.761 HD11 ' CE2' ' A' ' 130' ' ' TYR . 85.7 mt -59.64 -45.26 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.62 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.14 -41.85 84.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.87 -42.53 99.8 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.23 -42.26 98.61 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.98 -36.21 83.23 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -58.45 -44.49 89.22 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.37 -38.9 91.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.557 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.4 mm -60.49 -49.64 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.0 m -57.74 -35.56 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -65.1 -39.83 93.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -59.2 -45.12 91.91 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -70.71 -22.06 62.49 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.442 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.7 t -43.03 106.59 0.49 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.538 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.01 -32.88 8.21 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.107 1.872 . . . . 0.0 113.758 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.9 p -137.95 172.6 12.69 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.3 m -104.98 149.99 25.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.125 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.4 mm -49.92 -42.03 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.9 tp -60.33 -39.26 86.46 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.19 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.85 -11.43 55.59 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.633 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.8 mm -75.71 119.95 24.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.82 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -152.93 134.1 14.18 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -94.79 134.25 37.61 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.007 0.432 . . . . 0.0 111.665 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -90.7 158.17 25.96 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.7 -33.44 96.48 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.64 1.56 . . . . 0.0 111.275 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -81.13 -17.76 48.76 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.164 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -79.39 146.63 66.64 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.28 139.34 11.62 Favored 'Trans proline' 0 N--CA 1.507 2.271 0 C-N-CA 123.577 2.851 . . . . 0.0 114.267 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.408 ' O ' HG23 ' A' ' 165' ' ' VAL . 26.3 t80 -59.28 -26.72 65.2 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.422 ' H ' ' HA ' ' A' ' 224' ' ' PRO . 40.7 ttm180 -62.67 -51.44 67.23 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.811 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.27 -37.93 86.62 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.713 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -60.24 -50.56 73.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.674 0.75 . . . . 0.0 109.857 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 161' ' ' PHE . 54.7 t -64.7 -45.0 96.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.304 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -60.49 -51.51 69.13 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.948 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -66.24 -39.37 89.48 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.672 ' CE2' HG23 ' A' ' 186' ' ' THR . 87.8 t80 -58.78 -49.49 77.48 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -66.36 -36.25 82.42 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.299 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -58.27 -47.89 82.18 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 96.6 m -68.5 -39.39 81.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.133 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.24 -39.38 72.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.025 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -59.3 -41.72 89.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.307 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -80.87 -11.2 59.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.03 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -57.88 140.45 51.91 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.179 0.514 . . . . 0.0 111.705 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -71.93 -93.72 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.432 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -43.29 139.47 1.93 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.805 0.812 . . . . 0.0 112.082 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 70.8 m -64.8 178.11 0.84 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.955 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -48.8 -21.73 0.68 Allowed 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.025 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -56.15 -46.88 79.12 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 86.8 t -89.45 -56.51 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.921 176.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -42.33 -51.22 4.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.167 -1.378 . . . . 0.0 112.448 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -59.58 -44.55 93.31 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.741 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -60.9 -50.11 74.76 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.724 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 91.1 mmm -62.56 -43.89 97.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.177 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.672 HG23 ' CE2' ' A' ' 168' ' ' PHE . 62.1 m -61.09 -45.75 93.43 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.609 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.81 -48.29 80.17 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.205 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 96.7 m -67.35 -47.27 70.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.236 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.9 -31.55 71.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.838 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.439 ' CD1' HG22 ' A' ' 186' ' ' THR . 16.4 mt -52.38 -43.4 64.7 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.309 -0.957 . . . . 0.0 108.892 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.3 t -85.72 -47.82 16.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.817 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -61.06 -49.38 77.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -70.12 -22.7 62.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.704 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.52 150.86 25.74 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -68.97 153.71 95.81 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.184 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.419 ' HA ' ' HB3' ' A' ' 199' ' ' LYS . 52.3 Cg_exo -57.09 -45.68 34.06 Favored 'Trans proline' 0 N--CA 1.509 2.393 0 C-N-CA 122.544 2.162 . . . . 0.0 115.521 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.76 -50.22 74.68 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.554 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 36.4 t -69.4 -39.34 78.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 196' ' ' PRO . 40.3 ttmt -49.02 -32.12 8.8 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.427 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.9 m -59.71 -48.79 80.29 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.935 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.627 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 48.2 mm -67.67 -43.14 86.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.466 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.404 HD11 ' CE1' ' A' ' 161' ' ' PHE . 82.1 mt -59.87 -39.67 86.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -61.35 -38.99 88.94 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -59.73 -40.1 86.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.478 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.76 -41.23 90.57 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.911 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.77 -159.18 52.59 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.779 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.19 166.49 5.71 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 123.5 2.8 . . . . 0.0 112.557 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.76 -126.35 40.68 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 56.73 96.62 0.02 OUTLIER 'General case' 0 C--O 1.238 0.48 0 C-N-CA 120.396 -0.521 . . . . 0.0 110.332 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 76.4 p -61.65 157.58 17.26 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.152 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.35 -34.84 61.95 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -61.64 -50.15 73.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.352 0.596 . . . . 0.0 109.799 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.99 -42.43 94.19 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.6 ttm -60.87 -46.84 89.03 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.415 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 1.7 mmt -64.11 -41.43 97.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.1 0.476 . . . . 0.0 109.753 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.8 m -63.36 -49.83 72.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.409 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.96 -43.75 94.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.51 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 75.4 m -60.48 -40.76 92.49 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -60.97 -41.82 97.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.11 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.0 -39.93 96.31 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.527 HG21 HG21 ' A' ' 201' ' ' ILE . 34.4 m -91.95 6.04 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.903 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 70.34 18.85 75.51 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 120.27 -0.966 . . . . 0.0 111.842 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.453 ' N ' ' HD2' ' A' ' 224' ' ' PRO . . . -58.85 -42.16 96.48 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-O 119.038 -0.868 . . . . 0.0 112.128 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 223' ' ' GLY . 44.2 Cg_endo -69.04 -1.9 8.7 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.615 2.207 . . . . 0.0 112.809 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -98.85 -48.27 1.79 Allowed Glycine 0 CA--C 1.535 1.335 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -156.3 -49.0 0.08 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.263 0.554 . . . . 0.0 110.123 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -173.28 -158.85 0.1 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.453 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.23 -13.71 3.47 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.629 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 221' ' ' VAL . 66.7 mtp180 -50.67 128.39 20.41 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.732 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.8 m -37.43 -33.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 123.897 0.748 . . . . 0.0 112.568 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.431 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo . . . . . 0 N--CA 1.483 0.904 0 N-CA-C 109.349 -1.058 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.6 pt -77.78 125.06 37.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.5 t -127.63 127.4 68.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.457 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -63.66 126.15 26.62 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -81.43 -173.39 4.34 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.291 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 6' ' ' LEU . 86.7 mt -59.71 -38.54 81.9 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -67.39 -21.7 65.59 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.566 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.49 -7.73 58.17 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -72.15 124.86 25.91 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.695 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.0 mtt -79.52 130.98 35.9 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.735 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.96 138.91 50.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 120.174 -0.611 . . . . 0.0 111.396 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -57.5 142.23 44.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.219 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -144.91 140.37 28.25 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.606 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.56 139.84 51.59 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.785 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.443 HD12 ' HG ' ' A' ' 20' ' ' LEU . 38.0 pt -61.87 137.24 24.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.558 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.7 t -60.28 122.76 69.33 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.637 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.36 -38.55 73.48 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 120.852 1.035 . . . . 0.0 110.973 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -56.91 -43.35 81.32 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.279 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.4 m -63.11 -46.81 85.58 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.443 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -49.74 -60.51 2.82 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.328 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -57.74 -39.42 77.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.891 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -61.51 -43.1 99.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.491 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -58.93 -50.2 74.94 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.56 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.5 t -62.07 -42.23 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.206 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.99 -41.95 88.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.027 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 22' ' ' ALA . 49.3 t -58.74 -45.38 91.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 67.1 t -64.17 -37.12 79.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.844 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -55.56 -45.66 77.25 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.685 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -92.86 -27.75 16.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.85 38.25 3.56 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.697 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.82 -54.48 3.37 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -175.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -96.03 -5.75 40.33 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 t -51.81 139.2 31.86 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.208 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.98 -32.83 34.21 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.476 2.117 . . . . 0.0 112.959 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -57.98 -18.65 25.19 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.995 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.81 -42.74 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.834 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.422 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 8.0 mt -44.79 -61.18 2.36 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.853 -178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 71.3 Cg_exo -54.38 -42.0 71.6 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 120.081 1.065 . . . . 0.0 111.732 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.489 ' CE ' HG21 ' A' ' 26' ' ' VAL . 20.7 ttt -60.63 -44.94 95.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.349 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -55.42 -47.1 76.48 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -58.41 -44.84 89.2 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.997 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.59 94.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.53 0.681 . . . . 0.0 110.2 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.1 mt -70.44 -24.8 62.96 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.097 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.1 m -89.43 6.45 40.7 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.601 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.33 125.47 23.88 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.565 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.64 10.83 76.73 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.598 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' A' ' 52' ' ' LEU . . . -70.42 150.26 46.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.344 0.592 . . . . 0.0 112.354 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.8 m -99.72 142.38 24.51 Favored Pre-proline 0 C--O 1.217 -0.649 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.38 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -42.71 -38.82 6.8 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.466 1.444 . . . . 0.0 113.365 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -73.88 -61.32 1.89 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.041 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.452 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.93 -38.36 75.8 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.401 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . 57.3 tp -64.9 -44.29 90.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.648 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -57.72 -39.97 78.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 92.9 m -63.09 -39.58 95.13 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.953 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.45 ' O ' HG22 ' A' ' 58' ' ' THR . 28.2 ttt -56.8 -49.37 75.55 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.99 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.9 mt -69.8 -40.38 76.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.518 0.675 . . . . 0.0 110.155 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.53 -37.75 79.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.987 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 55' ' ' MET . 0.6 OUTLIER -66.33 -20.32 66.06 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.792 -178.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.85 140.0 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.51 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.84 -151.84 7.88 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.1 -127.75 45.92 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.924 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -51.32 -10.0 0.08 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.813 -0.693 . . . . 0.0 112.287 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -42.99 -21.28 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.39 -40.46 71.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.11 97.78 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.435 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 11.3 tmm? -58.32 -20.17 41.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.488 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.3 tp-100 -58.22 -39.32 78.75 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.4 tmm? -59.56 -42.36 92.26 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 66' ' ' MET . 61.3 tp -57.68 -40.7 80.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -59.15 -41.81 89.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.2 -39.64 93.1 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.81 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.1 m -59.83 -44.06 94.26 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.465 HD11 ' CD1' ' A' ' 134' ' ' ILE . 91.5 mt -60.82 -43.87 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -60.34 -41.91 94.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.483 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 88.8 tt0 -62.06 -46.84 87.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.19 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -63.83 -38.6 91.69 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.86 -39.19 88.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 75' ' ' GLU . . . -64.53 -51.24 63.89 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.845 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -64.8 -43.29 93.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 122.048 0.928 . . . . 0.0 109.468 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.494 ' CZ2' HD13 ' A' ' 104' ' ' ILE . 83.2 t90 -61.2 -41.47 96.87 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.779 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -59.6 -43.07 93.84 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -60.53 -33.77 73.14 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.597 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt -108.53 -48.41 3.33 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.434 ' CB ' ' HD3' ' A' ' 85' ' ' PRO . 8.5 m-70 -72.28 -69.08 0.37 Allowed Pre-proline 0 N--CA 1.473 0.709 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -177.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HD3' ' CB ' ' A' ' 84' ' ' HIS . 51.5 Cg_exo -58.24 -37.6 94.62 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 CA-C-N 121.578 1.599 . . . . 0.0 110.254 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.93 -14.66 3.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.724 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -45.98 -31.66 2.35 Favored 'General case' 0 C--N 1.348 0.503 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.71 -2.64 0.16 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.542 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 53.1 -116.22 5.38 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 107.776 -2.13 . . . . 0.0 107.776 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.36 145.75 92.52 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 CA-C-N 119.269 1.534 . . . . 0.0 110.405 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.2 tp -132.2 148.77 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.72 148.7 94.03 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -63.73 165.83 17.42 Favored 'Trans proline' 0 N--CA 1.508 2.357 0 C-N-CA 122.823 2.349 . . . . 0.0 113.048 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.37 -7.35 63.87 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.143 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -123.82 153.09 41.52 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.902 0.382 . . . . 0.0 111.085 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.1 mmt -63.17 146.34 53.54 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.498 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 -52.06 115.61 1.78 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.357 0.598 . . . . 0.0 109.555 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.78 156.42 86.93 Favored Pre-proline 0 C--O 1.24 0.565 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.096 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.24 128.76 14.86 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.921 1.748 . . . . 0.0 113.475 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.5 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 3.4 mtt85 -126.13 151.95 46.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.778 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.618 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -42.1 -61.32 2.38 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.479 -176.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 108' ' ' THR . 74.7 m -61.34 -37.88 84.88 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 122.073 -0.663 . . . . 0.0 110.844 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 6.7 m-20 -61.53 -38.1 86.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.865 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.624 HG21 ' CH2' ' A' ' 133' ' ' TRP . 7.0 tp -58.44 -31.47 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.578 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.24 -10.42 56.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.613 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.92 0.12 87.95 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 48.8 p -63.48 -23.99 67.63 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.06 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 102' ' ' SER . 20.8 p -123.92 18.75 9.33 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.746 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.5 m -119.21 131.17 55.79 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.34 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -70.94 147.54 48.62 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.3 tp -53.46 -44.69 69.12 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.287 -0.965 . . . . 0.0 108.448 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.43 -40.58 94.96 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.08 -43.51 98.67 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.19 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -62.78 -41.25 99.17 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.246 0.341 . . . . 0.0 110.979 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 34.7 pt -68.15 -41.83 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.924 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.99 -41.86 70.31 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -58.88 -46.16 88.48 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.013 -1.094 . . . . 0.0 109.102 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.9 ttt -71.39 -42.58 68.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.44 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.6 m -125.78 -26.9 3.42 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -58.43 -49.92 75.57 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 118.455 -1.298 . . . . 0.0 109.814 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -81.54 -177.88 1.05 Allowed Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.51 144.51 32.18 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 N-CA-C 107.105 -1.921 . . . . 0.0 107.105 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -45.86 124.0 6.66 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 121.348 1.365 . . . . 0.0 112.997 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.417 HG22 HG13 ' A' ' 126' ' ' VAL . 45.8 mm -113.47 108.33 52.28 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.408 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 72.0 Cg_endo -74.72 56.86 4.21 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.958 1.772 . . . . 0.0 113.111 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 127' ' ' GLY . 21.6 m -58.74 -45.75 91.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.481 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -63.63 -44.37 96.57 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.205 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 125' ' ' PRO . 88.7 tt0 -60.32 -44.63 95.29 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.973 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.09 -47.85 91.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.865 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -59.09 -50.13 75.26 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.912 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -61.91 -38.57 88.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.967 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -56.66 -43.67 80.61 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.624 ' CH2' HG21 ' A' ' 104' ' ' ILE . 44.4 m0 -63.35 -44.44 94.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.593 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.465 ' CD1' HD11 ' A' ' 73' ' ' ILE . 29.7 mm -58.33 -44.88 89.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.455 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.74 -42.44 88.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.16 -43.67 97.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.381 0.61 . . . . 0.0 109.615 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.32 -42.28 99.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.26 -35.9 81.88 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -58.32 -45.0 88.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.79 -38.64 91.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.473 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.4 mm -60.9 -49.8 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 16.7 m -58.28 -36.16 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -65.49 -38.79 90.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.822 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 63.7 tpp -59.74 -46.75 88.17 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -71.62 -15.62 62.25 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.215 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.3 t -49.07 116.94 5.98 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.846 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.46 -40.19 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.949 1.766 . . . . 0.0 113.539 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 58.3 p -138.38 169.04 18.49 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.2 t -92.26 148.53 22.07 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.471 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.628 HD11 ' CZ ' ' A' ' 168' ' ' PHE . 17.5 tt -51.28 -36.45 17.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.43 -39.45 92.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.238 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -66.8 -9.84 41.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.492 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.57 HD13 ' HA ' ' A' ' 168' ' ' PHE . 81.6 mt -81.87 120.31 33.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.945 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -142.33 123.55 14.67 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.56 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -83.12 128.53 34.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.34 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -90.25 164.17 30.69 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -62.17 -28.19 79.36 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.041 1.827 . . . . 0.0 110.572 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.64 1.35 55.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.491 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 160' ' ' PRO . 95.9 mt-10 -99.02 146.88 32.43 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.842 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 163' ' ' ASP . 5.4 Cg_exo -75.36 135.13 18.04 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.704 2.27 . . . . 0.0 114.019 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.4 ' O ' HG23 ' A' ' 165' ' ' VAL . 49.9 t80 -61.55 -36.27 80.12 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.433 ' N ' ' HA ' ' A' ' 224' ' ' PRO . 42.5 ttm180 -61.83 -47.7 83.9 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.087 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.419 ' H ' ' HB2' ' A' ' 160' ' ' PRO . 50.4 t0 -61.33 -41.62 97.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.86 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -61.13 -50.4 73.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.788 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 161' ' ' PHE . 53.5 t -62.14 -47.7 91.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.618 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.43 -50.99 70.57 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.28 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -64.85 -39.12 93.05 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.252 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.628 ' CZ ' HD11 ' A' ' 150' ' ' ILE . 88.1 t80 -60.42 -50.21 74.5 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.08 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.45 ' OH ' HD22 ' A' ' 211' ' ' LEU . 21.7 m-85 -69.49 -41.61 75.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.305 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -60.38 -46.33 90.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.511 ' CB ' HD11 ' A' ' 153' ' ' ILE . 91.9 m -65.21 -37.68 88.04 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.595 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.55 -49.15 78.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.314 0.578 . . . . 0.0 110.049 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -60.72 -43.77 97.45 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.69 -37.5 78.99 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.379 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -61.18 168.59 2.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.865 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -59.85 -163.52 0.01 OUTLIER 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -109.73 112.67 24.88 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 119.4 -0.92 . . . . 0.0 113.246 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.511 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 67.4 m -98.47 134.79 40.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -86.7 -65.49 1.01 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 117.033 -1.867 . . . . 0.0 110.366 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -88.48 -40.75 13.21 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.427 ' HB ' ' HB3' ' A' ' 178' ' ' SER . 25.0 t -55.74 -29.08 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 113.239 -1.801 . . . . 0.0 109.82 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 178' ' ' SER . 87.1 tttt -59.73 -50.11 75.13 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 118.236 -1.386 . . . . 0.0 108.953 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -70.0 -43.32 71.65 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.987 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -64.07 -50.89 66.59 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.281 0.563 . . . . 0.0 112.257 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.463 ' SD ' HG21 ' A' ' 150' ' ' ILE . 59.9 ttm -60.67 -46.05 91.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.575 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.516 HG23 ' HE2' ' A' ' 168' ' ' PHE . 65.8 m -59.35 -48.68 80.71 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.976 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.25 -47.68 84.95 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.702 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 97.1 m -63.15 -48.03 80.18 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.98 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.425 HD23 ' ND2' ' A' ' 193' ' ' ASN . 8.2 mp -68.4 -34.18 75.56 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.699 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 17.1 mt -50.01 -45.88 52.26 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.142 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.0 t -81.37 -47.38 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.852 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -61.92 -50.77 70.83 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.425 ' ND2' HD23 ' A' ' 189' ' ' LEU . 97.6 m-20 -73.21 -23.13 60.35 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.365 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 190' ' ' LEU . . . -57.02 155.09 8.67 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.787 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -72.58 155.68 90.83 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.72 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.19 -39.78 82.04 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 122.454 2.102 . . . . 0.0 113.72 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.535 ' CB ' ' HB3' ' A' ' 228' ' ' ALA . 98.7 m-20 -59.3 -49.33 78.25 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.808 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 9.6 t -73.51 -36.79 65.78 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -47.14 -37.88 10.66 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.741 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.3 m -60.3 -50.22 74.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.293 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.624 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 40.4 mm -68.11 -44.02 84.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.45 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 81.9 mt -59.12 -44.11 91.99 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -63.41 -38.1 89.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -60.03 -39.46 85.97 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.976 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.34 -35.84 70.42 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.699 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.02 172.75 49.03 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.55 155.31 54.95 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 123.733 2.955 . . . . 0.0 113.459 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.39 1.78 88.81 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.469 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.42 128.15 34.7 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.279 0.561 . . . . 0.0 111.126 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 34.7 m -66.31 143.97 56.86 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.45 HD22 ' OH ' ' A' ' 169' ' ' TYR . 68.4 tp -54.32 -44.67 72.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -57.92 -46.96 84.2 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -58.12 -43.72 87.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 98.3 mtp -62.35 -46.14 90.03 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.957 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 98.3 mtp -65.22 -41.04 94.81 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.825 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.0 m -63.28 -50.02 71.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.512 0.672 . . . . 0.0 110.468 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.31 98.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.408 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 76.2 m -60.88 -40.35 92.67 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.29 -39.23 82.31 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.83 -38.83 92.98 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.3 m -94.59 4.52 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 120.713 -0.395 . . . . 0.0 112.022 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.29 19.54 79.8 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.831 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.41 ' N ' ' CD ' ' A' ' 224' ' ' PRO . . . -58.43 -43.81 95.62 Favored Glycine 0 CA--C 1.542 1.723 0 CA-C-O 119.376 -0.68 . . . . 0.0 111.929 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.433 ' HA ' ' N ' ' A' ' 162' ' ' ARG . 86.3 Cg_exo -47.26 -37.58 24.51 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.951 1.767 . . . . 0.0 111.047 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -79.32 164.97 49.92 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.346 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -46.84 -23.42 0.43 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -96.44 165.16 12.31 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.535 ' HB3' ' CB ' ' A' ' 197' ' ' ASP . . . -147.7 148.2 30.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.314 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.425 ' HG3' HD11 ' A' ' 201' ' ' ILE . 55.7 ttp180 69.64 -71.07 0.13 Allowed 'General case' 0 C--O 1.238 0.487 0 O-C-N 123.758 0.661 . . . . 0.0 110.076 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.14 -46.01 95.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.4 tp . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.064 179.333 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.459 ' HB3' HG23 ' A' ' 48' ' ' THR . 12.5 Cg_exo . . . . . 0 N--CA 1.49 1.268 0 N-CA-C 109.147 -1.136 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.497 HG21 ' CG2' ' A' ' 115' ' ' ILE . 8.0 pt -73.07 109.57 5.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.147 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.82 145.68 34.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -61.75 138.22 58.31 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.384 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -97.31 -170.8 2.08 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.482 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.08 -41.54 83.65 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -69.95 -17.86 63.33 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.867 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.5 -7.96 63.95 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -72.1 127.73 33.49 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.698 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.1 mtt -74.81 128.37 35.4 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -127.61 130.16 70.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.097 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -59.48 141.27 55.12 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.733 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -146.07 144.73 30.22 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.912 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.3 142.52 50.47 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.201 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.484 HD12 ' HG ' ' A' ' 20' ' ' LEU . 33.3 pt -62.24 141.83 17.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.83 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.0 t -60.68 119.76 46.83 Favored Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.0 -36.19 74.81 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 N-CA-C 109.434 -1.025 . . . . 0.0 109.434 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -57.18 -49.02 77.27 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.015 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.6 m -61.27 -47.12 87.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.266 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.484 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -49.54 -60.27 3.01 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.813 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -55.07 -40.7 70.62 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.687 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -61.57 -41.37 97.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.429 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -58.25 -50.44 73.57 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.187 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.8 t -62.67 -43.11 98.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.875 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.37 -44.04 92.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.891 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 22' ' ' ALA . 53.9 t -58.86 -45.88 91.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 69.8 t -63.51 -36.34 75.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.745 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -54.46 -46.41 73.33 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.384 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -87.88 -33.57 18.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' HG21 ' A' ' 36' ' ' VAL . 38.2 mttt -130.46 40.05 3.56 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.918 -176.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.36 -50.03 5.1 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -95.12 -4.93 45.28 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.5 m -56.42 146.72 52.4 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.98 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.25 -34.97 11.98 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 122.661 2.241 . . . . 0.0 112.949 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -58.02 -18.57 25.05 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.914 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 30' ' ' LYS . 60.3 t -64.0 -42.3 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.49 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.426 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 8.0 mt -47.16 -60.59 3.76 Favored Pre-proline 0 C--O 1.24 0.57 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.594 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.426 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 73.2 Cg_exo -53.36 -42.15 67.48 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 119.971 1.026 . . . . 0.0 111.727 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.6 mtt -60.38 -44.51 95.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.496 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.66 -48.09 75.61 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.9 m -58.87 -42.88 90.51 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.824 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.22 -44.42 95.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.349 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.61 -22.45 60.97 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.388 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.0 m -88.27 5.89 39.57 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -61.88 125.89 25.43 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.857 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.15 10.74 74.3 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.804 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.99 149.34 39.32 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 1' ' ' PRO . 82.1 p -99.76 147.78 33.88 Favored Pre-proline 0 C--O 1.213 -0.851 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.379 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.26 -38.1 19.59 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.391 1.394 . . . . 0.0 113.221 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -68.31 -63.46 1.05 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.367 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.7 m-20 -58.24 -35.85 72.33 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.501 1.144 . . . . 0.0 108.024 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.525 HD21 ' HG2' ' A' ' 131' ' ' LYS . 58.2 tp -62.3 -48.86 78.0 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.104 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -58.18 -37.23 74.33 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 58' ' ' THR . 88.3 m -59.56 -40.83 88.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.455 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.0 -46.9 84.5 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.769 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.7 mt -66.85 -39.71 87.68 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.689 0.757 . . . . 0.0 109.514 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -60.68 -39.59 89.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.439 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 54' ' ' THR . 59.4 p -67.34 -23.99 65.67 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.815 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.4 t -72.65 135.66 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.917 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.8 -149.17 7.54 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.13 -125.82 38.88 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.723 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -49.57 -12.62 0.07 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.326 -0.437 . . . . 0.0 111.675 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -42.65 -21.57 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.139 0.576 . . . . 0.0 112.177 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.13 -42.56 77.09 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.52 92.66 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 47.1 ttp -60.62 -28.68 68.71 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -58.14 -39.78 79.63 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.0 tmm? -60.75 -41.84 96.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.28 -39.43 75.69 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.483 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -60.14 -40.62 90.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.41 -40.28 95.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.235 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 93.0 m -59.64 -50.53 73.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.615 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.431 HD12 ' CE1' ' A' ' 130' ' ' TYR . 45.5 pt -67.75 -27.6 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.767 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -62.73 -43.27 99.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -63.38 -44.28 95.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.147 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.02 -37.13 78.87 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.398 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.88 98.92 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.776 -0.77 . . . . 0.0 108.965 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.47 -50.32 65.79 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.549 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.28 -41.69 98.7 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.85 0.833 . . . . 0.0 108.998 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.43 ' O ' ' HD2' ' A' ' 85' ' ' PRO . 77.8 t90 -61.55 -42.27 98.58 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.07 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -57.49 -39.16 75.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.71 -13.14 61.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.505 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.8 mt -106.85 -49.0 3.38 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -99.14 -68.96 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.563 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 98.7 Cg_exo -49.09 -26.88 11.26 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 CA-C-N 121.209 1.467 . . . . 0.0 111.029 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -54.02 -17.34 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.147 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.521 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 28.9 p80 -48.22 -38.5 18.55 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.148 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 87' ' ' HIS . . . 167.72 123.21 0.01 OUTLIER 'General case' 0 C--O 1.238 0.455 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.27 -61.53 6.81 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.27 148.72 92.74 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.159 2.572 . . . . 0.0 111.704 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.9 tt -156.65 149.09 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.942 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.25 133.89 94.49 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.416 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.06 160.3 22.86 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 122.053 1.835 . . . . 0.0 111.687 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.93 -4.9 59.33 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.812 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -120.36 147.59 44.84 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 117.127 0.464 . . . . 0.0 109.884 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 63.2 mtt -65.01 142.47 58.42 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 120.893 0.378 . . . . 0.0 110.686 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -51.96 115.5 1.72 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.44 142.99 90.33 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.05 110.85 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.497 1.465 . . . . 0.0 113.498 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -83.15 169.92 15.31 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.463 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -57.47 -49.53 72.48 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.025 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.7 t -60.29 -40.55 90.87 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.746 0.784 . . . . 0.0 109.142 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.16 -34.43 76.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.428 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.52 HG21 ' CZ3' ' A' ' 133' ' ' TRP . 0.4 OUTLIER -53.78 -28.82 17.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.14 -14.11 26.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.347 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.86 -1.34 88.59 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.3 p -61.77 -20.28 63.4 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.7 p -127.96 33.06 4.83 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.503 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 t -134.66 131.69 38.04 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.935 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.6 m -65.82 146.14 55.11 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.1 tp -53.25 -43.41 67.36 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -39.97 93.3 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.705 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -62.79 -44.54 95.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.971 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -53.58 -63.37 1.17 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.497 ' CG2' HG21 ' A' ' 2' ' ' ILE . 45.7 pt -59.2 -25.28 29.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.971 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.7 -64.56 3.74 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 118' ' ' MET . 1.4 p90 -64.13 -28.23 69.63 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.247 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.405 ' N ' ' CD1' ' A' ' 117' ' ' TRP . 33.1 mtm -68.22 -40.0 82.21 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.6 p -115.63 -23.11 8.88 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -63.83 -75.66 0.08 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.128 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.22 -176.21 0.45 Allowed Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.38 144.44 13.43 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 N-CA-C 108.779 -1.277 . . . . 0.0 108.779 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.4 127.33 13.24 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.678 1.586 . . . . 0.0 114.009 -175.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.6 mm -114.73 108.74 48.61 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 114.637 -1.165 . . . . 0.0 107.894 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -87.34 60.2 3.67 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.811 1.674 . . . . 0.0 113.553 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -50.1 -39.47 16.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.87 -42.94 99.58 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.037 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -60.44 -47.85 84.3 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.312 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.403 HG22 ' CE2' ' A' ' 133' ' ' TRP . 90.1 mt -64.17 -47.91 87.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.466 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.792 ' CE2' HD11 ' A' ' 134' ' ' ILE . 87.4 t80 -59.2 -49.21 78.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.38 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.525 ' HG2' HD21 ' A' ' 52' ' ' LEU . 57.6 mtmt -62.87 -37.96 88.95 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.659 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -57.83 -43.43 85.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.52 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 43.7 m0 -63.03 -42.72 99.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.645 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.792 HD11 ' CE2' ' A' ' 130' ' ' TYR . 80.8 mt -59.02 -43.9 90.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.112 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.06 -40.28 80.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.91 -45.11 90.78 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.223 0.535 . . . . 0.0 109.709 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.32 -43.31 97.41 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.12 -36.49 83.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -58.46 -46.48 86.5 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -64.79 -38.57 91.44 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.713 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mm -60.42 -49.87 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.8 m -58.23 -34.48 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -66.65 -38.27 86.52 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 67.7 ttp -60.07 -46.28 90.07 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -71.13 -16.72 62.57 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.1 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -47.97 112.31 2.14 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.52 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.72 -35.87 4.18 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.936 1.757 . . . . 0.0 113.818 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.3 p -140.24 172.32 12.9 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 44.5 t -98.7 151.04 21.18 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.852 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.6 mm -51.9 -41.92 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.29 -39.08 81.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.802 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -66.7 -10.05 42.68 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.494 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.8 mm -80.29 125.36 39.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.739 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -152.49 129.7 11.22 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.99 0.424 . . . . 0.0 110.089 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -86.29 131.92 34.11 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.218 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -90.91 155.7 23.95 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -53.41 -37.26 81.62 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.33 2.02 . . . . 0.0 111.889 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -87.22 -10.16 53.26 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.371 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -81.64 131.75 56.96 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.45 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -67.55 134.36 32.79 Favored 'Trans proline' 0 N--CA 1.508 2.364 0 C-N-CA 122.524 2.149 . . . . 0.0 113.174 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.418 ' O ' HG23 ' A' ' 165' ' ' VAL . 37.4 t80 -58.73 -28.19 65.62 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.479 ' H ' ' HA ' ' A' ' 224' ' ' PRO . 41.9 ttm180 -63.76 -50.36 69.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.867 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -63.07 -40.23 97.06 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -58.65 -50.26 74.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.412 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 161' ' ' PHE . 54.2 t -64.21 -49.23 82.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.712 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -59.5 -51.43 69.89 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.641 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -63.07 -41.69 99.49 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.089 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.641 ' CE2' HG23 ' A' ' 186' ' ' THR . 88.2 t80 -56.41 -48.58 76.64 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.519 ' OH ' HD22 ' A' ' 211' ' ' LEU . 12.3 m-85 -63.71 -37.38 87.12 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.231 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -58.05 -49.5 76.67 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 93.0 m -67.18 -38.24 85.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.861 0.839 . . . . 0.0 108.831 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.462 HD11 ' CG ' ' A' ' 182' ' ' LYS . 22.6 tp -55.46 -42.03 73.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.606 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -61.69 -42.49 99.0 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.535 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -64.65 -27.01 68.64 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.528 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -46.91 150.07 0.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.295 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -81.19 -92.63 0.05 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.706 -1.133 . . . . 0.0 112.424 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -42.21 146.28 0.32 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.06 0.934 . . . . 0.0 112.808 -176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 69.0 m -64.42 179.11 0.63 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.094 -1.412 . . . . 0.0 112.126 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -57.49 -22.79 46.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.329 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -55.31 -48.55 73.96 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 118.782 -1.167 . . . . 0.0 108.392 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.3 t -89.94 -51.22 12.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.328 1.061 . . . . 0.0 110.092 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.462 ' CG ' HD11 ' A' ' 172' ' ' LEU . 39.9 ttpt -57.77 -46.51 84.46 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.19 -1.823 . . . . 0.0 112.991 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -60.3 -41.99 94.56 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.889 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -59.85 -48.52 81.37 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.464 0.649 . . . . 0.0 109.746 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 98.4 mtp -61.69 -40.68 95.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.441 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.641 HG23 ' CE2' ' A' ' 168' ' ' PHE . 58.1 m -61.3 -48.26 82.19 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.563 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.67 -49.06 78.02 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.278 0.561 . . . . 0.0 110.17 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 98.4 m -62.46 -48.69 78.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.16 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 81.8 mt -67.61 -35.83 79.68 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.79 -1.096 . . . . 0.0 112.898 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.1 mt -44.75 -49.19 10.72 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.17 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 11.3 p -81.27 -37.22 15.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.73 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -61.97 -50.03 73.75 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.12 -23.89 62.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.831 0.348 . . . . 0.0 111.767 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.15 145.75 25.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.638 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -66.1 152.6 93.58 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.31 -45.61 36.51 Favored 'Trans proline' 0 N--CA 1.508 2.367 0 C-N-CA 122.705 2.27 . . . . 0.0 115.727 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.688 ' O ' ' HB2' ' A' ' 228' ' ' ALA . 97.3 m-20 -59.68 -49.46 77.67 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 118.799 -1.16 . . . . 0.0 110.417 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . 0.459 ' SG ' HD23 ' A' ' 202' ' ' LEU . 37.9 t -66.66 -38.98 87.96 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -48.79 -34.54 12.5 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.008 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 97.5 m -58.42 -50.36 73.97 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.185 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.666 HG12 ' HB1' ' A' ' 228' ' ' ALA . 26.2 mm -65.41 -45.21 93.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.596 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.459 HD23 ' SG ' ' A' ' 198' ' ' CYS . 3.9 mm? -53.9 -49.36 68.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.111 0.958 . . . . 0.0 108.858 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.64 -38.16 86.65 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.729 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -59.04 -39.43 81.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.913 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.445 HD21 ' HB1' ' A' ' 217' ' ' ALA . 2.7 mm? -59.15 -36.4 75.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 81.44 174.19 48.88 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.65 154.43 59.57 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 123.484 2.789 . . . . 0.0 112.902 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 86.91 -7.71 79.11 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -62.69 129.58 41.15 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.442 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.9 p -75.38 161.96 28.8 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.652 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.519 HD22 ' OH ' ' A' ' 169' ' ' TYR . 65.4 tp -59.6 -44.23 93.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.32 -50.3 74.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.162 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.6 -39.05 86.7 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.979 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 25.9 tpp -62.39 -50.58 70.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.938 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 15.2 tpt -63.25 -45.1 93.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.323 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.8 m -62.92 -48.43 78.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.85 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.445 ' HB1' HD21 ' A' ' 205' ' ' LEU . . . -62.73 -50.54 70.71 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.768 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 29.5 p -61.95 -30.61 71.03 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -64.85 -42.74 94.65 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.031 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.74 -40.42 98.76 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.006 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 228' ' ' ALA . 2.7 t -83.67 -35.31 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 126.03 10.17 4.39 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.221 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -56.64 -47.64 83.23 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-O 119.114 -0.826 . . . . 0.0 113.498 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.479 ' HA ' ' H ' ' A' ' 162' ' ' ARG . 52.0 Cg_endo -70.29 -0.88 8.02 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 CA-C-N 120.274 2.037 . . . . 0.0 113.974 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -96.17 -51.25 1.77 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -156.11 -58.17 0.09 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.599 0.714 . . . . 0.0 109.71 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -140.25 -174.33 3.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.23 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' A' ' 197' ' ' ASP . . . -45.38 -51.05 11.79 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 123.153 0.283 . . . . 0.0 110.938 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -84.93 154.54 22.14 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.176 0.513 . . . . 0.0 111.599 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 9.6 p -55.53 -29.94 25.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.391 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--O 1.219 -0.537 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.435 179.431 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 N--CA 1.488 1.191 0 N-CA-C 108.948 -1.212 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.528 HG21 HG22 ' A' ' 115' ' ' ILE . 12.8 pt -63.74 112.3 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.253 0.549 . . . . 0.0 110.169 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.37 140.8 45.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.65 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -65.81 124.07 21.47 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.968 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -81.72 -172.23 3.76 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.369 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.24 -38.96 85.05 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -66.85 -19.2 65.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.453 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.52 -8.14 68.79 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.41 127.01 31.96 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.497 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 89.1 mtp -72.2 128.1 34.6 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.8 t -126.61 128.84 71.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.747 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -64.8 139.19 58.74 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.351 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -141.62 155.08 45.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.246 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.28 146.33 34.88 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.238 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.3 pt -62.79 144.15 14.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.916 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.8 m -61.89 121.18 63.44 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.44 -38.86 83.31 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 N-CA-C 109.794 -0.887 . . . . 0.0 109.794 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -59.53 -47.91 83.69 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.871 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.0 m -61.11 -46.11 91.92 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.87 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.524 HD13 ' C ' ' A' ' 20' ' ' LEU . 3.3 tm? -58.04 -49.14 77.9 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.245 0.545 . . . . 0.0 109.991 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -58.28 -42.3 86.25 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -62.22 -41.58 98.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.25 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -57.78 -49.42 76.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.6 t -62.08 -44.88 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.92 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -59.24 -42.78 91.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.529 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 22' ' ' ALA . 50.4 t -57.6 -44.58 85.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 53.8 t -64.63 -38.25 82.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.982 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -55.18 -49.22 72.43 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.086 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -81.07 -44.6 17.76 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -120.46 39.52 3.72 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.73 -52.19 3.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -95.83 -4.79 43.12 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -55.52 146.28 44.96 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 118.951 0.796 . . . . 0.0 111.734 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.19 -32.19 17.23 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 122.47 2.114 . . . . 0.0 112.544 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.26 -21.62 35.61 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.269 0.557 . . . . 0.0 109.667 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.5 t -63.27 -40.77 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.487 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.8 mt -42.75 -61.27 1.77 Allowed Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.317 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.04 -33.12 52.03 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 120.799 1.0 . . . . 0.0 111.499 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.1 tpt -60.23 -48.15 82.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.374 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 134' ' ' ILE . 63.9 t80 -55.77 -47.33 77.2 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.2 t -58.68 -43.89 90.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.89 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.05 94.02 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.04 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.7 mt -70.62 -24.53 62.75 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -91.34 25.94 2.4 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.561 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.6 126.17 30.56 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.161 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.29 11.21 75.56 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.055 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.28 150.67 43.37 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 111.915 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.9 p -99.3 149.12 35.53 Favored Pre-proline 0 C--O 1.218 -0.574 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.821 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -47.17 -37.44 23.64 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.192 1.261 . . . . 0.0 112.528 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -74.95 -62.51 1.52 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.61 -0.436 . . . . 0.0 112.139 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.77 -38.29 75.16 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 52' ' ' LEU . 56.4 tp -64.36 -44.21 92.13 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.595 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -58.22 -38.72 77.37 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 87.7 m -61.07 -40.36 93.36 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.963 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.16 -47.96 81.74 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.865 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.6 -41.5 92.69 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.218 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -61.62 -38.31 87.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.117 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.28 -24.15 66.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.522 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.8 t -58.67 154.52 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.78 -149.49 5.21 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.7 -128.5 47.79 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.208 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.452 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 18.7 p80 -53.82 -10.87 0.34 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.99 -0.605 . . . . 0.0 111.756 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -43.57 -22.2 0.04 OUTLIER 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.22 -40.29 67.53 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.08 97.63 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.2 tmm? -57.32 -21.4 34.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.52 -37.15 72.55 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.1 tpt -58.17 -45.63 87.17 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -56.23 -38.14 70.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -43.51 71.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.6 -35.53 73.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.987 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.5 m -58.34 -48.74 79.6 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 pt -67.68 -28.51 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -62.28 -43.47 98.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.02 -42.33 97.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.121 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.66 -40.02 90.51 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.24 98.29 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.225 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.3 -50.3 72.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.064 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.9 -39.18 93.58 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.893 0.854 . . . . 0.0 108.768 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.526 ' O ' ' HD2' ' A' ' 85' ' ' PRO . 76.4 t-105 -58.39 -45.29 88.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.779 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -57.38 -40.49 78.28 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -71.88 -14.07 61.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.599 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.405 ' O ' HG12 ' A' ' 86' ' ' VAL . 6.3 mp -108.46 -48.95 3.25 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.408 ' CB ' ' HD3' ' A' ' 85' ' ' PRO . 1.2 m-70 -97.22 -65.42 0.09 OUTLIER Pre-proline 0 N--CA 1.467 0.389 0 C-N-CA 119.987 -0.685 . . . . 0.0 112.523 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.526 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 82.9 Cg_exo -52.26 -29.41 38.01 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 CA-C-N 120.816 1.327 . . . . 0.0 110.212 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 83' ' ' LEU . 2.6 p -54.79 -20.17 5.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.999 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.498 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 21.9 p80 -48.9 -32.66 9.33 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.449 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 87' ' ' HIS . . . 168.76 107.15 0.01 OUTLIER 'General case' 0 C--O 1.238 0.448 0 O-C-N 123.415 0.447 . . . . 0.0 110.322 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.19 -62.9 5.78 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.17 143.51 90.14 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.88 2.386 . . . . 0.0 111.171 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.9 tp -150.22 144.53 17.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.84 149.4 93.2 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.915 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.12 161.24 46.73 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.66 2.24 . . . . 0.0 112.331 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.21 3.25 63.55 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.833 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -125.37 150.05 47.57 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 117.077 0.438 . . . . 0.0 110.682 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 53.6 mtt -67.33 152.66 45.32 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.353 0.597 . . . . 0.0 111.768 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -54.24 129.93 36.85 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.604 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -65.25 152.44 91.77 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.3 80.44 0.22 Allowed 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.216 1.944 . . . . 0.0 114.43 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -66.23 163.77 17.17 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.11 -44.29 96.45 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.405 ' HB3' HG23 ' A' ' 108' ' ' THR . 68.6 m -61.38 -39.97 92.62 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.07 -41.37 92.27 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.49 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.55 HG21 ' CH2' ' A' ' 133' ' ' TRP . 37.3 mm -58.72 -45.95 90.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.08 -20.5 65.82 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.89 -0.75 89.45 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 76.1 p -60.01 -21.41 61.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.405 HG23 ' HB3' ' A' ' 102' ' ' SER . 14.4 p -123.68 20.97 9.34 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.0 p -125.22 132.06 53.04 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.731 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -73.13 145.81 46.15 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.6 tp -50.98 -46.97 61.53 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.356 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.76 -41.29 97.49 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.29 -38.48 89.53 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.354 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -63.07 -42.08 99.57 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.824 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.528 HG22 HG21 ' A' ' 2' ' ' ILE . 35.0 pt -67.86 -42.14 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 118.907 -1.117 . . . . 0.0 111.06 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.26 -42.16 58.01 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 20.4 t90 -58.48 -44.71 89.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.421 ' SD ' HD11 ' A' ' 2' ' ' ILE . 28.2 ttt -73.29 -42.22 62.68 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.245 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 66.0 p -126.62 -23.66 3.7 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -56.11 -51.03 69.39 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.993 1.269 . . . . 0.0 110.279 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -81.14 -179.07 1.32 Allowed Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.05 143.65 17.67 Favored 'Trans proline' 0 N--CA 1.485 1.002 0 N-CA-C 107.441 -1.792 . . . . 0.0 107.441 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.85 123.85 4.23 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.849 1.699 . . . . 0.0 113.599 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.9 mm -113.64 108.41 51.76 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.43 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 73.1 Cg_endo -74.79 57.34 4.4 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.273 1.982 . . . . 0.0 113.503 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 127' ' ' GLY . 27.0 m -60.5 -44.49 96.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.515 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -63.3 -43.06 99.0 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.759 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 125' ' ' PRO . 88.7 tt0 -63.03 -44.89 94.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.63 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.5 mm -61.28 -47.54 93.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -57.87 -47.44 82.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.545 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -58.93 -41.85 88.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.887 -1.052 . . . . 0.0 109.785 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -57.72 -43.86 85.56 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.55 ' CH2' HG21 ' A' ' 104' ' ' ILE . 48.7 m0 -62.32 -45.54 92.77 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.765 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.476 HG21 ' CE2' ' A' ' 40' ' ' PHE . 32.3 mm -60.25 -46.67 94.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.424 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.61 -41.47 85.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 65.6 tp -60.52 -45.6 93.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.06 -41.14 96.35 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.35 -36.39 83.55 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -58.63 -44.83 90.13 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.49 -40.17 95.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.802 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.74 -49.26 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.353 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.7 m -58.02 -32.68 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.1 ttm-85 -67.98 -38.0 82.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 58.9 ttm -58.57 -44.15 89.65 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -74.84 -17.56 60.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.705 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.8 p -43.1 104.96 0.4 Allowed Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.39 -32.66 6.19 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.943 1.762 . . . . 0.0 113.673 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 70.6 p -139.35 173.04 11.95 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.6 t -106.72 150.12 26.6 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.887 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.577 ' HA ' HD12 ' A' ' 153' ' ' ILE . 13.6 mm -50.88 -46.51 29.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -59.4 -37.98 79.39 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.461 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -65.96 -5.04 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.216 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' A' ' 150' ' ' ILE . 92.6 mt -97.14 126.01 50.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.86 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -152.22 134.57 15.18 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.496 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -85.08 128.7 34.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -89.09 164.39 32.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.52 -36.18 78.07 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 121.831 1.687 . . . . 0.0 111.105 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -83.94 -17.15 41.6 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.497 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 160' ' ' PRO . 96.7 mt-10 -77.88 146.78 72.82 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.927 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 159' ' ' GLU . 5.2 Cg_endo -81.46 135.82 9.53 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.654 2.236 . . . . 0.0 113.418 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -58.93 -36.8 75.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 48.9 ttp180 -59.86 -49.77 76.4 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.02 -40.65 94.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.517 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -58.92 -49.59 77.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.463 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.65 -45.77 98.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.473 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.01 -52.19 66.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.019 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.64 -39.75 91.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.666 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.683 ' CE2' HG23 ' A' ' 186' ' ' THR . 81.2 t80 -56.71 -47.89 78.95 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -64.7 -36.59 84.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.943 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -57.98 -48.77 79.02 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.545 ' OG1' HD11 ' A' ' 153' ' ' ILE . 96.6 m -66.62 -38.91 87.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.729 0.776 . . . . 0.0 109.061 177.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 29.2 tp -56.42 -39.82 73.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.926 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -60.58 -38.87 86.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -76.53 -9.31 58.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.532 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -44.89 163.42 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.727 0.775 . . . . 0.0 112.573 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -104.73 -94.31 0.34 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.884 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -45.16 143.06 1.74 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.683 0.754 . . . . 0.0 111.643 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 67.9 m -51.77 166.74 0.13 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.002 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.71 -16.29 38.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.267 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.82 -45.23 82.43 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 43.9 t -89.33 -50.76 12.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.846 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -55.43 -46.74 76.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.897 -177.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -57.35 -43.31 83.37 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.897 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -60.81 -47.25 87.18 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.436 0.636 . . . . 0.0 109.917 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 98.3 mtp -60.67 -41.04 94.28 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.079 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.683 HG23 ' CE2' ' A' ' 168' ' ' PHE . 66.4 m -60.44 -48.84 80.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.143 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.03 -47.72 85.11 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.01 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 99.0 m -62.09 -48.42 80.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.684 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.17 -21.69 58.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.42 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 67.2 tp -54.06 -49.97 67.79 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.625 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.7 m -87.33 -38.24 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.646 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.63 -45.96 92.09 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.958 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -80.27 -9.87 59.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.23 155.7 34.24 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -70.4 151.22 95.72 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.119 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.41 -42.91 63.49 Favored 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 122.316 2.011 . . . . 0.0 115.072 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.16 -60.49 3.79 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.538 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . 0.758 ' HA ' ' HB2' ' A' ' 228' ' ' ALA . 49.4 t -62.16 -38.93 90.94 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -48.58 -34.64 11.87 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.856 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 99.3 m -59.92 -49.48 77.53 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 118.813 -1.155 . . . . 0.0 108.708 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.638 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 2.2 mp -64.75 -45.01 96.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.016 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.79 -42.16 92.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.51 -38.9 91.75 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -58.69 -40.47 83.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.278 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 205' ' ' LEU . 85.5 mt -63.0 -40.38 97.58 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.536 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 74.16 -160.49 53.3 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.999 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.05 165.91 4.65 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 123.822 3.015 . . . . 0.0 113.398 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 209' ' ' ALA . . . 61.08 -123.85 33.7 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 208' ' ' GLY . . . 64.86 99.29 0.04 OUTLIER 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.139 0.495 . . . . 0.0 111.231 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 50.9 m -57.76 144.27 38.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.2 tp -50.36 -40.96 50.89 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.223 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -57.98 -45.58 86.52 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.43 -42.23 91.42 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 5.5 mmt -61.58 -50.85 70.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.101 0.476 . . . . 0.0 110.961 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 59.3 ttm -63.69 -46.29 86.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.349 0.595 . . . . 0.0 110.574 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.8 m -61.8 -48.1 82.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.48 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.426 ' O ' HG23 ' A' ' 221' ' ' VAL . . . -61.05 -45.13 96.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.994 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 92.1 m -61.35 -40.98 96.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -56.7 -38.65 72.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.23 -38.98 93.99 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 228' ' ' ALA . 0.2 OUTLIER -94.97 5.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 72.75 20.04 79.55 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.267 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.429 ' N ' ' CD ' ' A' ' 224' ' ' PRO . . . -59.52 -40.87 96.82 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 119.212 -0.771 . . . . 0.0 112.394 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 223' ' ' GLY . 82.6 Cg_exo -48.97 -29.26 15.05 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 CA-C-N 120.016 1.908 . . . . 0.0 109.863 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -90.28 -178.98 44.17 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -57.66 141.7 47.47 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.017 -0.696 . . . . 0.0 109.811 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt 55.93 -172.18 0.07 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.92 0.391 . . . . 0.0 110.714 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.758 ' HB2' ' HA ' ' A' ' 198' ' ' CYS . . . -106.36 19.32 20.69 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.602 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -64.47 140.42 58.87 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.329 -0.549 . . . . 0.0 109.787 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 31.6 m -39.24 -31.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 O-C-N 123.848 0.717 . . . . 0.0 112.104 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.589 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.437 ' HB3' HG23 ' A' ' 48' ' ' THR . 8.0 Cg_exo . . . . . 0 N--CA 1.487 1.141 0 N-CA-C 109.238 -1.101 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.7 pt -71.21 110.11 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.403 0.621 . . . . 0.0 110.575 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.6 t -129.54 126.37 63.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.573 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -56.6 115.57 2.61 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.359 0.599 . . . . 0.0 109.847 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.56 -176.09 1.83 Allowed 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.281 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.99 -38.49 82.74 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.26 -19.51 66.0 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.731 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.25 -7.72 62.26 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -80.07 124.2 28.53 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.4 mtt -75.64 131.61 40.05 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.8 t -126.66 129.23 71.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.553 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -66.84 136.16 55.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.531 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -137.78 153.72 49.65 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.955 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.28 148.15 37.76 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.392 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.8 pt -62.44 144.48 14.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.173 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 m -63.68 121.98 73.87 Favored Pre-proline 0 N--CA 1.451 -0.399 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.15 -36.52 77.38 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 N-CA-C 109.507 -0.997 . . . . 0.0 109.507 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -57.63 -49.69 75.62 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.124 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 95.0 m -61.46 -46.14 91.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.458 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 65.8 tp -57.68 -49.9 74.96 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.832 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -58.47 -41.87 86.21 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -62.44 -41.67 98.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.751 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -57.55 -50.97 71.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.374 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.42 -41.84 94.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.365 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.74 -40.68 84.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.172 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 22' ' ' ALA . 47.2 t -58.55 -44.09 88.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 75.8 t -62.41 -35.96 72.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.998 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -57.03 -43.7 82.15 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.403 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -93.65 -27.1 16.76 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.545 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 99.6 mttt -132.41 38.3 3.46 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.956 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.79 -54.13 3.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -96.63 -5.17 39.64 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 55.4 m -52.49 144.34 24.24 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 118.906 0.776 . . . . 0.0 111.508 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.26 -31.62 17.96 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.453 2.102 . . . . 0.0 112.706 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -59.08 -18.86 39.04 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.771 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 30' ' ' LYS . 54.1 t -65.23 -41.27 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.944 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.427 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 6.4 mt -45.7 -60.79 2.99 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.237 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 77.8 Cg_exo -54.23 -41.22 77.92 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 CA-C-N 120.001 1.036 . . . . 0.0 111.795 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.9 mtt -60.86 -44.21 97.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.798 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -56.92 -49.44 75.62 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.779 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.4 p -60.86 -38.88 87.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.721 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.66 -46.08 91.7 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.067 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.61 -27.13 62.9 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.221 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -85.84 12.32 9.37 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.216 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -64.76 122.54 17.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.522 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.99 10.47 84.05 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 121.428 -0.415 . . . . 0.0 112.896 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.96 149.1 41.56 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.165 0.507 . . . . 0.0 112.117 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.437 HG23 ' HB3' ' A' ' 1' ' ' PRO . 81.3 p -99.19 148.69 34.97 Favored Pre-proline 0 C--O 1.212 -0.901 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.412 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -45.74 -37.17 15.76 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.477 1.451 . . . . 0.0 113.558 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -70.29 -63.35 1.1 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.254 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.509 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -57.88 -35.81 71.51 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.41 HD23 ' HD2' ' A' ' 130' ' ' TYR . 55.9 tp -62.4 -44.15 97.13 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.297 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -58.26 -38.05 76.17 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.53 ' O ' HG23 ' A' ' 58' ' ' THR . 88.3 m -61.21 -40.13 92.82 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.101 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 83.9 mmm -56.08 -46.49 78.99 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.581 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.78 -44.62 48.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.451 0.644 . . . . 0.0 111.145 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.25 -39.09 78.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.064 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 54' ' ' THR . 45.2 p -67.2 -19.69 65.6 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.999 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 60' ' ' GLY . 76.2 t -61.79 154.48 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.741 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 59' ' ' VAL . . . -140.65 -151.9 5.68 Favored Glycine 0 CA--C 1.535 1.338 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.96 -128.12 46.74 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.123 -1.037 . . . . 0.0 110.934 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -51.5 -10.59 0.1 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.956 -0.622 . . . . 0.0 112.11 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -43.46 -21.98 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.27 -41.09 68.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.13 96.36 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.3 tpp -56.78 -21.11 26.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.12 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -58.65 -38.4 78.03 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -58.58 -45.36 89.21 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -53.11 -43.04 66.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.086 178.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -59.62 -40.65 88.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -64.61 -40.78 96.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.593 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.7 m -60.17 -44.05 95.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.6 mt -60.33 -43.93 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -60.43 -42.13 95.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.444 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.23 -46.24 91.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.055 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.59 -39.21 93.81 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.66 98.51 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.435 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.29 -49.33 74.44 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.179 0.514 . . . . 0.0 111.186 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.22 -41.62 99.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 122.122 0.963 . . . . 0.0 109.1 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.469 ' CZ2' HD13 ' A' ' 104' ' ' ILE . 71.9 t90 -59.62 -44.42 93.44 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.083 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -53.87 -42.53 68.69 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.4 -26.75 68.13 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.477 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.452 ' O ' HG12 ' A' ' 86' ' ' VAL . 85.9 mt -98.3 -47.43 5.44 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -97.21 -69.52 0.05 OUTLIER Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 119.003 0.82 . . . . 0.0 112.069 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.26 -23.5 6.98 Favored 'Trans proline' 0 N--CA 1.501 1.944 0 CA-C-N 121.316 1.506 . . . . 0.0 111.012 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 83' ' ' LEU . 5.6 p -54.57 -14.68 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.095 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.488 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 29.9 t60 -47.07 -50.82 19.11 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 87' ' ' HIS . . . 169.86 123.01 0.01 OUTLIER 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.528 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.58 -53.93 42.01 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -63.35 147.34 93.66 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.882 2.388 . . . . 0.0 112.606 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 tt -162.07 150.63 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.56 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.52 152.54 96.57 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.369 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.47 170.49 18.34 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.709 2.273 . . . . 0.0 112.066 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.42 -5.91 77.74 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -124.58 146.54 48.99 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.3 mtt -66.2 146.84 54.17 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.759 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -52.18 119.01 3.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -60.62 158.92 27.97 Favored Pre-proline 0 C--O 1.239 0.541 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.069 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -48.17 130.44 20.52 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.718 1.612 . . . . 0.0 112.207 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.73 154.06 34.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.557 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -44.09 -61.28 3.16 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.605 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.569 ' OG ' HG23 ' A' ' 108' ' ' THR . 34.9 t -60.85 -39.03 87.59 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.667 0.746 . . . . 0.0 110.136 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -35.94 77.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.005 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.613 HG21 ' CZ3' ' A' ' 133' ' ' TRP . 6.5 tp -59.37 -33.35 50.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 102' ' ' SER . . . -70.59 -28.06 64.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.21 -8.1 79.82 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.7 p -57.78 -23.71 53.68 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.569 HG23 ' OG ' ' A' ' 102' ' ' SER . 23.0 p -114.79 8.51 16.09 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.684 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 62.0 m -111.79 131.34 55.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.078 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 35.0 m -71.04 156.03 40.11 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.8 tp -58.67 -47.83 83.16 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.244 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -61.61 -43.83 98.14 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.904 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.3 -39.38 86.75 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.192 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.619 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.5 pt -71.09 -39.76 74.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 118.971 -1.092 . . . . 0.0 110.952 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.33 -43.34 79.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -59.34 -45.15 92.16 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.915 -1.143 . . . . 0.0 109.084 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.2 ttt -72.04 -41.32 67.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.475 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.2 m -127.16 -26.4 3.11 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -57.4 -50.39 73.15 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 118.336 -1.346 . . . . 0.0 110.269 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -84.88 -178.23 1.13 Allowed Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 134.49 30.08 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 120.665 1.273 . . . . 0.0 109.224 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -36.77 116.72 0.16 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.681 2.254 . . . . 0.0 113.601 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.447 HG22 HG13 ' A' ' 126' ' ' VAL . 44.7 mm -108.83 108.54 60.82 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 87.4 Cg_endo -76.5 58.92 6.0 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.146 1.897 . . . . 0.0 112.692 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.47 HG23 ' N ' ' A' ' 127' ' ' GLY . 27.3 m -58.86 -45.08 91.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.956 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.47 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -64.18 -42.05 98.12 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.208 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 125' ' ' PRO . 88.4 tt0 -60.85 -45.89 92.74 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.415 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.84 -47.99 86.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.318 0.58 . . . . 0.0 110.415 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.7 ' CE2' HD11 ' A' ' 134' ' ' ILE . 86.7 t80 -58.59 -48.48 80.8 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.825 0.821 . . . . 0.0 108.858 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.491 ' HA ' HD12 ' A' ' 134' ' ' ILE . 60.2 mtpt -62.89 -38.16 89.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.035 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 24.7 tpp180 -57.79 -43.18 85.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.613 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 44.4 m0 -62.71 -43.74 98.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.885 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.7 HD11 ' CE2' ' A' ' 130' ' ' TYR . 84.4 mt -59.32 -44.57 92.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.933 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.0 mt -59.37 -41.79 85.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.86 -42.42 99.75 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.25 -42.86 98.89 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.13 -36.47 84.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -58.7 -44.63 90.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.28 -39.5 92.67 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.607 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mm -60.58 -49.65 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.6 m -57.47 -35.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -65.15 -40.39 94.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 94.2 mmm -60.62 -43.09 97.9 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.329 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -71.61 -19.68 62.09 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.889 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 21.4 t -48.42 117.39 5.85 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.625 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -85.15 -25.03 1.87 Allowed 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 122.174 1.916 . . . . 0.0 113.67 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.1 p -138.97 169.66 17.39 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 40.8 t -107.43 148.9 28.54 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.985 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.444 HD11 ' CE1' ' A' ' 168' ' ' PHE . 4.9 tp -48.94 -36.38 8.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.5 tp -66.55 -39.48 88.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.609 0.719 . . . . 0.0 109.581 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -64.63 -26.36 68.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.153 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.21 108.36 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.071 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -144.85 122.62 11.9 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -85.87 125.58 33.42 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.217 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -87.77 166.37 35.74 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.564 ' O ' ' HB2' ' A' ' 228' ' ' ALA . 26.0 Cg_endo -62.64 -25.82 75.4 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.19 1.927 . . . . 0.0 110.711 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -82.68 -18.57 40.51 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.875 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -90.22 137.01 28.01 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.07 155.94 23.03 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.62 2.213 . . . . 0.0 114.598 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 165' ' ' VAL . 20.7 t80 -60.16 -39.68 87.26 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.453 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.47 ' N ' ' HA ' ' A' ' 224' ' ' PRO . 56.0 ttp180 -62.99 -47.54 82.7 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.742 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -61.0 -43.34 99.03 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.907 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -62.15 -50.15 73.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.277 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 161' ' ' PHE . 55.1 t -61.07 -44.53 98.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.545 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -62.11 -53.88 49.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.6 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 61.5 mtm-85 -64.62 -41.0 96.46 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.173 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.615 ' CE2' HG23 ' A' ' 186' ' ' THR . 82.5 t80 -58.45 -48.8 79.54 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.55 ' OH ' HD22 ' A' ' 211' ' ' LEU . 8.9 m-85 -64.92 -36.9 85.88 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.538 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -59.62 -48.1 82.99 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 97.3 m -64.89 -39.6 93.79 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.579 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.442 HD11 ' HG2' ' A' ' 182' ' ' LYS . 17.0 tp -58.37 -38.26 76.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.103 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 27.9 ttt-85 -64.69 -38.23 90.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.656 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.55 -10.68 58.13 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.977 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -51.05 167.58 0.07 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.737 0.78 . . . . 0.0 112.405 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -93.7 -93.07 0.17 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.842 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -44.95 148.75 0.51 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.453 0.644 . . . . 0.0 111.36 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 70.1 m -74.79 179.0 5.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.661 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -47.23 -25.55 0.96 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.842 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.28 -62.03 1.76 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.014 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 49.4 t -87.57 -43.47 15.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.813 0.816 . . . . 0.0 109.931 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.442 ' HG2' HD11 ' A' ' 172' ' ' LEU . 39.3 ttpt -57.48 -48.59 78.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.13 -1.396 . . . . 0.0 112.806 -177.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -60.81 -41.64 96.09 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.332 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -59.79 -48.86 79.98 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.603 0.715 . . . . 0.0 109.671 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.402 ' O ' HD13 ' A' ' 189' ' ' LEU . 98.7 mtp -61.62 -40.33 94.46 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.027 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.615 HG23 ' CE2' ' A' ' 168' ' ' PHE . 60.4 m -59.69 -46.92 87.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.283 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.68 -47.71 84.55 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.797 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 98.0 m -64.23 -47.54 79.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.596 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 185' ' ' MET . 8.7 mp -66.82 -33.81 76.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.327 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.572 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 13.2 mt -49.43 -44.95 45.85 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.964 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.6 -47.52 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.553 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -61.48 -50.28 73.39 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -72.08 -25.9 61.95 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.311 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 190' ' ' LEU . . . -59.08 156.97 10.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.304 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -70.63 152.88 95.22 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.081 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.28 -45.9 31.83 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 122.778 2.319 . . . . 0.0 114.708 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.443 ' HB2' ' HB1' ' A' ' 228' ' ' ALA . 97.5 m-20 -54.6 -62.11 1.87 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.032 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . 0.601 ' SG ' HG11 ' A' ' 230' ' ' VAL . 46.5 t -58.5 -45.09 89.44 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.857 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -48.95 -31.06 6.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.578 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.9 m -59.76 -50.59 73.24 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.679 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.59 ' HB ' HG12 ' A' ' 230' ' ' VAL . 3.5 mm -79.3 -30.14 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.697 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -55.1 39.02 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.58 -39.28 90.61 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 201' ' ' ILE . . . -57.22 -32.5 66.58 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.92 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 205' ' ' LEU . 56.2 tp -56.34 -38.47 71.41 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 96.61 160.1 32.0 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.778 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.0 156.05 66.45 Favored 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 123.594 2.863 . . . . 0.0 113.215 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 81.15 -0.34 87.64 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.532 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.405 ' HB1' HD21 ' A' ' 205' ' ' LEU . . . -68.37 136.82 53.96 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.458 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.6 p -76.22 160.81 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.886 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.55 HD22 ' OH ' ' A' ' 169' ' ' TYR . 63.3 tp -60.41 -44.03 96.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.94 -48.97 79.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.808 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.28 -43.43 92.52 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.0 ttm -60.33 -48.88 79.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.524 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 94.9 mmm -62.86 -39.07 93.3 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.5 m -61.69 -50.27 73.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.215 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.36 96.5 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.94 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 97.0 m -60.45 -40.44 91.17 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -68.62 -39.31 80.86 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.995 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.28 -40.66 92.21 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.585 HG12 ' O ' ' A' ' 229' ' ' ARG . 12.4 t -95.09 -25.15 4.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-O 121.189 0.519 . . . . 0.0 110.598 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 230' ' ' VAL . . . 115.03 97.66 2.16 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.407 ' H ' ' HD2' ' A' ' 224' ' ' PRO . . . -139.78 -60.19 0.04 OUTLIER Glycine 0 N--CA 1.469 0.862 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.47 ' HA ' ' N ' ' A' ' 162' ' ' ARG . 34.6 Cg_exo -59.18 104.4 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.238 1.292 . . . . 0.0 109.674 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.435 ' H ' ' H ' ' A' ' 162' ' ' ARG . . . 87.98 -7.39 81.46 Favored Glycine 0 CA--C 1.54 1.599 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -106.15 116.3 31.7 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.02 0.41 . . . . 0.0 110.195 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 228' ' ' ALA . 63.8 pttt -36.37 -42.47 0.33 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 157' ' ' PRO . . . -178.31 31.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 118.991 -1.084 . . . . 0.0 112.939 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.585 ' O ' HG12 ' A' ' 221' ' ' VAL . 81.7 mtp180 -65.68 -14.35 61.06 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.024 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.601 HG11 ' SG ' ' A' ' 198' ' ' CYS . 72.9 t -59.99 -44.72 95.31 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.215 -0.751 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.929 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.486 1.049 0 N-CA-C 108.987 -1.197 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.467 HD11 ' SD ' ' A' ' 118' ' ' MET . 9.5 pt -62.31 109.85 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.494 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.1 t -128.88 123.58 59.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.486 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -57.13 110.63 0.87 Allowed 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.346 0.593 . . . . 0.0 110.003 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -68.5 177.78 2.28 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.011 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 pp -58.27 -33.45 69.42 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -63.18 -26.8 68.97 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.641 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.49 -7.19 53.55 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -85.73 124.72 32.56 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.894 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.0 mtt -73.75 134.49 43.47 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -128.62 130.07 68.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.813 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -68.19 136.27 53.35 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.518 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -137.9 153.6 49.52 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.254 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.86 142.95 40.0 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.985 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.432 ' CD1' HD21 ' A' ' 20' ' ' LEU . 37.9 pt -63.67 139.7 20.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.086 0.469 . . . . 0.0 110.488 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.0 t -61.01 126.09 85.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.82 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.09 -32.79 50.58 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 120.929 1.086 . . . . 0.0 109.884 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -58.76 -39.88 82.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 95.9 m -60.93 -46.2 91.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.732 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.432 HD21 ' CD1' ' A' ' 15' ' ' ILE . 68.1 mt -59.9 -45.02 93.87 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.64 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -60.55 -40.86 93.11 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.068 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.551 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -64.94 -46.65 80.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.284 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 42.3 t-105 -60.47 -50.69 72.57 Favored 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.878 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.89 -45.94 97.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.6 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -61.48 -43.5 98.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.364 0.602 . . . . 0.0 110.852 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 22' ' ' ALA . 46.7 t -59.27 -46.56 92.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.165 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 2.0 t -69.52 -25.94 29.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.393 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -58.98 -45.13 91.33 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.738 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -91.62 -36.35 13.71 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' O ' HG21 ' A' ' 36' ' ' VAL . 98.3 mttt -120.92 38.12 4.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.147 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.08 -51.64 4.49 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -96.11 -5.07 41.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.2 m -54.62 140.57 57.6 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 118.874 0.761 . . . . 0.0 112.22 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -59.93 -39.55 70.25 Favored 'Trans proline' 0 N--CA 1.507 2.265 0 C-N-CA 122.489 2.126 . . . . 0.0 112.817 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -54.15 -20.25 6.42 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.554 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.412 HG21 ' O ' ' A' ' 30' ' ' LYS . 52.9 t -62.57 -43.56 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.62 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.424 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 8.4 mt -46.97 -61.38 2.83 Favored Pre-proline 0 C--O 1.24 0.578 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.084 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 73.8 Cg_exo -53.62 -42.08 68.78 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 120.273 1.133 . . . . 0.0 111.781 176.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.0 mtp -61.41 -42.84 99.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.845 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -56.52 -48.84 76.37 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.8 t -59.23 -43.86 92.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.983 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.08 92.86 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.47 0.653 . . . . 0.0 110.069 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.4 mt -70.77 -25.64 62.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.459 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.9 m -89.53 7.76 34.61 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.785 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.22 128.41 35.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.573 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.76 10.54 76.79 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.58 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.67 149.86 38.05 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 111.973 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.9 p -99.05 150.29 36.56 Favored Pre-proline 0 C--O 1.218 -0.568 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.626 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.8 -39.55 18.82 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.492 1.461 . . . . 0.0 112.795 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -69.29 -63.35 1.08 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.349 -0.54 . . . . 0.0 112.018 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.492 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.4 m-20 -57.96 -36.15 72.16 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.27 1.034 . . . . 0.0 108.405 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -62.18 -46.45 88.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.879 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -59.08 -37.46 77.16 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 85.5 m -58.6 -41.0 84.83 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.225 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.15 -46.07 89.33 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.298 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.439 HD11 HD13 ' A' ' 134' ' ' ILE . 90.8 mt -66.14 -41.84 89.91 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.814 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.97 -26.94 68.51 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.403 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 m -65.7 -34.64 78.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.238 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 60' ' ' GLY . 4.3 t -59.13 163.54 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.199 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.441 ' N ' HG12 ' A' ' 59' ' ' VAL . . . -157.6 -161.98 11.31 Favored Glycine 0 N--CA 1.473 1.109 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.43 -125.28 38.99 Favored Glycine 0 C--N 1.342 0.868 0 C-N-CA 118.867 -1.635 . . . . 0.0 109.774 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -48.37 -17.05 0.12 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.58 -0.31 . . . . 0.0 110.866 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -45.77 -21.71 0.14 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.324 0.25 . . . . 0.0 111.302 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.74 -38.91 64.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.31 -40.55 96.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.0 mtt -63.74 -16.51 61.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.514 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -59.55 -39.05 82.73 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -60.62 -42.09 96.18 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -57.65 -39.28 76.67 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.096 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -60.63 -39.31 87.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.54 -40.48 95.68 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -59.39 -43.44 92.93 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 84.9 mt -60.78 -42.33 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -60.13 -41.8 93.44 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.486 -0.779 . . . . 0.0 108.97 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.32 -43.47 97.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.504 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.77 -40.47 97.39 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.73 98.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.564 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.1 -50.15 71.67 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.309 0.576 . . . . 0.0 110.87 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.81 -39.55 94.5 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.515 ' CH2' HD13 ' A' ' 129' ' ' ILE . 62.8 t-105 -58.12 -46.32 85.8 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.678 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -55.71 -41.79 74.33 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -72.26 -14.18 61.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.095 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt -105.1 -48.72 3.65 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.464 ' HB3' ' HD3' ' A' ' 85' ' ' PRO . 4.3 t-80 -102.5 -58.52 0.09 OUTLIER Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 119.696 -0.801 . . . . 0.0 112.913 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 51.7 Cg_exo -58.22 -25.58 72.62 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.125 1.216 . . . . 0.0 109.29 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.3 p -55.32 -17.44 2.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.356 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.536 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 17.8 p80 -48.09 -36.52 13.33 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.476 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 87' ' ' HIS . . . 163.12 117.06 0.0 OUTLIER 'General case' 0 C--O 1.239 0.505 0 O-C-N 123.621 0.575 . . . . 0.0 109.893 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.58 -54.62 36.35 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.04 148.57 91.46 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.934 2.423 . . . . 0.0 112.263 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.567 HD13 ' OE1' ' A' ' 98' ' ' GLU . 19.5 tt -155.6 152.75 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.929 0.395 . . . . 0.0 110.746 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.18 135.36 93.46 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.06 157.07 35.94 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 122.236 1.957 . . . . 0.0 112.36 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.1 5.98 60.49 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.307 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -125.06 146.58 49.38 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.068 0.461 . . . . 0.0 111.052 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -62.48 147.02 50.08 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.624 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 -56.97 114.56 2.16 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.567 ' OE1' HD13 ' A' ' 91' ' ' ILE . 17.6 mp0 -62.35 159.2 42.28 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.936 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.551 ' HB3' HD11 ' A' ' 104' ' ' ILE . 71.4 Cg_exo -51.24 141.31 39.79 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.437 2.092 . . . . 0.0 114.043 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.496 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 97.8 mtt180 -138.44 160.14 40.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.043 -1.89 . . . . 0.0 106.292 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.11 -47.64 85.96 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 118.348 -1.882 . . . . 0.0 109.63 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.1 p -64.78 -39.04 92.95 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.992 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.496 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 99.0 m-20 -63.91 -43.21 96.64 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.961 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.564 HG21 ' CZ3' ' A' ' 133' ' ' TRP . 0.8 OUTLIER -60.98 -37.89 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.69 -22.75 67.05 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.426 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.61 -3.26 69.31 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.4 p -67.53 -23.42 65.44 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.4 p -117.33 -2.32 11.61 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.154 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.0 m -105.45 131.42 52.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.726 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 83.8 m -70.65 151.47 44.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.4 tp -56.82 -49.73 74.52 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.039 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.91 -40.43 88.79 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.69 -41.74 86.96 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -61.8 -37.68 85.29 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.5 mm -57.75 -62.03 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.291 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.71 -40.69 97.64 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -56.33 -44.94 80.47 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.467 ' SD ' HD11 ' A' ' 2' ' ' ILE . 27.4 ttt -72.67 -42.02 64.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.356 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 75.5 p -125.52 -23.89 4.0 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -51.72 -64.34 0.84 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.852 1.205 . . . . 0.0 110.429 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -76.71 -175.89 0.55 Allowed Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.24 143.82 14.06 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 N-CA-C 108.28 -1.469 . . . . 0.0 108.28 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -47.23 129.71 16.03 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.813 1.676 . . . . 0.0 113.526 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.454 HG22 HG13 ' A' ' 126' ' ' VAL . 42.7 mm -113.82 108.57 51.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.1 55.87 2.99 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.17 1.914 . . . . 0.0 113.431 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 127' ' ' GLY . 17.7 m -61.1 -48.19 90.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.926 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.482 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -63.59 -42.51 98.8 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.603 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -62.18 -46.26 89.73 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.389 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.515 HD13 ' CH2' ' A' ' 80' ' ' TRP . 89.8 mt -63.61 -48.77 85.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.372 0.606 . . . . 0.0 110.517 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.666 ' CE2' HD11 ' A' ' 134' ' ' ILE . 85.7 t80 -58.25 -47.1 84.64 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.417 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -61.53 -39.99 93.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.486 -1.233 . . . . 0.0 109.596 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.29 -41.74 89.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.564 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 47.9 m0 -62.08 -43.8 98.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.666 HD11 ' CE2' ' A' ' 130' ' ' TYR . 85.8 mt -60.47 -44.44 96.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.973 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.1 mt -58.56 -41.27 81.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.729 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.8 -45.13 94.08 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.609 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.93 96.96 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -63.41 -36.41 83.65 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -58.05 -44.73 87.59 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.26 -38.62 90.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.778 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.66 -49.49 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.2 -36.06 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -65.81 -38.79 89.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.6 tpt -59.13 -47.39 85.45 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -72.93 -12.75 61.07 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.195 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.4 t -51.09 117.47 8.87 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.578 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -78.4 -35.04 1.29 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.956 1.771 . . . . 0.0 113.555 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.1 p -139.81 172.47 12.73 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.7 m -105.62 151.54 24.24 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.861 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.7 mm -49.35 -43.4 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 tt -58.79 -39.86 82.35 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.78 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -67.71 -14.49 62.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.081 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.2 mm -80.04 113.67 19.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.388 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -144.0 128.31 17.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -90.1 125.35 35.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.763 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -89.39 166.38 33.2 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.641 ' O ' ' HB2' ' A' ' 228' ' ' ALA . 22.0 Cg_endo -62.19 -35.46 74.58 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.666 1.578 . . . . 0.0 110.312 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -77.12 -17.41 58.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.484 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -84.62 127.3 66.03 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.662 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 148.53 54.1 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.247 1.965 . . . . 0.0 114.116 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.74 -43.09 94.39 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.836 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.522 ' H ' ' H ' ' A' ' 225' ' ' GLY . 36.1 ttp85 -60.58 -46.61 89.59 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.68 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -59.86 -41.42 91.42 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.962 -1.095 . . . . 0.0 108.313 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -61.52 -50.45 72.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.126 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.32 -43.95 97.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.763 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -61.59 -56.37 20.59 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.63 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -62.24 -39.54 93.18 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.664 ' CE2' HG23 ' A' ' 186' ' ' THR . 90.1 t80 -57.32 -47.62 81.06 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -64.39 -37.66 88.3 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.624 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -61.07 -45.35 95.11 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.719 0.771 . . . . 0.0 109.6 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 94.7 m -66.1 -40.2 90.59 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 16.7 tp -58.51 -38.98 78.84 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.323 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -61.51 -42.57 99.01 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.991 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -82.67 -10.65 58.83 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.205 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -49.78 167.73 0.04 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.592 0.71 . . . . 0.0 111.868 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -98.6 -93.57 0.25 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.494 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -44.57 143.8 1.25 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.675 0.75 . . . . 0.0 111.977 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 66.5 m -63.32 177.26 0.67 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.294 -1.321 . . . . 0.0 112.855 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -50.84 -27.28 7.05 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.051 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -51.65 -48.18 63.49 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 55.3 t -89.87 -61.23 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.175 0.988 . . . . 0.0 108.926 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -42.05 -53.08 4.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.552 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -59.46 -41.9 90.75 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.753 -178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -60.44 -48.87 79.87 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.577 0.703 . . . . 0.0 109.907 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 24.8 mmt -61.4 -41.21 96.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.289 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.664 HG23 ' CE2' ' A' ' 168' ' ' PHE . 66.7 m -60.54 -45.5 93.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.029 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -59.36 -49.86 76.2 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.813 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 97.6 m -64.62 -47.36 78.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.591 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.59 -37.56 87.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.28 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.539 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 9.4 mt -43.23 -54.0 4.79 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.013 0.435 . . . . 0.0 110.722 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 71.8 t -86.92 -40.62 14.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.947 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -59.76 -49.36 78.04 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 49.3 p30 -89.32 -4.96 57.91 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 119.074 -1.051 . . . . 0.0 112.087 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 190' ' ' LEU . . . -68.31 162.98 24.0 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -66.85 150.83 97.48 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.624 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.402 ' HA ' ' HB3' ' A' ' 199' ' ' LYS . 31.7 Cg_endo -64.2 -38.74 34.12 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.407 2.072 . . . . 0.0 113.588 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.539 ' HB2' ' HB1' ' A' ' 228' ' ' ALA . 98.6 m-20 -59.51 -50.54 73.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.21 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . 0.703 ' SG ' HG11 ' A' ' 230' ' ' VAL . 53.2 t -64.19 -43.59 94.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.035 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 196' ' ' PRO . 88.6 tttt -48.31 -30.27 4.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.847 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 92.6 m -59.47 -49.05 79.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.925 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.691 ' HB ' HG12 ' A' ' 230' ' ' VAL . 0.8 OUTLIER -82.67 -30.23 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.156 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.446 HD11 ' SG ' ' A' ' 198' ' ' CYS . 79.3 mt -60.94 -45.14 95.9 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.2 -39.45 94.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.001 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -59.05 -37.46 77.06 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.962 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 72.6 mt -59.78 -38.99 83.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.27 167.76 43.97 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.649 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.1 154.36 67.88 Favored 'Trans proline' 0 N--CA 1.507 2.32 0 C-N-CA 123.936 3.091 . . . . 0.0 113.871 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.19 16.3 80.8 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.749 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -79.9 135.54 36.45 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.094 0.473 . . . . 0.0 111.353 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 212' ' ' GLU . 42.0 m -73.35 137.37 44.71 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -51.64 -39.32 57.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.484 ' H ' HG22 ' A' ' 210' ' ' THR . 88.8 tt0 -59.25 -45.76 90.31 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.18 -42.18 90.24 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 60.7 mtt -62.7 -43.06 99.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.206 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 59.8 mtt -63.8 -43.54 95.98 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.682 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.1 m -65.86 -49.65 67.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.561 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -63.16 -44.53 95.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.031 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 81.0 m -61.32 -39.29 89.94 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.13 -36.68 83.79 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.174 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.37 94.35 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 229' ' ' ARG . 2.2 t -96.49 -16.58 7.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.199 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 109.98 105.32 2.92 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -147.84 -62.05 0.01 OUTLIER Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.629 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.449 ' HA ' ' N ' ' A' ' 162' ' ' ARG . 27.0 Cg_exo -59.71 90.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 121.945 1.763 . . . . 0.0 110.211 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.522 ' H ' ' H ' ' A' ' 162' ' ' ARG . . . 100.16 -7.17 58.44 Favored Glycine 0 CA--C 1.537 1.434 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -178.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -105.37 124.79 50.13 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 122.558 -0.378 . . . . 0.0 110.711 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -30.31 -66.4 0.1 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.436 1.085 . . . . 0.0 113.409 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 157' ' ' PRO . . . -163.11 28.13 0.09 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.056 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.454 ' O ' HG12 ' A' ' 221' ' ' VAL . 40.1 mmt180 -66.21 -6.57 14.06 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.76 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.703 HG11 ' SG ' ' A' ' 198' ' ' CYS . 53.2 t -59.04 -44.26 90.93 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.908 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.88 -179.666 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 N--CA 1.486 1.077 0 N-CA-C 109.408 -1.035 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.2 pt -75.85 125.61 35.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.481 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -127.18 130.0 71.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.877 -178.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.42 121.58 13.03 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -84.04 -174.12 5.1 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.349 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 6' ' ' LEU . 87.3 mt -59.86 -38.32 81.83 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -66.82 -23.37 66.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.353 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.42 -7.14 56.02 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -71.85 132.54 44.56 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.371 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.1 mtt -85.04 109.49 18.25 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.8 t -109.73 130.22 63.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.805 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -61.29 137.38 58.24 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.841 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -138.55 152.34 48.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.006 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.86 143.59 49.36 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.029 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.9 mm -64.42 138.46 23.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.2 t -58.69 121.58 54.78 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.44 -35.21 64.85 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 120.87 1.047 . . . . 0.0 110.029 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -59.42 -43.65 93.03 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.0 m -62.01 -46.19 90.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.97 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.7 mt -57.96 -50.17 74.3 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.311 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.11 -40.59 90.2 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.571 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -63.24 -43.4 98.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.693 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -59.75 -50.39 74.0 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.531 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.5 t -62.4 -42.66 96.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.175 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.82 -43.19 90.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 22' ' ' ALA . 49.2 t -58.79 -44.41 90.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 76.1 t -64.79 -35.92 76.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.636 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -54.07 -46.94 72.14 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.515 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -91.09 -39.47 12.15 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.675 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -116.83 38.17 3.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.001 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.6 -54.37 3.24 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -175.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -97.06 -5.69 36.95 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -50.83 140.4 20.13 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.399 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.3 -32.46 41.53 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 122.432 2.088 . . . . 0.0 112.7 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -57.84 -18.9 25.16 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.002 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.47 -42.76 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.766 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.424 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 7.2 mt -45.96 -61.5 2.47 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.731 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 77.8 Cg_exo -54.39 -41.53 75.86 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 CA-C-N 120.115 1.077 . . . . 0.0 111.569 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.5 tpt -59.66 -46.88 87.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.36 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -54.64 -48.65 72.02 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.2 m -59.48 -41.52 89.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.677 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.84 -44.67 93.97 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.094 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.58 -18.52 59.72 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.427 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -95.66 26.35 4.04 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.224 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -78.49 125.89 30.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.061 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.42 11.4 71.84 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.926 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 52' ' ' LEU . . . -68.21 149.08 49.96 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.301 0.572 . . . . 0.0 112.036 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.2 m -99.55 142.74 25.16 Favored Pre-proline 0 C--O 1.218 -0.569 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.482 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -43.64 -38.69 9.39 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.328 1.352 . . . . 0.0 112.852 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -71.54 -63.72 1.06 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.9 m-20 -58.91 -38.58 79.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.988 0.899 . . . . 0.0 108.917 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.479 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . 56.0 tp -63.95 -49.31 73.07 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.597 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -57.74 -39.83 78.24 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 96.9 m -61.17 -41.93 97.65 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.799 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 41.9 ttp -59.32 -48.16 82.66 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.888 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.49 ' H ' HD12 ' A' ' 56' ' ' LEU . 6.6 mp -63.3 -41.93 98.99 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.095 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -59.07 -33.8 71.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.374 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.4 m -65.37 -32.94 74.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.238 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.5 t -58.96 142.85 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.525 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.07 -151.88 6.95 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.79 -128.27 40.19 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -53.47 -12.85 0.5 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.817 -0.192 . . . . 0.0 111.414 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -44.38 -21.54 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.54 -39.26 70.35 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.67 93.79 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.5 ttm -57.54 -21.59 39.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.777 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -56.38 -37.35 69.98 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.2 ttp -58.55 -45.92 87.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 tt -58.19 -39.9 80.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -56.84 -41.56 78.11 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.007 -1.077 . . . . 0.0 108.377 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.9 -40.18 94.68 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -59.74 -43.95 94.01 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.79 -43.03 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -60.76 -40.02 90.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.949 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.55 -43.57 98.48 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -61.67 -39.48 91.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.83 -42.87 99.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.693 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.2 84.4 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.393 0.616 . . . . 0.0 110.393 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.48 -39.78 95.36 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.606 ' O ' ' HD2' ' A' ' 85' ' ' PRO . 76.4 t-105 -58.53 -47.98 82.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.259 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -55.07 -41.0 70.97 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.82 -22.89 64.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.745 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.4 mt -101.01 -49.13 4.21 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.426 ' HB3' ' HD3' ' A' ' 85' ' ' PRO . 20.8 t60 -102.6 -62.56 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 119.668 -0.813 . . . . 0.0 112.777 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 68.4 Cg_exo -54.46 -20.86 21.89 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 CA-C-N 120.935 1.37 . . . . 0.0 109.841 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -50.94 -20.0 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.643 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -40.43 -68.51 0.17 Allowed 'General case' 0 C--N 1.347 0.457 0 O-C-N 123.37 0.419 . . . . 0.0 111.112 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -175.62 125.3 0.23 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.061 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.16 -52.11 55.21 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.64 146.06 38.15 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.569 1.513 . . . . 0.0 111.832 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.9 tt -156.28 153.24 7.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.789 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.7 152.56 96.19 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.811 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.04 162.49 42.48 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.483 2.122 . . . . 0.0 112.081 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.57 -4.39 69.36 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 121.108 -0.567 . . . . 0.0 111.783 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -118.16 141.52 48.4 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 116.883 0.341 . . . . 0.0 110.36 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.04 147.11 53.86 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.128 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -52.21 121.24 6.5 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -63.31 158.08 59.37 Favored Pre-proline 0 C--O 1.24 0.563 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.425 ' HB3' HD11 ' A' ' 104' ' ' ILE . 52.2 Cg_exo -50.01 136.8 36.94 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.584 1.522 . . . . 0.0 112.872 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.603 ' O ' HD12 ' A' ' 104' ' ' ILE . 43.7 ttm180 -134.67 139.11 45.01 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -43.22 -49.71 6.57 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.223 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -61.72 -41.21 97.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.325 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.87 -43.68 98.35 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.037 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.603 HD12 ' O ' ' A' ' 100' ' ' ARG . 1.5 mp -59.17 -41.5 83.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.4 -27.4 68.98 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.79 -7.89 80.59 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.3 p -60.13 -29.85 68.9 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.6 p -116.94 -7.69 11.36 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.981 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.1 t -99.28 129.15 45.48 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.205 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.7 m -72.85 146.29 46.33 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.5 tp -54.36 -47.44 72.6 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.375 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.4 -39.37 87.12 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.49 -40.62 97.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.199 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.2 -41.35 96.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.192 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 24.9 pt -63.77 -47.66 89.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 118.342 -1.343 . . . . 0.0 111.388 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.41 -41.67 66.66 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.416 ' CZ2' HG11 ' A' ' 126' ' ' VAL . 13.1 t90 -57.78 -45.03 86.59 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.8 ttt -71.86 -43.77 64.92 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.451 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 81.8 p -125.92 -23.62 3.93 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -57.44 -50.77 71.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 118.535 -1.266 . . . . 0.0 110.206 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -83.57 -178.12 1.12 Allowed Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.79 144.04 21.48 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 N-CA-C 107.785 -1.659 . . . . 0.0 107.785 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.54 126.8 10.84 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.43 1.42 . . . . 0.0 113.421 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.461 HG22 HG13 ' A' ' 126' ' ' VAL . 42.1 mm -114.24 108.07 50.79 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.24 55.68 4.15 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.834 1.689 . . . . 0.0 113.341 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.461 HG13 HG22 ' A' ' 124' ' ' ILE . 23.6 m -59.44 -42.47 87.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.454 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -62.67 -45.05 96.6 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.768 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.63 -43.9 97.64 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.153 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.58 -48.07 89.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.443 0.64 . . . . 0.0 110.071 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.741 ' CE2' HD11 ' A' ' 134' ' ' ILE . 78.4 t80 -59.48 -46.85 87.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.522 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -60.69 -39.37 88.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.392 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -59.13 -43.09 91.96 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.469 ' CH2' HG21 ' A' ' 104' ' ' ILE . 50.6 m0 -62.4 -43.66 98.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.186 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.741 HD11 ' CE2' ' A' ' 130' ' ' TYR . 84.7 mt -61.76 -45.52 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.035 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.19 -42.6 87.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.25 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.38 -43.05 99.74 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.6 98.46 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.43 -36.75 84.78 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -58.29 -44.03 88.33 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.69 -38.31 88.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.748 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.6 mm -60.84 -49.37 84.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.611 -0.436 . . . . 0.0 112.031 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.6 m -58.34 -35.9 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -65.16 -38.99 92.32 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.3 tmm? -60.41 -47.51 85.79 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.443 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -71.44 -15.2 62.33 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.202 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.9 t -48.11 115.16 3.85 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.717 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -75.66 -41.85 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.979 1.786 . . . . 0.0 113.801 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 43.1 p -140.83 170.17 16.26 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 39.9 t -90.84 148.19 22.68 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.98 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 tp -50.17 -34.35 10.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.8 tp -65.06 -39.42 93.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.724 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.7 -11.3 44.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.837 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.485 HD11 ' CB ' ' A' ' 171' ' ' THR . 88.2 mt -79.16 125.99 38.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.862 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -144.46 133.16 22.31 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.095 0.474 . . . . 0.0 111.016 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -66.86 105.5 1.62 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.634 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -69.64 159.91 53.09 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.977 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.814 ' HA ' ' HB2' ' A' ' 228' ' ' ALA . 68.9 Cg_exo -53.82 -37.69 85.03 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 123.026 2.484 . . . . 0.0 112.785 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -109.31 22.91 15.21 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -96.75 136.84 21.5 Favored Pre-proline 0 C--O 1.24 0.588 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.198 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.86 136.55 16.84 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.203 1.936 . . . . 0.0 112.873 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 165' ' ' VAL . 53.4 t80 -59.56 -34.74 73.06 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.406 ' N ' ' HA ' ' A' ' 224' ' ' PRO . 59.3 ttt85 -60.19 -52.45 65.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.111 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.52 -41.47 98.5 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.874 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -59.49 -50.09 75.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.634 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 161' ' ' PHE . 56.1 t -61.76 -46.66 96.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.13 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -58.47 -49.63 76.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.121 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -63.23 -41.58 99.12 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.581 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.455 ' HA ' HD13 ' A' ' 153' ' ' ILE . 85.8 t80 -56.53 -49.35 75.03 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.924 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.53 ' OH ' HD22 ' A' ' 211' ' ' LEU . 28.8 m-85 -67.29 -37.43 83.37 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.825 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -58.6 -49.96 75.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.696 0.76 . . . . 0.0 108.974 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.485 ' CB ' HD11 ' A' ' 153' ' ' ILE . 94.6 m -66.83 -37.35 84.32 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.88 178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 64.6 tp -59.28 -48.65 80.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.318 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -60.28 -45.56 92.91 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.81 77.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.236 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -54.11 164.46 0.63 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.725 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -60.66 -163.45 0.01 OUTLIER 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -109.4 110.29 21.39 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 118.866 -1.134 . . . . 0.0 113.271 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.445 ' HB3' ' HB ' ' A' ' 181' ' ' VAL . 66.3 m -101.22 133.48 45.73 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -87.33 -65.68 0.99 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 117.035 -1.866 . . . . 0.0 110.174 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -88.6 -40.76 13.11 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 178' ' ' SER . 24.9 t -52.3 -31.66 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.482 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 178' ' ' SER . 87.3 tttt -59.38 -46.8 87.65 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 119.444 -0.902 . . . . 0.0 108.683 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -64.54 -46.08 84.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.35 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 77.4 t-105 -62.49 -51.12 68.69 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.25 0.548 . . . . 0.0 111.531 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 57.4 mtt -63.54 -45.33 91.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.7 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 73.0 m -60.65 -50.15 74.66 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.818 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.58 -49.4 76.8 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.187 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.5 m -64.41 -48.31 75.85 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.906 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.37 -37.85 88.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.992 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.596 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 14.2 mt -48.92 -47.88 43.08 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.467 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.1 m -86.18 -38.17 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.077 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.55 -50.12 72.59 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -74.79 -21.83 59.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.979 0.419 . . . . 0.0 111.347 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 190' ' ' LEU . . . -59.56 150.84 25.99 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.222 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.94 138.8 97.6 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 199' ' ' LYS . 78.1 Cg_exo -52.36 -50.06 15.29 Favored 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 122.354 2.036 . . . . 0.0 116.145 -176.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -63.32 -44.02 96.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.982 -176.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . 0.428 ' N ' ' HA ' ' A' ' 229' ' ' ARG . 37.0 t -67.96 -42.14 81.36 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 196' ' ' PRO . 87.6 tttt -52.11 -28.57 18.21 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.105 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 87.7 m -59.09 -48.59 81.05 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 0.8 OUTLIER -68.52 -43.93 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.865 178.172 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.46 HD11 ' SD ' ' A' ' 214' ' ' MET . 0.0 OUTLIER -50.6 -52.73 36.59 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.57 -39.82 95.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.923 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -55.17 -35.0 64.33 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.346 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.461 ' CD2' ' HB1' ' A' ' 209' ' ' ALA . 58.6 tp -58.73 -39.84 82.02 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 104.9 163.66 24.05 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.63 155.08 54.77 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.301 2.667 . . . . 0.0 113.321 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 71.81 15.19 75.84 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.461 ' HB1' ' CD2' ' A' ' 205' ' ' LEU . . . -72.31 138.1 47.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.035 0.445 . . . . 0.0 111.201 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 212' ' ' GLU . 88.7 m -62.61 139.29 58.63 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.53 HD22 ' OH ' ' A' ' 169' ' ' TYR . 67.6 tp -54.86 -44.22 73.8 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.442 ' H ' HG22 ' A' ' 210' ' ' THR . 88.6 tt0 -58.04 -46.52 85.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.03 -40.86 86.35 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.46 ' SD ' HD11 ' A' ' 202' ' ' LEU . 56.0 ttm -61.65 -50.02 74.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.124 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 63.8 tpp -62.1 -47.42 84.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.584 0.707 . . . . 0.0 110.171 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.5 m -61.56 -47.17 86.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.126 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.8 -46.35 90.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.987 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.68 -40.57 97.5 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -58.2 -38.33 76.55 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.862 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.67 -37.5 89.64 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 35.9 m -97.22 -4.71 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 91.5 14.23 57.29 Favored Glycine 0 CA--C 1.543 1.824 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.985 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.426 ' N ' ' CD ' ' A' ' 224' ' ' PRO . . . -59.35 -41.91 97.16 Favored Glycine 0 CA--C 1.553 2.437 0 CA-C-N 117.187 0.493 . . . . 0.0 112.742 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 223' ' ' GLY . 87.5 Cg_exo -50.59 -31.68 32.6 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.246 1.964 . . . . 0.0 111.647 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -78.01 158.91 46.87 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.917 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -56.5 108.94 0.54 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 10.2 tttt 172.8 143.31 0.04 OUTLIER 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.537 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.814 ' HB2' ' HA ' ' A' ' 157' ' ' PRO . . . -72.41 -16.41 61.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.37 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.428 ' HA ' ' N ' ' A' ' 198' ' ' CYS . 16.2 ptp180 -109.75 -178.27 3.49 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -177.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 4.0 m -52.21 -30.97 14.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 113.347 -1.752 . . . . 0.0 109.723 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.595 179.883 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.486 1.043 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.501 HG21 HG22 ' A' ' 115' ' ' ILE . 5.6 pt -57.42 108.26 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.342 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.01 133.54 19.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.18 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -60.97 136.42 58.08 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.38 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -98.38 -168.07 1.6 Allowed 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.657 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 6' ' ' LEU . 10.3 mp -58.67 -38.97 79.34 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -66.71 -23.32 66.1 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.237 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.4 -8.04 62.13 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.57 132.1 40.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 119' ' ' THR . 64.1 mtt -83.78 134.23 34.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.146 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.0 t -128.26 130.1 69.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.507 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.463 ' CD2' HD21 ' A' ' 111' ' ' LEU . 81.2 t60 -74.95 110.46 9.27 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.293 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -113.26 143.32 44.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.613 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.2 143.09 56.73 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.376 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.469 HD12 ' HG ' ' A' ' 20' ' ' LEU . 32.0 pt -60.57 144.57 13.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.721 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 m -62.76 122.76 76.38 Favored Pre-proline 0 N--CA 1.454 -0.26 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.877 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.58 -36.74 81.76 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 120.722 0.948 . . . . 0.0 109.738 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -56.75 -48.82 76.96 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.933 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.3 m -61.02 -46.94 88.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.042 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.469 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -48.9 -60.52 2.69 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.289 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -57.65 -38.79 75.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.821 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -61.77 -42.35 98.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.457 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -59.05 -51.06 71.66 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.829 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.7 t -63.18 -41.84 94.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.379 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.07 -43.68 91.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.372 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 22' ' ' ALA . 50.7 t -59.02 -44.98 92.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 60.7 t -62.45 -37.0 77.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.94 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -54.31 -46.72 72.89 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.528 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -89.42 -30.7 18.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' O ' HG21 ' A' ' 36' ' ' VAL . 98.9 mttt -130.91 38.44 3.69 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.871 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.51 -51.26 5.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -96.02 -4.65 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 30' ' ' LYS . 67.2 m -54.97 147.22 34.36 Favored Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 118.866 0.757 . . . . 0.0 111.772 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.72 -34.71 10.98 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 122.663 2.242 . . . . 0.0 112.831 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.64 -19.36 25.85 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.904 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 30' ' ' LYS . 53.9 t -64.2 -41.77 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.608 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.427 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 7.1 mt -46.54 -61.31 2.76 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.279 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 78.4 Cg_exo -54.74 -40.61 83.86 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 CA-C-N 120.111 1.075 . . . . 0.0 111.557 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.0 tpt -59.0 -48.13 82.71 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.25 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -56.0 -46.77 78.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m -57.72 -44.2 85.79 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.858 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.27 99.17 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.462 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.91 -26.5 64.19 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.926 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.4 p -87.44 1.18 54.16 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -54.56 126.16 22.59 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.734 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.12 10.95 78.93 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.597 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.33 149.23 46.29 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.327 0.585 . . . . 0.0 112.564 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 84.7 m -99.96 141.7 23.25 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.135 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -41.74 -38.68 4.62 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.436 1.424 . . . . 0.0 113.056 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -71.05 -64.12 0.97 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.196 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.5 m-20 -59.18 -37.61 77.79 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.327 1.06 . . . . 0.0 108.503 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.08 -47.89 82.65 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.826 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -58.12 -39.27 78.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 58' ' ' THR . 91.6 m -60.65 -39.93 90.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.404 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 97.8 mtp -57.39 -48.08 80.01 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.654 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.521 HD11 HD13 ' A' ' 134' ' ' ILE . 88.1 mt -65.09 -40.62 94.86 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.799 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -60.54 -39.33 87.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.515 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 54' ' ' THR . 58.6 p -67.45 -19.04 65.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.896 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.2 t -61.18 152.97 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.587 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.54 -153.09 5.92 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.99 -128.16 46.85 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 120.363 -0.923 . . . . 0.0 111.018 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -51.93 -10.29 0.11 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.846 -0.677 . . . . 0.0 112.113 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -42.95 -21.7 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.14 66.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.6 96.29 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.6 tpp -57.09 -22.12 37.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.03 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -58.42 -38.11 76.75 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -58.85 -42.91 90.44 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.61 -40.86 76.07 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.498 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -58.18 -41.33 83.65 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.736 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.92 -40.4 95.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.499 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.5 m -59.61 -46.43 88.99 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.38 -41.06 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.305 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -60.33 -42.17 95.07 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.902 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.69 -46.03 90.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.996 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 133' ' ' TRP . 81.2 mm-40 -61.43 -38.54 87.51 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.68 90.93 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.54 66.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.891 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.46 -43.75 96.47 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.015 0.912 . . . . 0.0 108.854 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.648 ' CZ2' HD13 ' A' ' 104' ' ' ILE . 83.4 t90 -60.5 -39.82 89.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.613 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -54.32 -41.0 68.5 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -69.55 -20.56 63.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.832 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.95 -48.09 4.36 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.419 ' HB2' ' CE2' ' A' ' 80' ' ' TRP . 7.1 m80 -95.14 -67.14 0.08 OUTLIER Pre-proline 0 C--O 1.223 -0.34 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.676 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 85.6 Cg_exo -51.17 -37.46 58.75 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 CA-C-N 121.626 1.617 . . . . 0.0 111.687 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 t -79.9 -12.17 13.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -42.63 -31.72 0.49 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.557 0.218 . . . . 0.0 110.45 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.1 4.82 0.55 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.082 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.7 -127.1 39.61 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.37 145.13 98.82 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 CA-C-N 119.352 1.576 . . . . 0.0 110.627 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.2 tp -126.94 149.65 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.99 155.0 85.2 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.79 167.35 27.46 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 123.028 2.485 . . . . 0.0 112.837 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.9 -10.17 60.34 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -125.25 154.43 41.67 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 122.602 -0.352 . . . . 0.0 110.774 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 62.0 mtt -61.77 146.38 49.61 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.18 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -51.37 116.41 2.05 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.337 0.589 . . . . 0.0 109.47 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -61.83 154.36 67.68 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.777 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.15 126.29 6.23 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.661 1.574 . . . . 0.0 113.118 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.564 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 1.1 mpt_? -115.55 151.32 35.1 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 113.773 -1.558 . . . . 0.0 107.774 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.549 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -49.35 -54.29 16.57 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.3 p -63.65 -33.94 76.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.875 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.564 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 82.9 m-20 -63.08 -39.86 95.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.857 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.648 HD13 ' CZ2' ' A' ' 80' ' ' TRP . 4.5 tp -56.8 -31.92 36.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.72 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.1 -27.8 61.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.204 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.88 -8.2 80.22 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 108.441 -1.863 . . . . 0.0 108.441 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 71.4 p -62.31 -19.24 63.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.0 p -122.96 10.57 9.5 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.003 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.1 m -114.81 130.77 56.92 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.271 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 m -73.0 151.14 41.9 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.463 HD21 ' CD2' ' A' ' 12' ' ' HIS . 68.3 tp -54.54 -46.03 73.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -61.01 -40.63 94.29 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -61.87 -45.85 91.98 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.277 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -62.29 -41.94 98.93 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.142 0.276 . . . . 0.0 111.38 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.501 HG22 HG21 ' A' ' 2' ' ' ILE . 47.1 pt -65.84 -43.26 93.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.931 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 120' ' ' HIS . . . -71.52 -41.05 58.63 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -58.56 -45.9 88.01 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.247 -0.976 . . . . 0.0 108.717 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.473 ' SD ' HD11 ' A' ' 2' ' ' ILE . 27.7 ttt -72.98 -41.1 64.71 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.377 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.529 HG21 ' SD ' ' A' ' 10' ' ' MET . 72.2 p -125.96 -24.26 3.8 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.406 ' HB2' ' HA2' ' A' ' 116' ' ' GLY . 50.3 t-80 -53.54 -64.78 0.71 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.93 1.241 . . . . 0.0 110.54 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -77.14 -177.4 0.78 Allowed Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.54 137.41 25.87 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 N-CA-C 108.276 -1.471 . . . . 0.0 108.276 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.59 127.31 3.32 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.627 2.218 . . . . 0.0 114.415 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.406 HG22 HG13 ' A' ' 126' ' ' VAL . 46.7 mm -113.34 108.26 52.65 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.99 57.31 4.52 Favored 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.309 2.006 . . . . 0.0 113.725 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 127' ' ' GLY . 19.3 m -59.48 -46.09 93.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-O 121.145 0.497 . . . . 0.0 109.975 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -62.92 -42.86 99.59 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.089 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.42 -45.24 95.13 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.339 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 mm -63.77 -48.63 85.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-O 121.318 0.58 . . . . 0.0 110.415 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.726 ' CE2' HD11 ' A' ' 134' ' ' ILE . 83.0 t80 -58.49 -49.45 77.32 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.142 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.495 ' HA ' HD12 ' A' ' 134' ' ' ILE . 38.0 ttpt -62.41 -39.24 92.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.402 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -56.58 -43.34 79.93 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.603 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 45.0 m0 -62.73 -43.45 98.78 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.293 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.726 HD11 ' CE2' ' A' ' 130' ' ' TYR . 82.2 mt -58.25 -44.05 87.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.809 -178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.7 mt -59.23 -41.97 85.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.308 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.82 -42.63 99.8 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.57 98.42 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.55 -35.68 81.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -58.01 -45.35 87.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.55 -39.19 93.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.684 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.5 mm -60.55 -49.74 83.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.168 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.2 m -58.74 -36.0 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -64.73 -39.52 93.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 60.8 ttm -60.08 -47.27 86.59 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -68.82 -22.08 64.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.062 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 p -43.09 114.84 1.65 Allowed Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.357 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.25 -41.79 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.93 1.753 . . . . 0.0 113.943 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.9 p -138.53 167.56 21.67 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 40.1 t -87.4 146.92 25.67 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.308 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.465 HD11 ' CE1' ' A' ' 168' ' ' PHE . 9.8 tp -52.66 -35.55 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.35 -38.61 90.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.029 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -64.57 -27.44 68.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.263 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.479 HD13 HG21 ' A' ' 171' ' ' THR . 1.3 mp -64.82 121.31 13.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.364 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 85.9 mtp180 -142.56 132.38 24.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.754 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -94.28 131.37 39.96 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.647 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -95.6 157.43 21.82 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.97 -42.83 56.23 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.749 1.632 . . . . 0.0 111.508 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -73.74 -18.96 60.92 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.611 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.65 131.95 59.49 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.282 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.59 136.89 52.15 Favored 'Trans proline' 0 N--CA 1.508 2.33 0 C-N-CA 122.626 2.217 . . . . 0.0 114.223 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.403 ' CE2' HG21 ' A' ' 165' ' ' VAL . 72.4 t80 -60.38 -38.52 84.17 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.439 ' N ' ' HA ' ' A' ' 224' ' ' PRO . 79.8 ttt180 -60.19 -50.12 74.92 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.674 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -61.48 -39.5 91.16 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.146 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -60.29 -50.61 72.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.753 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.403 HG21 ' CE2' ' A' ' 161' ' ' PHE . 55.8 t -62.62 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.501 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -58.32 -51.23 70.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.345 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -65.27 -38.91 91.73 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.498 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.465 ' CE1' HD11 ' A' ' 150' ' ' ILE . 83.9 t80 -57.8 -48.69 78.98 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -67.87 -38.8 83.54 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.235 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -58.71 -47.49 84.39 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.479 HG21 HD13 ' A' ' 153' ' ' ILE . 98.2 m -64.94 -38.38 90.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.061 -1.427 . . . . 0.0 108.85 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.423 HD21 ' HE2' ' A' ' 182' ' ' LYS . 63.8 tp -59.48 -47.8 84.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.716 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -59.95 -44.29 94.49 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.71 79.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.051 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -53.02 158.74 1.36 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.171 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -62.87 -162.4 0.01 OUTLIER 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -104.38 110.35 22.57 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 118.804 -1.159 . . . . 0.0 112.802 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 70.7 m -100.01 132.84 45.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -87.88 -66.66 0.89 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 116.984 -1.886 . . . . 0.0 110.186 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -88.77 -40.04 13.49 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 178' ' ' SER . 37.1 t -52.47 -29.35 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 113.166 -1.834 . . . . 0.0 109.052 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 178' ' ' SER . 63.1 tttm -58.9 -47.02 86.46 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.229 -0.989 . . . . 0.0 108.523 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -68.92 -41.48 78.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.215 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -65.42 -50.68 64.52 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.159 0.504 . . . . 0.0 111.227 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 54.8 mtt -63.1 -47.22 83.75 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.547 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 86.5 m -60.45 -48.81 80.16 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.478 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.04 -49.22 78.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.996 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 74.8 p -70.66 -44.81 66.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.148 0.499 . . . . 0.0 111.493 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.34 -36.41 84.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.975 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.44 HD21 ' SD ' ' A' ' 214' ' ' MET . 65.0 tp -46.86 -51.52 16.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.651 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.06 -40.39 13.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.166 0.508 . . . . 0.0 111.859 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -59.8 -48.2 82.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -86.8 -1.57 57.88 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.541 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.74 158.87 33.83 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.814 0.34 . . . . 0.0 111.677 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . 0.485 ' OD1' ' HB1' ' A' ' 228' ' ' ALA . 24.7 p30 -69.85 152.77 95.92 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.147 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 199' ' ' LYS . 20.8 Cg_endo -60.81 -43.37 31.85 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 122.751 2.301 . . . . 0.0 115.993 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.561 ' HB2' ' HB3' ' A' ' 228' ' ' ALA . 99.1 m-20 -60.2 -45.27 93.74 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.871 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 41.1 t -71.88 -40.07 69.18 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 196' ' ' PRO . 88.0 tttt -49.83 -34.32 19.4 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.888 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 98.2 m -58.87 -49.97 75.78 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.606 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 46.6 mm -66.4 -46.3 87.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.654 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 202' ' ' LEU . 1.0 OUTLIER -55.08 -50.72 68.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.203 1.001 . . . . 0.0 108.609 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.38 -37.03 79.46 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.385 -1.279 . . . . 0.0 107.777 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -58.2 -40.01 80.49 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.176 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 205' ' ' LEU . 88.9 mt -61.97 -36.72 82.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.74 -164.9 41.6 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.82 171.93 11.45 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 123.188 2.592 . . . . 0.0 112.463 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.63 -130.35 48.14 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.562 ' HB3' ' HE2' ' A' ' 214' ' ' MET . . . 59.88 109.8 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.274 0.559 . . . . 0.0 110.435 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 72.1 p -62.49 158.4 17.96 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.289 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 65.9 tp -56.77 -38.44 72.47 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -57.19 -49.25 76.55 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -59.96 -42.4 93.99 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 119.626 -0.83 . . . . 0.0 108.966 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.562 ' HE2' ' HB3' ' A' ' 209' ' ' ALA . 60.9 mtt -62.43 -45.73 91.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.199 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 25.9 ttt -65.84 -44.93 84.03 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.24 0.543 . . . . 0.0 110.355 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 99.2 m -62.78 -47.63 82.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.53 0.681 . . . . 0.0 110.201 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.89 -44.19 97.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.326 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 92.6 m -61.54 -39.43 91.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -58.11 -38.55 76.68 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.088 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.79 -39.11 93.34 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 28.1 m -92.65 3.42 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.609 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 75.19 17.11 80.27 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.661 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.422 ' N ' ' CD ' ' A' ' 224' ' ' PRO . . . -57.97 -44.48 94.5 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-O 119.515 -0.603 . . . . 0.0 111.808 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.439 ' HA ' ' N ' ' A' ' 162' ' ' ARG . 99.2 Cg_exo -47.76 -38.35 29.62 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.179 1.919 . . . . 0.0 110.64 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -80.22 169.52 52.86 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.989 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -46.4 -26.82 0.91 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.765 -0.218 . . . . 0.0 111.551 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.27 121.19 21.81 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 197' ' ' ASP . . . -88.49 30.09 0.93 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.422 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 176.31 174.33 0.35 Allowed 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 8.0 p -50.35 -27.86 4.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 231' ' ' LEU . 11.6 tp . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.039 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.423 ' O ' HG23 ' A' ' 3' ' ' VAL . 1.9 Cg_endo . . . . . 0 N--CA 1.486 1.047 0 N-CA-C 108.949 -1.212 . . . . 0.0 108.949 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.527 HD11 ' SD ' ' A' ' 118' ' ' MET . 11.9 pt -54.9 109.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.504 0.668 . . . . 0.0 110.837 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 1' ' ' PRO . 93.5 t -132.44 126.84 55.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.345 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -65.33 121.5 14.96 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -74.0 -170.07 0.86 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.182 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.85 -39.41 85.08 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.35 -23.41 66.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.365 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.61 -7.78 57.99 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -71.79 125.65 27.7 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.421 ' SD ' HG21 ' A' ' 119' ' ' THR . 66.7 mtt -75.71 133.69 40.7 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.312 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.4 t -127.98 129.91 69.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.804 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.422 ' CD2' HD21 ' A' ' 111' ' ' LEU . 84.3 t60 -78.14 109.87 12.61 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.04 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -107.71 157.09 18.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.11 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.63 150.08 38.07 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.051 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.7 pt -65.51 143.02 16.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 120.966 0.412 . . . . 0.0 110.435 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.0 t -62.14 120.3 56.78 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.53 -36.07 69.16 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 120.763 0.976 . . . . 0.0 110.104 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -58.85 -48.28 81.91 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.723 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.7 p -66.64 -39.03 88.07 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.035 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.9 tp -59.0 -50.09 75.44 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.072 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -59.16 -41.81 89.28 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.405 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.518 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -62.13 -42.1 98.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.588 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.1 t-105 -58.16 -48.73 79.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.44 -44.3 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.336 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.84 -40.02 83.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.255 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.527 HG21 ' CE ' ' A' ' 39' ' ' MET . 53.8 t -58.08 -45.19 88.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 54.3 t -64.48 -37.72 80.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.126 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -53.94 -46.94 71.7 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.641 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -89.53 -39.24 13.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.442 ' O ' HG21 ' A' ' 36' ' ' VAL . 99.6 mttt -120.65 38.23 4.08 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -41.78 -54.19 3.43 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -95.76 -5.74 41.29 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -53.94 140.23 51.45 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 118.561 0.618 . . . . 0.0 111.571 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.82 -29.68 34.83 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 122.563 2.175 . . . . 0.0 113.275 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -59.32 -21.69 60.13 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.542 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 30' ' ' LYS . 53.8 t -62.73 -43.35 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.131 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.43 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 8.7 mt -45.09 -61.19 2.44 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.844 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 73.9 Cg_exo -53.43 -42.25 66.97 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 120.072 1.062 . . . . 0.0 111.803 176.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.527 ' CE ' HG21 ' A' ' 26' ' ' VAL . 24.2 ttt -61.53 -44.14 97.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.726 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.423 ' CE2' HG21 ' A' ' 134' ' ' ILE . 62.9 t80 -54.82 -47.74 73.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -58.79 -43.54 90.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.809 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.85 -46.23 89.94 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.379 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.67 -26.11 64.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.254 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.0 m -88.14 6.7 35.25 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.483 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -62.65 125.1 22.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.617 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.66 10.67 83.08 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.961 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.1 150.74 35.62 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.12 0.486 . . . . 0.0 112.221 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.1 p -98.91 148.75 34.99 Favored Pre-proline 0 C--O 1.216 -0.677 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.694 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -45.08 -36.63 11.94 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 121.577 1.518 . . . . 0.0 112.923 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -69.74 -64.55 0.86 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.792 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.504 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -59.69 -37.37 78.63 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 122.378 1.085 . . . . 0.0 108.565 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 52' ' ' LEU . 56.2 tp -61.78 -46.81 87.97 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.243 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -59.19 -38.59 80.2 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 84.9 m -60.38 -40.12 89.74 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.045 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.72 -48.4 81.27 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.274 -0.97 . . . . 0.0 110.046 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.84 -41.46 95.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.229 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.49 -37.74 84.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.14 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.3 m -65.22 -34.81 79.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.327 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.5 t -55.34 151.3 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.44 -144.51 4.49 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.69 -127.65 45.74 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 119.926 -1.131 . . . . 0.0 110.545 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.473 ' CD2' ' HB1' ' A' ' 31' ' ' ALA . 22.3 p80 -54.26 -11.12 0.45 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.636 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -43.57 -24.36 0.11 Allowed 'General case' 0 C--O 1.234 0.286 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.33 -44.09 68.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.23 -40.58 97.86 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.781 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 58.0 ttm -56.14 -22.39 28.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.397 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -57.04 -35.06 68.86 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 63.3 ttp -56.71 -46.9 80.99 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 tt -58.38 -38.31 77.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -55.68 -42.58 75.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.73 -40.19 88.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.699 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.656 HG22 ' OE2' ' A' ' 76' ' ' GLU . 99.9 m -57.75 -45.59 85.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.99 -41.57 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.093 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -59.96 -41.82 92.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.399 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.34 -47.3 86.52 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.235 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.656 ' OE2' HG22 ' A' ' 72' ' ' THR . 1.3 mp0 -62.74 -37.24 85.82 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.428 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.44 -42.38 91.81 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.223 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.91 -51.58 57.44 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.88 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.53 -43.23 94.67 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.592 0.71 . . . . 0.0 110.203 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.594 ' CZ2' HD13 ' A' ' 104' ' ' ILE . 66.7 t90 -60.77 -50.52 73.14 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.955 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -58.42 -37.68 75.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.621 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 80.1 ttt180 -63.14 -43.68 97.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.096 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 88' ' ' ALA . 84.2 mt -111.5 -36.42 5.52 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -176.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.17 -58.06 15.67 Favored Pre-proline 0 N--CA 1.47 0.556 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -176.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -52.78 157.42 7.7 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 120.994 1.129 . . . . 0.0 110.983 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.498 HG12 ' CD2' ' A' ' 87' ' ' HIS . 19.6 t -44.98 145.77 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.251 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.554 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 92.2 m-70 53.85 36.47 24.19 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 82' ' ' ARG . . . 77.31 -55.34 0.54 Allowed 'General case' 0 C--O 1.241 0.608 0 O-C-N 124.026 0.829 . . . . 0.0 108.976 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.67 -66.9 0.06 OUTLIER Glycine 0 CA--C 1.54 1.615 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.86 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.23 140.17 26.36 Favored 'Trans proline' 0 N--CA 1.512 2.592 0 C-N-CA 123.813 3.009 . . . . 0.0 114.617 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 98' ' ' GLU . 78.6 mt -117.74 129.66 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 114.431 -1.258 . . . . 0.0 110.148 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.52 140.28 84.44 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.348 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.95 163.83 29.59 Favored 'Trans proline' 0 N--CA 1.514 2.698 0 C-N-CA 122.953 2.436 . . . . 0.0 114.268 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 93.09 5.47 63.96 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.768 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -126.75 167.79 15.28 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.948 0.374 . . . . 0.0 111.267 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 66.2 mtt -69.3 154.35 42.18 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.205 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -51.76 112.15 0.72 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.591 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.539 ' HB2' HD13 ' A' ' 91' ' ' ILE . 80.9 mm-40 -88.9 155.35 50.06 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.468 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -39.99 103.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.136 0 C-N-CA 122.477 2.118 . . . . 0.0 114.386 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.413 ' H ' ' HB2' ' A' ' 103' ' ' ASP . 69.4 ttt180 -99.05 158.45 15.65 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.571 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -54.99 -52.7 44.99 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.772 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.445 ' HB3' HG23 ' A' ' 108' ' ' THR . 66.8 m -63.46 -36.63 84.38 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 117.553 0.676 . . . . 0.0 109.701 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 100' ' ' ARG . 94.8 m-20 -59.31 -38.75 81.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.022 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.594 HD13 ' CZ2' ' A' ' 80' ' ' TRP . 4.4 tp -58.23 -30.82 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 119.487 -0.885 . . . . 0.0 108.938 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.28 -20.53 37.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.158 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.97 -0.97 89.44 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.2 p -63.95 -25.89 68.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.445 HG23 ' HB3' ' A' ' 102' ' ' SER . 20.5 p -117.13 4.46 12.7 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.146 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.8 t -110.75 130.26 55.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.532 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.6 p -74.82 164.37 26.64 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.422 HD21 ' CD2' ' A' ' 12' ' ' HIS . 66.5 tp -59.38 -46.66 88.03 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.48 -41.78 94.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 117' ' ' TRP . 54.2 tp10 -61.51 -46.34 90.39 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.882 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -61.66 -43.21 99.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.398 0.436 . . . . 0.0 111.289 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.8 tt -66.03 -44.07 92.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.048 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.76 -42.37 79.66 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.416 ' CB ' ' O ' ' A' ' 113' ' ' GLU . 12.4 t90 -58.49 -45.77 88.04 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.165 -1.018 . . . . 0.0 109.275 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.527 ' SD ' HD11 ' A' ' 2' ' ' ILE . 27.9 ttt -72.5 -41.91 65.44 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.582 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.421 HG21 ' SD ' ' A' ' 10' ' ' MET . 66.6 p -125.32 -24.85 3.88 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -58.81 -49.06 79.09 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 118.317 -1.353 . . . . 0.0 109.324 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.18 179.52 1.86 Allowed Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.91 135.5 36.11 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 N-CA-C 108.66 -1.323 . . . . 0.0 108.66 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -35.84 114.74 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.866 2.378 . . . . 0.0 113.5 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mm -106.88 109.04 62.89 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 72.8 Cg_endo -75.47 57.75 4.96 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.951 1.767 . . . . 0.0 112.872 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 127' ' ' GLY . 28.4 m -58.78 -43.28 87.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 126' ' ' VAL . . . -64.09 -42.49 98.09 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.442 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 125' ' ' PRO . 88.8 tt0 -63.21 -45.15 93.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.322 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 89.0 mt -63.47 -49.47 82.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.05 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.661 ' CE2' HD11 ' A' ' 134' ' ' ILE . 86.8 t80 -59.3 -48.2 82.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.219 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.426 ' HA ' HD12 ' A' ' 134' ' ' ILE . 40.6 ttmt -61.17 -40.43 93.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.687 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -57.41 -43.08 83.44 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.589 ' CH2' HG21 ' A' ' 104' ' ' ILE . 46.3 m0 -60.8 -44.63 96.59 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.04 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.661 HD11 ' CE2' ' A' ' 130' ' ' TYR . 84.7 mt -58.52 -43.86 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.286 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.99 -41.69 87.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.759 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.63 -45.49 86.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.308 0.575 . . . . 0.0 110.044 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.74 -43.1 98.15 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.16 -36.79 84.81 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -58.67 -45.28 89.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.81 -39.69 94.85 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.494 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.1 mm -61.1 -49.97 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.9 m -58.09 -36.81 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.2 ttm105 -65.51 -38.67 90.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.803 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -60.58 -46.36 90.53 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -67.78 -25.49 65.63 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.73 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.3 t -43.78 111.93 1.22 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.972 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.74 -21.43 7.12 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.96 1.773 . . . . 0.0 113.761 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 70.8 p -138.18 167.57 21.56 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 66.1 m -107.18 149.47 27.67 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.949 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.534 ' HA ' HD12 ' A' ' 153' ' ' ILE . 5.1 tp -48.98 -36.54 8.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.589 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.1 tp -66.76 -39.62 87.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.43 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.61 -12.37 57.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.609 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 150' ' ' ILE . 90.1 mt -79.45 123.33 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.411 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -152.5 154.95 36.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.077 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -81.95 119.79 24.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.321 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -74.13 160.92 53.59 Favored Glycine 0 CA--C 1.54 1.605 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.539 ' O ' ' HB2' ' A' ' 228' ' ' ALA . 72.7 Cg_exo -51.92 -38.0 67.84 Favored 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 123.181 2.588 . . . . 0.0 112.844 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -112.68 20.67 16.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.043 0.449 . . . . 0.0 109.801 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -82.65 115.41 58.17 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.398 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 225' ' ' GLY . 29.8 Cg_exo -62.36 143.09 93.15 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.15 1.9 . . . . 0.0 111.218 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -57.44 -33.47 67.96 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.484 ' N ' ' HA ' ' A' ' 224' ' ' PRO . 58.9 ttp180 -61.32 -45.91 92.49 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -60.29 -45.35 93.67 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -61.74 -50.57 71.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.341 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.7 -46.75 95.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.421 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -61.57 -51.97 66.36 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.203 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -63.05 -43.69 97.94 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.048 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.572 ' CE2' HG23 ' A' ' 186' ' ' THR . 85.5 t80 -58.55 -48.11 81.97 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.559 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -63.36 -37.33 86.87 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.625 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -59.42 -48.67 80.77 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.534 ' CB ' HD11 ' A' ' 153' ' ' ILE . 95.4 m -66.28 -39.5 89.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.442 HD12 ' CE2' ' A' ' 168' ' ' PHE . 7.7 tt -55.89 -37.81 69.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.137 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.9 ttt-85 -64.64 -38.36 90.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.049 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.74 -10.71 57.93 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.115 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -49.37 168.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.816 0.817 . . . . 0.0 112.433 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -98.75 -92.84 0.26 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.407 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.419 ' HB1' ' HB ' ' A' ' 181' ' ' VAL . . . -44.3 146.53 0.66 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.75 0.786 . . . . 0.0 112.042 -177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 70.3 m -65.76 169.23 6.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.525 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -47.33 -23.56 0.6 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.801 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.82 -46.93 81.35 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 118.578 -1.249 . . . . 0.0 107.906 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.419 ' HB ' ' HB1' ' A' ' 177' ' ' ALA . 25.3 t -89.82 -51.61 11.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 122.017 0.913 . . . . 0.0 110.19 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -57.42 -46.37 83.59 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.427 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -60.88 -41.7 96.49 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.279 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -60.98 -45.9 92.92 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.828 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 61.9 mtt -61.98 -41.6 98.21 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.204 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.572 HG23 ' CE2' ' A' ' 168' ' ' PHE . 61.1 m -60.0 -43.5 95.14 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.855 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -57.92 -48.33 80.2 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.694 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 77.5 p -72.08 -43.55 64.65 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.833 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.2 mp -66.93 -31.29 71.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.344 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.411 HD21 ' SD ' ' A' ' 214' ' ' MET . 68.3 tp -51.82 -49.28 63.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.08 -45.18 18.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.89 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -59.11 -48.84 80.14 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -70.12 -24.93 63.27 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.66 145.27 54.97 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.556 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . 0.47 ' ND2' ' HB1' ' A' ' 228' ' ' ALA . 4.9 m-20 -59.48 143.53 85.78 Favored Pre-proline 0 C--N 1.346 0.447 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.487 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.46 -44.33 47.83 Favored 'Trans proline' 0 N--CA 1.504 2.131 0 C-N-CA 122.786 2.324 . . . . 0.0 115.477 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.38 -46.41 90.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 118.766 -1.173 . . . . 0.0 110.437 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 42.5 t -66.16 -43.13 87.84 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -49.62 -27.27 4.38 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.74 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 91.1 m -59.65 -49.35 78.09 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 119.602 -0.839 . . . . 0.0 108.778 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 4.5 tp -77.3 -38.37 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.746 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.425 HD22 ' SG ' ' A' ' 218' ' ' CYS . 0.1 OUTLIER -54.42 -44.11 72.12 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.03 -38.08 89.7 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.732 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -55.47 -37.69 68.12 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.966 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.31 -35.32 67.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.75 171.33 44.08 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.668 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.06 146.95 97.03 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 123.49 2.794 . . . . 0.0 113.357 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.16 1.28 87.78 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.43 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.749 ' HB3' ' CE ' ' A' ' 214' ' ' MET . . . -64.62 136.02 56.55 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.259 0.552 . . . . 0.0 111.695 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 212' ' ' GLU . 90.4 m -68.83 139.29 55.21 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 66.0 tp -57.03 -44.12 82.59 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.246 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.444 ' H ' HG22 ' A' ' 210' ' ' THR . 88.7 tt0 -58.2 -45.38 87.69 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -58.69 -42.3 88.23 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.749 ' CE ' ' HB3' ' A' ' 209' ' ' ALA . 60.5 mtt -63.51 -43.84 96.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.944 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 60.3 ttm -62.16 -50.11 73.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.52 0.676 . . . . 0.0 110.162 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 98.2 m -64.75 -45.43 86.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.064 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.05 79.12 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.109 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.425 ' SG ' HD22 ' A' ' 202' ' ' LEU . 97.8 m -64.69 -36.68 85.07 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.4 ' HA ' ' H ' ' A' ' 223' ' ' GLY . 63.4 tt0 -59.6 -36.76 76.91 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.986 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.73 -42.15 91.03 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.21 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.56 -18.27 6.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 117.179 0.489 . . . . 0.0 111.325 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 128.39 88.03 0.56 Allowed Glycine 0 CA--C 1.528 0.886 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.4 ' H ' ' HA ' ' A' ' 219' ' ' GLN . . . -112.03 -81.36 1.13 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.484 ' HA ' ' N ' ' A' ' 162' ' ' ARG . 96.9 Cg_exo -46.23 -29.25 6.46 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.376 2.05 . . . . 0.0 110.003 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 160' ' ' PRO . . . -99.56 -135.12 8.78 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 1.6 p80 60.07 170.92 0.08 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.472 0.653 . . . . 0.0 111.724 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -90.57 -67.51 0.84 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.139 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 157' ' ' PRO . . . -152.59 16.7 0.6 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.836 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -135.15 158.15 45.08 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.434 0.635 . . . . 0.0 111.873 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 2.9 p -49.22 -26.84 2.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.218 -0.555 0 CA-C-O 117.946 -1.025 . . . . 0.0 111.055 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo . . . . . 0 N--CA 1.482 0.794 0 N-CA-C 109.13 -1.142 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.456 HD11 ' SD ' ' A' ' 118' ' ' MET . 14.1 pt -65.42 113.78 2.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 109.891 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.0 t -126.27 126.71 69.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.187 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -63.58 127.57 31.95 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -83.96 -172.69 4.3 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.52 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.85 -38.04 80.99 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -66.71 -22.9 66.06 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.131 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.69 -7.96 57.95 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -73.21 126.35 29.86 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.985 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.2 mtt -81.56 135.22 35.58 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.005 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.5 m -133.1 134.1 58.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.518 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.414 ' NE2' HD11 ' A' ' 111' ' ' LEU . 62.2 t-80 -57.27 142.23 43.94 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.008 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -144.63 144.21 31.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.746 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.17 143.07 50.65 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.417 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.466 HD12 ' HG ' ' A' ' 20' ' ' LEU . 38.6 pt -61.87 142.42 16.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -61.07 118.68 38.23 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.23 -36.7 78.73 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 N-CA-C 109.734 -0.91 . . . . 0.0 109.734 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -58.44 -48.27 81.25 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.149 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.6 m -61.05 -46.18 91.73 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HG ' HD12 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -48.96 -58.36 5.01 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.843 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -58.35 -39.19 78.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.843 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -61.6 -42.4 98.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.511 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -58.74 -50.68 73.02 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.546 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.3 t -62.74 -42.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.492 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.99 -42.89 91.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.371 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 22' ' ' ALA . 50.8 t -58.74 -44.32 89.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 76.9 t -64.29 -35.95 75.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.772 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -53.7 -46.71 70.83 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.679 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -92.28 -35.14 13.93 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.698 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' O ' HG21 ' A' ' 36' ' ' VAL . 98.9 mttt -121.22 37.84 4.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.778 -176.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 27' ' ' VAL . . . -42.14 -53.62 3.94 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -96.96 -5.93 36.72 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -51.7 138.87 31.31 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.224 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.91 -31.89 46.4 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.392 2.061 . . . . 0.0 112.709 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.04 -18.75 26.44 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.935 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 30' ' ' LYS . 54.1 t -64.82 -42.48 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.925 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.426 ' HB ' ' HD3' ' A' ' 38' ' ' PRO . 6.9 mt -44.86 -60.67 2.84 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.814 -177.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.426 ' HD3' ' HB ' ' A' ' 37' ' ' ILE . 76.9 Cg_exo -53.95 -42.4 67.06 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 CA-C-N 119.985 1.03 . . . . 0.0 111.857 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 98.1 mtp -61.17 -43.41 98.93 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.672 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -56.03 -47.77 77.22 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.9 t -58.6 -44.69 89.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.042 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.77 -44.77 93.71 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.518 0.675 . . . . 0.0 110.114 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.72 -25.12 63.7 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.022 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.4 m -87.04 6.4 32.67 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.612 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.84 125.33 23.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.562 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.41 11.22 76.12 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 116.35 -0.387 . . . . 0.0 112.605 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.52 149.57 40.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.7 p -99.99 148.93 35.5 Favored Pre-proline 0 C--O 1.215 -0.722 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.622 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -45.81 -38.2 17.43 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.543 1.495 . . . . 0.0 113.323 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -70.37 -62.78 1.26 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.649 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.502 ' O ' ' HB ' ' A' ' 54' ' ' THR . 98.6 m-20 -58.15 -36.73 73.43 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 52' ' ' LEU . 56.1 tp -62.12 -45.36 93.8 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -57.91 -37.86 74.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 51' ' ' ASP . 84.8 m -59.47 -41.86 90.73 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.652 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.9 mtt -49.69 -50.08 45.04 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.274 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.09 -42.75 68.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.798 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -60.68 -40.72 93.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.799 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.413 HG23 HG22 ' A' ' 54' ' ' THR . 54.3 p -68.73 -26.53 65.3 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.89 158.54 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.87 -149.72 5.08 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.43 -127.54 45.43 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -51.21 -10.55 0.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.044 -0.578 . . . . 0.0 112.171 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -41.8 -24.34 0.04 OUTLIER 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.68 -42.97 75.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.91 94.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -56.92 -28.04 61.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.471 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -56.38 -35.41 67.69 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.8 ttp -58.07 -44.99 87.83 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.22 -40.71 86.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -54.26 -41.57 68.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.75 -41.53 95.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.7 m -59.28 -42.62 91.67 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.498 HD11 HG12 ' A' ' 134' ' ' ILE . 15.9 mm -60.01 -44.16 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -60.63 -41.87 95.77 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.194 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.71 -45.94 91.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.448 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -63.26 -39.25 94.07 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.23 -41.59 97.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.072 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.4 -50.46 69.76 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.447 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -64.23 -41.52 96.97 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.048 0.928 . . . . 0.0 108.94 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.419 ' O ' ' HD2' ' A' ' 85' ' ' PRO . 78.5 t90 -60.37 -38.84 85.15 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 113.91 -1.496 . . . . 0.0 109.36 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -53.67 -45.33 70.25 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -66.64 -40.62 88.81 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.424 0.63 . . . . 0.0 110.946 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.49 -43.53 69.53 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -113.81 -63.91 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 80' ' ' TRP . 72.4 Cg_exo -53.85 -38.5 85.73 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 CA-C-N 121.24 1.479 . . . . 0.0 111.39 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.8 t -66.6 -12.19 14.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.758 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -49.28 -31.04 8.17 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.17 -10.18 0.38 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.43 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 53.57 -117.0 6.49 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.71 143.94 99.54 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 CA-C-N 119.27 1.535 . . . . 0.0 109.536 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.4 HD12 ' CD ' ' A' ' 98' ' ' GLU . 16.7 tt -130.64 154.01 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.321 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.43 149.36 83.79 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.415 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.79 168.16 25.31 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.785 2.323 . . . . 0.0 113.013 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.02 -4.35 71.22 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.91 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -125.21 159.23 32.09 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.773 0.321 . . . . 0.0 110.67 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 96.2 mmm -62.23 142.94 57.42 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.08 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -60.48 127.12 30.16 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.373 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' CD ' HD12 ' A' ' 91' ' ' ILE . 64.6 mt-10 -70.42 151.18 95.7 Favored Pre-proline 0 C--O 1.237 0.446 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.96 112.95 3.53 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.446 1.431 . . . . 0.0 113.675 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -73.4 171.52 12.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.493 ' O ' HG22 ' A' ' 104' ' ' ILE . . . -54.23 -48.97 61.64 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 119.111 -1.518 . . . . 0.0 109.884 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.493 ' HB3' HG23 ' A' ' 108' ' ' THR . 70.3 m -60.65 -38.04 83.51 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.579 0.704 . . . . 0.0 109.517 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -59.61 -38.74 82.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.592 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.562 HG21 ' CZ3' ' A' ' 133' ' ' TRP . 0.4 OUTLIER -55.55 -31.39 28.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.78 -21.35 26.56 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.276 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.17 -6.93 82.37 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 72.7 p -57.6 -22.82 47.44 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.493 HG23 ' HB3' ' A' ' 102' ' ' SER . 36.1 p -119.55 29.87 7.38 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.632 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.9 m -129.53 135.05 48.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.279 -0.569 . . . . 0.0 112.393 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.2 m -76.86 145.31 38.43 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.414 HD11 ' NE2' ' A' ' 12' ' ' HIS . 6.8 tt -50.03 -45.96 52.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.154 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -62.07 -39.33 92.02 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.065 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.04 -40.36 96.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.289 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.37 -50.18 74.63 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.4 pt -70.67 -24.31 25.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.809 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.07 -65.91 2.65 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.451 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.437 ' C ' ' CD1' ' A' ' 117' ' ' TRP . 2.0 p90 -61.62 -31.44 71.53 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 118.125 -1.43 . . . . 0.0 109.137 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.456 ' SD ' HD11 ' A' ' 2' ' ' ILE . 27.6 ttt -63.59 -45.14 91.75 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.8 m -115.26 -26.7 7.52 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -58.87 -72.61 0.1 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.085 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -73.74 -177.01 0.54 Allowed Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.61 141.6 15.0 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 120.641 1.265 . . . . 0.0 109.459 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -46.16 123.94 6.99 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.671 1.58 . . . . 0.0 113.766 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.429 ' HB ' ' HD1' ' A' ' 117' ' ' TRP . 47.3 mm -114.91 107.97 49.38 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.84 60.13 4.06 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.909 1.739 . . . . 0.0 113.943 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.6 m -51.57 -37.34 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.73 99.67 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.423 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.46 -45.71 89.56 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.472 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 90.2 mt -64.71 -48.67 83.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.569 0.699 . . . . 0.0 110.17 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.699 ' CE2' HD11 ' A' ' 134' ' ' ILE . 84.4 t80 -59.01 -48.98 79.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.021 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.415 ' HA ' HD12 ' A' ' 134' ' ' ILE . 39.1 ttpt -63.02 -39.03 93.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.886 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -57.43 -43.19 83.64 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.562 ' CZ3' HG21 ' A' ' 104' ' ' ILE . 44.1 m0 -62.69 -43.2 99.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.837 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.699 HD11 ' CE2' ' A' ' 130' ' ' TYR . 78.9 mt -58.43 -42.84 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.525 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.03 -41.6 83.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.78 -44.24 93.98 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.26 -42.57 97.36 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.52 -35.7 81.33 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -58.09 -44.51 87.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.67 -37.89 87.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.415 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.2 mm -60.77 -48.32 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.75 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.8 m -59.27 -34.76 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 118.42 -1.312 . . . . 0.0 107.471 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -65.83 -39.18 90.56 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.4 ttt -58.88 -45.44 90.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -74.89 -15.32 60.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.321 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.1 t -49.3 115.67 5.01 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.72 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -84.12 -30.35 0.72 Allowed 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.107 1.871 . . . . 0.0 113.812 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.3 p -138.01 170.94 15.17 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 39.1 t -105.68 148.22 27.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.638 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.654 ' HA ' HD12 ' A' ' 153' ' ' ILE . 5.4 tp -49.46 -38.41 12.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.549 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.7 tp -65.6 -39.33 91.43 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.556 0.693 . . . . 0.0 109.798 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -67.64 0.32 3.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.553 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 150' ' ' ILE . 96.8 mt -100.65 119.0 48.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.025 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -145.93 132.04 19.35 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.8 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -84.41 134.17 34.48 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.407 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -90.86 159.25 26.59 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.82 -41.79 74.89 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.182 1.921 . . . . 0.0 111.867 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -81.2 -17.95 47.86 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.625 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -73.76 138.37 76.85 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.721 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.28 136.19 23.85 Favored 'Trans proline' 0 N--CA 1.512 2.579 0 C-N-CA 123.171 2.58 . . . . 0.0 113.613 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.414 ' HB3' ' HA ' ' A' ' 224' ' ' PRO . 11.8 t80 -61.51 -28.17 69.12 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.401 ' H ' ' HA ' ' A' ' 224' ' ' PRO . 58.9 ttt85 -61.96 -50.94 70.09 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.775 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -64.92 -40.26 94.78 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -59.2 -50.86 72.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.395 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 161' ' ' PHE . 54.5 t -61.76 -43.82 97.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.8 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.68 -59.16 5.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.058 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.44 -40.75 97.59 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.073 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.626 ' HE2' HG23 ' A' ' 186' ' ' THR . 76.0 t80 -57.69 -47.1 83.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -62.5 -41.77 99.05 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.542 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -59.75 -40.29 87.65 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.092 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.595 ' OG1' HD11 ' A' ' 153' ' ' ILE . 93.6 m -62.63 -41.89 99.28 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.58 HD11 ' CE2' ' A' ' 168' ' ' PHE . 82.6 mt -60.69 -39.45 88.51 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -60.36 -40.25 90.11 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.002 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.45 -10.67 57.29 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.077 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -59.18 145.03 44.12 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.524 0.678 . . . . 0.0 112.203 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -70.23 -95.06 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.034 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -44.99 149.91 0.42 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.519 0.676 . . . . 0.0 112.39 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 82.4 p -74.17 179.32 4.52 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.638 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -47.43 -26.0 1.21 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.58 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -51.21 -49.68 60.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.418 HG12 ' CE ' ' A' ' 185' ' ' MET . 47.0 t -89.83 -58.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.775 176.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -42.08 -53.39 3.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.691 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -59.37 -44.11 92.79 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.679 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -60.31 -50.58 73.07 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.648 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.418 ' CE ' HG12 ' A' ' 181' ' ' VAL . 74.0 mtm -62.84 -41.29 99.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.947 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.626 HG23 ' HE2' ' A' ' 168' ' ' PHE . 54.4 m -59.46 -46.05 89.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.148 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.46 -47.05 86.99 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.513 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.3 m -67.49 -49.54 63.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.315 0.579 . . . . 0.0 112.007 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.35 -32.29 73.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.876 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.602 HD21 ' SD ' ' A' ' 214' ' ' MET . 62.9 tp -51.03 -46.36 61.57 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.504 HG22 HD12 ' A' ' 202' ' ' LEU . 85.2 t -85.79 -46.16 16.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.028 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -60.31 -49.44 77.61 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -70.37 -22.55 62.76 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.705 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.74 153.75 10.16 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.621 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -68.99 148.5 97.89 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.74 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.23 -41.98 67.7 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.377 2.051 . . . . 0.0 114.376 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.63 ' O ' ' HB2' ' A' ' 228' ' ' ALA . 97.8 m-20 -59.62 -50.0 75.56 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.447 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 228' ' ' ALA . 10.5 t -70.0 -37.77 75.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -47.11 -26.89 1.21 Allowed 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.092 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 69.0 p -62.49 -55.06 31.11 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.421 -1.312 . . . . 0.0 108.455 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 204' ' ' ALA . 40.0 mm -65.07 -45.66 93.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.154 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.504 HD12 HG22 ' A' ' 191' ' ' VAL . 0.1 OUTLIER -54.82 -51.5 65.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.057 0.932 . . . . 0.0 108.834 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.31 -36.55 78.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 201' ' ' ILE . . . -59.0 -39.71 82.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.747 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -57.46 -44.38 84.74 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 119.421 -0.911 . . . . 0.0 108.713 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 79.43 175.57 47.66 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.085 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.73 150.95 79.98 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 124.011 3.141 . . . . 0.0 113.38 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 81.06 0.27 88.54 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -69.6 119.2 13.48 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.178 0.513 . . . . 0.0 110.382 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 212' ' ' GLU . 94.2 m -61.07 139.36 58.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 68.1 tp -54.82 -46.08 74.5 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.604 -0.838 . . . . 0.0 108.873 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.401 ' H ' HG22 ' A' ' 210' ' ' THR . 80.8 tt0 -55.41 -48.11 74.88 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.482 0.658 . . . . 0.0 109.332 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -57.76 -42.47 84.06 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.602 ' SD ' HD21 ' A' ' 190' ' ' LEU . 58.9 ttm -63.01 -45.72 91.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.75 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 61.8 tpp -61.99 -45.64 92.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.9 m -62.54 -49.75 74.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.74 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.72 95.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.708 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 78.3 m -61.02 -40.81 94.99 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.67 -40.85 97.86 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.087 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.12 97.92 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 23.9 m -82.59 -23.61 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.675 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 104.57 14.28 24.0 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.844 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -58.65 -45.69 94.35 Favored Glycine 0 CA--C 1.545 1.943 0 CA-C-O 119.689 -0.506 . . . . 0.0 112.474 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.414 ' HA ' ' HB3' ' A' ' 161' ' ' PHE . 50.6 Cg_exo -55.64 -17.86 18.81 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.11 1.873 . . . . 0.0 111.989 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -90.56 -49.73 3.12 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 123.595 0.56 . . . . 0.0 112.093 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -152.69 -51.95 0.11 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 122.402 -0.47 . . . . 0.0 110.961 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -165.65 -175.57 3.55 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.467 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 197' ' ' ASP . . . -32.45 -81.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.335 1.022 . . . . 0.0 111.531 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.47 152.68 37.75 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.943 0.401 . . . . 0.0 110.714 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 9.9 p -51.93 -27.99 9.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.797 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.35 179.425 . . . . . . . . 1 1 . 1 stop_ save_